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FOREWORD 
Biotechnology in general and genetic engineering in particular have been among the 
most controversially discussed modern technologies for decades. They are regarded as 
an important key to increasing economic competition on the one hand, but provoke 
concerns about health, safety and environmental issues on the other. The public 
perceptions of biomedical applications and of applications in agriculture and food 
production have clearly diverged. While there has been growing acceptance of medical 
applications, the public’s rejection of genetically modified (GM) foods persists in 
many countries. Particularly in Europe, agricultural GM technology is still being 
contested. For over two decades, the proponents and opponents of GM have not 
succeeded in finding a common ground despite major efforts invested in conducting 
numerous projects, in organising dialogues and in developing and implementing 
elaborated regulatory tools. 
Problems arose at different levels: in European Union (EU) Member States as well as 
within and among EU institutions. GM crops and food policy ran into troubles. For 
example, the coexistence of GM crops with conventional and organic crops, as well as 
the labelling and tracing of GM food products are topics of ongoing discussion. 
Repeatedly, there have been regulatory impasses over the approval of particular crop 
varieties. At a global level, there have been trade conflicts over GM products in recent 
years. Today, the future of GM crops in Europe is as unclear as ever. In contrast to the 
development and use of GM plants and foods in the United States and other countries, 
the cultivation of GM crops in Europe is very limited. 
However, in spite of the apparent lack of change regarding this situation, it is possible 
to identify some movement and various changes which will lead to new challenges to 
European policies as well as to intensified public debate. Apart from past and present 
regulatory conflicts, important technological developments and far-reaching shifts in 
framework conditions have recently taken place which will considerably influence 
future debates: 
> Novel varieties of crops with new traits are about to enter the regulatory approval 
procedures. A new generation of GM crops, capable of producing medicine and 
industrial chemicals, for example, is emerging. 
> The demand for agricultural products has changed to include more energy crops. 
Market conditions for agricultural products have turned out to be highly volatile and 
are increasingly linked to the energy markets. 
> Environmental challenges and the requirements of sustainable development have 
altered the conditions for agriculture in many places. 
The question today is whether and how all this will translate into new challenges to the 
governance of GM technology in Europe. Can we expect old impasses to vanish or 
new ones to arise? Can we identify indications for change, and if so, in which 
direction? What could be tomorrow's issues in the GM debate in Europe? What could 
be done in order to prepare policy makers and the European public for these newly 
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emerging questions? These questions formed the main motivation to initiate and 
conduct the joint EPTA (European Parliamentary Technology Assessment) project 
"Genetically Modified Plants and Foods". 
GM crops and foods have been a major topic for the EPTA (www.eptanetwork.org) 
members and associates. Building on their wealth of experience in the field of 
Technology Assessment (TA) on GM issues, the following eight members of EPTA 
have come together to identify the developments and challenges ahead: 
> Centre for Technology Assessment (TA-SWISS – Switzerland) 
> Danish Board of Technology (DBT – Denmark) 
> Institute Society and Technology (I.S.T. – Flanders) (the former Flemish Institute 
for Science and Technology Assessment – viWTA) 
> Institute for Technology Assessment (ITA – Austria) 
> Norwegian Board of Technology (NBT – Norway), together with the Norwegian 
Biotechnology Advisory Board 
> Office of Technology Assessment at the German Parliament (TAB – Germany) 
(project co-ordinator) 
> Parliamentary Office of Science and Technology (POST – United Kingdom) 
> Scientific Technology Options Assessment (STOA – European Parliament) 
The final report of the project "Genetically Modified Plants and Foods" departs from 
the results of a considerable number of TA and TA-inspired projects in the past. 
Specific perspectives and positions from different countries, extracted from 
parliamentarian and other TA exercises, were brought together and evaluated with 
respect to a pan-European perspective. On the basis of this review, the joint EPTA 
project concentrated on new questions and possible new answers by identifying future 
challenges rather than by attempting to simply establish a mainstream view on 
contested issues of the past. Thus, the project applied a forward approach to the GM 
plants and foods field creating added value to existing work. The main conclusions of 
the joined effort are on 
> The regulatory challenges for the European system in the upcoming years, 
> Issues of a possible public debate in the future, 
> Approaches for TA to handle the future issues. 
As its main results, the final report includes a picture of the current state of affairs in 
the GM field, identifications of challenges ahead as well as some hints at possible 
paths to take in the future. These results are focused on conclusions rather than on 
policy recommendations. The conclusions address the European level and take into 
account new developments in the fields of technology and regulation. We hope that 
this report will be helpful in clarifying relevant issues of the next phase of the 
European GM debate, and that it will find its way to the European audience and 
beyond. 
Armin Grunwald, Head of TAB 
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EXECUTIVE SUMMARY 1. 
GM plants and their role in European agriculture as well as in the regulatory system 
and in society at large have long been controversial issues. In addition, recent 
developments with respect to new technologies, expanding international trade and the 
increasing demand for food and fuel have changed the general framework. The 
question is whether these developments challenge the established way in which GM 
plants and food have been dealt with in Europe so far. 
Reviews of reports from EPTA member organisations on various aspects of GM plant 
application, their regulation and associated problems rendered a list of developments 
and consequently possible challenges to European policy on GM plants. Proceeding 
from this list of challenges, a questionnaire was developed, and 183 experts involved 
in the development, assessment and policy making on GM plants in Europe were 
invited to respond. These experts, 71 of whom completed the questionnaire, come 
from Austria, Belgium, Denmark, Finland, Germany, Norway, Switzerland and the 
United Kingdom. The questionnaire results and the experts’ comments were analysed 
in the light of the results of the EPTA members’ reports.  
All in all, the regulatory system for GM plants and food in Europe does not seem to be 
fully prepared to meet all existing and foreseeable future challenges. Five key areas of 
challenges for the European system of GMO regulation in the years to come were 
identified, as were a number of possible approaches for future technology assessment 
activities. 
CHALLENGE 1: NEW DRIVING FORCES FOR GM PLANT 
INTRODUCTION 
Altogether, more factors were identified that encourage rather than discourage the 
introduction of GM crops, in particular the increasing use of and demand for bioenergy 
and biomass. This is a major difference to debates in the past. GM plants for non-food 
uses can be attractive to farmers. Further, such products may also find more demand 
from consumers, or at least be less prone to be avoided by sceptics as their GM origin 
is more obscure.  
A decisive issue for the future cultivation of GM crops in Europe is the question of 
which aims agriculture is expected to fulfil. Sustainability is expected to be given 
strong weight, more particularly input and impact reduction while ensuring high 
product quality.  
Area of action: The future of GM plants and food in Europe is not only determined by 
negotiations over regulatory details, it is also a question as to which kind of sustainable 
agriculture will be developed in Europe in the light of different, and sometimes 
conflicting, sustainability goals. A broad societal dialogue on future sustainable 
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European agriculture in a global context is, therefore, needed in order to determine the 
future role of GM plants and food.  
CHALLENGE 2: NOVEL GM PLANTS, TECHNOLOGIES AND 
APPLICATIONS 
Several classes of novel GM crops are currently under development. These include 
both crops for food uses, for instance crops with improved nutritional value, and crops 
for non-food uses such as energy, plastics or pharmaceuticals. A majority of the 
experts consulted think that a variety of such crops will be available and authorised for 
cultivation in Europe within the next 10 years. Such novel GM plants, especially those 
for the non-food sector, could pose regulatory challenges. In the case of plant-made 
pharmaceuticals, different approval procedures might have to be reconciled.  
In general, discussions over criteria and procedures for risk assessment/management, 
may be ongoing in the future. At the same time, the potential risks from outgrowing or 
gene flow from non-food crops might pose additional problems for coexistence. On the 
other hand, crops developed to provide benefits in terms of health and food quality 
factors (e.g. nutritional enhancement) are also expected to appear, which may 
encourage public acceptance and consumer demand. This ambivalence is also mirrored 
in the discussion of whether benefits should be included in assessment procedures. 
While the proponents of GM technology may hope that such a measure could 
overcome public rejection, opponents claim that uncertainties are not tolerable in the 
absence of clear public benefit.  
While understanding risks is expected to remain an important priority for European 
public research in the future, experts also expect resources for the development of new 
crops. Novel technologies such as smart breeding and cisgenics are regarded as 
important for plant breeding in general, but not as an alternative that could replace 
GM. However, they may blur the distinction between GM and non-GM plants. 
Area of action: As is true for every field of technology, research policy is an important 
area of action. Crop development may again come to the forefront of public research. 
To make good use of any money that becomes available in this context, it would be 
necessary to assess not only the technical performance of newly developed plants but 
also the chances of these plants to meet societal goals. Concerning GM regulation, 
non-food GM plants might render an ongoing revision of the regulatory framework 
necessary. This pertains to parameters for risk assessment and management, 
confinement, coexistence and liability, as well as to the question of including benefit 
evaluation. 
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CHALLENGE 3: PUBLIC OPINION: STILL A DECISIVE FACTOR 
Public attitudes are considered an important factor influencing both the use of GM 
technology and its development. Concerning future GM non-food products, a majority 
of experts expect public attitudes to become more positive over the next 10–15 years, 
while the level of acceptance of GM food products will remain unchanged. Factors 
considered highly important for consumer acceptance are free consumer choice and a 
high quality of information, as well as consumer benefits and the absence of risk issues 
related to health and the environment. Non-food GM plants may, however, also give 
rise to specific environmental and health concerns. In addition, expectations regarding 
the popularity of biofuels may be overoptimistic considering that they will be 
competing with food. It, therefore, remains unclear whether and how the overall public 
acceptance of GM plants will change. 
Area of action: For the time being, there is little indication of an increase in overall 
acceptance. While it is possible that public perception will change as new consumer-
oriented GM products become available, this cannot be taken for granted. Since public 
attitudes are subject to the influence of many factors, including ethical concerns, 
consumer protection policy is not the only one of relevance. A variety of other fields 
from agricultural policy to GM regulation are also relevant. An early discussion and 
open dialogue concerning the potential opportunities and possible problems can help to 
prevent disappointment on either side. Meeting the expectations regarding the high 
quality of information remains a major challenge. 
CHALLENGE 4: COEXISTENCE AND LABELLING UNDER A 
GROWING USE OF GM PLANTS IN EUROPE AND THE WORLD 
The concept of coexistence can be considered a political answer to the normative 
demand for freedom of choice. However, it also has implications for the (presumably 
descriptive) scientific risk assessment, as the behaviour, and thus risks, of a crop are 
more predictable if volunteering and intermixing can be ruled out. Due to small areas 
and the relatively short time of agricultural cropping, robust experience with the EU 
regulation on coexistence is still some way ahead. For the first generation of GM 
plants, many EPTA member reports and the majority of expert opinions conclude that 
coexistence can work in principle over the next 15 years. But experts are divided on 
many details, for instance whether coexistence will work for certain specific crops or 
for a broad range of them, for small- or large-scale cultivation, and whether all risks 
can be contained through such measures. While a majority expect first-generation GM 
plants to be grown within the next 10 years in Europe, fewer than half of the 
respondents believe this will be the case in their home countries. With regard to 
marketing, half of the respondents think that coexistence and labelling will generally 
work. The rest expect different scenarios such as failure of the labelling regime or the 
blockade of GM food. Taken together, this suggests that the concept of coexistence 
remains a challenge, despite existing regulation and an extensive debate in the past. 
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Area of action: Doubts as to whether coexistence will work may pertain to particular 
items of regulation on the assessment and management of GM plants; however, they 
could also be taken as an indication that the expertise involved or elements of the 
authorisation process are at stake. In particular, independence from the vested interests 
of authorities involved could be better demonstrated by incorporating a broader 
spectrum of scientific opinions and/or representation of interests. Regarding 
authorisation, a recurrent problem seems to be the proper disentanglement of science 
and policy. The requirements for scientific evidence, on the one hand, and room for 
manoeuvre in politics, on the other, do not seem to be sufficiently defined. Likewise, a 
defined remit for political decision-making at the national level would be desirable, for 
example in order to restrict, or promote, the use of GM plants. 
CHALLENGE 5: INTERNATIONAL TRADE RULES AND DOMESTIC 
DECISION-MAKING 
The global increase in acreage covered by GM crops, pending international trade 
conflicts, the development of international regulations, and different approaches to risk 
assessment in various countries have challenged EU policy on GM plants. Regardless 
of the outcome of the recent World Trade Organization (WTO) conflict, most experts 
are convinced that the general principles of the EU regulatory system can be 
maintained. Concurrently, many respondents think that restrictive practices of 
individual EU Member States will have to change, and more harmonisation among 
them will be necessary. 
Area of action: The recent WTO conflict highlights the need to reconcile different 
international agreements in order not to thwart the aims of these agreements. 
Therefore, not only areas specific for GM organisms (GMOs) might be considered to 
be at stake, but also the possible integration of environmental and social standards into 
WTO regulations. Many of the problems encountered at the WTO level are said to 
have derived from different interpretations by member states of the EU regulatory 
framework. Possible solutions would be to give more leeway to national sovereignty 
(subsidiarity) or to increase harmonisation among Member States. A considerable 
number of experts seem to consider further harmonisation and a reform of competent 
authorities/institutions an option for further improving the robustness of the EU 
regulatory system. 
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UPCOMING ISSUES FOR TECHNOLOGY ASSESSMENT 
Agricultural biotechnology has been one of the most prominent technological fields 
TA has dealt with, and this will probably continue to be the case in the future. Four 
developments call for further interest and novel approaches. 
> Technological developments extending the use of GM plants include energy plants, 
plants for nutritionally enhanced products, or plants for producing pharmaceutically 
active substances. In addition, crops with enhanced agricultural traits such as 
drought resistance could have enhanced survival capabilities and improved yield. 
Under environmental conditions of climatic change they might pose novel 
challenges for risk assessment.  
> Changed general conditions for agriculture challenge established practices and 
aims, as shown by the example of fuel production from staple crops, and the 
increasing demand in food.  
> Institutions and levels of decision-making are under continuous debate, for instance 
regarding the room left for national manoeuvre. A rising issue is the repercussion of 
international agreements, and of globalised trade in food and feed. 
> Public attitudes towards GM plants and food may change in the future, which could 
have an impact on future political decisions. In the past, many factors not 
immediately related to GM technology as such but to broader social and cultural 
issues have been shown, or suspected, to influence public perception. In addition, 
with a larger number of Member States the diversity of the European landscape of 
public perceptions might even increase. 
TA is required to help clarify available or requested technological solutions and their 
societal implications. TA should provide an improved understanding of social and 
cultural factors influencing these technological developments, their embedding into 
society, and the ways implications such as risks and benefits are perceived. Efforts 
should be taken to involve experts, stakeholders and citizens in dialogues about new 
developments. The development of novel forms of negotiation aimed at opening up 
new communication channels for actors who find it hard to speak to each other 
remains a task for TA. 
Despite past extensive investigations, there is no doubt that the issue of GM plants will 
remain on the TA agenda. As different TA organisations dispose of different expertise 
and experience regarding approaches, transnational cooperation remains an attractive 
option. 
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BACKGROUND, CONTEXT AND AIMS OF 
THE PROJECT 2. 
Biotechnology, and especially genetic engineering, has long been one of the most 
controversial modern technologies. On the one hand, it is seen as an important key to 
increasing economic competition and a source of innovation with a high potential for 
solving agricultural and environmental problems. On the other hand, it raises concerns 
about health and safety issues as well as ecological impacts and provokes certain 
ethical and moral objections.  
The first GMO was produced in 1973. Over the past three and a half decades, great 
progress has been made in modern biotechnology. Today, it plays an important role in 
medicine and in agriculture. However, favourable public perception of biomedical 
applications has significantly and lastingly diverged from the perception of agrifood 
biotechnology. Extensive surveys such as the Eurobarometer have repeatedly shown 
that on average in the EU, public perception of GM plants is hardly positive at all, 
while that of GM food has long been, and still remains, decidedly negative, although 
there are significant differences between EU Member States.  
This goes well with the observation that over the past 15 years, heated debates have 
taken place in many European countries among decision makers, experts and 
stakeholders about GM plants and foods.  
While the proponents of GM plants argue in favour of the environmental benefits of 
GM crops (fewer fertilisers, fewer pesticides, less tillage) and on higher productivity 
perspectives, the opponents put more emphasis on health and environmental risks, as 
well as factors such as naturalness and the integrity of nature. An additional point of 
criticism is the ownership of seeds and the power of multi-national companies. 
Confronted with these opposing claims, consumers may have difficulties in seeing 
clear benefits for themselves and/or society at large (at least with regard to so-called 
first-generation GM food products, see below), which may have contributed to the 
general scepticism towards GM crops observed in surveys on public perception. This 
scepticism is claimed to have influenced EU regulation on GM plants – often regarded 
as restrictive compared to its US counterpart.  
Whether a sceptical public is the “cause” and a restrictive policy the “effect” remains 
hypothetical. There are, however, various dimensions of public perception that often 
become condensed in the debate: Citizens may be concerned about the long-term 
impact on the environment or yield, for example, especially for farmers in developing 
countries. Citizens as political subjects may entertain general concerns about power 
relations, values and the way our lives should be organised. Citizens as consumers may 
follow different rationales, guided mainly by individual benefit and risk calculations. 
These are all politically relevant but rely on, and are susceptible to, different lines of 
argumentation. It is not always clear which of these takes the lead in a public debate. 
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Therefore, when considering the future of GM plants and food in Europe and reflecting 
on the way this debate could evolve, it is necessary to take all dimensions into account. 
More specifically, it is necessary to consider whether GM technology will find a more 
positive response from the European public or not, and whether or not consumers will 
remain sceptical about GM crops and products. 
The multitude of factors involved and arguments raised have made it difficult to devise 
a policy on GM plants and food that would be acceptable to the majority of the 
European public and suit the interests of industry and various sectors of agriculture as 
well. In response to public concerns on the one hand, and to regulatory difficulties and 
delayed decision-making at the European level on the other, the European Directive on 
deliberate releases (2001/18/EC) and other relevant EU regulations have put a new 
framework for GM crops and food in the EU into force. This framework puts more 
emphasis on the precautionary principle, specifies the criteria for risk assessment, 
stipulates a general and a case-specific post-market monitoring, and introduces a time 
limit for authorisations as well as a mandatory follow-up evaluation. In addition, the 
labelling regime has been changed. 
In the first instance, the regulations focus on GM crops commercialised for fodder and 
for human consumption. In order to secure the coexistence of GM crops with 
conventional and organic crops and food products, proper labelling and traceability of 
GM food products have become major topics of concern and ongoing discussion. 
Taken together, the regulatory framework for GM crops, feed and food has developed 
comprehensively. It was not until recently, however, that a number of new applications 
for GM product approvals were issued, so that it is still unclear how functional the 
regulatory framework really is. First experience revealed that some regulatory 
problems that were supposed to have been solved in fact still exist. It remains to be 
seen whether the EU regulation will prove capable of fulfilling expectations in daily 
practice. 
While the regulatory framework is currently being put to the test with the first 
generation of GM crops, technical development has not come to a halt. New varieties 
with new properties are about to be launched and may enter the authorisation pipeline. 
In this context, it has been claimed that public perception could change due to new 
properties of GM products that carry consumer benefits. Further, an increase in 
demand and prices seems to call for more productivity in agriculture, which could also 
favour GM approaches.  
Finally, the WTO ruling in 2006 has been interpreted as putting pressure on the 
regulatory approach in Europe. It highlighted different interpretations on both sides of 
the Atlantic with respect to the necessary level of evidence for possible risks that had 
caused tensions for considerable time without having been finally resolved. 
These developments, amongst others, may lead to new debates, entail challenges for 
the European regulatory system and give rise to new tasks for TA. In order to discover 
more about future challenges, we devised a project that builds on the combined 
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experience of eight major European TA institutions. In recent years, these institutions 
have contributed to the debates on the impacts and the prospects of GM plants. They 
have carried out a considerable number of projects on issues related to GM plants and 
food, including consensus conferences, expert surveys, or scientific assessments. The 
ensuing reports have flagged up many agricultural, technological, economical and 
political developments that could turn out to be challenging for the EU regulation on 
GM crops, feed and food. The present work under the umbrella of EPTA aims to make 
use of the many insights gained during these projects and of the different expertises of 
the colleagues involved. Although they give some consideration to developments at the 
European level, national TA institutions generally direct their efforts at national issues 
and the needs of national parliaments in the first place. However, we think that 
collectively we will be able to acquire a more comprehensive view and thus arrive at 
more substantiated general conclusions. 
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APPROACH 3. 
Eight EPTA members and associates met to conduct the joint EPTA project 
“Genetically modified plants and foods”. These were: 
> Centre for Technology Assessment (TA-SWISS – Switzerland) 
> Danish Board of Technology (DBT – Denmark) 
> Institute Society and Technology (I.S.T. – Flanders) (the former Flemish Institute 
for Science and Technology Assessment – viWTA) 
> Institute for Technology Assessment (ITA – Austria) 
> Norwegian Board of Technology (NBT – Norway), together with the Norwegian 
Biotechnology Advisory Board 
> Office of Technology Assessment at the German Parliament (TAB – Germany) 
(project co-ordinator) 
> Parliamentary Office of Science and Technology (POST – United Kingdom) 
> Scientific Technology Options Assessment (STOA – European Parliament) 
The EPTA Council approved the joint EPTA project and its approach on 17th October 
2006. A Project Manager Group with researchers from all participating EPTA 
members and associates organised and carried out the project work. The project’s 
objectives were to provide information on the following: 
> Regulatory challenges for the European system in the years to come, 
> Points of public debate in the future, 
> Approaches for TA to handle the issues identified. 
In addition to using the collected knowledge and expertise of the participating TA 
institutions in order to identify relevant future topics, the project combined a look back 
into the past – by means of reviewing recent TA projects – with a view to the future 
through an experts’ survey.  
IDENTIFICATION OF ISSUES 
All researchers participating in the project had been involved previously in at least one 
or, as a rule, several TA projects on issues related to GM plants. Therefore, we could 
assume that the combined expertise of all participants would cover a wide variety of 
topics previously addressed in national TA reports. The overall perspective, however, 
was set by the central question as to whether or not EU regulation is fully adequate to 
meet new challenges. 
In a series of brainstorming sessions among the group of researchers (Project Manager 
Group), several issues were identified that merit further investigation. These sessions 
took place during the initial project meetings, and the results were further discussed via 
electronic communication.  
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REVIEW AND DISCUSSION OF RESULTS FROM PAST TA 
PROJECTS 
The aim of the review exercise was to make use of previous TA project reports on 
questions pertaining to GM plants (including food and feed issues as well as non-food 
plants) in order to put together different pieces of knowledge from various 
perspectives. This served to learn more about the developments that gave rise to the 
present situation, and to identify questions that might still be relevant for the future. 
Apart from constituting an independent source of information, the reports also flagged 
up topics that could be investigated further through the following experts’ survey.  
Before starting the review process, the Project Manager Group developed common 
criteria for the selection of projects and a checklist for the reviews. Selection criteria 
were: 
> The project was executed by an EPTA member, an associate member or a national 
or domestic TA institution. 
> The project used an interdisciplinary or multi-dimensional approach. 
> The project included recommendations, options and/or needs for action. 
Additionally, one of the following criteria had to be fulfilled in order to restrict the 
sample to relevant and important reports: 
> The project results served to back up a political decision. 
> The project was an important participatory event or exercise at a national or 
regional level. 
> The project and its results were highly visible and played a role in public debate. 
In addition, we aimed at a broad variety of approaches, such as expert opinions and 
reviews of scientific findings, reports from expert committees or from hearings, 
stakeholder discourses and projects involving lay people such as consensus 
conferences and citizens’ juries. All participating institutions reviewed a number of 
project reports from their own country (and one each from France and Finland) and 
drafted short summaries. In general, the reviews follow a common scheme:  
> Background;  
> Basic data about the project; 
> Major outcomes; 
> Impacts and follow-up; 
> Identify major challenges. 
A list of project titles can be found in Annex 2; the full texts of all project reviews are 
available on the project website as Annex 3 
(www.eptanetwork.org/EPTA/projects.php?pid=150). In total, 29 reviews were 
produced. Six reports each came from Austria and Germany, four each from Denmark 
and Switzerland, three each from Belgium (Flanders) and Norway, and one each from 
Finland, France and the United Kingdom. The unequal number of reports from various 
countries may be regarded as having been influenced by the differing measure of 
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attention attracted by the issue in public debate, regulatory action, and work in TA 
institutions. 
The range of projects covered very different topics related to issues of GM plants, as 
well as different TA approaches, in order to gain an overview of the status of the 
debate and of different opinions and standpoints in society. We are, of course, aware 
that from a methodological point of view, it might be difficult to compare results from 
such a variety of different exercises in any systematic way. However, in this step we 
primarily aimed at collecting pertinent issues and relevant views rather than 
performing a systematic comparison. Again, we strived to exploit the combined 
knowledge of the participating institutions generated over recent years on technical and 
regulatory issues and societal debates regarding GM plants and food. 
PRELIMINARY CONCLUSIONS IDENTIFYING POINTS TO 
CONSIDER 
In a next step, the major results of the reviewed projects as they appeared in the 
summaries or recommendations were screened for statements with regard to prospects 
for the future, predicted problems, possible impacts of decisions, and demand for 
future action. These statements were grouped in clusters according to their main point 
of reference. This resulted in three clusters:  
> Technological challenges,  
> Societal challenges, and  
> Regulatory challenges.  
Each group had a number of sub-clusters. These clusters were then condensed in 
several rounds of discussions among project members during the following project 
meetings and served as a basis for preliminary conclusions and points to consider, to 
be further corroborated or challenged by the following experts’ survey. 
EXPERTS’ SURVEY 
The aim of the survey was to collect information and opinions from experts (from a 
wide variety of backgrounds and fields of expertise) on major challenges in the area of 
GM plants and foods as identified in the previous step. 
CHOICE OF EXPERTS 
National experts of the following affiliations were identified by the members of the 
Project Manager Group, respectively, and invited to fill in a questionnaire: 
> Science: Plant breeding, genetics/genome research 
> Science: TA, ecology, society, innovation and policy research 
> Administration: Ministries, competent authorities 
> Industry: Biotech industry (incl. consulting) 
> Industry: Plant breeding 
 17
3.  APPROACH 
> Stakeholder: agriculture, food, retailer, trade unions 
> Stakeholder: environment and consumers 
In total, 183 experts in the field of GM crops and food were invited to participate in the 
questionnaire. The number of experts invited again differed according to country, a 
factor largely depending on the national context. We do not claim that the survey is 
strictly representative –the restricted number of countries represented in the project 
alone would prohibit such a claim. Rather, we tried to cover variety as much as 
possible, with a broad range of expertises and affiliations. 
The experts had different areas of expertise, with a considerable number sharing a 
technical background. The questionnaire we developed (see below) was not tailored to 
tap into a particular area of expertise, but covered a very broad set of issues, including 
societal ones. In other words, all experts would be confronted with issues where they 
had no professional expertise. For example, experts for breeding transgenic crops were 
asked for their views on public perception, an area in which they would not be 
expected to possess any professional expertise.  
The reason we did this was that we considered these experts to have been exposed, 
time and again, to relevant issues outside their professional area, so that they could be 
expected to entertain a well-based opinion. Further, we believe it is interesting in its 
own right to give a picture of current thinking by prominent experts and stakeholders. 
These individuals' perceptions of the future influence their internal strategies and 
decisions, thereby forming an independent driving force for the future of GM plants 
and food. Moreover, they are often asked to give their opinion on regulatory and 
societal issues regarding GM plants, thereby playing an important though informal role 
in determining future policies. Thus, their views may be important in relation to 
legislation and decision-making, even if their knowledge does not derive from any 
immediate professional occupation but from contingent exposure.  
DEVELOPMENT OF THE QUESTIONNAIRE 
The questionnaire was developed on the basis of the points identified for consideration 
in the reviews, with the intention of covering the relevant topics. As this would have 
resulted in a questionnaire that was far too long, the project members chose the most 
relevant topics from their own TA experience. Inevitably, this implied a certain 
amount of deliberate shortening; however, this was necessary in terms of practicality. 
Topics to be taken on board were discussed intensely in several rounds, and a final 
choice made. 
The resulting broad scope of questions, combined with the number of experts we 
wanted to involve, led us to rely on a questionnaire with closed questions. Such a 
methodology is usually adopted for quantitative surveys. However, in this case, it was 
obvious that a strictly quantitative analysis would be hardly feasible, due to the 
relatively low number of respondents. We therefore left ample space for comments and 
thus allowed experts to display more thorough reflections, and thus included elements 
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of a qualitative approach. A first version of the questionnaire was pre-tested with one 
to three experts per participating country. 
The final questionnaire consisted of 15 closed questions (with the option of providing 
explanations or comments) and one open question on areas for further investigation. 
The sections of the questionnaire were: 
I. Factors influencing the future of GM plants in Europe 
I.1 General assessment 
I.2 New GM plants, new applications 
I.3 Public attitude and acceptance 
II. Challenges for European/EU policy 
II.1 Challenges linked to freedom of choice, labelling and coexistence 
II.2 Challenges linked to new generation of GM crops 
II.3 Global aspects of GM regulation 
III. Challenges for research policy 
IV. Areas of action  
The whole questionnaire and the tables of results are documented in Annex 4 and 5, 
available on the project website (www.eptanetwork.org/EPTA/ projects.php?pid=150). 
SURVEY 
The survey was conducted online from mid-November to the end of December 2007. 
Overall, 101 of the 183 invited experts opened the file; 30 of these then decided not to 
fill in the questionnaire; most of them discontinued after reading the introductory page. 
We received a full set of answers from 71 respondents. This gives a response rate of 
39 %. 
The survey was carried out in the home countries of participating institutions’ plus 
Finland. Table 1 shows the distribution of respondents by country. 
TABLE 1: COMPLETED QUESTIONNAIRES BY COUNTRY 
Country Number of participating experts 
Austria 17 
Belgium 6 
Denmark 7 
Finland 3 
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Germany 21 
Norway 8 
Switzerland 5 
United Kingdom 1 
Not assignable 3 
 
In a self-categorisation as part of the questionnaire, the 71 respondents assigned 
themselves to different affiliations (Table 2). Nearly half of the experts ticked the 
category “university/research institute”. 
TABLE 2: COMPLETED QUESTIONNAIRES BY AFFILIATION 
Affiliation Number of participating experts 
University/research institute 34 
Industry 11 
Governmental agency 13 
Agricultural organisation 5 
Environmental or consumer organisation 2 
Other, please specify 6a 
a These 6 respondents described themselves as: ’communication, journalist’, ’environment and 
development organisation’, ’NGO on critical technology assessment’, ’used to work at NGO, 
now consultant’, ’Trade Association Biotechnology’, ’retail. 
When interpreting this figure, one must realise that “science” was not specified and 
therefore included very different sciences. Consequently, plant scientists, sociologists, 
ecologists, bioengineers, philosophers, etc. all ticked this category. Regrettably, the 
participation from representatives of NGOs such as consumer and environmental 
groups was low. Sample controls revealed that some experts assigned themselves to 
universities/research institutes even if they had frequently performed work for NGOs 
or were prominent members. A similar situation might have occurred with scientists 
affiliated to industry. Regardless of the underlying reasons, this bias tends to reduce 
the accuracy of such self-assignment. 
ANALYSIS AND DISCUSSION  
In a final step, the results from different parts of the Project Manager Group 
discussions, project reviews, and experts’ survey were brought together. In the group 
discussions, the material was sorted and divided into chapters, and project members 
joined in “tandems” to perform a first analysis of each chapter. The main points to 
consider were discrepancies between the results of the Project Manager Group 
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discussions and the project reviews, on the one hand, and the experts’ survey on the 
other. The draft analyses were further refined in several rounds of discussions with all 
project members, whereby the original partition was in part revised. On the basis of the 
Project Manager Group discussions, a draft report was written, with one group member 
each responsible for a particular chapter and another one for its review. In a final 
round, conclusions were drafted and discussed among all members. 
The draft report was peer-reviewed by six experts from different European countries. 
Comments from the peer review were discussed in a project meeting. Three project 
members were assigned the task of organising the writing of a new version which took 
the reviewers' comments into account. The second draft version was again reviewed by 
the same six experts. Taking into account the resulting comments, the report was 
discussed in a final round of all project members, and a final revision authorised. 
Chapter 4 presents the main findings. For each section, background information is 
provided, which is mostly derived from the Project Manager Group discussions. This 
is followed by the results of the project reviews, leading to preliminary conclusions 
and resulting questions. Results from the experts’ survey are then presented in the form 
of bar charts. This does not mean that we understood this survey to be predominantly 
quantitative. As mentioned above, we were more concerned about bringing in people 
with a broad set of backgrounds rather than obtaining the most representative sample. 
This also prevents any statistical analysis of the data. Nevertheless, on a few occasions 
we mention explicitly how responses are distributed according to the respondents’ 
affiliations. In the final part of each sub-chapter, we discuss the results from the 
experts’ survey and the results of the review analysis with a view to formulating 
conclusions. These conclusions provided a basis for identifying future challenges for 
different areas of political action and possible future TA exercises (in Chap. 5). 
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REVIEW AND SURVEY RESULTS 4. 
THE FUTURE DEMAND FOR GM PLANTS AND FOOD: 
FACTORS AND PROSPECTS 4.1 
BACKGROUND 
For centuries, ways of enhancing productivity in the agricultural sector have been and 
continue to be in high demand. In this context, many agronomists argue that since GM 
crops are assumed to have a better performance than conventional ones, the demand 
for GM varieties and their cultivation will noticeably increase over the coming years. 
In 2007, the estimated global area of GM crops was around 114 million hectares 
(representing approx. 5 % of arable land worldwide). GM crops were grown in 23 
countries (James 2007). Twelve years after the commercial introduction of transgenic 
plants, there are still only two genetic traits (herbicide tolerance and/or insect 
resistance) and four crops that represent more than 99 % of the acreage: soybean 
(51 %), maize (31 %), cotton (13 %) and rapeseed/canola (5 %). The global area of GM 
crops has grown continually, including in some important emerging countries. The 
leading country is the USA with 57.7 million hectares, representing half of the total 
global area, followed by Argentina (19.1 million hectares), Brazil (15.0 million 
hectares), Canada (7.0 million hectares), India (6.2 million hectares) and China (3.8 
million hectares). In contrast, the cultivation of GM crops in Europe is very limited. In 
1999, the approval process for GM plants came to a temporary halt in the EU (until 
2004). The GM crop area in Europe is still very restricted, with around 110,000 ha in 
2007 (combined in the Czech Republic, France, Germany, Portugal, Slovakia and 
Spain), and only GM insect-resistant maize is approved for planting. 
However, new technological, political, economical and societal developments may 
affect the way GM crops and related issues will be considered in European politics and 
among the public. This chapter explores the relevance of different driving forces that 
affect the demand for GM plants and food in Europe. 
RESULTS FROM THE TA PROJECT REVIEWS AND FUTURE ISSUES 
Several of the projects reviewed discussed factors that could influence the future of 
GM plants and food (while others primarily focused on a retrospective analysis). The 
following summary is based on information from eleven reports: 
> Austria, “GMO-free” claims and the avoidance of GMOs in food 
> Germany, Green Biotechnology Discourse 
> Germany, Gene technology Report 
> Germany, Genetic engineering, breeding and biodiversity 
> Germany, Transgenic plants of the 2nd and 3rd generation 
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> Denmark, New GM crops – new debate 
> Denmark, Coexistence 
> Norway, Coexistence 
> Norway, GM food 
> Switzerland, Genetic Technology and Nutrition 
> UK, GM dialogue 
First, it is considered that technological developments will be a crucial driving force. 
Innovations include the development of plant varieties with better resistance to 
drought, cold, flooding, pests and diseases. Moreover, research is directed at 
developing the second and third generation of GM plants capable of producing 
pharmaceutical ingredients or industrial materials. Research developments also 
concern “energy plants” that produce biomass, which may be used for biofuels. 
Promoters of these developments expect them to bring benefits for both human health 
and the environment, even though many uncertainties remain. There are also hopes for 
business opportunities and for more efficient production methods (Germany, 
Transgenic plants of the 2nd and 3rd generation; Denmark, New GM crops – new 
debate; see Sect. 4.2). 
Second, economic factors must also be considered when discussing the future of GM 
plants and food. Europe is part of a globalised world, where more and more GM crops 
are being planted and exported. Will it be possible for Europe to stay apart from this 
global trend, considering that substantial quantities of GM soy and maize are imported 
into European countries? Can European countries and their agricultural sectors remain 
competitive without breeding GM plants? (Austria, “GMO-free” claims and the 
avoidance of GMOs in food; Denmark, Coexistence; Norway, Coexistence;). 
Other structural factors may affect the future of GM plants and food as well. These 
relate to the increasing world food demand, which requires more efficient agriculture 
at global and local levels. Parallel to this, the increasing use of biomass and bioenergy 
as an alternative to fossil energy could also affect the demand for GM plants 
(Germany, Gene Technology Report). Furthermore, concentration trends in the food 
chain may have an impact. The seed industry is undergoing a fundamental change as 
big agrochemical companies heavily invest in agrobiotechnology and absorb small 
seed companies (Germany, Genetic engineering, breeding and biodiversity). The retail 
sector is also experiencing a trend towards concentration, with a few retailers 
dominating the market and thus being able to dictate the kind of products to be sold 
(e.g. GM-free products). At the same time, consumers demand an ever wider and more 
diverse supply of food products, from fresh products to a broad range of processed 
food. There is a trend towards specific “categories” of food: “light” products, organic 
food, food produced according to sustainability principles, fair trade food, etc. Such a 
multitude of consumer demands may also support a market for innovative 
technologies. 
Moreover, there are regulatory factors that affect the future of GM plants and food. EU 
regulation of GMOs is based on the precautionary principle and the freedom of choice 
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(which entails segregation and labelling), and adopts a process-oriented approach. It is 
different from the US system, which is predominantly product-based and does not 
include any mandatory labelling of GM products (UK, GM dialogue). The question of 
how these two systems could coexist and whether the EU system is robust in particular 
with respect to WTO rules, is discussed in more detail in Sect. 4.6. 
The impact of the trends mentioned will be influenced by public reactions. Most 
surveys - as confirmed by various TA projects reviewed - show that one of the most 
important concerns relating to GM plants and food is their possible detrimental impact 
on health (antibiotic resistance, allergic reactions, etc.). The impact of GM plants on 
the environment is another important public concern in Europe. How will perceptions 
of risk evolve in the future? How will people react to and perceive new applications, 
new production systems and new policies? (Germany, Gene technology Report; 
Germany, Green Biotechnology Discourse; Norway, GM food). 
PRELIMINARY CONCLUSIONS AND RESULTING QUESTIONS 
A wide range of factors potentially influence the future demand for and use of GM 
crops, and it is hardly possible to foresee which of these will be the most important in 
the future. The TA projects reviewed did not reveal one single factor or driving force or 
even a few of them that will be particularly influential; rather, there will be a mix of 
factors depending on the context.  
We therefore decided to begin the survey by asking the experts to give their overall 
view on the importance of different factors that could positively or negatively 
influence the future situation of GM plants and food in Europe. The two following 
questions pertained to their expectations on the future demand in general and whether 
the already existing "first generation" of GM crops would be grown to a noticeable 
extent over the coming years in Europe. 
RESULTS OF THE EXPERT SURVEY 
INFLUENCING FACTORS 
All the factors listed (Fig. 1) were perceived as relevant for the future demand for GM 
plants and food, judging from the low rate of respondents ticking ‘Neither’ or ‘Don’t 
know’. Accordingly, the future of GM plants and food would be affected by a mix of 
factors. 
 25
4.  REVIEW AND SURVEY RESULTS 
FIGURE 1: INFLUENCING FACTORS FOR THE FUTURE OF  
 GM PLANTS AND FOOD IN EUROPE (Question 1A; n = 71) 
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Question: Many factors will influence the future of GM plants and food in Europe. Below is 
a list of frequently cited major factors. Please indicate for each factor whether you 
think it will encourage or discourage the demand for GM plants and foods. Please 
feel free to add other important factors not listed. 
Looking at the results in more detail, it appears that three in four experts considered the 
use of bioenergy and biomass to be a factor encouraging the demand for GM plants 
and food. This result must be seen in the light of the increasing demand for alternative 
energy sources. Respondents seemingly expected that GM plants might be required to 
satisfy this fast-growing market. 
The trend towards more efficient agricultural methods was also considered an 
important factor, with two-thirds of respondents expecting it to encourage GM 
demand. This certainly reflected a recent trend in increasing prices for some 
agricultural products.  
Around half of the respondents (44 % and 55 %, respectively) considered attitudes to 
health and the environment as discouraging the future demand of GM plants, nearly a 
third (31 % and 28 %, respectively) as encouraging. While the latter probably assumed 
that a new generation of GM crops might be acknowledged to bring benefits to human 
health and the environment, the former assumed that GM crops will be perceived as 
inferior in these respects. 
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Overall, experts from industry had a higher-than-average tendency to expect different 
factors to encourage GM demand. This especially pertained to global trade (eight in ten 
compared with the average of five in ten for all respondents), world food demand and 
international trade regulation (for both: seven in ten compared with five in ten on 
average) and in particular concerning the differentiation of food products (five in ten 
compared with two in ten on average). Interestingly, fewer than half of the experts 
from industry expected GM plants for pharmaceuticals to play a role in encouraging 
demand for GM plants, compared to six out of ten researchers – perhaps because the 
development of such plants is still confined to the researchers' labs, whereas industry 
experts recognise the economic difficulties of such applications. 
Some respondents also named other factors that might have an impact on the future of 
GM plants. One mentioned that if GM crops became significantly cheaper this might 
increase demand for them in times of rising prices for agricultural products. On the 
other hand, another respondent expressed the opinion that, as the average household 
income in the EU was rising, this could increase the demand for GM-free and organic 
products. Since the survey was carried out in late 2007 and the economic situation has 
changed meanwhile, this statement may be taken as highlighting the importance of the 
current economic context. For another respondent, “consumers’ perception of collusion 
between public administrations and multi-national companies will (continue to) 
minimise demand”. Food scandals and related fears (regardless of whether the food 
was of GM origin or not) might also hinder future demand for GM plants and products. 
The role of NGOs and the media was emphasised as well: depending on their power 
and credibility, they might influence public opinion on GM plants and food. 
THE PLACE OF GM PLANTS AND FOOD IN EUROPEAN AGRICULTURE 
Overall, a majority of experts expected most of the cited factors as encouraging 
demand for GM plants and food. But this does not directly indicate what the overall 
effect will be, as certain factors may outweigh others. We therefore asked whether the 
demand to introduce new GM plants in European agriculture will increase or decrease. 
Six out of ten experts expected an increase, less than one-fifth considered that it would 
remain stable, and only one-seventh expected a decrease (Fig. 2). 
FIGURE 2: FUTURE DEMAND FOR NEW GM PLANTS IN EUROPEAN  
 AGRICULTURE (Question 1B; n = 71) 
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Question: Overall, would you think that the demand to introduce new GM plants in the 
European agriculture will increase or decrease? 
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It is of no surprise that respondents from the industry sector had the highest 
expectations regarding a growth in demand for GM plants and food (nine in ten), 
followed by the group of researchers (seven in ten). 
Due to the uncertainty of the introduction of new generations of GM crops (see Sect. 
4.2), we were interested to learn if the experts also predicted whether the existing "first 
generation" of GM crops (such as insect-resistant and herbicide-resistant plants) would 
be grown to a noticeable extent over the coming years. As shown in Fig. 3, more than 
half of the experts estimated that first-generation GM plants would be grown on more 
than 5 % of the available European cropland within the next 10 years. This was a 
surprising result, knowing that only limited areas are currently cultivated with first-
generation GM crops in Europe, and that no noticeable changes have occurred during 
the past years. 
FIGURE 3: FUTURE CULTIVATION OF FIRST-GENERATION GM PLANTS IN EUROPE  
 (Question 2; n = 71) 
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Question: Do you think that the "first generation" of GM plants (such as insect-resistant 
(IR), herbicide-resistant (HR) and virus-resistant (VR) plants) will be grown in 
Europe to a noticeable extent (say more than 5 % of the available agricultural crop 
land) in the next 15 years)? 
It is a striking result of the survey that experts had a completely different view on the 
subject when asked about cultivation in their own country: only a quarter of them 
predicted that first-generation GM plants would be grown in their own country to a 
noticeable extent within the next 10 years (Fig. 3). This result, contradictory at first 
glance, was probably influenced by the national provenance of our experts. Amongst 
the countries represented, the only commercial planting of GM crops– on a very small 
scale – is in Germany. Many respondents probably expected countries which have 
shown a more positive attitude towards the use of GM crops in the past (e.g. Romania 
or Spain) to grow them to a larger extent in the near future. 
In accordance with their view on the development of future demand in general, 
industry experts, and to a lesser extent researchers, entertained the highest expectations 
that first-generation GM crops will be grown to a noticeable extent in Europe and in 
their respective countries. All industry experts (except one who ticked 'Don't know') 
considered that first-generation crops will be grown in Europe within the next 15 years 
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(compared to four out of five overall), and three quarters (compared to half the experts 
overall) of them considered that they will be grown in their own country. 
DISCUSSION 
Overall, the general conditions for agriculture are changing. First, food supply is high 
on the agenda in response to increasing demand and jumps in food prices. The role of 
agriculture for food security and development is also back on the development agenda 
as two recent assessments show: 
> World development report 2008 (World Bank 2007) 
> International Assessment of Agricultural Knowledge, Science and Technology for 
Development (IAASTD 2008a + b) 
The focus on food supply also has an impact on debates on GM plants both in Europe 
and worldwide. With regard to perspectives in developing countries, the views on the 
potential contributions of modern biotechnology towards productivity enhancement, 
improvements for small-scale farmers, and reaching the Millennium Development 
Goals, remain divergent – as has been the case ever since the 1980s. TA projects also 
came to differentiated and ambivalent conclusions, including that a number of 
important development goals could not be achieved through GM plants (e.g. Denmark, 
Genetically modified crops in developing countries). In the responses to the present 
survey, world food demand does not rank highest in encouraging demand for GM 
technologies. On the other hand, the survey indicates that a trend towards more 
efficient agricultural production methods will encourage GM-demand (Question 1). 
Recent years have seen a dramatic increase in the importance of biomass as a 
renewable resource, especially for biofuels (for example EC 2006, GBEP 2007, Meyer 
et al. 2007, SRU 2007). This is illustrated both by the actual increase in biofuel 
production and by the formulation of ambitious goals for future biofuel use. 
At the same time, crop breeding for bioenergy is more or less at its beginning. 
Reflecting this situation, experts considered the use of bioenergy and biomass to be a 
very important encouraging factor for GM introduction. But it has to be kept in mind 
that the biofuel policy itself is becoming increasingly controversial, as can be seen 
from the demand for a moratorium in biofuel use (for example EEA 2008). 
Experts saw attitudes to the environment and to health as well as the structures and 
power relations in the food chain as discouraging factors for the future of GM plants 
and food in Europe, in line with the results from the TA project reviews. 
In summary, the experts expected the demand to introduce new GM plants in Europe 
(Fig. 2) to increase. Accordingly, the majority of respondents expected a rise in the 
cultivation of first-generation GM crops that have in principle been available for a 
considerable time also in Europe (Fig. 3). Expectations concerning the time frame for 
introducing first-generation GM plants in European agriculture differ remarkably 
among different groups of experts. However, it is rather surprising to see that for many 
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of them, cultivation of first-generation GM plants will substantially increase in Europe, 
or at least in some European countries. These rather high expectations may reflect 
observations that the acreage of agricultural land cultivated with GM crops worldwide 
keeps increasing each year, and expectations that this trend will also involve some 
European countries. 
In conclusion, experts see driving forces arising that will influence the demand for GM 
plants and food, and they expect the use of such plants in Europe to increase. Chapter 5 
will discuss whether these expected developments could have consequences for GM 
regulation and for further TA projects. 
NOVEL GM PLANTS, TECHNOLOGIES 
AND APPLICATIONS 4.2 
BACKGROUND 
The appearance of novel applications of GM crops has been announced and expected 
for many years. One main focus of scientific and political debate is on GM plants with 
modified properties for the user (so-called “output traits”, as opposed to agronomic or 
"input traits", which serve to optimise agricultural production). These plants are 
designed to produce pharmaceuticals or industrial raw materials (so-called molecular 
pharming); they are also expected to feature improved, especially healthier contents as 
a source of food. The latter could be particularly attractive to final consumers, while 
most of the other possible novel applications would serve industrial purposes in the 
first instance.  
Recent interest has focused on options for using GM plants as a source for renewable 
energy production. The potential contribution of GM technology is seen in increasing 
the biomass yield in general or that of specific components such as fatty acids. Such 
plants may eventually be associated with environmental advantages and thus become 
more persuasive in public perception than the existing “first” generation of GM plant 
crops. On the other hand, some novel traits for new areas of application, such as the 
production of pharmaceuticals, may throw up serious new questions for risk 
assessment and management. 
However, the suitability of genetic engineering to address such complex breeding aims 
as yield is controversial. It may also be put to the test by other advanced technologies 
such as smart breeding, which makes use of molecular genetics to support 
conventional breeding approaches.  
RESULTS FROM THE TA PROJECT REVIEWS AND FUTURE ISSUES 
Only two of the 29 projects reviewed overall explicitly dealt with new applications of 
GM plants – also called the second and third generation ("second generation" 
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describing those GM plants which are closer to commercialisation, and “third 
generation” referring to those being researched or at a very early stage of 
development): 
> Denmark, New GM crops – new debate 
> Germany, Green genetic engineering – transgenic plants of the second and third 
generation 
One further report focused on relevant applications, but only marginally touched on the 
topic of GM plants (Flanders, Industrial biotechnology and Functional Food), while 
another (German, Gene technology Report) predominantly covered technological 
questions (also in related areas of modern plant breeding). 
The Danish citizens’ jury assessed the new uses of GM plants as predominantly 
beneficial, but had different attitudes towards the use of GM plants for medical, other 
industrial, or ornamental purposes. One important demand made was that applications 
should not give rise to more harmful agricultural practices than the corresponding 
traditional modes of production (particularly concerning fertiliser or pesticide usage). 
Thus, a precondition for allowing the new plants was that the environmental 
consequences of new practices should be thoroughly assessed (Denmark, New GM 
crops – new debate). 
Another challenge identified was the retention of a free consumer choice. Some reports 
even implied that GM products also for non-food and non-feed purposes could or 
should be labelled. In addition, public research should be strengthened to provide a 
counterweight to private research and development, as public research was considered 
necessary to maintain sufficient control of the new GM plants. The clearest message 
from the citizens’ jury, however, was not about tangible advantages, disadvantages and 
conditions with regard to GM plants, but about the necessity of informing the public 
about these issues as part of an open and balanced debate (Denmark, New GM crops – 
new debate). 
A major outcome of the TAB project, which was based predominantly on the analysis 
of scientific expertise, was that fundamental uncertainties remain regarding the 
developmental status of most GM plants for molecular farming as well as for the 
production of functional food, so that the economic potentials are very difficult to 
assess. In several cases, expectations of attainable product yields have not been 
fulfilled even after many years of development. In the course of maximising content, it 
seems that undesired side effects tend to emerge which then result in lower yields. 
While this does not make the concept (economically) unusable, it does affect the range 
of substances that can be produced on a commercially competitive basis.  
In addition, approaches based on GM plants have to compete with well-established or 
more intensively investigated technologies in the chemical and pharmaceutical sector, 
and particularly in the food industry, where food ingredients are gained by chemical 
synthesis, microbial production or isolation from natural sources. The resource-
intensive and comparatively long development period for new GM varieties, as well as 
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regulatory requirements, represent a disadvantage over more rapid and flexible 
alternatives. According to the TAB report, the most probable perspectives are localised 
in the field of pharmaceutical production, as a growing demand for biotechnological, 
high-value drugs and a need for additional production capacities can be deduced from 
recent market developments. With regard to the production of low-priced, so-called 
bulk chemicals, a major restriction was identified in the form of GM-specific 
regulation and management measures which increase the production costs (Germany, 
Transgenic plants of the second and third generation). 
Since most GM plants modified for output traits are at an early stage, the risk 
discussion is still in its infancy and has so far concentrated on the question of how to 
reliably prevent gene flow or outgrowing and contamination of staple food. However, 
at least for GM plants producing pharmaceutical substances, the conditions for risk 
regulation (i.e. risk assessment, risk evaluation and risk management) are 
fundamentally different. Compared to existing GM plants with agronomic traits, they 
bear an inherent risk due to the possible medical and physiological impact of their new 
ingredients. At the same time such crops exhibit benefits (e.g. of a life-saving drug) 
which may be given weight if the approval procedure were amended in the direction of 
a comparative risk-benefit analysis (compare Sect. 4.5). 
All in all, a thorough examination of the current European regulation was 
recommended to check its appropriateness for molecular farming. The overall 
conclusion of the TAB project was that, due to the limited emphasis on “molecular 
farming” within the debate on GM plants, there was an overall need at the EU and 
national levels for a more thorough consideration of opportunities and potential risks of 
GM plants modified for output traits (Germany, Transgenic plants of the second and 
third generation). 
The report by the Berlin-Brandenburg Academy of Sciences and Humanities (BBAW) 
brought up the question of alternative novel methods or technologies for plant breeding 
(Germany, Gene technology Report). "Smart breeding", the use of genomic 
information to empower and refine conventional breeding strategies, may be able to 
handle complex traits like yield or tolerance to abiotic stress (drought, salinity, etc.). At 
the same time, it uses molecular techniques without producing GM plants and thus 
avoids all aspects of GM-specific risk regulation and measures. "Cisgenic" approaches 
using only species-immanent traits for genetic modification are also on their way. 
Some experts and stakeholders ask whether cisgenics may blur the distinction between 
GM and non-GM plants, and one may ask if this technology will influence the public 
attitude towards GM technology. 
PRELIMINARY CONCLUSIONS AND RESULTING QUESTIONS 
Novel applications of GM plants have been announced for a long time, but have not 
yet appeared at all on the European market and only to a negligible extent elsewhere. 
So the basic question remains whether a technological breakthrough (i.e. a plant 
variety with new characteristics ready for marketing) can be expected in the next few 
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years. We asked for the experts’ assessments of the availability of different traits, 
including a number of output traits, as well as new agricultural input traits. 
Such “technical” availability does not mean that the GM plants can be introduced to 
the market – they still have to be authorised. At least for some novel output traits, it is 
obvious that serious risk questions have to be resolved, including the design of reliable 
risk management procedures (see below). Thus, a second question concerns the 
possible and expected authorisation of different categories of new GM plants as a 
prerequisite for their future market appearance. 
The fulfilment of both requirements, the technical availability and the market approval 
does not automatically imply that a GM plant will actually be taken into use – this 
again depends on the demand by growers and the acceptance of possible users or, for 
pharmaceutical GM plants, the cost of the substance produced. Such acceptance and 
demand may vary according to the characteristics of the very heterogeneous categories 
of new GM plants. They depend on a variety of parameters such as the expected area 
of cultivation (which could be very small and possibly covered by glasshouses for 
pharmaceutical crops or special high-value chemical compounds) and the agronomical 
needs and measures (which could be more or less similar to established agricultural 
practices). Furthermore, how "close" the application is to the consumer will also play a 
role; uses as a source of food may be more sensitive than a very specialised 
"consumer-remote" purposes (e.g. phytoremediation, the extraction of toxins from the 
soil). These aspects could not be explored in detail in a questionnaire, but should be 
kept in mind in interpreting the answers received. 
The usual scientific risk assessment procedures rely heavily on the concept of 
substantial equivalence, both in EU and US approval regimes. By proving that there 
are only minor differences between the GM plant and its conventional counterpart, the 
risk assessment focuses on the genes transferred and the specific traits they confer, and 
to a much lesser extent on the properties of the new plant as such. However, when the 
result of the genetic modification is a major change in the plant’s physiology or a new 
synthesis of specific molecules in large amounts, GM plants are no longer equivalent 
to existing varieties. Therefore, their safety may need a more thorough or different type 
of investigation compared with existing “first-generation” GM plants. In the 
questionnaire, we asked the experts if they shared this view and, if so, in which areas 
they would possibly expect regulatory challenges. 
RESULTS OF THE EXPERT SURVEY 
AVAILABILITY – AUTHORISATION – DEMAND –  
ACCEPTANCE OF NEW GM PLANTS 
Overall, the respondents tended to expect new GM plants to be introduced in the 
coming decade. With the exception of trees for industrial or energy purposes and 
plants for phytoremediation, the majority of respondents expected all other categories 
of plants listed to be available and authorised for cultivation in Europe within the next 
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10 years. The experts did not add any other category to those listed in the 
questionnaire. 
Asked whether the various plants “will become available”, “GM plants for plant-made 
industrials” scored highest (four in five, see Fig. 4), followed by plant-made 
pharmaceuticals, plants for bioenergy and new GM flowers (about three in five each). 
“GM plants for phytoremediation” and “GM trees designed for industrial/energy 
purposes” received the lowest support (about one in four), while “GM plants with 
consumer benefits” got support from half of the respondents, comparable to “new 
agricultural input traits”. 
The answers to “will be authorised” (Fig. 5) show a similar pattern except for "GM 
plants for pharmaceuticals": They are regarded as less likely to be authorised although 
they would be available (less than half vs. three in five). This difference may reflect 
that such products can be supplied in most cases from restricted cultivation in 
greenhouses without authorisation for commercial planting. In general, one reason for 
the relatively low support for GM pharmaceutical plants, trees and plants for 
phytoremediation may be that they might be associated with different kinds of risk, 
which could be seen as requiring different assessment regimes (see Fig. 11). 
FIGURE 4: AVAILABILITY OF NOVEL GM PLANTS  
 (Question 3A; n = 71) 
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toxics from the soil)
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lawns and golf courses)
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Question: Currently there are several classes of new GM plants in development. Please 
check if you believe the statement: “Such crops will become available within the 
coming 10 years.” 
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FIGURE 5: AUTHORISATION OF NOVEL GM PLANTS (Question 3B; n = 71) 
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Question: Currently there are several classes of new GM plants in development. Please 
check if you believe the statement: “Such crops will be authorised for cultivation 
in Europe.” 
The question of “demand from farmers” (Fig. 6) tapped into expectations concerning 
the interest and willingness to grow the respective GMP. By comparing with the 
question on “acceptance with consumers” (Fig. 7), we can deduce a possible conflict 
between a high demand from farmers compared to low acceptance from consumers 
anticipated for “GM plants with new agricultural input traits” (seven vs. three in ten). 
A similar, though weaker discrepancy arose for “GM plants for bioenergy” (seven in 
ten vs. half), and an opposite relation for “GM plants with consumer benefits” (two 
versus three in five). Maybe a reason for the latter is that respondents believed that 
crops with consumer benefits would only make up a niche market, so the average 
farmer would not benefit from it. 
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FIGURE 6: DEMAND FROM FARMERS FOR NOVEL GM PLANTS (Question 3C; n = 71) 
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Question: Currently there are several classes of new GM plants in development. Please 
check if you believe the statement: “Such crops will find significant demand from 
farmers.” 
The assumed low interest of farmers in growing GM plants for pharmaceuticals is not 
surprising, because such plants will probably be cultivated, if at all, only on a contract 
basis. The high numbers of “Not valid” for “GM plants for phytoremediation”, “GM 
trees designed for industrial/energy purposes”, and “New GM flowers” also reflect 
their nature as non-agricultural plants which are not relevant for most farmers. 
The relatively high expectation for consumer acceptance of “GM plants for 
bioenergy”, “GM plants for plant-made industrials” and "GM plants for 
pharmaceuticals" is in line with the responses to Question 6 where a majority of 
experts perceived that GM non-food products would meet more positive public 
attitudes (see Fig. 12 in Sect. 4.3). It also fits with the cautious but affirmative vote of 
the Danish citizens' jury on these issues (Denmark, New GM crops – new debate). 
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FIGURE 7:ACCEPTANCE WITH CONSUMERS OF NOVEL GM PLANTS (Question 3D; n = 71) 
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Question: Currently there are several classes of new GM plants in development. Please 
check if you believe the statement: “Products from such crops will find 
acceptance with consumers.” 
Concerning “demand from farmers”, several participants commented that “Farmers 
will probably be willing to grow anything for which there is a demand, either from 
consumers or from industry.” Regarding “acceptance with consumers”, one 
respondent commented: “Every single person is a consumer, so obviously this is not a 
homogeneous group. What percentage of consumers is needed to answer “valid” - 
10 %, 30 %, the majority? I have interpreted this as acceptance by a majority of 
consumers. There will be a minority that will not accept any GM crops (this is about 
15 % of all consumers).” 
FUTURE IMPORTANCE OF SPECIFIC ADVANCED GENETIC BREEDING 
TECHNOLOGIES 
Questions on the future importance and implications of smart breeding and cisgenic 
technologies are of interest because both have the potential to provide novel varieties 
that may be more acceptable to a sceptical public since the degree of “manipulation” 
may be perceived to be less severe. 
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FIGURE 8:FUTURE IMPORTANCE OF “CISGENIC” GM TECHNOLOGY (Question 4A; n = 71) 
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have to be adapted.
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Question: In the future, technical developments such as “cisgenic” GM technology may 
become more important. While traditional “transgenic” plants result from gene 
transfers which use recombined DNA from other species, “cisgenic” plants result 
from gene transfers which use only recombined DNA from the same species. 
Please indicate if you agree or disagree with the following statements. 
The importance of cisgenic GM technology does not seem to be very clear as 
responses show a high rate of “Don’t know” answers (more than half; Fig. 8). The 
statements that this technology “blurs the boundaries” and a “need for adapting 
existing regulation” ensues each met with quite high support from more than half of 
the respondents. On the other hand, the statement “Cisgenic GM technology will 
undermine the demand for transgenic GM technology” met with the lowest support, 
which indicates that respondents expect cisgenes to at best supplement, rather than 
replace, transgene technology. 
FIGURE 9: FUTURE IMPORTANCE OF “SMART BREEDING” (Question 4B; n = 71) 
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Question: “Smart breeding” is another new technical development. "Smart breeding" derives 
from traditional methods of plant breeding but includes tools on the basis of 
modern recombinant DNA technology such as molecular markers. Please indicate 
if you agree or disagree with the following statements. 
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Whether the public would regard products derived from such technologies as “less 
hazardous” was controversial (one-third agree, slightly more disagree). In the written 
comments respondents emphasised that “Most consumers will, if asked to distinguish, 
see cisgenics as less hazardous than transgenics, but that doesn’t mean they will 
accept them in their back yard or on their dinner plates.” A similar consideration was: 
“I guess cisgenic will be defined - publicly as well as in terms of regulation - as 
transgenic. Argument: rearrangement within the genome calls for precaution as well.” 
Compared to cisgenic GM technology, many more (seven in ten) considered “smart 
breeding” to be important: more than half saw a “good public image” (Fig. 9). 
However, smart breeding is not considered an alternative to GM technologies (more 
than half disagreed), and it will not overcome the current need of GM plant regulation 
(three in four disagreed). One respondent noted “that all these techniques will 
contribute to the development of plants for different purposes”. 
REGULATORY ISSUES OF NOVEL GM PLANTS FOR THE NON-FOOD 
SECTOR 
Almost half of the experts agreed that novel GM plants for the non-food sector would 
pose new regulatory challenges, while one in four disagreed (Fig. 10). 
FIGURE 10: NEW REGULATORY CHALLENGES CAUSED BY NOVEL GM PLANTS? 
 (Question 10A; n = 71) 
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Question: Newly developed GM plants for the non-food sector (e.g. GM plants for plant 
made pharmaceuticals, for industrial raw materials, and for bio-energy) are 
sometimes said to have new properties compared to gm plants for food and 
therefore pose new regulatory challenges. Do you or don’t you agree with the 
following statement? 
Those who expected regulatory challenges were then asked what kind of challenge 
they would expect (Fig. 11). Aspects such as “new parameters for risk assessment and 
management, “confinement / containment measures”, “regulation of coexistence” and 
“liability” were all regarded as very likely or likely to be on the agenda during the next 
10-15 years by around nine in ten of the experts. In comparison, “labelling” was 
identified as a highly likely or likely issue by only seven in ten. This could reflect the 
fact that non-food/feed products may not necessarily have to be labelled. 
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FIGURE 11: AREAS OF NEW REGULATORY CHALLENGES OF NOVEL GM PLANTS  
 (Question 10B; n = 44) 
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Question: If you ticked "Yes" [in question 10B], please assess which regulatory challenges 
non-food GM plants will raise in the next 10-15 years, and whether this will be 
very likely, likely, unlikely or highly unlikely. Please feel free to add other 
regulatory challenges not listed. 
The experts did not add any other category to those proposed in the questionnaire, but 
in the written comments it was emphasised that “Regulators also need to address 
issues such as ethics, sustainable development and societal utility” and that “In 
general, since most non-food GM plants presumably will produce high value products, 
there will be a natural interest to keep them confined from other crops in order to 
preserve the value of the products.” Another participant added that “Answers refer 
primarily to plants producing pharmaceuticals. Some other non-food traits, e.g. for 
bioenergy, would not raise new regulatory challenges.” 
DISCUSSION 
Will new GM crops with novel properties be available, and will they come onto the 
market? Will new regulatory challenges arise, and what about alternative or 
complementary novel methods/technologies such as smart breeding and cisgenics? 
Amongst the experts asked, the overall expectations that such new GM plants would 
be developed and in principle be available "within the coming 10 years" remained 
high. A more precise forecast was not requested, thus no conclusions can be drawn 
about when the experts expected such crops to be market-ready and authorised in 
Europe. 
Interpreting the rough forecast for different categories remains difficult. As already 
mentioned, GM plants with improved output traits have been announced for many 
years, but no information is available on whether the technological development has 
been substantially accelerated. In some cases, high expectations could be due to 
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wishful thinking (or continuing fear) rather than informed judgement. The TAB report 
showed that many research and development projects in the past failed in their late 
stages (Germany, Transgenic plants of the second and third generation), which makes 
it difficult to forecast the fate of current projects. A plausible reason for the high 
expectations concerning industrial applications probably is the availability of a 
particular GM crop, the BASF starch potato "Amflora" – whose authorisation was 
applied for more than 10 years ago. However, the "Amflora" example also illustrates 
that industrial GM crops may have difficulty obtaining authorisation even in a case that 
has been extensively tested for a long time and assessed, according to the European 
Food Safety Authority (EFSA) GMO Panel, to be unlikely to have adverse effects. It is 
not clear whether this will change in the foreseeable future. 
The pattern of the experts' expectations regarding demand from farmers and 
acceptance by consumers vis-à-vis GM crops with new input traits and functional food 
properties were basically in line with familiar opinions: respondents regarded farmers 
to demand more agricultural traits and consumers to demand improved nutritional 
value (irrespective of the factual rejection of GM foods in Europe until now). 
However, the acceptance of growers and consumers seem to diverge for other 
applications as well. One reason may be that certain types of crops are closer to the 
consumer, and thus more sensitive.  
For food crops, there should be a strong relation between consumers' demand and 
farmers' production. In contrast, for plant-made pharmaceuticals, industrial substances 
and crops for bioenergy it is the pharmaceutical, chemical and energy industry that 
creates demand. On the one hand, this might change the role of farmers, who in the 
future might be working increasingly on a contract basis – a development that is also 
taking place with food production, as the requirements of identity preservation and 
quality control constantly rise. On the other hand, as the produce becomes refined to 
fuels, plastics or pharmaceuticals, their agricultural and thus GM origin becomes 
obscure. More "remote" value chains such as these may be less sensitive to GM 
opposition, although recent actions against the "Amflora" potato were similar to former 
campaigns against GM food crops. 
The future role of cisgenics and smart breeding seems to be somewhat unclear. 
Although they were considered important for plant breeding in general, the majority of 
experts did not expect them to substantially reduce the demand for transgenic 
technologies. There might be a gain in popularity, however; and some existing 
regulations might need to be adapted in order to cover cisgenics. 
GM plants for the non-food sector, and especially in the case of plant-made 
pharmaceuticals, were expected to pose various regulatory challenges. This confirms 
the results of the TAB report (Germany, Transgenic plants of the second and third 
generation). A majority of respondents considered it likely or very likely that new 
parameters for risk assessment and management, confinement and/or containment 
measures, regulation of coexistence and liability will be put on the agenda over the 
next 10-15 years. 
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Taken together, the appearance of new categories of GM crops remains difficult to 
predict. However, if they occur in the coming years, at least some of them will evoke 
novel regulatory questions. 
PUBLIC ATTITUDES AND ACCEPTANCE 4.3 
BACKGROUND 
The history of GM plants in Europe is a history of strong debates between decision 
makers, experts and various stakeholders, including industry, consumer groups and 
environmentalists. Proponents of GM plants argue in favour of the environmental 
benefits of GM plants (less fertiliser, less pesticide, less tillage) and higher productivity 
perspectives. Opponents emphasise potential health and environmental risks as well as 
a variety of non-technical issues, such as the multiple purposes of agriculture, pending 
dependence on multi-national companies and questions of ethics and (food) culture.  
Over the years, this debate has found resonance in and received inputs from the public 
in European states’ to varying degrees. The ensuing reluctance to buy GM products 
has almost prohibited their commercial introduction. Public scepticism might have had 
an influence on the EU regulation on GM plants and food as well, which some claim to 
be rather restrictive. When considering the future of GM plants and food in Europe, it 
is thus important to reflect on the way public debate will evolve and, more specifically, 
whether or not agricultural GM technology and its products will find more acceptance 
over time.  
However, it must be kept in mind that acceptance or the lack of it is the result of a 
process of shaping public opinion with many factors involved. Therefore, any such 
reflection must take into account numerous possible reasons for the perception 
entertained by the European public. 
Overall, repeated European surveys1 have identified growing scepticism throughout 
the 1990s and a slight change over the last couple of years. Regarding GM food, the 
majority still seem to be sceptical (Gaskell et al. 2006). Several explanations have been 
proposed. Firstly, since the so-called first-generation of GM crops was mainly 
developed in order to suit the needs of the producers, one line of explanation stresses 
the rational choice of consumers: since buying GM food products would not as yet 
bring clear individual benefits, and the potential risks claimed by opponents could not 
be entirely dismissed, consumers tend to remain sceptical. Consequently, with new 
GM plants delivering products which might be considered beneficial for the consumer, 
or products other than food or feed, some expect attitudes to change.  
                                                 
1 In particular, six Eurobarometer surveys on biotechnology in 1991, 1993, 1996, 1999, 2002 
and 2005, see http://ec.europa.eu/research/press/2006/pr1906en.cfm 
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However, even if one takes into account consumer calculation of risks and benefits, 
this alone may not be sufficient to explain how attitudes are formed. Analyses of 
surveys have shown that, regardless of considerations of risk or personal benefit, if 
someone has moral objections to genetic modification this acts as a “veto” (Gaskell et 
al. 2006). Such objections can be directed, for example, towards the perceived role of 
GMOs as “tinkering with life”, which would collide with a certain understanding of 
nature.  
Such general arguments lead to another line of explanation that emphasises someone 
having a general opinion of GM plants (Lassen et al. 2002; Lassen and Jamison 2006). 
Reasons may be based on arguments of the general environmental effects, common 
welfare and/or democratic accountability. For example, such arguments could pertain 
to GM plants considered to reduce or create environmental risks either directly or 
through the way agriculture is conducted. Whether or not risk management will be able 
to mitigate risks is controversial, as is the question of whether coexistence will secure 
consumer choice or, if it fails, will result in negative effects for non-GM agriculture. 
Patenting may contribute to enhancing research to secure the world food supply, but it 
may also give rise to problems of equity and dependence on “big business”. There are 
also links to voices criticising the way food scandals have been dealt with and how 
expert committees and regulatory bodies have failed to provide and act upon expertise, 
independent of special interests. Accordingly, the perceived lack of accountability has 
contributed to a reluctance to accept reassurance from experts that there is no risk 
(PABE 2001). This again is linked the debate on the risk issue, but at a different, 
societal level. 
In other words, several lines of argumentation may explain the perceptions measured 
in a survey. In addition, it must be kept in mind that there may be a gap between the 
role of the citizen supporting or rejecting GM technology on the one hand and the role 
of the consumer purchasing GM food products or not in practice on the other, whereby 
one and the same person could take on both roles at different times.  
RESULTS FROM THE TA PROJECT REVIEWS AND FUTURE ISSUES 
A number of TA reports from various institutions, many of them involving lay panels 
or other forms of involving non-experts, have tried to shed light on the reasons behind 
past and present public perceptions and on factors that may influence them in the 
future, such as participation, communication and public debate. Project members used 
information from the following summary of some of the most important points to 
consider from the reviews of these reports in forming their hypothesis. Relevant TA 
projects reviewed were: 
> Denmark, Genetically modified foods 
> Denmark, New GM crops – new debate 
> Finland, Debate concerning the plant gene technology 
> Flanders, New impulses for the debate on genetically modified food 
> Germany, Green Biotechnology Discourse 
 43
4.  REVIEW AND SURVEY RESULTS 
> Norway, GM food 
> Switzerland, Genetic Technology and Nutrition 
> United Kingdom, GM dialogue 
Other reports mentioned public perceptions as a factor to be taken into account, such as 
> France, Co-construction 
> Flanders, Industrial biotechnology 
> Flanders, Functional Food 
> Austria, Precautionary Expertise 
> Germany, Transgenic plants of 2nd and 3rd generation 
> Switzerland, The future of plant biotechnology 
Almost unanimously, the project reviews suggest that consumer attitudes, and the 
ensuing reluctance of retailers to put GM products on the shelves, have strongly 
influenced the economic performance of GM food. Consequently, the question of how 
attitudes will develop over the next 5-10 years is likely to be the key to any future 
success of GM crops (United Kingdom, GM dialogue). This applies to current GM 
plants for food, future developments, and GM crops for non-food 
purposes/applications. In some countries, consumers may even have become less 
confident and more sceptical over the years (Norway, GM food). This may also have to 
do with a loss of trust in the scientific community and in regulatory bodies and not 
only with the risks associated with the technology alone (France, Co-construction). 
There are contrasting experiences in Finland, however, where acceptance seems to 
have improved (Finland, Debate concerning the plant gene technology).  
In general, it is difficult to determine whether acceptance has changed in practice. 
What can be said, however, is that perceptions are split: some reports emphasised 
strong dissent among members of stakeholder panels over risk, benefits and major 
definitions such as on the precautionary principle and ecological damage (Germany, 
Green Biotechnology Discourse). 
Surveys over the last decade have repeatedly pointed out that consumers are quite 
sceptical towards food products from first-generation GM plants, as they do not see 
clear benefits for themselves, and also fear risks related to health and the environment. 
This argument was also emphasised in citizens’ panels and consensus conferences (for 
example Denmark, Genetically modified foods). However, a Swiss panel of non-
experts considered no danger to be proven, and although no final judgement could be 
made on the presence or absence of a risk, some members considered that GMOs 
should not therefore be banned (Switzerland, Genetic technology and Nutrition). 
Several reports quote expectations that acceptance of new GM food products could 
grow as future products may entail obvious benefits to consumers (for instance 
healthier nutrition or better food quality, Germany, Green Biotechnology Discourse). 
Non-food products may also find more acceptance, as health issues are less sensitive, 
and new products may be associated with clear advantages. In particular, GM plants 
for medicines received support because of the importance of the product, in contrast to 
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ornamental flowers. Therefore, a “conditional yes” can be expected – which seems to 
depend on the perceived societal usefulness of the product compared with its possible 
risks (see also Sect. 4.2) (Denmark, New GM crops – new debate). 
However, attitudes are not only the result of a simple balancing of (environmental or 
health) risks and (societal or personal) benefits. Citizens are also concerned with 
general issues such as equity regarding benefit allocation (Flanders, Functional Food) 
and justice, in particular with regard to developing countries (Denmark, Genetically 
Modified Foods). Several reports highlighted that attitudes towards nature play an 
important role, too (Switzerland, Genetic Technology and Nutrition), and that ethical 
considerations should be taken more seriously (Denmark, Genetically modified foods). 
Finally, aspects of food culture may also influence perceptions (Flanders, Functional 
Food). 
This said, however, non-experts also understand and evaluate national economic 
arguments such as concerns for the research area (Switzerland, Genetic Technology 
and Nutrition). However, economic benefits are not only considered to be associated 
with the introduction of GM technology, as in agriculture there may be disadvantages 
from using GM plants for the national agricultural system (Norway, GM food). For 
example, if the organic sector considered particularly vulnerable to contamination with 
GM plants is prominent in a country, economic losses from jeopardising this sector 
could be considerable. 
More procedural factors have also been proposed as possibly influencing public 
attitudes, such as communication and participation in decision-making processes. 
Several reports point to the desire for broader participation and involvement of the 
public and stakeholders to help ensure that as many relevant questions as possible are 
addressed. Citizens call for an intensified dialogue between the general public and 
researchers, and some voted for the public to already be involved in the decision-
making processes on GM plants when the technology is at the research stage 
(Switzerland, Genetic Technology and Nutrition; Switzerland,  The future of plant 
biotechnology; Flanders, New impulses for the debate on genetically modified food; 
Austria, Precautionary Expertise for GM Crops). 
Moreover, the importance of understandable, down-to-earth communication about GM 
plants was identified, although it was emphasised that the social acceptability of GM 
plants does not only depend on the level of information. In other words, more 
information does not necessarily mean more people will accept the technology. 
(Flanders, New impulses for the debate on genetically modified food; Switzerland, The 
future of plant biotechnology in Switzerland). This confirms the criticisms of many 
social scientists about the “deficit model” of the Public Understanding of Science 
approach. 
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PRELIMINARY CONCLUSIONS AND RESULTING QUESTIONS 
Public attitudes are a major factor determining the prospects of new GM plants, both 
for food and non-food purposes. It is therefore important to gain more insight into the 
possible trajectories of developing public perceptions. However, since perceptions are 
a result of multi-factorial influences, it will be difficult to predict such a trajectory. 
There are contradictory indications as to which direction the development will take. On 
the one hand, some countries have experienced a loss of acceptance, at least for 
products from first-generation GM plants. For some people, the label “GM” seems to 
be associated with deep-rooted aversion, regardless of any actual benefits. The risk 
issue, especially regarding the environment, has not been settled for good, and general 
questions of ethics and equity still hamper the prospect of the technology. Labelling 
and consumer choice might not be the solution for those who consider GM products 
unacceptable for the latter reasons. This indicates there will be little change from the 
status quo. 
On the other hand, new products promise consumer and health benefits or aim to 
deliver products other than food, where health risks no longer play the same role. Over 
time, arguments related economic advantages or ecological benefits may gain a 
foothold. Such arguments have been brought forward to support the notion that 
acceptance may improve in the future. In addition, a habituation effect cannot be ruled 
out once products are on the market.  
We conclude that for the time being, it is impossible to seriously predict how public 
attitudes will actually develop. However, for future regulatory decision-making and 
strategy building this is not the only important question to be asked. Rather, we think it 
equally or even more important to know what the experts who influence the shaping of 
public opinion and who advise regulators and other decision-takers deem to be the 
most likely development – almost irrespective of whether such a development comes 
about or not. The perceptions of experts will, for instance, ultimately have an influence 
on what decision-takers consider relevant for their decisions. 
Following this rationale, we devised some questions for our expert survey aimed at 
challenging our preliminary conclusions on the development of public perceptions of 
GM plants in the future. If policy decisions are influenced by the way experts perceive 
what the public thinks of GM plants and food in Europe and how ordinary people 
might act in the future, the question is what do experts consider to be crucial in 
determining public perceptions. Is it risk or personal benefit? Do common welfare 
arguments play a role? Will future risk management succeed in assuring confidence? 
And is it the citizen or the consumer who will decide the future fate of GM plants and 
food in Europe? 
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RESULT OF EXPERT SURVEY 
PUBLIC ATTITUDES OVER THE NEXT 10-15 YEARS 
In order to address these issues, we put the question: “Will public attitudes to GM 
crops and food change in the next 10 to 15 years?” with three sub-questions, in which 
we asked for the experts’ opinions on public acceptance of GM technology in general, 
new GM food products, and GM non-food products. This distinction is important, as 
acceptance may vary according to the type of products.  
FIGURE 12: PUBLIC ATTITUDES (Question 6; n = 71) 
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Question: Will public attitudes to GM crops and food change in the next 10 to 15 years? 
A (small) majority of experts expect a more positive attitude towards GM technology, 
with an important difference between food and non-food products (Fig. 12). Overall, 
three in four expected more positive attitudes towards new non-food GM products and 
only about one in three for new food products. Thus, a majority of experts consider the 
next generation of GM food products to be met with scepticism. On the other hand, a 
significant majority expect positive attitudes in relation to non-food products. It should 
be noted that for all items in the question, industry experts and those from universities 
and research institutes have higher expectations of a positive change than others. 
It is interesting to note that even though only one-third of the experts expect more 
positive attitudes for new GM food products, half of them expect these products to be 
on the market within the next 10 years (Fig. 3, Sect. 4.1). Obviously, some experts 
think that public attitudes will not prevent the marketing of new GM food products. 
Concerning new non-food products, the number of experts expect public attitudes to 
grow more positive is about the same as those who expect GM plants for bioenergy, 
industrials and ornamental flowers to be on the market within 10 years.  
INFLUENCING FACTORS 
In a second question, we wanted to know which factors may influence acceptance, 
regardless of whether positively or negatively: “Currently the consumer acceptance of 
GM plants and food varies across Europe. Many factors have been associated with 
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public acceptance. Please rank the factors in the list below in their importance for 
consumer acceptance over the next 10 to 15 years”. The emphasis here was laid on 
consumer attitudes. 
FIGURE 13: FACTORS INFLUENCING PUBLIC ATTITUDES (Question 5; n = 71) 
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Question: Currently the consumer acceptance of GM plants and food varies across Europe. 
Many factors have been associated with public acceptance. Please rank the factors 
in the list below in their importance for consumer acceptance over the next 10 to 
15 years. Please feel free to add other factors not listed. 
The answers indicate that risk will remain an important factor (Fig. 13): Nine in ten 
experts considered issues related to health risks as important or very important. 
Interestingly, two-thirds of the industry experts (compared to slightly more than half 
on average) considered them to be very important. At the same time, four in five (and 
all of the industry experts) found the factor “consumer benefits related to food quality 
and health” to be important or very important, suggesting that they might see a 
possibility that acceptance could improve in case such benefits would materialise.  
In previous studies, “price benefits for consumers” were understood as genuine 
consumer benefits, but citizens did not necessarily look at the price as an important 
advantage (Denmark, Genetically modified foods). Similarly, in our study, experts did 
not regard price benefits to be as important in influencing public attitudes as food 
quality and health.  
The results suggest that, for the consulted experts, public attitudes would mainly 
depend on personal health benefits or risks that are associated with GM products. The 
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high number of industry experts emphasising health and food quality supports the idea 
that industry is aware of the consumer focus on food safety and health issues. 
In the same vein, experts considered environmental risk to be high on the agenda. Four 
in five considered “risk issues related to the environment” to be of major concern in 
the future, too. In Question 11 (see Fig. 19 in Sect. 4.5), “environmental benefit” was 
considered to be the most likely aspect to be included in future assessment procedures, 
which is somehow at odds with the finding that one of the four least-scoring factors for 
acceptance was “environmental upsides (e.g. reduced need for fertiliser, pesticides or 
tillage).” This suggests that most experts did not expect this argument, which is often 
brought forward by industry, to find any public resonance. It could also indicate that 
experts expect the public to be more concerned about risks to the environment from 
GM plants than to have confidence in such plants solving environmental problems. 
Global issues were considered to be less important for consumer acceptance. Low 
values for “perspectives on global food security” and “global distribution of risk and 
benefits” may indicate that experts considered consumers to assess GM products from 
an individual or European perspective. Likewise, “opportunity for public participation 
in decision making” attracted low scores. Most directly this could be taken as 
dismissive of a deficit model, which would hypothesise consumer acceptance to 
correspond to the level of public participation. On the other hand, those who appreciate 
the role of such participation in creating acceptance also tend to be more enthusiastic 
about such participation in general (Question 15; see Fig. 23 in Sect. 4.7). Whether 
they expect this to result in higher or lower public acceptance remains, however, an 
open question.  
In contrast, information and communication scored highly. Four in five experts 
considered “quality of information to citizens” to be important or very important, as 
did almost nine in ten for “efficient and transparent labelling and free consumer 
choice” (compared with two thirds for “performance of risk management systems”). 
Thus, they seemed to expect that consumers would focus on safety and on clear and 
reliable information in deciding whether to buy products, but not on active 
participation in decision-making.  
GM plants have now been produced for more than a decade. A majority of experts 
seemed to expect that people could get used to GM products. Seven in ten experts 
(and, again, all industry experts) considered “getting accustomed to GM products” 
would be important or very important for consumer acceptance.  
DISCUSSION 
The survey results indicate that experts expect consumers to be sceptical towards GM 
food products, mainly for reasons of (a perceived lack of) safety for human health and 
the environment. Together with the finding that they consider consumer benefits to be 
important factors influencing acceptance, this may reflect a perception that the future 
of GM plants and products could mainly be a question of personal benefit and risk 
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balancing. This is in line with the finding in Sect. 4.2 that experts consider new GM 
food crops with consumer benefits to be on the market within the foreseeable future. 
Apparently, experts think that benefits such as food quality or health effects will foster 
consumer acceptance. A possible habituation effect is also expected to play a role, 
while price premiums are not considered to be equally important. 
The emphasis on the individual consumer can also be deduced from the weight given 
to information and communication. This is unquestionably a necessary prerequisite for 
making an informed choice, both with regard to buying a product and making up one’s 
mind on a political question. In the light of the reluctance to grant importance to the 
issue of participation in decision-making, many experts seem to conceive the question 
of acceptance as being resolved by the market – provided full information is granted to 
allow the consumer to make a rational decision on whether or not to buy – or by 
established politics. 
Expectations are also high with regard to public attitudes towards GM non-food 
products. However, it is not quite clear how consumers will be able to make choices, 
for instance where biofuels produced on a GM basis are mixed with conventional 
fuels. Here, the aspect of the individual consumer making a personal and rational 
decision clearly has its limits, and the citizen balancing his own personal values is 
addressed. Citizens’ deliberations may be equally rational, but they may also be 
influenced by more general considerations that do not necessarily concern individual 
benefits or risks alone. 
In contrast to numerous TA reports, where time and again citizens have expressed the 
opinion that societal issues and ethical concerns should be addressed seriously, many 
experts seemed to be of the opinion that normative demands would become less 
important for future attitudes than individual benefit and risk balancing. Were our 
experts not aware of the societal dimension of the issue? We believe this is not the 
case: many of them come from countries known to harbour a critical public, such as 
Austria, Denmark, Germany, Norway and Switzerland, so it is more than likely that 
they have consciously perceived the ongoing public debate and more general societal 
and ethical questions. 
However, recent survey results seem to indicate that consumers are not very aware of 
buying food that contains GM products, despite claiming to oppose the use of GM 
technology for food purposes (Consumerchoice 2008). This seeming discrepancy may 
relate to the “consumer” expressing buying preferences as opposed to the “citizen” 
expressing general value judgements. We interpret the opinion of the experts given 
above as pertaining more to consumer choice. From the point of view of industry and 
food retail, market acceptance might be considered to solve the problem of alleged 
public opposition to GM plants and food, while the political issues behind it are more 
related to values and might remain unaddressed. 
From a TA perspective, the ethical and societal arguments frequently brought forward 
in participatory procedures as well as the results emerging from large surveys that 
indicate unease in significant parts of the population do not go away, even if some 
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products do find buyers. Rather, they indicate issues that may not only be related to 
GM plants, such as concerns about the behaviour of regulatory bodies and industry, 
deteriorating food culture, or increasing dependence on the interests of multi-national 
companies. These issues, which are related to citizens’ concerns rather than those of 
the consumer, can probably not be comprehensively addressed in the restricted context 
of a debate on the risks and benefits associated with GM plants, but they also cannot be 
dismissed as irrelevant either. 
FREEDOM OF CHOICE, COEXISTENCE AND LABELLING4.4 
BACKGROUND 
For a considerable time, there has been public reluctance to buy agricultural products 
derived from GM plants. At the same time, the biotechnology industry has promised 
agricultural producers that the need for inputs will be reduced, yield increased, and 
environmental benefits provided. Thus, for political reasons, a compromise had to be 
found that would allow the introduction of such products on the market for producers 
and consumers without entailing any consequences for those who, for whatever reason, 
did not want to cultivate GM plants or buy these products. The latter should be 
guaranteed a continued supply of products that are GM-free, at least, for practical 
reasons, under a very low threshold level for unintended GM contens. 
In a recommendation released in 2003, the European Commission issued guidelines for 
member states to ensure the coexistence of GM crop cultivation and conventional and 
organic farming. Since other regulations on admission to the market took care of 
environmental and health risk aspects and the labelling of GM products, the purpose of 
such provisions was merely to allow individual producers and consumers the freedom 
to choose whether or not to use those GM plants and products allowed onto the market. 
For farmers, this means that any influences from GM plants onto non-GM plants 
during production (such as through unintended cross-pollination and volunteering) and 
harvest (through contamination) must be minimised on a crop-specific basis.  
In recent years, states have devised instruments to (a) require GM farmers and actors in 
the food chain to take practical segregation measures to minimise the chance of 
intermixing, and (b) make those who fail to take these measures liable for any losses 
incurred on others. Some states also (c) require actors to contribute to a common 
liability fund that compensates losses of more diffuse origin. There are thus a variety 
of measures in place that should guarantee freedom of choice, although some states 
have not yet fully implemented all required measures.  
Controversies arose as to whether coexistence is feasible in practice and whether the 
ensuing burdens are distributed fairly. The risk of failure to maintain segregation may 
differ according to crop, but also according to agricultural practices or environmental 
conditions, and should be subject to regional variations. Some actors claim that 
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coexistence may only be feasible for certain crops, depending on their reproductive 
biology and/or for a certain scale of cultivation. Others claim that challenges relate 
mainly to institutional or procedural issues, for instance reaching a general agreement 
between farmers in a region whether or not to cultivate GM crops. Under the current 
EU legislation, there is no way of imposing a general decision to use or not to use GM 
crops in a certain area, as this should be left to individual choice. However, such 
provisions are up for debate. 
Policies aim to maintain coexistence along the entire food chain to ensure consumers 
have free choice of products with or without GM. GM products must be traced and 
labelled in order to provide appropriate consumer guidance. However, distinguishing 
GM products from non-GM products for the purpose of labelling has inspired debate. 
For instance, there have been controversies over the amount of GM ingredients that 
can be tolerated in non-GM products. The threshold was set at 0.9 %, provided that the 
ingredient in question has been through the EU risk assessment and authorisation 
procedure, and the admixture is unintended. In addition, some claim that labelling 
should not be restricted to the marketing of primary products from GM plants, but 
should also be mandatory for products where GMOs are used as inputs in secondary 
production, for example meat from animals fed on GM feed. 
Finally, the relation between risk assessment, risk management and coexistence is not 
entirely clear. One interpretation is that these three measures supplement each other. 
First, it is mandatory to carry out an environmental and health risk assessment before a 
GM variety is admitted to the market. If any non-negligible risk can be demonstrated, 
the variety will not be authorised or appropriate measures will have to be taken to 
mitigate the risk. But even if no risk can be demonstrated, products from GM plants 
have to be segregated and labelled as such to allow freedom of choice. This rationale 
implies that while regulatory authorities would ensure that only crops that will be 
managed safely are admitted to the market, individuals should still be allowed to 
decide whether to use them or not. According to this interpretation, it would follow 
that the responsibility to contain risks falls strongly in the hands of regulatory 
authorities. 
Alternatively, coexistence is not only enforced to enable freedom of choice, but also as 
a tool for risk management. First, coexistence measures would render it possible to 
trace back and contain risks that suddenly appear and which had not been anticipated 
during risk assessment. Secondly, there could also be cases where risk assessment 
concludes that a specific crop will be safe under certain conditions. Coexistence 
measures would then be necessary to ensure that the crop is kept under these 
conditions.  
The latter approach would be all the more important if food crops were modified for 
non-food purposes. Such plants might give rise to undisputed hazards if they 
accidentally intermixed with food crops and entered the food chain. Some substances 
produced might be poisonous or at least inedible, so crops must be strictly segregated. 
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In addition, the possibility of the relevant genes being transferred and expressed should 
be kept to the absolute minimum. 
Lastly, it is also reasonable to argue that safety is never absolute and that not all 
concerns can be catered for. Accordingly, coexistence and labelling can be seen as 
means to enable individuals to pursue their preferences regarding whatever risks may 
remain. Such risks can take on different meanings. Apart from individual health 
hazards, risks for the environment that would not necessarily infringe on the 
individual’s personal interests could also be addressed, as could risks of other types 
(e.g. economic risks to farmers not applying GM crops) not subject to risk assessment. 
To conclude, coexistence is intended to provide a way of performing different methods 
of agriculture in parallel and thus rendering the freedom of choice possible. However, 
there are indications that the feasibility of coexistence cannot be taken for granted. It 
remains to be seen whether GM agriculture does not preclude other forms, in particular 
organic farming. We therefore wanted to explore whether coexistence schemes can 
adequately provide freedom of choice for producers and consumers. 
RESULTS FROM THE TA PROJECT REVIEWS AND FUTURE ISSUES 
A number of TA projects in Austria, Denmark, Flanders, Germany, Norway 
Switzerland and UK explored coexistence and labelling. However, all projects 
explicitly dedicated to such issues were undertaken prior to the introduction of the 
relevant regulation. Thus, there is no ex-post assessment of the actual instruments set 
in place. Even if it cannot be deduced from these reports whether the instruments 
available adequately address the problem or not, particular points to consider emerged. 
The following summary is based on ten reports:  
> Austria, “GMO-free” claims and the avoidance of GMOs in feed 
> Austria, Coexistence 
> Denmark, Coexistence  
> Flanders, New impulses for the debate on genetically modified food 
> Flanders, Functional food 
> Germany, Green Biotechnology Discourse 
> Norway, Coexistence 
> Switzerland, Coexistence 
> Switzerland, Genetic Technology and Nutrition 
> UK, GM dialogue 
In general, the reports underline the need to provide for free choice, not least in 
response to as yet unresolved risk claims and contradictory opinions on the potential 
benefits and detriments (Denmark, Coexistence). In some countries, coexistence seems 
to be considered a political solution to facilitate the introduction of GM plants (UK, 
GM dialogue). Free choice implies that correct labelling is provided and that the 
existence of conventional and organic farming must be guaranteed (Denmark, 
Coexistence; Switzerland, Genetic Technology and Nutrition). To this end, it is 
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mandatory for completely separate distribution channels to be installed (Flanders, New 
impulses for the debate on genetically modified food).  
Several reports come to the conclusion that coexistence is feasible in principle, 
however, only under certain conditions (Switzerland, Coexistence; Denmark, 
Coexistence; Austria, Coexistence). The European rules for authorising GM plants are 
adequate in general, but may be leaky in some cases (Flanders, New impulses). Since 
the risk of spreading and intermixing cannot be eliminated, technical precautions must 
be taken and enforced. Such measures must be tailored to the crop type, the 
agricultural system and the geography – a point already emphasised in the European 
Commission’s recommendations. Ultimately, it is necessary to consider the scope of 
cultivation of GM crops as well (Denmark, Coexistence). However, in many reports 
doubts are expressed as to whether coexistence will be possible for all crops. Even in 
cases where coexistence appears feasible, the necessary measures to maintain 
segregation between GM and non-GM plants and their products entail rather 
demanding crop-specific logistics along the entire production, processing and 
distribution chain (Austria, Coexistence).  
The reports frequently highlight practical challenges related to establishing thresholds 
for unintended GM ingredients in non-GM products. Two fields are considered to be 
particularly problematic: contamination of organic products and of seed sold as non-
GM (Germany, Green Biotechnology Discourse; UK, GM dialogue). In both cases, 
reports quote demands for threshold levels below those foreseen and close to the level 
of detection, which would be a considerable challenge to industry.  
Since intermixing cannot be ruled out, according to many reports, systems of 
compensation and liability are considered imperative, and it was stressed that rules 
should be uniform across Europe (Denmark, Coexistence; Norway, Coexistence; 
Switzerland, Coexistence; Switzerland, Genetic Technology and Nutrition). Reports 
also raise questions about the considerable costs of commitments and measures to 
minimise the effect of segregation failure, such as extra checks and quality controls, 
which would raise the costs of non-GM products and would have to be borne by the 
GM sector (Flanders, New impulses for the debate on genetically modified food, 
Austria, Coexistence).  
Some sceptical reports raise doubts as to whether coexistence as conceived by the 
European institutions would be feasible at all and, even if it were feasible, whether it 
would be worth the considerable social and economic cost entailed (Austria, 
Coexistence, Norway, Coexistence). In addition, and in the light of doubts about 
whether unilateral EU policies are possible at all, given the global market for seed, 
food and feed, any European regulatory approach might be doomed to failure (Austria, 
“GMO-free”; Norway, Coexistence). 
Although the general impression from most of the reviews is that labelling is supported 
in principle, there are also questions over whether consumers can handle a possible 
information overload (Flanders, Functional food). In addition, different interpretations 
of the term “GMO-free” seem to exist in the public, and there are demands for 
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labelling not only primary products, but also derived, or secondary, ones such as meat 
from animals fed on GM crops (Austria, “GMO-free”; Norway, Coexistence).  
Taken together, the reports seem to imply a conditional 'yes' in response to whether 
coexistence would be feasible, although a general consensus on this question between 
experts and stakeholders seems to be difficult to reach (Germany, Discourse). 
Elaborate, costly and rather far-reaching measures must be taken in order to guarantee 
segregation and labelling, and many there questions still remain unanswered regarding 
the practical implementation and the division of burdens. 
PRELIMINARY CONCLUSIONS AND RESULTING QUESTIONS 
The proper functioning of coexistence and labelling is a prerequisite for turning the 
concept of freedom of choice into reality. Despite criticism, it is still considered an 
appropriate answer to the concerns of both citizens and consumers, the interests of 
individual farmers who wish to perform very different forms of agriculture and the 
(often diverging) interests of trade and industry.  
The question is whether coexistence is feasible and, if so, for which crop, under which 
conditions and at which costs. While the reports reviewed (theoretically) seem to 
provide a cautiously positive answer, the lack of experience so far and some incidence 
of contaminations that have occurred over recent years in other countries preclude a 
final judgement. Whether coexistence is now feasible and will be so in the future 
depends mainly on whether the instruments for coexistence can be shown to work for 
“first-generation” GM plants. In particular, it will be crucial to see whether all GM 
products that qualify for labelling in principle will also be so in practice. This, 
however, can only be assessed if the relevant products are placed on the market, which 
again is subject to the proper functioning of coexistence. It seems that we have a catch 
22 situation regarding the answer to the question whether coexistence can function. 
RESULTS OF THE SURVEY 
WILL COEXISTENCE WORK FOR FIRST-GENERATION GM PLANTS? 
In the light of different answers given in the project reviews, we wanted to know 
whether experts thought that coexistence would work for “first-generation” GM plants 
(e.g. insect- or virus-resistant and herbicide-tolerant plants) over the next 15 years. 
Overall, it emerged that opinions among the experts approached were split (Fig. 14): 
roughly one-third of the respondents thought that coexistence might work for some 
specific crops for large-scale cultivation, compared to one-quarter who considered it 
would work only for cultivation on a small scale. One in six expected that coexistence 
could work on a large scale for almost every crop, while a similar number thought it 
would not work at all. Experts from industry had more confidence in coexistence, with 
8 out of 11 expecting that coexistence would work on a large scale. 
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In their comments, respondents further explained their views. A respondent who 
believed coexistence could work stated: “Only for a few crop types in certain small 
scale farming regions will it be very difficult for GM crops to coexist.” A more 
sceptical respondent referred to historical examples: “Contamination is unavoidable, 
e.g. StarLink, US rice, etc. There are too many places where contamination could take 
place, so it is impossible to separate.” Somewhere in between, another respondent 
argued crop-specifically: “In my opinion coexistence might be possible for non-food 
potatoes but not for canola or sugar beet.” A respondent who ticked the “Don’t know” 
option enlarged the view from the purely technical to the organisational level: “I’m 
sure that technically efficient measures can be devised for some crops in some places 
(and not for others). However, I’m less confident the industry is ready for such a clear 
commitment to the polluter pays principle.”  
FIGURE 14: WILL COEXISTENCE WORK FOR FIRST-GENERATION GM PLANTS?  
 (Question 7; n = 71) 
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Question: Coexistence measures are a central part of risk management under GM-
cultivation. Coexistence is also a central prerequisite for freedom of choice. 
Coexistence may be a challenge, depending on type of crop and location. Do you 
think that coexistence will work for the "first-generation" of GM plants (e.g. 
insect-resistant, herbicide-resistant and virus-resistant (VR) plants) in the next 15 
years? (Please tick one possibility). 
In conclusion, responses to this question indicated that the issue of coexistence has not 
been settled and a consensus has not yet been achieved.  
CAN CONSUMER CHOICE BE MAINTAINED? 
Question 9 (Fig. 15) was reciprocal as it covered a similar issue, this time viewed not 
from the producers’ but from the consumer perspective. Referring to the close 
connection between coexistence and labelling, we asked the experts for their opinion 
on which of five different scenarios they expected to come true regarding the 
possibility of maintaining consumer choice. Notably, the majority of respondents 
believed that coexistence and labelling would work generally (Fig. 15). The second 
largest group of respondents, however, considered that GM food would only play a 
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marginal role in the future. The other alternatives offered were attracted fewer 
responses. Thus, respondents did not believe that European consumers are about to 
experience a lack of GM-free alternatives.  
FIGURE 15: CAN CONSUMER CHOICE BE MAINTAINED? (Question 9; n = 71) 
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Question: Coexistence and labelling of GM food are closely connected. There are different 
opinions over how well the current EU regulations would cope with the extended 
use and growing of GM plants in Europe. Please indicate which scenario in your 
opinion is most likely. (Please tick one scenario) 
To further analyse how respondents saw the relationship between coexistence and 
labelling we compared responses to Question 9 and Question 7. It was evident, for 
instance, that those who supported the scenario of successful coexistence/correct 
labelling in Question 9 had diverse perspectives on the feasible scale of GM-
cultivation in Question 7. And vice versa: a high proportion of those who did not show 
any confidence in coexistence in Question 7 thought that GM food would generally be 
blocked from the market in Question 9. 
A respondent who ticked the “successful coexistence” option commented: “(….) it is 
highly questionable whether non-GM food will be available in the future. Of highest 
importance is the question of seed and threshold levels for non-GM seed.” Another 
expert stated that “the reality is a blockade of GM food on the market, but one could 
have successful coexistence allowing up to 0.9 % of approved GMs in products (….).” 
In addition, one respondent questioned the wisdom of leaving everything to consumer 
choice alone: “Labelling is important in relation to human health concerns but hardly 
addresses the environmental risks.” 
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DO COEXISTENCE SCHEMES ADDRESS RISKS? 
The latter remark brings us back to the discussion from the Introduction of whether 
coexistence and labelling merely provides for freedom of choice, or also is part of risk 
management. From this discussion we can deduce a controversy over whether current 
risk assessment, as a basis for coexistence schemes, will be able to contain all relevant 
risks. If not, risks not covered could possibly be passed on to third parties, which is 
considered problematic. In Question 8, therefore, respondents were asked to provide 
their views on whether there could be relevant environmental or economic risks that 
would not be contained by current risk assessment and coexistence schemes.  
The majority of respondents believed that risks might occur that would not be 
contained by current risk assessment and coexistence schemes, while only one in six 
believed that such risks do not exist at all (Fig. 16). Almost half of the respondents 
thought that such risks might occur for all GM crops. To further explore the 
judgements of the sub-sample who believed risks remain, we asked how serious they 
considered such risks to be and whether they found it feasible to come to a fair 
distribution of risks and burdens. The question allowed multiple responses. 
FIGURE 16: DO COEXISTENCE SCHEMES ADDRESS RISKS? (Question 8A; n = 71) 
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Relevant risks exist for a few particular GM crops.
Relevant risks exist for all GM crops.
Don’t know
 
Question: For the cultivation of GM crops some experts have discussed whether there could 
be relevant environmental or economic risks (e.g. to farmers not applying GM 
crops) that would not be contained by current risk assessment and coexistence 
schemes. Please tick the statement that comes closest to your opinion. 
Only one in eight responded that remaining risks are negligible, and, taken together 
with those who believe they do not exist at all (mentioned above), these two groups 
make up an total of 20 respondents (Fig. 17). At the opposite end of the spectrum, one 
in three (26) found the remaining risks to be unacceptable and to require regulatory 
intervention. The remaining respondents, approximately one in four, can be interpreted 
to judge that risks remain that should not be ignored but could be handled by current 
regulation. 
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FIGURE 17: HOW TO MEET RISKS? (Question 8B; n = 56) 
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Don’t know
 
Question: If you think that relevant risks might exist [in question 8A], please tick those 
statements that come closest to your opinion (multiple answers possible). 
The strong call for regulatory intervention contrasts with the rather lower rejection of 
coexistence and labelling discussed in previous sections. One explanation may be that 
saying “coexistence will not work at all”, as in the previous section, is a more 
categorical rejection than saying “there are risks that would not be contained by current 
coexistence schemes, and such risks are unacceptable and need regulatory 
intervention”, which permits solutions other than rejection. 
Against this background, the next question explored whether the same sub-sample of 
56 respondents deemed current regulations sufficient. One in three (of the sub-sample) 
agreed, while more than one in three found them entirely insufficient (Fig. 18). 
Somewhat smaller was the number of those who considered them adequate today but 
expected problems in the future. 
FIGURE 18: ARE REGULATORY PROVISIONS SUFFICIENT? (Question 8C; n = 56) 
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Question: Do you think that current regulatory provisions are sufficient to deal with such 
risks [see question 8B], today or for the foreseeable future? 
The 36 respondents who found current regulations insufficient, now or in the future, 
were further asked how these risks should be addressed. Rather than new regulation, 
stronger liability and new approaches to risk assessment were the most frequently 
mentioned remedies. 
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DISCUSSION 
Can coexistence be considered a viable concept, and will it work? Without 
coexistence, no sensible labelling would be possible, and the freedom of choice could 
not be realised. Indications towards an answer in one or the other direction have been 
inconclusive so far. 
Many experts believed that GM food will be labelled correctly and that non-GM food 
will continue to be available, indicating confidence in current systems of traceability 
and labelling. According to Question 7 (Fig. 14), most respondents in our expert 
survey expected coexistence to work in general, which is in accordance with the 
majority of the TA reports reviewed. 
However, at the same time, both the reports and the expert survey indicated that 
coexistence might be rather intricate and dependent on many conditions. We can take 
this as a reason why a number of our respondents have no confidence in current 
coexistence schemes. Apart from those who bluntly reject the overall approach to 
coexistence for one reason or another, some respondents believe that coexistence could 
work for crops with a certain reproductive biology only and/or provided that certain 
precautions are taken, including a consideration of the scale of cultivation.  
In conclusion, coexistence may be considered a viable concept, but one that would be 
difficult to realise for all crops and perhaps impossible under certain circumstances 
(INRA 2008). Agronomic research results show that it may depend on the individual 
case, the crop, the plant variety, the location and the agricultural context (neighbouring 
crops, field size, etc.) whether coexistence is deemed to work or not. Therefore, it is 
not surprising that answers to the initial questions are found to be contradictory. 
Some light may be shed on the reasons behind this discrepancy by considering risk 
aspects, even if coexistence was intended as a means to escape from, or to circumvent, 
contentious risk debates. Despite widespread expectations that coexistence as such 
may be implemented, almost half the respondents expected current schemes for risk 
assessment as a prerequisite for coexistence to be insufficient to contain all relevant 
risks. Some may have thought the assessment might not be able to cover risks 
adequately, or they might have considered particular topics relevant that are not subject 
to risk assessment. In other words, under the auspices of coexistence the debate on risk 
has not come to a halt. 
If current provisions are not considered to be sufficient, this points to the need to 
recalibrate approaches to assessing, authorising and/or managing GM crops. Some 
respondents put their hopes in a compensation system, which directs attention to the 
fair distribution of the benefits from cultivating GM crops and the burdens from 
unintended consequences. Therefore, a discussion of benefits and the aims of 
agriculture appears necessary. 
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BENEFIT ASSESSMENT AND AIMS IN AGRICULTURE 4.5 
BACKGROUND 
Ever since the need for assessing possible risks of GM plants became topical, criteria 
have been a point of discussion. Various reports have thrown up the question of 
whether today’s assessment criteria are adequate. A particular point where opinions 
diverge is whether benefit should be taken into consideration, and if so, what “benefit” 
means.  
The European regulation of GM plants only foresees an assessment of environmental 
and health risks. Nevertheless, the Norwegian regulatory approach also includes an 
obligation to consider “benefits to society”. In the German law which aims to promote 
genetic engineering, benefits are at least indirectly included in the regulation. In this 
latter case, however, only risks to human health and the environment are currently 
considered in practice, while societal or moral concerns are considered impossible to 
assess objectively. Similarly, The Austrian law governing genetic engineering 
stipulated in its original form that genetic engineering applications should not be 
socially unsustainable, but this could not be translated into regulatory criteria. 
Over recent years, and separate from debates on risk, a public debate has developed on 
the benefits of GM plants and food. Here different arguments have been introduced. 
On the one hand, it was argued that the first generation of GM plants provided benefits 
to farmers only (if at all), and that they carried no benefits for consumers. Accordingly, 
if uncertainties in risk assessment remained, they were considered unacceptable. This 
highlighted the question of the degree of risk that might be acceptable or conversely, 
what degree of risk could constitute a veto.  
On the other hand, it was expected that a new generation of GM plants would bring 
benefits for consumers, such as increased nutritional properties, which should be 
weighed against potential risks. GM plants might also replace conventional plants and 
processes that were also not risk-free, or they might reduce other risks. Thus, at least in 
public debate, there is a discussion that benefits might possibly outweigh certain risks. 
For policy-making, the problem is how to respond to demands for considering benefit 
or the lack of it in dealing with the issue of GM plants. One option would be to 
consider benefit at a political level, without formally integrating its assessment into the 
case-to-case authorisation procedures. This would imply general policies such as the 
decision to promote those GM applications that carry a consensus that they would 
bring societal benefit, or to promote alternative pathways if not. Currently, opinions 
seem to be deeply split on this issue.  
Another possibility would be to explicitly devise a case-based assessment in the 
authorisation procedures for products, but there are few precedents for such an 
approach. So far, the most prominent example is with the authorisation of drugs, where 
such an approach follows acknowledged criteria for efficacy and lack of side effects 
and further involves a comparison with established drugs. 
 61
4.  REVIEW AND SURVEY RESULTS 
For transgenic crops, both the criteria and the comparator are contested. So far, the 
normative framework for regulating novel agricultural varieties is derived from the 
sum of current aims of the established practice in agriculture. This framework is in 
principle applied to GM plants as well; in other words, they must (at least) meet the 
same criteria as “conventional” non-GM plants cultivated in today’s agriculture. 
However, even these conventional aims of agriculture are under discussion and 
continue to shift, as can easily be deduced from the debates surrounding the 
formulation of the European Common Agricultural Policy. New developments such as 
the quest for sustainable agriculture might interfere with more traditional aims such as 
high productivity.  
In addition, tasks other than producing food have been assigned to the agricultural 
system, such as landscape protection or providing a basis for tourism, leading to 
increased importance for the concept of multi-functional agriculture. Such multiple 
tasks might also have an influence on how the risks or benefits of growing particular 
GM plants might be assessed in the future. Such very basic considerations have 
influenced the debate on GM, conventional and organic agriculture, and tap into a 
variety of issues in different countries. Therefore, specific domestic aspects cannot be 
discounted when the options for including benefit in the assessment criteria for GM 
plants are discussed. 
RESULTS FROM THE TA PROJECT REVIEWS 
Several reports from EPTA members came up with the issue of benefit assessment in 
various contexts. This summary is based on the following reports:  
> Denmark, GM crops in developing countries 
> Flanders, Functional Food 
> Germany, Green Biotechnology Discourse 
> Germany, Risk assessment and post-marketing monitoring 
> Norway, Sustainability and societal impact of GM food 
> Switzerland, Future of plant biotechnology 
Three main questions come to mind that would be necessary to address: firstly, the 
kind of benefits discussed; secondly, the way such benefit could be assessed, and 
thirdly, the way the result of such assessments could be taken into account.   
With regard to the kind of benefits, several potential ones have been assigned to GM 
plants. For example, certain GM crops are said to assist in ensuring sustainable 
agricultural production and food supply particularly in Third World countries 
(Denmark, GM crops in developing countries). On the domestic front, consumer 
benefits might arise from GM foods in the form of improved food products which lead 
to healthier nutrition (Germany, Green Biotechnology Discourse). There might even be 
scientific evidence of health benefits from GM functional food products to be taken 
into account. However, proving them might be difficult (Flanders, Functional Food), 
and a consensus over whether and what kind of a benefit could be expected seemed 
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difficult to establish (Germany, Green Biotechnology Discourse). An interesting 
perspective comes from a Swiss lay panel that established a link between benefits and 
a particular understanding of risk: accordingly, if the potential benefits from GM plants 
are not be realised in the future because research on them does not take place today, 
this might be considered a risk (Switzerland, Future of plant biotechnology).  
Various views were expressed on how to assess benefit. Here, the ruling normative 
framework determines the choice of criteria. However, few reports explicitly highlight 
the normative dimension arising from the multi-tasking nature of agriculture. The issue 
came up when a normative framework for desirable agricultural practice or sustainable 
agriculture was considered to be missing (Germany, Risk assessment and post-
marketing monitoring). The most elaborate investigation came from Norway, the 
country with most experience in discussing benefit criteria. It came to the conclusion 
that any kind of pragmatic benefit assessment would have to rely on checklists to be 
amended case-specifically according to the properties of the product and the 
contingencies of its production and use. Where the necessary information for such an 
assessment could be derived from, however, remained unclear (Norway, Sustainability 
and societal impact of GM food). Benefits might also be assessed indirectly through 
comparative risk analysis: risks related to a new technology such as GMOs could be 
compared to the risks of the technology it is replacing, which might be considered a 
benefit (Switzerland, Future of plant biotechnology).  
Thirdly, where a benefit can be established, how should this be taken into account in 
regulatory decision-making? Norway is the only country so far where benefit 
assessments have been officially integrated in the authorisation procedure for GM 
plants. Here, an assessment of societal benefit as well as of the contribution to 
sustainability is mandatory even for experimental releases; however, its 
implementation has not yet been fully accomplished (Norway, Sustainability and 
societal impact of GM food). One question was whether benefits should be considered 
as an additional requirement or a factor that might soften up the requirement for the 
absence of risks for health and the environment. 
Implicitly, and irrespective of whether benefits can be demonstrated in an assessment 
or not, the Swiss lay panel emphasised that the relation between scientifically 
established risk and societal preferences must already be balanced today. Since a zero 
risk level cannot be achieved, an acceptable level of risk had to be determined 
(Switzerland, Future of plant biotechnology). 
PRELIMINARY CONCLUSIONS AND RESULTING QUESTIONS 
While the idea of taking benefits into account is attractive to many, the implementation 
of a workable system of assessment, the establishment of relevant criteria and of an 
acceptable way of incorporating the findings from such an assessment into regulatory 
decision making remain to be solved. In other words, the practical dimensions of 
benefit assessment must be determined. It is therefore unclear whether such 
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assessments will ever become reality. What are the criteria, if indeed there are any, 
against which benefit might feasibly be measured? 
Closely linked to the question of whether and how to assess benefits is the question of 
aims in agriculture. A benefit can only be measured according to a particular aim, and 
what might constitute a benefit for one aim might be detrimental to another competing 
aim. Which aims will gain in importance in the future? 
RESULTS OF THE QUESTIONNAIRE 
BENEFIT ASSESSMENT 
Different forms of assessment can be envisaged that take into account parameters other 
than environmental and health risks. We, therefore, wanted to know whether experts 
could consider criteria other than risk (in conventional terms), in particular whether it 
was considered acceptable and feasible to include benefits in the assessment of GM 
plants, as is the case with pharmaceuticals.  
FIGURE 19: BENEFIT ASSESSMENT (Question 11; n = 71) 
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Question: So far, the assessment procedures for GM plants and food only takes into account 
potential risks. Some actors have advocated that also potential benefits should be 
taken into consideration as applied in areas such as pharmaceuticals.  
Below is a list of potential benefits that could be included in such considerations. 
Please assess how likely it is that in future different benefits will be considered 
for GM approvals. Please feel free to add other groups not listed. 
The responses showed that experts were split over the likelihood that benefits would be 
considered for GM approvals (Fig. 19). A majority of respondents thought it likely that 
environmental benefits would be taken into such consideration, while the opposite is 
true for pending economic return. The experts were divided on the likelihood of taking 
food quality and nutritional benefits into consideration, while a slight majority 
considered food safety a probable field where benefits could be taken into account in 
the future.  
Despite the substantial proportion of those who considered the consideration of 
benefits likely or very likely, many comments emphasised the regulatory difficulties 
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involved in such a step. One respondent expressed that “there are a number of serious 
difficulties in the inclusion of extensive benefit analysis. However, it is something that 
clearly could be considered.” Another questioned whether licensing is the right place 
to include a benefit assessment: “Regulators only take care of risks. The Market takes 
care of the benefits and the risks.” Obviously, for this expert benefits could only be 
conceived on a personal level amenable to market forces. 
Benefits were clearly considered subject to interests and values, in contrast to health 
risks that were deemed unacceptable to everybody. A number of respondents 
highlighted that drug assessments were the only example in product regulation where 
benefits would be taken into consideration, and contrasts were drawn: “In the health 
sector people are willing to take a risk if there is enough benefit. In GM crops people 
will not be willing to take any risk” and: “taking pharmaceuticals, we consider that we 
may have to take risks. Eating food is something different.” Medical benefits usually 
were seen as weighing heavier than possible side effects if people were to regain their 
health – but food consumption as an important part of everyday life was considered 
different, and risks deemed unacceptable.  
Some comments addressed the issue of comparisons between conventional and GM 
crops. They proposed attributing a benefit to conventional crops compared with their 
GM counterparts due to the absence of uncertainty associated with the technology, all 
other parameters being equal. Support for such systematic and a priori suspicion of risk 
with GM crops, however, was only encountered sporadically among the comments. In 
addition, public perception remained a controversial problem. Although “these 
initiatives may substantially improve public perception, and so potentially pave the 
way for profitable GM crop production”, another expert stated that “…in the current 
public perception setting, I don’t believe that positive considerations would be taken 
into account.” 
AIMS IN AGRICULTURE 
In order to determine whether a GM crop conveyed a benefit, it would be necessary to 
know which aims are assigned to agriculture at large. For comparative risk assessment, 
too, aims are important because comparisons must be drawn with established practices 
in agriculture. In Europe, these practices vary according to climate or soil, but also 
according to the tasks assigned to agriculture. For example, in addition to efficiently 
producing crops or providing jobs, agriculture is called to protect the traditional 
landscape and the natural environment. Thus, agriculture must pursue different aims, 
against which the performance of GM cultivation could be measured.  
In the light of a certain lack of coverage in the reviews, we wanted to know which 
tasks of agriculture respondents considered likely to become salient in the foreseeable 
future. We presented a list of tasks and asked the experts to rank them. 
In total, the majority of experts agreed that the aims for future agriculture proposed in 
the questionnaire would become salient (Fig. 20). For most aims, those who ranked the 
aim to become important outnumbered the others by at least two to one. The only 
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exception pertained to the promotion of organic farming, whose salience was doubted 
by two in five experts. This probably reflected the controversial nature of the debates 
on organic farming among proponents and opponents.  
FIGURE 20: AIMS IN AGRICULTURE (Question 12; n = 71) 
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Question: In order to assess risks and benefits of GM cultivation, it must be compared to 
established practices in agriculture. In Europe, these practices vary according to 
climate or soil, but also to the tasks assigned to agriculture. For example, and 
apart from efficiently producing crops or providing jobs, agriculture should also 
protect the traditional landscape and the natural environment, among others. Thus, 
agriculture must pursue different aims, against which the performance of GM 
cultivation will be measured. Please rank the aims in the list below in their 
importance over the next 10 to 15 years. 
The most unanimous vote was seen for crop production with the least possible 
environmental impact, which more than nine in ten expected to become important. 
Only slightly less popular with the experts was the production of high-quality food in 
great variety and reducing inputs in crop production. This again could be seen as 
relating to minimising environmental impact. Following this argumentation, there 
seemed to be a consensus among the experts that the general aim of sustainable 
agriculture would likely be a guiding principle in the future. 
However, caution must be applied in interpreting the results since they may reflect 
different conceptions of the underlying basic terms. For example, environmental 
impact has always been difficult to define, and the future conditions of agriculture 
(such as pest infliction or drought) are difficult to foresee. 
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DISCUSSION 
Experts were split over the likelihood that assessing benefits would be part of future 
assessment procedures, but a substantial proportion think it likely. Considering the 
doubts expressed in some comments, the question arises as to why there is such a 
support. One reason simply might have been the wording in the questionnaire, where 
the word “consider” rather than “assess” was used. This might have allowed an 
interpretation that topics were to be considered on a general level and not in the case-
by-case assessment and approval procedure.   
On the other hand, environmental benefits turned out to be considered more likely to 
be implemented than economic criteria, which might reflect a general emphasis on the 
aim of state action in sustaining the public good rather than safeguarding individual 
benefit. It might also indicate the implicit aim on the part of some experts to pass over 
problems of acceptance in a situation where the benefits of GM plants, in the opinion 
of some, might not be sufficiently appreciated.  
This raises the question of who could be considered to benefit from the introduction of 
benefit assessments in some form. It could work in different directions; some may 
argue that if a GM crop does not bring additional benefits, this should veto the crop 
entirely. On the other hand, GM advocates would hope that the consideration of 
environmental benefits would strengthen their case. 
The main question remains as to the level, if there is one, at which such state action 
should be implemented in order to make it both practically sound and politically 
legitimate. Should it be at a political level, with open commitments for particular forms 
of agriculture such as promotion of high productivity, large-scale production or of 
small-scale, diversified and/or organic farming where possible and desired? Or should 
it be at a regulatory level where formal procedures are incorporated? As comments 
suggested, the latter seems to be hampered by some rather basic problems. From a 
practical point of view, there are almost no examples of benefit assessment in product 
authorisation procedures to draw upon, apart from medical substances and devices. For 
the latter, societal benefits have always been linked to health gains, which can be 
established by scientific means.  
From the perspective of political legitimacy, societal benefit is difficult to determine 
because of a lack of generally accepted criteria. Usually, marketable products are 
considered to deliver personal benefits in the first place, and the market is considered 
to be effective in determining such personal benefit and providing the appropriate 
signals to producers. In contrast, societal benefit, if accepted to be different from the 
sum of individual benefits, is a much less obvious concept. If it is considered at all, it is 
often deemed subject to political preferences rather than market forces, and generally 
accepted methods to determine such benefit are difficult to establish. It remains to be 
seen whether a suitable regime can be found that will live up to the expectations 
entertained by some with regard to benefit assessment. 
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The normative framework at the basis of any benefit assessment depends on the 
acknowledged aims in agriculture. From the survey, it appeared that reducing the input 
and impact on the environment while sustaining food quality and variety were 
expected to become salient in the future. Such a result is not very surprising, as the 
aims mentioned can be considered part of the sustainability propagated as the overall 
frame for future European agriculture (and in other world regions). Nevertheless, the 
clear result is noteworthy; reducing input and environmental impact while sustaining 
high quality is obviously considered almost indisputable among the participating 
experts. By contrast, the promotion of organic farming has attracted more doubts. It 
seems to be too controversial an approach for a future paradigm for agriculture. This 
suggests that conventional farming will remain a central starting point for a more 
sustainable agriculture. 
Nevertheless, it remains a matter of a broader debate whether the aims experts 
regarded as likely to be dominant in the future would become so in reality. There are 
many competing aims, including those directed towards mostly economic parameters, 
which may become more dominant in the future. If GM plants are to find a place in 
European agriculture, they will have to fit into the aims pursued by a future 
agricultural system. Thus, their future is dependent on the developments of this system 
rather than on particular pieces of legislation alone. 
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GLOBAL ASPECTS OF GM REGULATION 4.6 
BACKGROUND 
The trade in agricultural (and food) products has increased substantially over the last 
20 years with the expansion in trade by leading export and import countries and with 
new countries participating in the globalisation of markets. In the current round of 
multi-lateral trade negotiations in the WTO, the so-called Doha Development Agenda 
(DDA), major objectives include the further opening of the market and the relationship 
between WTO rules and multi-lateral environmental agreements. Discord on 
agricultural issues was one of the main reasons why DDA negotiations have not yet 
been successfully concluded. 
The practice of GM regulation in the EU was previously already challenged before the 
WTO. In 2003, the United States, Canada and Argentina complained about the delay in 
approving and marketing new GM crops (the so-called de facto moratorium) in the 
EU, which was considered to go against WTO rules. The WTO dispute settlement 
panel came to the conclusion that the EU had violated the Agreement on the 
Application of Sanitary and Phytosanitary Measures (SPS) (WTO 2006) by 
> An alleged general EU moratorium of approving GM products for 
commercialisation, 
> Product-specific SPS measures, 
> EU Member State safeguard measures against GM products. 
The EU defended its regulatory regime with reference to its Cartagena Protocol on 
Biosafety commitment, which takes a precautionary approach to regulating GMOs. 
The WTO dispute settlement panel rejected the precautionary defence of the EU and 
ruled that the Cartagena Protocol is not relevant if disputants are not party to the 
agreement. In this way, the panel accentuated the schism between the WTO and the 
United Nations system. However, there could have been an alternative: The panel 
could have declined to rule, given the lack of consensus on risk assessment and risk 
management options in multi-lateral agreements (Suppan 2006). This means that at 
certain times different systems of international agreements can come to different 
conclusions regarding risk regulation. There is reason to believe that conflicts between 
differing agreements and approaches on trade and risk regulation will be with us for 
some time. 
Substantially, the WTO ruling could be seen as indicating that only those restrictions 
that are rooted in the demonstration, if not proof, of particular risks would be 
acceptable within international trade regulations. This highlighted not only the 
different approaches taken by the US and its allies, on the one hand, and the EU, on the 
other: It also became obvious that among EU member states, the implementation 
practice differed to some extent, despite a common regulatory framework, so that some 
Member State’s practices came into conflict with WTO rules. 
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RESULTS FROM THE TA PROJECT REVIEWS AND FUTURE ISSUES 
The solution to such controversies remains open. Although this could turn out to be an 
important topic for future regulation of GM plants in Europe, most TA reports over 
recent years have only addressed international issues in passing. The reports reviewed 
also concentrated on the debates and regulation in their own countries of origin and in 
the EU. A small number of reports assessed the risks and opportunities for GM crop 
use in developing countries. In all cases, the global aspects of GM regulation were not 
the main focus. Nonetheless, a number of reports did address the global increase of 
GM crop acreage, the question of international trade conflicts, the development of 
international GM regulations and the different approaches to risk assessment and 
regulation in some way. The following points are based on information from six 
reports 
> Austria, The Role of Precaution in GMO policy 
> Germany, Green Biotechnology Discourse 
> Norway, Reconvening the lay people’s panel on GM food 4 years after 
> Norway, Sustainability and societal impacts of GM food 
> Switzerland, Genetic Technology and Nutrition 
> UK, GM dialogue 
In the first place, regulatory challenges were identified in the context of international 
dependencies and international harmonisation. One of the challenges identified was 
how the EU would respond to the WTO dispute panel’s findings on the 
implementation of GM crop regulations in the EU (UK, GM dialogue).  
Furthermore, there was a demand for laws and regulations to be co-ordinated at the 
international level (Norway, Sustainability and societal impact of GM food). Two 
countries within Europe that are not EU member states, Switzerland and Norway, 
maintain a close relationship, but retain regulatory approaches to GM plants that differ 
in some respects from those in the EU. Proceeding from the specific regulations in 
Norway and Switzerland, reports from these countries identified challenges for their 
unilateral policies: 
> As an open question, it was discussed to what degree a unilateral Swiss policy is 
possible, and to what extent there is a need to use of GMOs in Switzerland 
(Switzerland, Genetic Technology and Nutrition). 
> The criteria of sustainability and societal benefit in the Norwegian legislation 
appear to be unique and raise questions of access to relevant information about the 
products and the willingness of applicants to provide such data just for Norway. In 
consequence, Norway cannot fully undertake the relevant assessments, and due to 
this lack of documentation, Norwegian authorities may end up not authorising any 
given product. However, the EU might not consider such terms legitimate for 
rejecting an authorisation, which might be necessary under Norway’s commitment 
as member of the EEA. Thus, a number of questions regarding the harmonisation of 
regulation within the EU/EEA remain. (Norway, Sustainability and societal impact 
of GM food). 
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Another considerable challenge identified is to find ways to proceed from the 
precautionary principle to an applicable approach and concrete actions, and to define 
its relation to the risk assessment framework. The precautionary principle should not 
be used as a technical barrier to trade or a tool for protectionism (Austria, The Role of 
Precaution in GMO policy). The further definition and operationalisation of the 
precautionary principle was specified as a task in various reviews (Austria, The Role of 
Precaution in GMO policy; Germany, Green Biotechnology Discourse).  
One argument taken up by several reports was that the “sound science” approach (as 
prevalent in US policies), with its tendency to delay safety obligations until the causal 
chain between a harmful impact and its source has been fully established, runs counter 
to the precautionary principle. This underlies several pending or already manifest 
conflicts between the US and EU (as materialised in the WTO dispute). The EU could 
possibly build on a “de facto coalition” with developing countries in favour of the 
precautionary principle in order to strengthen its position and promote its 
understanding of precaution (Austria, The Role of Precaution in GMO policy). 
In summary, conflicts involving WTO regulations in the context of applying the 
precautionary principle and/or sustaining unilateral safeguard measures were identified 
as important future challenges for current European regulation. 
PRELIMINARY CONCLUSIONS AND RESULTING QUESTIONS 
It is probable that in the future, more types of GM crops will be released, both in 
exporting countries and in Europe. Therefore, there is a possibility that, in the future, 
the US and other countries might continue to challenge the current EU regulation 
which is based on the precautionary principle and the case-by-case risk assessment and 
authorisation that is so far mandatory. To explore the judgments of the experts, two 
questions on global aspects of GM regulation were included in the questionnaire. One 
question pertained to the consequences for the EU regulation and the other to the 
consequences of the EU regulation, in other words, on its future robustness and on its 
future influence on non-European countries. 
RESULTS OF THE EXPERT SURVEY 
In the light of the increasing global use of GM crops and WTO conflicts, and with 
regard to the consequences for EU regulation, the experts saw a good chance that the 
EU regulatory system for GM crops and foods might survive (Fig. 21). Only a 
minority (one out of seven respondents) thought that the EU regulatory system could 
not be maintained due to future WTO challenges, etc. Nearly four in five were 
convinced that at least the general principles and approaches of the EU regulation 
could be maintained.  
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FIGURE 21: ROBUSTNESS OF THE EU REGULATORY SYSTEM (Question 13A; n = 71) 
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through the WTO.
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Question: It is probable that more types of GM crops will be released both in export 
countries and in Europe. The current EU regulation, based on the precautionary 
principle and case-by-case risk assessment and authorisation, might be challenged 
by the US and other countries also in the future. Please give your judgement on 
how robust the EU regulatory system will turn out to be to challenges for example 
at the WTO in the next 10 to 15 years. (Please tick one possibility) 
This question also addressed the topic of varying implementation of the EU regulation 
in the EU Member States and what this means in the context of WTO challenges (Fig. 
21). One in four respondents assumed that the varying implementation by the EU 
Member States could withstand challenges from the WTO, while more than half of the 
experts (40 respondents) expected that restrictive practices of individual EU Member 
States would be challenged. Of the latter, 23 respondents (or one-third of all 
respondents) found that the most restrictive practices of individual EU Member States 
would have to be changed, while 17 answered that more substantial harmonisation 
among the EU Member States would be necessary. Together, this can be interpreted as 
an indication that some amendments on national level and/or more harmonisation on 
the EU level could move onto the political agenda over the coming years. 
The written comments give some insight into the assumption underlying these 
assessments. The compatibility of the general principles and approaches of the EU 
regulation with international regulations and the political standing of the EU are not 
the only reasons for the expected robustness of the EU regulatory systems. At least in 
some cases, changes to the GM regulation systems in other countries, a change (or the 
need for a change) in WTO rules and/or a decreasing influence of the WTO were 
assumed, as highlighted by the following comments: 
“The need to develop a regulatory frame which is addressing the regulatory needs 
of the public is not only a European topic. It may even be that the US will change 
its risk regulation frame.” 
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“The influence of the WTO will probably decrease in the future. The political 
system is moving to a multi-polar world with neoliberal globalisation losing 
influence.” 
“Better change the WTO regulations to take into account the demand of citizens 
thus democratise decision making also in the context of WTO.” 
However, some respondents considered the restrictive practices of some EU member 
states as “politically” driven (and thus discrediting the system), in contrast to sound 
science:  
“While the EU regulations with their basis on scientific appraisal are well 
accepted in many countries, the de-facto blockade by the Member States discredits 
the EU process.”] 
The differing emphasis in these comments highlights the fact that considerable 
uncertainties are seen in the future development of multi-lateral agreements and global 
governance as well as in the EU's role here, and not only in the GM regulation proper. 
With regard to the question on the consequences of EU regulation (Fig. 22), nearly 
seven in ten experts believe that it will continue to be influential on a global scale. This 
is in line with the assessment of the EU regulation to be generally robust. 
FIGURE 22: THE FUTURE ROLE OF THE EU LEGISLATION (Question 13B; n = 71) 
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Question: The EU legalisation has been a model for regulations in some other countries. 
Will the EU regulation continue to be influential in the future? (Please tick one 
possibility) 
The EU labelling regime is thought to be particularly influential: 
“Food labelling in particular is emerging as a regulatory field where governance 
beyond Europe moves towards EU principles and standards (not traceability, 
which is too expensive to implement elsewhere)” 
“The EU model will remain very influential, especially through its labelling 
regime. This regime has an impact all over the world, for products that will be 
imported into the EU.” 
The opinion that the EU’s GM regulation will influence those of other countries does 
not in itself indicate whether this is regarded as a positive or negative feature. But that 
can be illustrated by the following comment: “I can only add: Unfortunately!” 
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DISCUSSION 
Will the EU be able to uphold the principles of its regulatory approach, in particular 
the precautionary principle? And can individual countries, even as Member States of 
the EU, proceed with their own interpretation of the EU regulation through an 
“adapted” implementation of EU rules? 
Challenges clearly arise from conflicts inside the EU that are based on different 
implementations and policies in various Member States, who have repeatedly been 
shown to exploit their remit within allowed tolerance of the EU regulatory or even 
outside it. Therefore, the EU regulatory approach is not as consistent internally as it 
may appear from the outside. Experience so far could suggest that this will not be 
easily overcome; however, a majority of experts considered a challenge to be probable 
and many thought that action would ensue. The survey shows that an amendment of 
the most restrictive practices by individual EU Member States and/or more substantial 
harmonisation of the implementation of EU regulation could come onto the political 
agenda. 
While countries such as Norway and Switzerland are not full members of the EU, large 
portions of the relevant EU regulation nevertheless have a strong influence. Either it is 
mandatory, through the EEA (Norway), or de facto hard to circumvent, due to bilateral 
agreements and strong trade relations. Experiments in these countries are, therefore, 
interesting to follow up. So far, their special regulatory approach has survived for quite 
some time, despite the obvious discrepancies. Perhaps this is a way of flexibly 
adapting the GM regulation to national peculiarities without openly diverging too far 
from the common EU path. 
The regulatory variation in the microcosm of the EU (although it covers quite a large 
and important area) might be considered enhanced at an international level. Different 
approaches between the EU and the US (e.g. regarding the role of functional 
equivalence and the precautionary principle) have so far been reconciled in a 
pragmatic rather than a conceptual way. This does not seem to cause grievances unless 
there is a particularly painful instance, as has been the case with the “de facto 
moratorium” in the EU. The experts seemed to have different opinions of whether the 
EU approach is more adequate or not.  
Nevertheless, the majority of experts interviewed considered the EU approach to be 
robust in the future as well. Overall, they seemed to think that conflicts with WTO 
agreements would probably not be enough to change the EU regulation on GM plants 
and foods. Whether this was mostly due to the international de facto power relations in 
this question or on a perceived conceptual superiority is not addressed here. However, 
even some of those who did not seem to approve of the EU approach considered it to 
be quite viable. This can also be seen in the amount of influence they considered the 
EU regulatory approach would continue to have at an international level in relation to 
other (developing) countries. 
 74
4.6  GLOBAL ASPECTS OF GM REGULATION 
This prompts the question as to what will happen in those future challenges that the 
majority of experts anticipated. If the EU approach turns out to be sustainable, 
something must happen to the rules that the challenge will be based upon. 
POLICY FIELDS 4.7 
BACKGROUND 
If one proceeds from the picture that emerged from the project reviews and the expert 
survey so far, the question is what can be learned from this and where do we go from 
here? In particular, we were interested in identifying and assessing policy options. 
While this is common in many TA exercises, particularly if they include public or 
stakeholder participation of some sort, it is especially difficult in this case. The long-
lasting debate has quarried robust interests and firm opinions, which pose great 
challenges to political decision-making and demands a very subtle way of proceeding. 
We therefore decided to leave the question of policy options open. Rather, we 
identified several policy fields at a very general level where action could be taken, and 
to ask the experts to give us their opinion. 
The last part of this analysis is therefore slightly different from the former. The issues 
addressed in earlier sections were the future of GM plants in Europe and what is most 
likely to happen in relation to challenges for policy and research. In this final section, 
we turned to more normative issues related to policy fields. 
RESULTS FROM THE TA PROJECT REVIEWS 
Many TA project reports come up with a list of options for actions to be taken not only 
with respect to policy but also with respect to identifying fields for further TA studies. 
The following summary is based on information from six reports: 
> Austria, Precautionary Expertise for GM Crops 
> Denmark, New GM crops – new debate 
> France, Co-construction of a research programme 
> Norway, Sustainability and societal impact of GM food 
> Switzerland, Genetic Technology and Nutrition 
> Switzerland, The future of plant biotechnology in Switzerland 
In many of the project reviews, a variety of policy options were identified subject to 
the focus of the study and the form of TA that was chosen. In general, many reports 
took up the point of interaction with the public, which is certainly an important issue, 
but not one that comes immediately to the forefront in the present context of 
challenges for European GM policy.  
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The other options for state action that came up can be grouped on a very general level 
according to different policy fields:  
> Amendment or implementation of existing regulation; 
> Institutional reforms including the taking different actors on board; 
> Research policy 
Subject to the general assessment of whether or not the European framework was 
sufficient in particular aspects, various stakeholders in the project reports called for 
amendments or adaptations to existing rules and pieces of legislation. Demands 
expressed in those reports where public participation was essential often pertained to 
considering uncertainty aspects and issues of benefit and risk distribution and ethics in 
a broader sense (Norway, Sustainability and societal impact of GM food) or some sort 
of benefit for society (Switzerland, The future of plant biotechnology in Switzerland).  
Institutional reforms have been a major issue ever since the debate on GMOs started. 
More recently, the EU has engaged in institutional reforms in order to render risk 
assessment and management more credible and less prone to influence by national 
policies (Levidow et al. 2005), which resulted, for instance, in setting up centralised 
agencies such as EFSA. In contrast, demands by stakeholders for more participation on 
their own part in decision-making have been issued frequently. In addition, public 
involvement in various guises has also been discussed (Austria, Precautionary 
Expertise for GM Crops). 
Almost every project review stipulated the need for research on issues that are not very 
likely to be taken up by the private sector. Research funding was often mentioned in 
discussions on other issues such as coexistence or risk management as a precondition 
to gaining necessary insights. Many of the challenges identified indirectly concerned 
the role of publicly funded research. It is seen as a means to maintain sufficient control 
over new GM plants and as a balance to private research and development (Denmark, 
New GM Crops – New Debate; Switzerland, Genetic Technology and Nutrition). From 
this perspective, public research could disentangle the outcome of R&D activities and 
applications (France, Co-construction of a research programme). The need for free 
and unbiased public research was also stressed as a means to determine the 
possibilities of scientific research and to recognise the limits of knowledge 
(Switzerland, The future of plant biotechnology); Public research could define research 
priorities in terms of identified agronomical problems that are considered politically 
relevant (Switzerland, The future of plant biotechnology). 
PRELIMINARY CONCLUSIONS AND RESULTING QUESTIONS 
Unease over whether the assessment of GM plants and food is adequate has long been 
prominent. In particular, the question of who to ask and involve in the assessment and 
decision-making process has never been resolved. Another contested field is how gaps 
should be bridged between national methods of implementing general frameworks 
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and/or differences between divergent international frameworks. Closely linked to such 
questions is the problem of institutional reform at both EU and national levels. 
A second area of concern is the role, magnitude and direction of publicly funded 
research. Although many stakeholders support an increase in the proportion of such 
research, it is not clear what the money eventually should be spent on. Preferred 
research aims may be linked to more general stances with respect to the desirability of 
GM or non-GM solutions. 
RESULTS OF THE SURVEY 
In order to identify areas of action for government institutions, we listed possible 
actions and asked respondents to indicate whether these should be prioritised. 
The answers revealed that around three-quarters of the experts would not like to just let 
the system work as it is (Fig. 23). This certainly can be interpreted as an indication that 
respondents are not very content with the status quo. 
The major field identified was research funding, which was prioritised by almost nine 
in ten respondents. This is, however, no surprise in the light of the fact that the 
majority of the experts were researchers themselves. 
Other types of action that received priority (by slightly more than half of the 
respondents, although one-third did not approve) related to better implementation of 
regulations and, to a lesser extent, to amending such regulations. Regarding the 
direction of such an amendment, one may draw conclusions from other survey 
questions. In preceding sections, we have seen that a number of respondents were not 
confident with current approaches to coexistence and liability, and that they supported 
the development of new parameters for risk assessment and management, especially 
with an eye to future non-food GM crops. In addition, some respondents explicitly 
commented that regulation must be simplified and streamlined.  
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FIGURE 23: PRIORITISATION OF POLICY FIELDS (Question 15; n = 71) 
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Question: In order to meet challenges that have been explored in this questionnaire, it could 
be necessary for government institutions to take further action. Please prioritise 
the areas below in which you consider action needs to be taken. Please feel free to 
add areas of action not listed 
Adaptation to international (WTO) rulings and the issue of subsidiarity received 
ambiguous support, with those who would prioritise the field equalling those who 
would not. Obviously, the issue of international harmonisation versus letting countries 
pursue their paths is something the group of experts had conflicting opinions about. 
With regard to institutions, a majority prioritised the reform of competent 
authorities/institutions, which might indicate a measure of discontent with institutional 
performance. In terms of who else should be involved in the decision-making process, 
there seemed to be some enthusiasm for the involvement of experts, which again is not 
very surprising. However, stakeholder involvement also received priority from a 
majority of respondents, and even involving the public was not rejected on the priority 
list.  
Looking at the way responses are distributed over the different categories of 
respondents, experts from universities/research and those from governmental agencies 
follow the general trend of being most supportive of ‘research funding’ and ‘expert 
involvement in decision making’. Experts from industry also support ‘expert 
involvement in decision making’, but also ‘adaptation to international ruling’. Taken 
together, the remaining group of experts (from agricultural organisations, 
environmental and consumer organisations and ‘others)’ are more supportive of 
‘stakeholder’ and ‘public involvement in decision making’, although even in these 
groups there is strong support for ‘research funding’.  
A comparison of how respondents prioritise expert involvement with how they 
prioritise public involvement also reveals interesting insights. Out of the 50 
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respondents who said that action to involve experts in decision-making should have 
high or very high priority, almost half said that action to involve the public should have 
low or very low priority. On the other hand, out of 36 respondents who said that action 
to involve the public should have high/very high priority, less than a third said that 
expert involvement should have low/very low priority. In contrast, there is a tendency 
that those who think stakeholder involvement should be prioritised also think the same 
about public involvement. In addition, higher enthusiasm for public involvement in 
decision-making also tends to go along with higher appreciation for the role of such 
involvement in forming consumer acceptance (Sect. 4.3). 
On the topic of research funding, the high priority assigned requires better clarification 
of the  type of research the experts might have had in mind. In particular, how do the 
experts see the role of publicly funded research: as a counterbalance to private 
research, basically oriented towards risks and the restriction of possible negative 
effects or as a means to improve the economic competition of the region by developing 
innovative products? In the survey we presented three options to the experts and asked 
them to judge the likelihood that they would become an objective of publicly funded 
research in their own country over the coming years. 
The answers showed that two-thirds of the experts considered risk assessment and 
management to be a likely objective, and more than half that it would be filling in the 
gap left open by private research. A similar number found the aim of developing 
(innovative) products to be a likely candidate for publicly funded research (Fig. 24). 
The distribution of answers did not differ according to the experts' backgrounds 
(research, industry, government, NGO). 
FIGURE 24: OBJECTIVES OF PUBLICLY FUNDED RESEARCH (Question 14; n = 71) 
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Question: In view of new developments in the research on GM plants, what will be the 
objectives of publicly funded research in your country in the coming years? 
Please feel free to add other objectives not listed. 
DISCUSSION 
Only a small minority of experts indicated a preference for leaving the current 
management system for GM plants and food alone and letting it work as it is. Thus, 
this is a call to policy makers to take action. The overwhelming majority of 
respondents supported a call for more research funding. While we cannot directly draw 
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conclusions on what directions such research should take, preceding sections have 
revealed a number of topics that may be worthy of attention (see also below).  
Apart from research funding, respondents encouraged stronger involvement of experts 
and, to a lesser degree, stakeholders but also the public in decision-making. Some 
respondents tended to encourage the first while discouraging the latter, and vice versa. 
This may indicate different opinions regarding the general ability of non-experts to 
make informed judgments in such complex and controversial matters. The demand for 
a stronger role for experts could be interpreted as indicating that, according to many 
respondents, current policies were not sufficiently funded in science. Respondents also 
prioritised a better implementation of existing regulations as well as some 
amendments. The nature and direction of such amendments remains an open question, 
however. The same can be said about the reform of competent authorities/institutions. 
Nevertheless, in the light of the discussions in preceding sections, the interested reader 
might be able to draw his or her own conclusions. 
Regarding the role of publicly funded research, the experts expressed the opinion that 
its scope will probably be rather broad over the coming years. Accordingly, it could be 
an instrument for supporting regulation of topics such as risk assessment, but maybe 
also coexistence, screening, labelling, etc. where commercial research would perhaps 
not be directed. At the same time, experts did not rule out that publicly funded research 
could also be an instrument in research and innovation policy in order to improve 
economic competitiveness. Interestingly, the distribution of opinions in this question 
did not differ very much regardless of the experts’ background (university/research 
institute, industry, NGO), which might indicate there is a consensus among experts 
from different fields on this point. 
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EPTA members and many other European institutions have carried out numerous 
research projects and written many reports on issues concerning GM plants and food. 
The present report is the result of a collective effort of eight EPTA member institutions 
who used their combined knowledge to gain more comprehensive and substantiated 
insights than each could reach alone. By analysing past TA results and supplemented 
by an expert survey, we tried to identify challenges for the European system of GMO 
regulation in the years to come. The aim was to find out  
> Whether and how the situation had changed in recent times due to different general 
conditions,  
> What kind of technical, societal, regulatory and political challenges could be 
identified,  
> Where future areas of action could be located, and  
> How TA (institutions) could address these issues. 
In the following section, we present a selection of our main findings, together with 
some implications as we see them, which may touch on areas of action relevant for 
policy. We do not claim that these are particularly novel but, taken together, they may 
shed a different light on an issue many stakeholders consider to have been talked to 
death. 
DEMAND FOR ACTION 
An overall conclusion from our results is that the regulatory system for GM plants and 
food in Europe does not seem to be fully prepared to meet all existing and foreseeable 
future challenges. This notion is seriously supported by the experts' survey, as most 
experts asked expressed some degree of discontent with the status quo regarding GM 
plants and food in the light of the challenges ahead. Only five of the 71 respondents 
supported the statement “let the system work as it is”. This suggests that many 
consider it necessary to take action. 
New solutions or fundamentally new views do not seem to be immediately at hand, nor 
are there any indications that these might develop in the near future. However, analysis 
of the survey results in comparison with the review findings provided us with valuable 
hints. These allowed us to corroborate and supplement results from past research 
exercises and reports, as well as from our ongoing technology-monitoring activities. 
Overall, we identified five main challenges for policy making on GM plants and food, 
and discuss possible TA contributions related to these. 
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CHALLENGE 1: NEW DRIVING FORCES FOR  
GM PLANT INTRODUCTION 5.1 
The general overall conditions for agriculture are changing, and this may influence the 
future of GM crops. Nevertheless, it remains difficult to draw conclusions for future 
developments. For instance, the TA project review results did not reveal a single or 
major driving force for or against GM technology implementation. However, our 
expert survey confirmed a recent development in scientific and public debates (see 
Sect. 4.1): not only is the demand for food on the agenda, but also that for biomass as a 
renewable resource. Such added emphasis on biomass per se may increase the 
incentive to use GM technology. 
Productivity gains through raising agricultural efficiency or mitigating pest pressure 
have traditionally been perceived to promote the use of GM technology, whilst the 
ever more globalised trade of food products contributed to its distribution across the 
world. The experts considered that these factors would also be influential in the future. 
Indeed, such a future seems realistic: in parallel with a rising demand for bioenergy 
and biomass, the majority of experts expected that GM plants will be available and 
authorised for cultivation in Europe for such purposes within the next 10 years. Non-
food uses such as these may be less sensitive to avoidance by sceptical consumers: 
firstly because the products are less sensitive than our diet; secondly because they 
involve new value chains where it is the industry, rather than consumers, who make up 
the (direct) demand. However, regulatory challenges and controversies concerning 
biosafety may be intensified (see Sect. 4.2). 
At the same time, the overall aims that society sets for agricultural practice will have a 
profound influence on the chances of new GM crops in the future. Nine in ten experts 
regard methods for crop production with the least possible environmental impact to be 
an important aim for the next 10-15 years. They also expect the production of high-
quality food in great variety and the reduction of input into crop production to be 
important, which again can be seen as related to the environmental impact to be 
minimised. We can, therefore, deduce a strong emphasis on sustainability and on 
reducing input and impact on the environment while sustaining food quality and 
variety. 
RESULTING AREA OF ACTION 
The general conditions for European agriculture keep changing, and the driving forces 
for GM plant introduction are closely linked to these changing conditions. Global 
challenges to agriculture make it necessary to reconcile various and sometimes 
conflicting demands: rising world food demand and replacing fossil fuels; volatility of 
market prices and sustaining rural income; decreasing arable land area and 
preservation of biodiversity, to name but a few. In the light of these factors and the 
quest for sustainability as an overall aim, conflicts in terms of goals are unavoidable – 
as one expert commented, we need “sound decision making between conflicting 
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interests towards sustainable development.” The question is therefore which kind of 
sustainable agriculture Europe will develop over the next few decades. Most probably, 
this answer will shed more light on the prospects of GM plants in Europe than any 
specialised regulatory debate over the use of GM technology and its products. In some 
ways, the question of “GM – yes or no?” could become less important than the 
question “What are the aims and duties of our agricultural sector?” (see Sect. 4.5). This 
implies a range of more specified questions such as “What role should European 
agriculture play for non-food – compared with food – production?” or “Which aims 
other than agricultural production should be pursued?” or “What are the conditions 
under which particular tasks should be fulfilled?” 
The most important area of action, therefore, is agricultural policy. This has always 
been a highly controversial field, so it is no wonder that stakeholders and scientists 
have different views on the future shaping of agriculture and the role of GM plants and 
products. Considerable efforts have already been made on exploring and discussing 
sustainable agriculture. However, in the light of changing conditions, it will be 
necessary to resume the discussion.  
Challenge 1: New driving forces for GM introduction 
In addition to continuing encouraging and discouraging factors of the past, the 
increasing demand for bioenergy and biomass poses new challenges. This will change 
the agricultural framing conditions. 
Resulting area of action: Agricultural policy 
> The possible future role of GM plants could be determined in a broad societal 
dialogue on future sustainable European agriculture in a regional and global 
context. 
CHALLENGE 2: NOVEL GM PLANTS, TECHNOLOGIES  
AND APPLICATIONS 5.2 
Several classes of novel GM crops are currently under development in Europe as well 
as in other countries. The majority of experts thought that most would be available and 
authorised for cultivation in Europe within the next 10 years, with the exception of 
trees for industrial or energy purposes and plants for phytoremediation.  
Newly developed GM plants for pharmaceuticals and other non-food applications will 
be important, but could pose regulatory challenges. Nearly all experts consider it likely 
or very likely that new parameters for risk assessment and management, confinement 
and/or containment measures, regulation of coexistence and liability will be put on the 
agenda over the next 10-15 years. We can, therefore, conclude that the discussion on 
adequate criteria for risk assessment for novel GM plants will be ongoing for the 
foreseeable future. 
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Traditionally, health aspects of GM food have primarily been discussed in terms of 
risks. However, some future GM plants are designed to bring health benefits, for 
instance through improved nutritional value or pharmaceutical substances. Most 
respondents expect that in the medium term such consumer benefits will appear and 
proceed to influence acceptance with GM plants. A third of respondents expect that 
attitudes to health may encourage, rather than discourage, the demand for GM plants 
and food. However, at the same time new risks may appear from gene flow or 
outgrowing and contamination of ordinary food staples. Such uncertainties over health 
risks from novel plants must be seen in relation to problems of coexistence (see 
Challenge 4). 
Experts were ambivalent in answering the question of whether benefits should be 
included in assessment procedures. Previous research by EPTA members has shown 
that stakeholders have different expectations when discussing the inclusion of benefits: 
some hope that such a move could allow small uncertainties over risks to be balanced 
against benefits, others claim that neither for farmers nor for consumers is there any 
real benefit and that small uncertainties over risks are not tolerable. 
New technologies such as cisgenics or smart breeding are said to blur the distinction 
between GM and non-GM and to meet with less resistance from a sceptical public. The 
survey shows that these are considered important for plant breeding in general, but the 
majority of experts do not regard them as alternatives to GM technology as such. Some 
existing regulations might need adaptation to cover cisgenics, however.  
RESULTING AREAS OF ACTION 
As for every field of technology development, research policy is the area of action. 
The European research landscape of GM plant development is fragmented, and some 
member countries have redistributed their national activities towards other fields. 
However, survey results suggest that, firstly, there is a demand for more public sector 
research on new GM plants. As one expert commented, “more of the technology 
development needs to come back to the public sector and open-source technology 
protection (need to be) developed.” Secondly, plants that are newly developed could be 
checked as early as possible whether they meet European agricultural aims and current 
coexistence schemes. How to meet this challenge appropriately also needs to be dealt 
with at the European level.  
Even though experts do not expect new developments in plant breeding to be a 
substitute for GM technology, different approaches must compete for research funds. 
To set priorities, it is not only necessary to assess technical performance but also the 
chances of newly developed plants satisfying the intricacies of public debate (see 
Challenge 3). In this way, the relationship between genetic modification and new 
‘intermediate’ technologies such as cisgenics and smart breeding could be clarified.  
The second important field is GM regulation policy in the EU. Many proposals have 
been made to improve, streamline or enhance regulatory policy, to the degree that the 
balance achieved is sometimes considered too fragile to challenge. However, as the 
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general framework keeps changing, regulatory revision is probably necessary. 
Properties of newly developed GM plants for the non-food sector could make it 
necessary to consider amendments and additions in risk assessment and risk 
management parameters, confinement and/or containment measures, regulation of 
coexistence and liability. In addition, the question of benefit evaluation might be put 
on the political agenda. Taken together, the status quo of regulation might again be up 
for revision. 
Challenge 2: Novel GM plants, technologies, and applications 
Several classes of new GM plants will probably be available and authorised for 
cultivation in Europe within the next 10 years. This poses a number of research and 
regulatory challenges. 
Resulting area of action: Research policy 
> The aims of public sector research could be better aligned with European 
agricultural aims.  
> The most promising GM and non-GM approaches could also be selected in terms 
of public acceptance. 
Resulting area of action: GM regulation policy 
> The regulatory framework for non-food GM plants could be reconsidered. 
CHALLENGE 3: PUBLIC OPINION –  
STILL A DECISIVE FACTOR 5.3 
In many European countries, public attitudes are considered an important factor 
influencing both the use of GM technology and its development. Therefore, influences 
on consumer acceptance must be analysed in order to assess whether public attitudes 
are changing, and if so in which direction. The majority of experts thought that a more 
positive attitude towards GM technology is likely over the next 10-15 years. This is 
mainly be due to the potentially growing acceptance of new GM non-food products, 
while the (lower) acceptance of GM food products will remain unchanged (see Sect. 
4.3).  
However, it is uncertain whether the expectations towards overall higher acceptance 
will prove to be realistic. Non-food GM plants can also raise environmental and health 
concerns, especially where doubts exist over the performance of coexistence schemes 
(see Challenge 4). In the light of recent debates on whether biofuels are a sensible 
option for reducing carbon dioxide emissions or whether they compete with food 
production, expectations that plants for renewable bioenergy will elicit more positive 
public perceptions may turn out to be overoptimistic.  
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In the past, developments that were seemingly unrelated to the issue of GM plants and 
food have made their mark on the debate and influenced acceptance. This shows that 
public perception is multi-faceted and that it is not only a matter of the technology at 
stake or of consumer risks or benefits. Neither is consumer acceptance a matter of 
specific technological knowledge of particular products. Rather, the whole context of 
food production and regulation as well as the relationship between actors in the food 
chain, from the farmer to the end consumer, determine the fate of potential products. 
Attempts at deliberately guiding public perception by influencing a single factor have 
proved to be futile. 
In conclusion, both old and new topics, expectations and arguments can be expected to 
make their mark on public debates and influence public attitudes in the future. Whether 
and how the overall public acceptance of GM plants will change remains unclear. 
RESULTING AREA OF ACTION 
Although consumer benefits are important, public attitudes are subject to many 
influences, including ethical concerns, and the area of action is less clear than for other 
challenges. For the time being, little indicates increasing acceptance. It cannot be taken 
for granted that with new consumer-oriented GM products, and with bioenergy as a 
new track of GM plant production, the public perception of the GM technology will 
change.  
The challenge of public opinion is closely linked to other challenges such as the future 
role of GM plants in European agriculture (see Challenge 1), a realistic evaluation of 
benefits and risks of new GM crops (see Challenge 2), and the performance of 
coexistence schemes (see Challenge 4). Accordingly, both consumer protection policy 
and a variety of other fields from agricultural policy to GM regulation come into the 
picture – it is a truly cross-sectional task. An ongoing dialogue between consumers, 
scientists and various stakeholders over potential chances and possible problems might 
help to avoid disappointments and the emergence of scandal stories. 
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Challenge 3: Public opinion – still a decisive factor 
Against the background of established arguments, new topics, expectations and 
concerns can be expected to influence public debates and public attitudes in the future. 
Although there is a difference in acceptance between food and non-food products, it 
remains unclear whether and how the overall public acceptance of GM plants will 
change. 
Resulting area of action: Consumer protection policy and cross-sectional tasks 
> An open dialogue on potential chances and possible problems could be enhanced. 
CHALLENGE 4: COEXISTENCE AND LABELLING UNDER 
A GROWING USE OF GM PLANTS IN EUROPE  
AND THE WORLD 5.4 
In the European regulatory system, authorisation of a GM plant is based on a scientific 
risk assessment. In addition, coexistence must be allowed for, and appropriate labelling 
is required, in order to guarantee consumers the freedom of choice. The concept of 
coexistence can be considered an answer to the political demand for freedom of 
choice, but it also influences the parameters of scientific risk assessment. As the two 
pillars for the authorisation and management of GM crops build on different rationales, 
they might not always be easy to reconcile. 
Until now, only first-generation GM plants with herbicide tolerance and/or insect 
resistance have been grown in some European countries, often on small areas and for a 
relatively short time. Therefore, robust experience with the EU regulation on 
coexistence is still some way ahead. There is still thus some uncertainty whether the 
concept of coexistence will prove viable under all circumstances. 
Reports from many EPTA members come to the conclusion that coexistence is feasible 
in principle. In support of this finding, only a minority of experts believed that 
coexistence will not work at all for first-generation GM plants. In line with this, most 
respondents expected them to be cultivated in Europe at least in the medium term. 
When it comes to more detailed questions, however, experts are divided. Will 
coexistence work for some crops only or for a broad range? Can it work only on a 
small scale or also for large-scale cultivation (see Sect. 4.4)? The practical context 
seems to be more important than feasibility in principle. A caveat also pertains to the 
type of risk that coexistence measures address. Half the respondents believe current 
schemes are insufficient to contain all economic and environmental risks – depending 
on what is deemed relevant. Again, experts are split over how to process remaining 
risks – weigh them up against societal benefits, seek economic compensation, or rely 
on regulatory intervention? 
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Coexistence measures aim at implementing freedom of choice, and half of the 
respondents believed that GM food will be labelled correctly and that non-GM food 
will continue to be available. The others expected different negative scenarios such as 
the misapplication of labelling or the entire failure of coexistence and the ensuing 
blockade of GM food. 
Controversies over coexistence can sometimes be traced back to differing degrees of 
confidence in systems of risk assessment and authorisation. Some doubts arise as to 
whether institutions involved in such an assessment are fully independent from vested 
interests – for example, one expert suspects that “EFSA … is just established to put its 
rubber stamp on all GMOs.” Crossing the boundaries of conventional expertise and 
interest representation is sometimes considered a remedy. However, experts have 
different opinions on whether more scientific expertise or more stakeholder or public 
participation (or all three) should be implemented.  
In addition, misfits between parts of the regulatory system and politics are highlighted. 
For example, one expert calls for "the conflict between the scientific decisions and the 
political actions” to be resolved. 
RESULTING AREAS OF ACTION 
Overall, questions remain over the concept of coexistence as a core element of 
European GM plant regulation, which also concerns the limited use of GM plants in 
Europe so far. Coexistence and labelling are considered to function reasonably well 
under certain conditions. However, there are doubts that this will be the case for all 
cases of GM crop cultivation. Despite regulation and an extensive debate in the past, 
problems in the future cannot be excluded with specific crops and large-scale 
cultivation. Therefore, continuous monitoring and perhaps a revision of coexistence 
rules are required. 
As the implementation and warranty of coexistence is intimately bound up with 
approval procedures for GM crops in general, further possible areas of action are 
related to basic aspects of risk assessment and/or management of GMOs. Reports from 
EPTA members have highlighted that the expertise involved in regulatory decision-
making and the way parts of the regulatory system work together may come under 
scrutiny. A number of comments addressed the independence from vested interests of 
bodies involved (such as EFSA) as a prerequisite for public and stakeholder trust. A 
practical solution could be to incorporate a broader spectrum of scientific opinions and 
to enable a broader representation of interests, including those of civil society, and of 
different forms of expertise such as citizens’ knowledge. 
Moreover, disentangling science (embodied in risk assessments by EFSA and national 
authorities) and political decision-making (on the EU and national level) has been a 
major aim of regulation, but it does not seem to have been accomplished in a fully 
satisfactory way. Therefore, a way must be found to better define the requirements of 
scientific evidence and the room for manoeuvre in politics.  
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GM PLANTS 
A further, recurrent problem is the remit for political decision-making at the national 
level, e.g. on restricting or promoting the use of GM plants in a particular area. This 
issue is discussed in the context of Challenge 5. 
Challenge 4: Coexistence and labelling under growing use of GM plants in 
Europe and the world 
In Europe, GM plants have been grown on relatively small areas and only for a short 
time. Therefore, there is still a lack of robust experience with the EU regulation on 
coexistence. With specific crops and large-scale cultivation, problems cannot be 
excluded in the future. 
Resulting area of action: GM regulation policy 
> Aspects of GM regulation on the requirements for maintaining coexistence and 
freedom of choice might have to be revisited. 
> Incorporation of different types of expertise and interests could enhance and 
demonstrate independence from vested interests. 
> The relation of science and policy could be better defined, with a clear remit for 
policy also on the national level. 
CHALLENGE 5: INTERNATIONAL TRADE RULES AND 
DOMESTIC DECISION-MAKING 5.5 
The recent WTO conflict between the US and its allies and the EU has put pressure on 
some aspects of the European regulatory practice concerning GM plants and food. It 
made clear that the future shaping of international trade rules will greatly influence 
GM regulation in the EU. However, European ideas on how to regulate such issues 
might also be influential outside Europe and affect international agreements as well. 
Apart from the concrete instance mentioned, the global increase in acreage covered by 
GM crops, pending international trade conflicts, the development of international GM 
regulations and the different approaches to risk assessment and regulation in various 
countries could turn out to be a challenge in the future, too. The question is whether the 
European regulatory system will be able to cope with this. 
Despite the outcome of the WTO conflict, the experts saw a good chance the European 
regulatory system surviving, even in view of increasing global GM crop use. Most are 
convinced that at least the general principles can be maintained, but many think that 
restrictive practices of individual EU Member States will have to change and more 
harmonisation among the EU Member States will be necessary (see Sect. 4.6). 
Accordingly, the robustness of the EU regulatory system is based on the perceived 
compatibility of general principles and approaches of the EU regulation with 
international trade regulations as well as on the political standing of the EU. In 
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addition, some experts consider a change to the GM regulatory system in non-EU 
countries or a change of WTO rules possible or at least desirable. 
RESULTING AREAS OF ACTION 
International trade policy is the obvious area of action. However, the trade conflict 
surrounding GM plants and food only pertains to one of several arenas within the 
WTO regulations. Therefore, not only those areas specific to GMOs might be 
considered at stake, but also the possible integration of environmental and social 
standards into WTO regulations. The relation of treaties, conventions and agreements 
reached under the auspices of different supra-national bodies (e.g. WTO and UN) will 
have to be clarified in order not to thwart the aims of these different agreements,. This 
is, however, beyond the scope of national influence and the issue of GM plants. 
With regard to GM regulation policy, problems are said to have arisen from 
discrepancies between the implementation of the European regulatory framework in 
different Member States. Two possible solutions come to mind: giving more leeway to 
national sovereignty (often captured under the term ‘subsidiarity’) with respect to 
GMO regulation, or enforcing harmonisation among member states also with regard to 
minor details. In the past, the compromises reached did not always deliver fully 
satisfactory results, and many experts consider further harmonisation and/or 
institutional reforms necessary. It remains to be seen how far subsidiarity can be 
upheld under the auspices of WTO rulings.  
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Challenge 5: International trade rules and domestic decision-making 
Uncertainties about the compatibility of the European GM regulation with 
international trade regulations remain. At the same time, international trade rules may 
be up to reforms. 
Resulting area of action: International trade policy 
> Reconciling discrepancies between various international treaties could be 
intensified. 
Resulting area of action: GM regulation policy 
> National implementation could be harmonised, including institutional reforms. 
UPCOMING ISSUES FOR TECHNOLOGY ASSESSMENT 5.6 
Over the years, technology assessment has made great efforts to clarify particular 
aspects of agricultural biotechnology, one of the most prominent technological fields 
that TA has ever dealt with. Not only with respect to technical analyses but also 
regarding public involvement, this issue has featured prominently among TA themes 
for two decades. Thus, one may question whether there is any particular shortcoming 
since almost every issue has already been focused on. 
Nevertheless, some upcoming issues may prove to warrant increased attention from the 
point of TA. At least four developments call for renewed interest and novel 
approaches: 
> First, there are a number of technological developments that extend the use of GM 
plants beyond the current range of applications, such as energy plants, plants for 
nutritionally enhanced products or for producing pharmaceutically active 
substances. Furthermore, crops of a new generation with enhanced agricultural traits 
such as drought resistance and other low-input properties throw up questions of 
enhanced survival capabilities (and thus invasiveness) together with improved yield 
under difficult environmental conditions. They are said to be much more common 
in a future determined by climatic change, so they might pose novel challenges for 
risk assessment. 
> Second, apart from technological novelties, changed general conditions for 
agriculture continue to challenge established practices and aims. The example of 
fuel production from renewable resources, initially hailed as a tool to save fossil 
fuels and to mitigate carbon dioxide release, has shown that the general framework 
can change over a very short time. Volatile food prices and a depletion of staple 
stocks have re-opened the debate over whether it will be necessary to boost food 
production not only in developing countries but also in areas where overproduction 
has been a problem.  
> The third area is decision-making. On the one hand, there are recurring conflicts 
about institutions and levels of decision-making, for instance between the EU 
bodies and Member States, and about singling out what belongs to the science of 
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risk assessment versus the politics of risk management. On the other hand there is 
the repercussion of international politics, including the WTO conflict, on national 
agricultural production. Trade liberalisation, globalised trade in food and feed, and 
international rules for the use of technology (or its prevention for example through 
patents) can challenge established practices at very short notice. 
> Fourth, public attitudes towards GM plants and food may change in the future. This 
might not only influence the strategies of relevant actors such as farmers, food 
retailers, or NGOs, but also impact future political decisions. The direction of such 
a change, however, is impossible to predict. In the past, many factors not 
immediately related to GM technology as such but to broader social and cultural 
issues have been shown, or suspected, to influence public perception. In addition, 
national differences are obvious, and with a larger number of Member States the 
diversity of the European landscape of public perceptions might even increase. 
Taking past experiences with R&D on transgenic plants into account, new forms of co-
ordinated involvement of experts, stakeholders and citizens need to be organised in the 
process of the development of new generations of plants. The task of TA is to help 
clarify technological solutions and their societal implications. TA is one area that could 
contribute to developing new forums to open negotiating channels between actors who 
have found it hard to speak to each other or arrive at sustainable compromises. 
Further discussion is needed on the TA approaches that are required and suitable. It 
largely depends on the expertise and experience of the TA institutions involved. This 
could be an indication to seek transnational co-operation, for example under the 
auspices of EPTA. 
Relevant issues for TA identified: 
> Assessment of novel GM plants, especially those with enhanced agricultural 
traits 
> Assessment of technological solutions offered or demanded to meet changed 
framework conditions for agriculture, and their societal implications 
> Identification of impacts of international treaties and trade liberalisation and of 
possible solutions to meet them 
> Understanding social and cultural factors influencing technological 
developments, their embedding into society and the ways implications such as 
risks and benefits are perceived 
These issues require the development of new forums for dialogue and a better co-
ordinated involvement of experts, decision makers and the public in issues related 
to GM plants and food. 
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Finland: 
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after" (2000) 
[Norway, GM food] 
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> Review of UK projects since 2000 
[United Kingdom, GM dialogue] 
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AUSTRIA 1. 
ECOLOGICAL MONITORING OF GENETICALLY MODIFIED 
ORGANISMS (2000) 1.1 
BACKGROUND OF THE PROJECT 
Context 
On March 12th, 2001, the European Union (the Parliament and the Council by the co-
decision procedure) adopted Directive 2001/18/EC on the deliberate release into the 
environment of genetically modified organisms. As a significant part of this Direc-
tive there is a Monitoring Plan sketched to be further elaborated in Guidance Notes. 
These supplementing Guidance Notes have been adopted by decision of the Council 
on October 3rd, 2002. 
The present research was realised and finished between these two dates and ad-
dresses the need for further elaboration of the monitoring system, presenting prelimi-
nary proposals to be discussed on a national Austrian basis and EU-wide, afterwards.  
The Austrian situation in the domain of green biotechnologies is characterised by a 
quite restrictive legislation, regional efforts to completely forbid GMOs and a broad 
GM-critical consensus between the political parties, farmers, interest groups, NGOs 
and the public. Already in the 1990s with the Directive 90/220/EEC in force, Austria 
pushed for a monitoring instrument. Basically, there were and there are two funda-
mental positions on the EU-level: those who demand an extensive monitoring of the 
approved GMOs, arguing that it is impossible to know every relevant effect of the 
product in a risk assessment ex ante; and those who understand a product which is 
approved after an exhaustive risk assessment as fully admitted. The critique of the 
latter on monitoring is that it is not affordable and even if it would be one cannot 
know what parameters exactly to trace – one cannot detect and measure anything 
which possibly could be of relevance. Austria maintained its pro-monitoring attitude 
and the present paper has to be read in this stable policy-line.  
Demanding institutions 
This study was financed by the Austrian Federal Ministry of Agriculture, Forestry, 
Environment and Water Management. As documented in the Third Report of the 
Austrian Genetic Engineering Commission (Gentechnikkommission), the study was 
also demanded and partly financed by the Austrian Federal Ministry of Health and 
Women. The paper was published in the monograph series of the Austrian Federal 
Environment Agency. The authors are, partly, from this agency and, partly, scientists 
from outside (University of Vienna, Austrian Federal Office and Research Centre of 
Agriculture). The main author Andreas Traxler has no institutional affiliation.  
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Guiding questions 
How can we deal with the uncertainty about potential environmental effects of 
GMOs? What proposals can be made for the guidance notes to amend and complete 
Annex VII of the Directive 2001/18/EC with a framework concept for ecological 
monitoring that satisfies the needs of the EU and the Member States? 
BASIC DATA ABOUT THE PROJECT 
Type of project: 
This project is a survey on ecological monitoring and the translation (to present it to 
a larger audience) of an abridged version of a more extensive monography (contain-
ing more Austrian-specific details) of the Austrian Federal Environment Agency 
(published in 2000). The methods used are basically a review of the legislative texts 
and scientific publications on the subject, and an exposition of Austrian ecological 
protection targets. Two case studies (GM maize and GM oilseed rape) were used in 
the original German version to delineate the requisites of an ecological monitoring 
device. However, the focus lies on the elaboration of a method, more than on apply-
ing already established methods.  
Topics: 
At first, the survey presents the EU-wide legal provisions on GMO monitoring. 
Then, the framework concept and the guidelines for monitoring of GMOs are 
sketched. There are criteria elaborated, the questions of financing and public partici-
pation are addressed and a terminology is elaborated. In a next step, the authors in-
troduce the monitoring parameters and test methods they recommend.. After sugges-
tions for Austrian specific ecological protection targets, the authors conclude with 
some words on biogeographical regions in Austria.  
Duration: 
The longer version in German language was published and presented in the year 
2000, this paper in 2001. The project work took approximately a year.  
MAJOR OUTCOMES OF THE PROJECT 
Central findings 
The study’s analysis of the respective legislative acts on GMOs brought the authors 
to the conviction that ecological monitoring is one of the few methods to increase 
GMOs’ environmental safety. It is the only way to detect unforeseen effects, to pos-
sibly prevent adverse effects in time, and to get to learn about the ecological risks of 
GMOs. There is a broad agreement, also in the EU (see directive 2001/18/EC) and 
between the interest groups, that it is a necessary instrument to control possible risks 
of the release of GMOs. However, there is uncertainty on how to implement it. Rep-
resentatives of the industry, on the one hand, and ecologists, on the other, have quite 
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divergent views on the nature, extent and duration of the investigations to be carried 
out in a monitoring tool. 
From the authors’ point of view, ecological monitoring must be planned and carried 
out by ecologists in co-operation with molecular biologists and cannot be accepted as 
a burdensome necessity involved in the release of a GMO.  
In line with the EU directive’s indications, there should be a case-specific monitoring 
(limited in time, hypothesis-based) and general surveillance (nation-wide long-term 
monitoring without time restrictions, designed to observe the effects of all consented 
GMOs). The present monography also suggests a monitoring of the state-of-the-art 
(collect and structure international monitoring results; periodically adjust current 
monitoring plans in terms of methodology and subject matter) and an ecosystem 
monitoring (because of the high costs, it would be feasible only at few locations; 
however, this could unearth important findings and initiate interdisciplinary envi-
ronmental monitoring on an integrated basis). A list of guidelines for ecological 
monitoring for releases and for the placing on the market is compiled in the study. 
The paper votes for the participation of the public (to improve acceptance and in-
crease objectivity) and a broader and interdisciplinary integration of scientific fields 
and interest groups. 
There is a great amount of monitoring parameters and test methods proposed by the 
contributors, which reflect the inconvenience of not knowing what to detect and as-
sess, exactly. It seems that with the recommended ensemble, there should be reached 
an integrated, holistic vision able to catch problematic effects on the ecobiological 
system on various points and as fast as possible: There are standard parameters (bio-
mass, phenology, cover values, vegetation structure, etc.) and methods of plant ecol-
ogy proposed, furthermore biochemical, ornithological and entomological monitor-
ing methods, and soil analyses.  
The ecological protection targets should be stipulated by each individual Member 
State – the present survey attempts this for Austria.  
Options for action 
Amend Directive 2001/18/EC in line with the aspects prompted by the Austrian posi-
tion. Each notification for the deliberate release or placing on the market of GMOs 
must contain a detailed monitoring plan on a case-by-case basis.  
Identified future issues 
The survey claims that the following points have to be clarified for future GMO noti-
fications with regard to efficient ecological monitoring: 
> determination of the executing institutions 
> definition of threshold values 
> definition of ecological damage (the term is not sufficiently defined: is it “dam-
age” if a native plant population is suppressed or already if there is a GMO-
occurrence in ruderal biotops?) 
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> establishment of a national and international information network (with a central 
coordination office for the GMO-monitoring as collector and administrator of 
monitoring data and findings) 
These issues should be discussed at the earliest possible stage: 
> planning of a nation-wide, representative monitoring network for animals and 
plants 
> definition of the ecological targets likely to be affected by GMOs 
> financing  
IMPACTS AND FOLLOW UP OF THE PROJECT 
According to the press release of the Austrian Federal Environment Agency, the 
frame monitoring concept was developed to be placed at the EU-level in the discus-
sion on the monitoring guidelines complementing directive 2001/18/EC. These 
guidelines were published in 2002 by decision of the Council of the European Union. 
Only a comparative study of the two documents and the positions of other Member 
States and the relevant interest groups could clarify the concrete influence of the 
Austrian proposal.  
CHALLENGES IDENTIFIED 
The development of this monitoring concept, according to the authors, does by no 
means give a “clean bill of health” for releasing or placing GMOs on the market. 
Moreover, ecological monitoring is necessary and a useful tool – however, it does 
not work wonders: it is expensive, time-consuming, and methodologically limited. 
LITERATURE 
Traxler, A., Heissenberger, A., Frank, G., Lethmayer, C., Gaugitsch, H. (2000): Durch-
führung von Untersuchungen zu einem ökologischen Monitoring von gentechnisch 
veränderten Organismen. Umweltbundesamt, Monographien Band 126, Wien 
http://www.bmgfj.gv.at/cms/site/standard.html?channel=CH0810&doc=CMS1085
490251342 
English version (2001): Ecological Monitoring of Genetically Modified Organisms. Aus-
trian Federal Environment Agency, Wien 
http://www.umweltbundesamt.at/fileadmin/site/publikationen/M147.pdf 
AUTHOR OF THE REVIEW 
Helge Torgersen 
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PRECAUTIONARY EXPERTISE FOR GM CROPS (2004) 1.2 
BACKGROUND OF THE PROJECT 
Demanding institution (initiator): 
The research project "Precautionary Expertise for GM Crops" was funded by the 
European Commission, Quality of Life programme. It was the third in a series of EU 
funded projects on policy problems associated with the regulation of GMOs in sev-
eral EU member states, co-ordinated by the Open University, Milton Keynes. 
Context: 
Background for this project was the increasing need of changes in regulatory proce-
dures regarding GM crops. When Member States blocked the EU–level regulatory 
procedure in 1999, new legislations were adopted to meet their demands. New pro-
cedures were supposed to provide a mechanism to ensure full traceability and label-
ling of GMO crops and to enhance the application of the precautionary principle on a 
national level. Although the precautionary principle was widely invoked for dealing 
with uncertain risks by Member states, criticism remained considering the principle 
as a pretext for political agendas. One important reason was that largely, a generally 
accepted coherent view on the scope and modes of application of the principle was 
considered to be lacking. 
The project analysed the different approaches to the precautionary principle and their 
consequences for regulatory measures as they appeared from regulatory actions by 
some Member States as well as from statements made by various stakeholders. Par-
ticularly the broader accounts leave the scope wide open for different interpretations. 
As a result, disagreements about the practical meaning emerged. The main goal of 
the study was to accommodate different views and give guidelines for the implemen-
tation of the principle. Thus it was an attempt to construct a comprehensive concept 
of the precautionary principle in the context of agricultural biotechnology. 
The main guiding questions were: 
> How do current European practices compare with different accounts of the pre-
cautionary principle? 
> How are risk research, risk assessment and risk management linked in practice?   
> How do stakeholder groups attempt to influence regulatory measures within or 
> beyond formal procedures? 
> How do expert advisory bodies mediate between regulatory science and public-
scientific controversy? 
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BASIC DATA ABOUT THE PROJECT 
Type of project: 
The project was performed as an inter-disciplinary policy research exercise, aiming 
at comparative evaluations of national policy events, investigated by the national 
partners, and developments on the EU level researched by the co-ordinator. 
The research activities mainly consisted of an analysis of relevant documents as well 
as interviews and workshops with key actors, involving a wide range of stakeholders.  
Duration / start and closing date: 
Work was performed within the years 2002 -2004, with the final report in 2004. 
Topics of the project: 
The investigation focused on the practical application of the precautionary principle 
in the member states with respect to transgenic crops.  
Participants: 
> D. Wield, S. Carr, L. Levidow, S. Oreszczyn, Open University, Milton Keynes, 
UK (Co-ordinators);  
> H. Torgersen, A. Bogner, Institute of Technology Assessment; Austrian Academy 
of Sciences, Vienna, Austria; 
> B. Gill, K. Boschert. Ludwig-Maximilians-Universität München, Germany; 
> J. Toft, Roskilde University Library, Copenhagen, Denmark; 
> C. Marris, P.-B. Joly, St. Ronda, Institut National de la Recherche Agonomique, 
Ivry, France; Ch. Bonneuil, Centre Koyré d'Histoire des Sciences et des Techni-
ques, Grenable; 
> L. Lemkow, D. Tàbara, D. Polo, Universitat Autònoma de Barcelona, Spain.  
Subcontracts (consultants): 
> P. Schenkelaars, Schenkelaars Biotechnology Consultancy, The Netherlands; 
> J. Tait, University of Edinburgh, UK. 
Events: 
> National stakeholder workshops were held in all participating countries (UK, A, 
D, DK, F, SP, NL) and on the EU level. Workshops proceedings were distributed 
and, in part, published. 
MAJOR OUTCOMES OF THE PROJECT 
Central findings 
The project places emphasis on the different understandings of the concept of pre-
caution. As the different reports of the member states show, the concept is very con-
tentious in its details and led to many conflicts among experts. In practise, the differ-
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ent accounts have a strong impact on regulatory procedures. Narrow and broader 
accounts differ in three general respects – uncertainties in risk assessment, the trigger 
for management measures, and the scope of action (including alternative solutions). 
Despite institutional reforms regulatory disagreements continue, for instance, over 
the criteria for evidence, definitions of harms and means to manage uncertain risks. 
One main outcome of the project is that different accounts should not be seen as 
fixed types but as dynamic tensions within the regulatory procedures. It is important 
to note that precaution has obtained its practical meanings through regulatory con-
flicts, more than by explicit interpretation or application of an a priori principle.  
The project draws the conclusion that the diversity of views of member states is not 
considered impeding coherent policy or decisions. Through dynamic tensions among 
different accounts regulatory expert-procedures identified and addressed more scien-
tific uncertainties than before. Thus, the precautionary principle helps to raise new 
questions about various unknowns in risk assessment. It shall be a flexible policy 
framework offering stronger means for shifting and clarifying regulatory criteria.  
Options for action 
The project analysed the need of common regulatory standards on EU level in order 
to handle existing expert conflicts. The establishment of the EFSA was an important 
step towards harmonizing the different understandings trough objective scientific 
advice. It is designed to override and reconcile national regulatory differences. How-
ever, the project made clear that on the EU-level different views are not being re-
spected unless they are based on relevant scientific arguments. According to EFSA, 
Member States shall supply the necessary data and explain their scientific basis for 
different options within their risk management. 
Identified future issues: 
In future, this might stimulate more transparency in framing uncertainty and assign-
ing a burden of evidence. Since many risks are not clarified yet, a great burden is 
born on science and expert judgements. Consequently common regulatory standards 
shall provide a more rigorous and transparent basis to deal with legitimacy problems.  
Another future issue identified by this project is the broader participation of the pub-
lic and stakeholders. The involvement of diverse stakeholders, including critical sci-
entists and NGOs, can help to ensure that as many relevant questions as possible are 
addressed. 
IMPACTS AND FOLLOW UP OF THE PROJECT 
In every participating country as well as on the EU level a workshop with stake-
holders such as regulators, scientists, industry and NGO representatives was held, 
where comments were collected and incorporated into the final report. These work-
shops took on different shapes in every country; in Austria, it was held as a “meeting 
on neutral grounds” between regulators from different ministries and scientists in 
order to explore policy future options. 
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The results of the project were published in a special issue of the scientific journal 
Science and Public Policy (32/4, 2005) and, individually, in various other scientific 
journals by several project team members. 
CHALLENGES IDENTIFIED 
The relation between scientific advice and political decision making on GM plants 
remains precarious despite agreed policy principles such as precaution. Rather than 
suggesting a once-and-for-all procedure with fixed and scientifically unambiguous 
criteria for the assessment of new GM plants, the authorisation, application and mar-
keting of such plants and their products remain politically sensitive and open for ne-
gotiation. The issue turns out not to be able to be dealt with on the basis of science 
and law only, so that changes in the decision making due to political considerations 
will have to be taken into consideration in the future as well. 
LITERATURE 
Special issue on precautionary expertise for EU agbiotech regulation. Science and Public 
Policy 32(4), August 2005 
AUTHOR OF THE REVIEW 
Helge Torgersen 
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RISK ASSESSMENT OF GMO PRODUCTS IN THE EUROPEAN 
UNION. TOXICITY ASSESSMENT, ALLERGENICITY 
ASSESSMENT AND SUBSTANTIAL EQUIVALENCE 
IN PRACTICE AND PROPOSALS FOR IMPROVEMENT 
AND STANDARDISATION (2004) 1.3 
BACKGROUND OF THE PROJECT 
Context 
Toxic and allergenic properties are considered focal aspects in the assessment of po-
tential health risks of GM food. In contrast to other regulatory contexts such as che-
micals, plant pesticides and food additives, detailed requirements for toxicity and 
allergenicity assessment have not been put into concrete terms until recently. During 
the time this study was carried out there was no detailed guidance available at all1. 
However, a number of genetically modified plants (GMPs) had already been author-
ised under Directive 90/220/EEC and the Novel Food Regulation. The authors state a 
distortion between the provided guidance for risk assessment and the complex situa-
tion characterised by rapid scientific progress, varying interpretation of EU regula-
tion by the national authorities, and pressures from industry and public interest 
groups. The assessment practice resulting from this constellation is described as be-
ing time-consuming and inconsistent. 
Demanding institution 
The present monograph was funded by the Austrian Federal Ministry for Agriculture, 
Forestry, Environment and Water Economy and the Austrian Federal Ministry for 
Health and Women. The research that provided the basis for this document (two pre-
ceding studies in German language) was financed by the Austrian Federal Ministry 
for Work and Labour and by the Austrian Federal Ministry for Health and Women. 
Parliamentary documentation states that this compilation was carried out by order of 
the Austrian Federal Ministry for Health and Women.  
Guiding questions 
Which risk assessment practices exist regarding potential toxic and allergenic proper-
ties of GMPs? How would a consistent toxicity and allergenicity risk assessment 
approach look like? Which shortcomings can be identified in current risk assess-
ment? Out of this review of the state-of-the-art, which proposals may be given in the 
context of recent regulatory developments for guidance documents etc.? 
                                                 
1 The authors mentioned the guidance document of EU’s Scientific Steering Committee 
(SSC) that lists toxicity and allergenicity of gene products as issues to be considered. At 
present, there is the EFSA GMO panel’s Guidance Document for the assessment of 
GMPs published in April 2004 (as an updated version of the SSC document) and actu-
alized in 2006. This document more extensively addresses the aspects of toxicity and al-
lergenicity. 
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BASIC DATA ABOUT THE PROJECT 
Type of the project, methods 
The present monograph is an abridged and condensed but updated English version of 
the content, conclusions and recommendations of two earlier research projects car-
ried out in German language with the main goal to review the practice of risk as-
sessment procedures on GMPs in the EU.  
The practice of toxicity and allergenicity assessment was scrutinised in a range of 
Directive 90/220/EEC and Novel Food Regulation dossiers. Relevant dossiers were 
selected, investigated and their respective assessment procedure described. The dif-
ferent approaches to risk assessment were compared and evaluated. A literature re-
view on the concept of substantial equivalence was also implemented. Based on this, 
the study elaborates proposals aiming at improvement and standardisation of risk 
assessment procedures. Surveys on toxicity and allergenicity assessment in regula-
tory documents covering GMPs in Europe and the US provided information which 
was included in the conclusions and proposals. 
Topics 
> current practice of toxicity and allergenicity assessment 
> its shortcomings 
> requirements for a comprehensive toxicity and allergenicity assessment 
> proposals for improvement and standardisation of risk assessment regulation and 
practice 
Duration 
The two studies that form the basis of the present English version were conducted 
between 2000 and 2003. The English paper was first published in July 2004. 
Participants 
The current English version is authored by a subset of the original project team 
which consisted of scientists from the Austrian Federal Environment Agency, the 
Inter-University Research Centre for Technology, Work and Culture (IFZ) Graz, the 
ARC Seibersdorf Research GmbH, the Research Center for Biotechnology, Society 
and the Environment at the University of Hamburg and a range of individually con-
tracted experts. 
The subset of this team and, hence, the authors of the updated English version are: 
Armin Spök (IFZ), Heinz Hofer (ARC Seibersdorf), Petra Lehner and Rudolf Valen-
ta (contracted), Susanne Stirn (University of Hamburg), and Helmut Gaugitsch (Aus-
trian Federal Environment Agency). 
Events 
In the course of the investigation, various internal project workshops were held. 
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Prior to publishing the English version an international conference was held in au-
tumn 2003 in Vienna, where the outcomes of the two preceding studies were dis-
cussed and a fundament for the updated English version was laid. Besides some of 
the studies’ authors, a representative of the European Commission (Andreas 
Klepsch) and a member of the environmental NGO Global2000 gave lectures. 
MAJOR OUTCOMES OF THE PROJECT 
Central findings 
With regard to the toxicity and allergenicity assessment procedures and the use of the 
concept of substantial equivalence, the study points out significant shortcomings in 
the dossiers based on Directive 90/220/EEC, as well as in the Novel Food Regulation 
dossiers: 
> The formal structure of the risk assessment approach is not based on and does not 
clearly distinguish between exposure assessment and hazard assessment (which 
are both necessary). The claims of substantial equivalence are frequently based on 
trials and analysis that are not properly designed. 
> Assessments and conclusions drawn often cannot be entirely verified given the 
lack of details. 
> Although the overall approaches in risk assessment are similar in the dossiers, 
differences became evident at the level of details – this fact points to a lack of de-
tails in the guidance documents. 
> Safety conclusions are often based on indirect evidence and/or assumption based 
reasoning, and they are partly based on questionable methods, approaches and as-
sumptions. 
> Unintended effects of genetic modification are usually not investigated and even 
dismissed. Significant differences found in compositional analysis are disre-
garded.  
Options for action 
Proposals were developed aiming at further improvement and standardisation of risk 
assessment: 
> The structure of risk assessment approaches and dossiers should be standardised. 
> The role of substantial equivalence for risk assessment should be further clarified. 
> Significant differences in the results of analysis of the same GMPs should at least 
trigger repetition of the analysis. 
> Dossiers should be “stand-alone” documents, including full reports of available 
safety studies, quoted literature, statistical evaluation sheets for compositional 
analysis, and thorough description of methods applied. 
> The direct testing of toxic or allergenic properties should be preferred compared 
to indirect testing and assumption based reasoning. 
> Testing should be extended to include whole-plant/whole-food testing. 
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Identified future issues 
The authors mention that some of these proposals have already been included in most 
recent guidance documents. Others might require further discussion and even addi-
tional studies – the particular minimum set of toxicity endpoints, for example. Some 
proposals might require further improvement of testing methods or even the devel-
opment of new methods. 
IMPACTS AND FOLLOW UP OF THE PROJECT 
Parliamentary debate 
Austria refers to the study in an EU meeting of the Standing Committee on the Food 
Chain and Animal Health, claiming a comprehensive toxicological risk assessment as 
described in the study. In the Austrian Parliament there is no immediate discussion of 
the study. However, it details and shapes the Austrian position on GMP risk assess-
ment issues. 
Scientific recognition and public perception 
An article based on the present study and written by some of its authors (together 
with other scientists) was published in the International Archives of Allergy and Im-
munology (137/2005). 
Furthermore, the work is cited in Science, Technology & Human Values (32/1), in a 
Press Release of the Institute of Science in Society, and in a Nature Biotechnology 
correspondence. It was presented on the Third World Network’s website and men-
tioned as additional material by the Third Meeting of the UNEP Ad Hoc Technical 
Expert Group on Risk Assessment. 
CHALLENGES IDENTIFIED IN THE PROJECT 
At the time of this English paper’s publication, the 2003 SSC guidance document 
was the state-of-the-art standards on GMP risk assessment. As mentioned, it contains 
some of the proposals made by this study, as, for example, the need of complete dos-
siers containing all information required for a full risk assessment. Other aspects, 
however, remain unclear, ambiguous, or disregarded: Good Laboratory Practice is 
only demanded for toxicological studies. The SSC guidance is ambiguous with re-
gard to the toxicological testing of the introduced proteins. The possibility of secon-
dary effects is acknowledged, but in a more limited way than in this monograph. Fur-
ther guidance for homology studies than the indications given by the SSC document 
is needed. Unlike the case-by-case basis favoured by the SSC guidance notes, this 
paper proposes compositional analysis for all processed products. 
Taking into account these differences, this monograph sees the challenges in address-
ing the shortcomings still remaining. If this is not accomplished by further and better 
regulation, risk assessment practice on toxicity and allergenicity is still to be called 
deficient. 
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LITERATURE 
Spök, A., Hofer, H., Lehner, P., Valenta, R., Stirn, S., Gaugitsch, H. (2004): Risk As-
sessment of GMO Products in the European Union. Toxicity assessment, allergenic-
ity assessment and substantial equivalence in practice and proposals for improve-
ment and standardisation. Austrian Federal Environment Agency. Wien 
AUTHOR OF THE REVIEW 
Helge Torgersen 
 18 
FEASIBILITY STUDY ON »GMO-FREE« CLAIMS AND 
THE AVOIDANCE OF GMOS IN FOOD (2005) 1.4 
BACKGROUND OF THE PROJECT 
Context 
The study bases its predications regarding to the feasibility of a correct use of the label 
“GMO‐free”, on  the one hand, on  the definition according  to  the Codex Alimentarius 
Austriacus and, on the other hand, on the EU‐regulation 1829/2003 concerning the (not 
required) labelling of animal feed and comestibles as GMO.  
The public debate on GMOs  in Austria was a more critical one compared  to other EU 
Member States. Moreover,  it was characterised by an unusual common understanding 
between political representatives, social movements and significant parts of the agricul‐
tural sector. This constellation led to a more restrictive handling of the label “GMO‐free” 
in Austria. For example, the Austrian label requires additional standards concerning the 
application of production facilities, the fabrication of additives, and feeding.  
The study was carried out while the use of GM‐seeds in Austria and other EU Member 
States was prohibited by regulations of  the EU‐Council. Hence,  the possibility was ex‐
cludable that in Austria and large parts of the EU there would be GM‐seeds employed. 
In case of additives, the situation in the year 2005 was already different: some of them 
were almost exclusively accessible from sources involving GM‐micro‐organisms. 
Demanding institution 
The Austrian Federal Ministry of Health and Women, the Austrian Federal Ministry of 
Economics and Labour and the AMA Marketing GesmbH assigned the Austrian Agency 
for  Health  and  Food  Safety  with  the  realisation  and  coordination  of  this  feasibility 
study. 
The  study was  realised  in cooperation with  the University  for Natural Resources and 
Applied  Life  Sciences  and was  continuously  evaluated  by  Prof. Maurer,  head  of  the 
former Ludwig‐Boltzmann‐Institute for Organic Farming and Applied Ecology and now 
chairman of the new Bio Research Austria Institute. 
Guiding questions 
> Is there a transfer of GMOs from animal feed to derived food products? 
> Are the raw materials and additives for feed production available? 
> From the viewpoint of nutritional requirements, is the use of GMO-free feeds fea-
sible? 
> Does a GMO transfer happen via bee products? 
> What strategies and efficient monitoring exist to avoid GMO contamination? 
> From an economical viewpoint, is the use of GMO-free feeds feasible? 
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BASIC DATA ABOUT THE PROJECT 
Type of project 
The present project is a feasibility study that tries to estimate the existing possibilities 
(taking into account nutritional requirements, economical factors and constraints, 
etc.) to accomplish the requirements established in the legal frameworks in Austria 
and the EU. A broad inquiry into Austrian and international scientific studies and 
publications forms the basis of this study. The study investigates legislative texts and 
economical measures (market prices; amounts of consume and production of seeds, 
etc.), and undertakes some basic calculations to estimate the differential costs for the 
production of food applying GMO-free feeds.  
Topics 
The topics addressed by the study are basically the legal situation for the denomina-
tion of a product as “GMO-free” in Austria and the EU, the necessities to meet the 
legal requirements and control their compliance (monitoring) and the additional costs 
of gaining the “GMO-free” label. Besides, the world agricultural product market is 
taken into consideration regarding the availability of indispensable import products.  
With these concrete topics the main problematic of the feasibility of GMO-free pro-
ducts appropriate to the current legal frameworks is addressed. 
Duration 
The study was commissioned in late autumn 2004, finished and published in No-
vember 2005. 
Participants 
> Austrian Agency for Health and Food Safety: Leopold Girsch (project manage-
ment),  
> Institute for Seeds: Natascha Balarezo (internal project coordination), Christine 
Kargl 
> Institute for Animal Feed: Veronika Kolar, Thomas Kickinger, Herbert Würzner 
> Vienna Institute for Comestible Testing: Rainer Bernhart, Klaus Riediger 
> Risk Assessment: Roland Grossgut, Daniela Hofstädter 
> Institute for Apiology: Rudolf Moosbeckhofer 
> Biochemistry Competence Centre: Hermann Hoertner, Rupert Hochegger 
Subcontracts 
> University for Natural Resources and Applied Life Sciences (Institute for Market-
ing and Innovation): Siegfried Pöchtrager, Josef Penzinger, Stefan Großauer 
> Evaluation: Ludwig Maurer 
Events 
The study was presented to a broad range of interest groups at the end of 2005. On 
November 2nd, 2005, there was a press conference at the Austrian Agency of Health 
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and Food Safety in Vienna. In the following weeks until February 2006 there were 
presentations, for example, for the Chambers of Agriculture of Austria, Upper Aus-
tria, Styria and Lower Austria and other communities of the agricultural sector.  
MAJOR OUTCOMES OF THE PROJECT 
Central findings 
> No evidence was found in the international scientific literature stating that even 
traces of transgenic DNA were detectable in foods derived from animal produc-
tion after feeding GM-feed.  
> 90% of the imported soy used for feeding in Austria is transgenic. The global 
share of GM-soy is still increasing. However, following the requirements from the 
EU directive 1829/2003, in a short- and medium-term raw materials for animal 
feed production which do not have to be labelled as GMOs will be available. With 
respect to the provisions established by the Austrian Codex, protein substitutes for 
soybean extraction meal produced in Austria and the EU will be available. It has 
to be said that these substitutes can only be used to a certain limit and no forecast 
can be given for the development of the raw material markets. In terms of the ad-
ditives for animal feed production, there are products available which do not re-
quire labelling in accordance with the EU-directive but would so according to the 
Austrian law.  
> Feasibility of the usage of feed labelled as GMO-free: following the EU directive, 
it is feasible in a short- and medium term; following the Austrian Codex, it is fea-
sible only for cattle but not for pigs, poultry and turkey (because of the necessary 
additives) 
> The content of pollen in honey is usually noticeably below the labelling threshold 
levels in accordance with the EU-directive.  
> Monitoring and strategies to avoid contamination: self-control of the companies; 
separated and closed production processes; appropriate cleaning; more provisions 
in monitoring and surveillance for the Austrian label 
> The use of animal feed containing soybean extraction meal labelled as GMO-free 
or not requiring labelling leads to additional costs of up to over 8%. These costs 
vary considerably depending on the line of production (beef, pigs, etc.). In the fu-
ture, by-products from bio-fuel production that contain protein and are available 
in Austria and the EU will be commercially employable as a protein supplying 
substitute for soybean extraction meal.  
Options for action 
> enhance the production of substitutes for soybean (for example, from bio-fuel 
production) 
> try to assure a reliable labelling in the world market’s production chains 
> try to safeguard Austria’s share of Brazilian and US GMO-free soybeans 
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Identified future issues 
> monitor the world raw material market’s development and the share of available 
and affordable GMO-free products 
> integrate more aspects into the calculations of the additional costs 
IMPACTS AND FOLLOW UP OF THE PROJECT 
Parliamentary debate 
The Federal Minister of Agriculture, Forestry, Environment and Water Management 
mentioned in a parliamentary inquiry presented by the Green Party in the year 2006 
that the present study was presented to the ministerial working group on genetic en-
gineering. Moreover, he cited the study’s insights into the additional costs and tech-
nical needs for contamination prevention. In another parliamentary inquiry in 2004, 
also presented by the Greens, the same Minister explains the financing and planning 
of the study. He says, inter alia, that there was (as usual) an interchange on the plan-
ned contents with the relevant experts, on beforehand. Also in the regional Parlia-
ment of Salzburg the study was subject of a parliamentary inquiry. 
Interestingly, the study was cited in a parliamentary debate in the German Bundestag 
by Christel Happach-Kasan (FDP). She exposed and interpreted the study’s finding 
that GM-free pig and poultry breeding is quite impossible because of the additives 
needed. Not using genetic engineering technologies would lead to a higher mortality 
in the animal stocks. There was disagreement expressed by the German Greens.  
Public perception 
After the press conference on November 2nd, 2005, there was ample recognition of 
the study in local media and partially in the German-speaking world. The Austrian 
Press Agency published an article delivered by the Agrarian Information Centre. The 
ORF (the Austrian public news channel) reported, too. 
Furthermore, the study was mentioned by the Austrian Federal Chamber of Com-
merce. Details were cited by the Austrian Chamber of Labour, Greenpeace, Austrian 
agricultural communities such as BioAustria, the German Information Service on 
Genetic Engineering (Informationsdienst Gentechnik) and other German citizen’s 
action committees. 
The public perception of the study is characterised by the conclusion that GMO-free 
production of comestibles is feasible, principally, but there are some costs to take 
into account. However, there are also new opportunities for the Austrian agriculture, 
especially concerning the production of GMO-free substitutes for soy from bio-fuel.  
Scientific recognition 
A research paper of the Austrian Federal Ministry of Health and Women on the need 
to label GMOs already pointed to the study in 2005, before its finishing.  
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CHALLENGES IDENTIFIED IN THE PROJECT 
The development of the international market for reliable GM-free seeds and feed can 
not be predicted and lies outside the Austrian room for manoeuvre. The availability 
of GM-free additives is already quite limited.  
LITERATURE 
Austrian Agency for Health and Food Safety/University for Natural Resources and Ap-
plied Life Sciences, Vienna (2005): Feasibility Study on “GMO-free” claims and the 
avoidance of GMOs in food. 
AUTHOR OF THE REVIEW 
Helge Torgersen 
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COEXISTENCE (2005) 1.5 
BACKGROUND OF THE PROJECT 
The cultivation of genetically modified crops is growing steadily and fast in the ulti-
mate years, mostly in North and Latin America. In the EU there is already an exten-
sive set of legislation on the regulation, admission and limitation of GMO cultiva-
tion, import etc.  
In 2003, the European Commission released the Recommendation No. 2003/556/EC 
on guidelines for the development of national strategies and best practices to ensure 
the coexistence of genetically modified crops with conventional and organic farming. 
The Commission underlined that these guidelines should focus on economic conse-
quences of GMO cultivation given that ecological and health aspects are already 
taken into account in the GMO admission procedure. The scope of the guidelines 
spans from the agricultural production to the first point of sale – higher levels of 
elaboration are not considered. In addition, national catalogues of measures, as to be 
defined by the member states, should allow for every country’s specificities regard-
ing topography, climate, the agricultural structures and the production systems. The 
Commission’s Recommendation together with the country’s implementation strate-
gies should ensure that the compliance with the threshold values for non-GMOs is 
not impeded by the diversity of the producing regions, the productive systems and 
technical matters. 
The Austrian situation in the domain of green biotechnologies is characterised by a 
quite restrictive legislation and a broad GM-critical consensus between the political 
parties, farmers, interest groups, NGOs and the public. Seeds in the initial examina-
tion have to be free of GM contaminations to be authorised in Austria. In the follow-
up examination a threshold value of 0,1% is fixed. 
BASIC DATA ABOUT THE PROJECT 
The present study was conducted (under the guidance of Prof. Georg Grabherr) by 
Kathrin Pascher and Marion Dolezel from Vienna University’s Department of Con-
servation Biology, Vegetation Ecology and Landscape Ecology between the end of 
2003 and March 2005 on behalf of the Austrian Federal Ministry for Health and 
Women (Section IV). The overall goal of the document is to define rules and meas-
ures providing a general framework for coexistence of GM-, conventional and bio-
logical crops for the specific Austrian case as demanded by the Commission’s Rec-
ommendation. The authors argue that measures for the cultivation of GM-crops 
would assure the farmers the possibility of planting just the crops they want to, as 
well as the consumers the security and freedom of choice they look for.  
Following the Commission Guidelines which establish that the measures have to be 
crop-specific, the study focuses on maize, oilseed rape and sugar beet – for the au-
thors primarily expect these crops to be commercially cultivated as GMOs in Europe. 
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Sources of GM-contaminations are outlined and evaluated, then the measure propos-
als for the reduction of these contaminations are given and experiences from other 
countries with coexistence of the mentioned crops are incorporated.  
The project was realised in terms of a scientific study from an eco-biological per-
spective. In the course of the project, the authors attended a series of conferences and 
lectures, amongst others the 1st European Conference on the Coexistence in Den-
mark, a conference on GMO Risk Assessment in Vienna, other forums on coexis-
tence in Austria and a Conference of the European network of GMO-free Regions. 
There were basically two methods applied: Firstly, a theoretical evaluation of the 
problematic of coexistence and contamination by means of a review of existing stud-
ies of a European and non-European institutions and authorities (FiBL, Union of 
Concerned Scientists, BUWAL, JRC, MAFF, MAF), literature databases, organisa-
tional websites (saveourseeds.orf, transgen.de, biosicherheit.de, ucsa.org, etc.), per-
sonal contacts to Austrian authorities, organisations and firms (AGES, Saatbau Linz, 
ZAMG, Chambers of Agriculture, etc.), and conference attendance. Secondly, GMO-
crop growing was simulated for different Austrian regions. The amount of field 
losses due to the necessary belts of isolation (to avoid exogamy) was simulated for 
random and clustered repartition of GM-crop fields in the cases of maize, oilseed 
rape and sugar beet.  
MAJOR OUTCOMES OF THE PROJECT 
The study’s outcome is a catalogue of measures to prevent contamination with 
GMOs and to delineate the exigencies of a reasonable coexistence.  
In the case of maize, the use of barriere-plants or of varieties with different flowering 
dates will not be sufficient to reduce GMO contamination rates to 0,9%. Isolation 
distances of at least 200m seem to be the only viable measure to guarantee this quota. 
However, if GM proportions grow beyond 10% and if a threshold value of 0,1% in 
the harvest is to be realised, cultivation, harvest and post-harvest processes have to 
be thoroughly separated and cross fertilisation completely avoided. Not even isola-
tion distances of one to several kilometres could assure this due to other factors that 
until now couldn’t be exhaustively studied – the establishment of large-scale GMO 
free zones would be the only possible way to guarantee these low threshold values. 
Imports of basis seeds and possible cross fertilisation are the crucial points for con-
tamination control in oilseed rape. Necessary measures for the consumption produc-
tion are, therefore, a purity control of the imported basis seeds, long growing inter-
vals of at least 8 to 12 years (to reduce volunteers of oilseed rape) and isolation dis-
tances of 4 kilometres (allowing for the flying distances of pollinating insects). Re-
gional and continuous examinations of their effectiveness could facilitate more flexi-
ble isolation distances. The management of the segetal weed flora, barriers with non-
GM oilseed rape and the removal of bee hives near the fields seem to be viable 
measures, too. Transportation routes should be as short as possible. However, the 
creation of a closed seed production area would be the most effective measure. Con-
sidering the specificities of agronomic and topographic structures, climatic particu-
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larities, the necessary extent of the isolation zones, regional occurrence of volunteers, 
etc., the authors argue that coexistence of oilseed rape will not be feasible in Austria.  
Sugar beet for consumption is not flowering. Hence, the unwanted hybridisation 
events affect seed production areas. To achieve a threshold value for GM contamina-
tion of 0,5% much larger isolation distances than the currently widespread 300, 600 
or 1000m would be needed. The highest risk is currently posed by imported seed. 
Reliable choice and control is needed; moreover, suitable cultivars, coordination of 
farmers, at least 2 kilometres of isolation distance, control of bolters, weed beets, 
volunteer beets and Beta-forms. Pollen barriers should be used and a crop rotation of 
at least eight years guaranteed. 
Beyond these crop specific arguments the study presents measures to avoid technical 
contamination at cultivation and harvest. The technical processes of GM and con-
ventional or organic field crops should either be completely separated or strict guide-
lines for adjustment, operation and cleaning measures should be provided and de-
manded. Seeding and harvesting machines have to be cleaned before and after their 
application for GM crops. Losses during the transport must be prevented, hoppers 
cleaned and controlled, contracts established (e.g. between vicinal farmers on loca-
tion of their fields or on the requirements and criteria for a joint use of machines), 
etc. 
IMPACTS AND FOLLOW UP OF THE PROJECT 
A Green Party’s delegate to the National Assembly asked the Federal Minister of 
Health and Women and the Federal Minister of Agriculture, Forestry, Environment 
and Water Management in a written parliamentary request about the costs of coexis-
tence in Austria. As an initial point he cited the present study which, in his interpreta-
tion, comes to the conclusion that the coexistence of GMOs and conventional and 
biological products is possible, if at all, only with high technical and organisational 
efforts.  
The study is also cited by further studies of the Federal Ministry of Health and 
Women and the Austrian Agency for Health and Food Security, the network of 
GMO-free regions and an Upper-Austrian text introducing this region’s characteris-
tics and the structure of its economy. In a slightly different reading some of the 
study’s findings are presented in an information letter of Les Professionels des 
Semences et de la Protection des Plantes, a French syndicate of the seeding indus-
tries. They mention that the study posits the possibility of coexistence always re-
specting the right isolation distances. It is just rape where coexistence doesn’t seen 
viable in Austria. 
CHALLENGES IDENTIFIED IN THE PROJECT 
The study’s tenor is that coexistence is possible in some cases but not in all. And 
even if it is possible this would lead to economical and social costs and much regula-
tory work on a national base. The mentioned feasible measures to assure coexistence 
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are presented in a sceptical light. The whole issue of coexistence seems to be a prob-
lematic one since it is at least an expensive endeavour and potentially impossible, at 
the end. The reader could get the impression that the study provides and tries to pro-
vide scientific arguments underpinning GM-critical positions.  
LITERATURE 
Pascher, K., Dolezel, M. (2005): Koexistenz von gentechnisch veränderten, konventio-
nellen und biologisch angebauten Kulturpflanzen in der Österreichischen Landwirt-
schaft – Handlungsempfehlungen aus ökologischer Sicht. Bundesministerium für 
Gesundheit und Frauen, Sektion IV, Band 2/05, Wien 
http://www.bmgfj.gv.at/cms/site/standard.html?channel=CH0810&doc=CMS1113
391269254 English summary: 
http://www.bmgfj.gv.at/cms/site/attachments/6/4/4/CH0810/CMS1113391269254/
summary_-_coexistenz.pdf 
AUTHOR OF THE REVIEW 
Helge Torgersen 
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THE ROLE OF PRECAUTION IN GMO POLICY (2006) 1.6 
BACKGROUND OF THE PROJECT 
Context 
In the year 2000, the European Commission published the so called Communication 
on the Precautionary Principle. This document proposed guidelines for the handling 
of scientific uncertainty. Since then, precautionary language and criteria have been 
integral part of the respective legislation, for instance, in the Deliberate Release Di-
rective concerning GM crops or the Biosafety Protocol. Today, the Precautionary 
Principle (PP) is firmly established in European law. 
Notwithstanding, the principle has not ceased to be contentious and much less to be 
interpreted in different ways. Besides the narrow account of the European Commis-
sion’s document, there are broader ones from other sources like the European Par-
liament, experts, member states and stakeholders. The project “Precautionary Exper-
tise for GM crops” (see section 1.2) studied varying understandings and applications 
of the PP within and between 7 European States. The scenario in Austria could be 
sketched as characterised by a wide GMO-critical political consensus between gov-
ernment, stakeholders and the public, despite divergent concepts of precaution.  
Demanding institution 
The present conference was initiated jointly by the Austrian Federal Ministries of 
Agriculture, Forestry, the Environment and Water Management and of Health and 
Women. The Federal Environment Agency was responsible for realisation. The con-
ference took place in the frame of the Austrian EU-Presidency in the first half year of 
2006. The actual and possible development of the PP in GMO policy was examined 
from legal, scientific, and political perspectives as well as on the basis of case studies 
at national, EU and international levels.  
Guiding questions 
> What different interpretations of the PP exist? 
> Is there room for the principle in the EU legislative framework and how is it spe-
cified? 
> What are practical experiences with the principle? 
> What is the scientific background to be taken into account? 
BASIC DATA ABOUT THE PROJECT 
Type of project and duration 
The project was an international and interdisciplinary expert conference held at the 
Hofburg in Vienna with the participation of experts and stakeholders from a scien-
tific and a political background. It took place on the 18th and 19th of April 2006.  
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Topics 
Relevant aspects of the precautionary approach towards regulation of GMOs were 
addressed. The main topics discussed were possibilities and limits of precautionary 
measures within the existing legal framework, the scientific background of precau-
tionary approaches, as well as the practical experiences of putting to use the princi-
ple.  
Some of the contributions’ subject areas were how EU legislation on GMOs relates 
to and gives room for the PP, how and where it is discussed controversially, how it is 
interpreted in the CEE countries and what were practical experiences with the use of 
the principle, as well as the question of risk assessment. 
Participants 
Approximately 135 scientists, state and interest group representatives  
Speakers: (in order of appearance): 
> Hugo-Maria Schally (Chairperson), DG Environment, European Commission 
> Christine von Weizsäcker, Germany 
> Kathryn Tierney, DG Environment, European Commission 
> Liina Eek, Ministry of the Environment, Estonia 
> David Wield, Open University, UK 
> Eric White, Legal Service, European Commission 
> Thomas Jakl (Chairperson), Ministry for Agriculture, Forestry, Environment and 
Water Management, Austria 
> Brian Wynne, Centre for the Study of Environmental Change, Lancaster Univer-
sity, UK 
> Jürgen Zentek, Freie Universität Berlin, Germany 
> Christopher Pollock, Institute for Grassland and Environmental Research, UK 
> Margaret Mellon, Union of Concerned Scientists, USA 
> Katja Moch, Öko-Institut Freiburg, Germany 
> Michel Haas (Chairperson), Ministry for Health and Women, Austria 
> Brian Wynne on behalf of David Gee, European Environment Agency 
> Harry Kuiper, GMO-Panel EFSA, RIKILT – Institute of Food Safety, The Nether-
lands 
> Jan Husby, Norwegian Institute of Gene Ecology, Norway 
> Simon Barber, Plant Biotechnology Unit, EuropaBio 
> Helmut Gaugitsch, Federal Environment Agency, Austria 
IMPACTS AND FOLLOW UP OF THE PROJECT 
It was concludingly addressed by Helmut Gaugitsch that there is a need for a follow-
up. A good starting-point would be the discussion on the PP and ways towards its 
application. Kathryn Tierney (EU Commission) enunciated that the debate on GMOs 
and the PP would continue at the EU Environmental Council in Luxembourg in June 
2006. 
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There was no parliamentary debate on the conference. However, it was presented by 
the authorities as an asset in the Austrian EU-presidency 2006 to address the issue in 
such an international expert conference, bringing forward the respective EU-wide 
discussion. The national press (Der STANDARD, 20.4.2006) reported in a short 
statement. The Institute for Applied Ecology (Freiburg/Germany), the USDA For-
eign Agricultural Service, biotrin.cz and the Biosafety Information Centre mentioned 
the conference on its website. 
MAJOR OUTCOMES OF THE PROJECT 
Central findings 
As Helmut Gaugitsch in his closing remarks points out, there is broad consensus 
around an understanding of the PP as one of the central aspects of European GMO 
legislation. It was described as a tool that allows countries to adopt the level of pro-
tection that was felt necessary, even in the absence of scientific certainty. However, 
it remains questionable whether there is a common understanding of the PP and the 
way it can or should be implemented.  
Regarding the question whether the PP is a risk management issue only, it became 
clear that risk assessment on its own is an important prerequisite for decision making 
but not enough as it is inadequate to assess uncertainty, by definition cannot assess 
ignorance and also falls short of acknowledging any benefits. As Bryan Wynne ex-
pressed it, precaution should rest on the recognition that knowledge is always lim-
ited. The assumption that the need for precautionary policy can be subjugated to pre-
liminary risk assessment is misconceived. 
The PP should contribute to protection and not protectionism and should be used to 
gain further scientific knowledge. It was stated that the PP can be a possible instru-
ment of scientific innovation. 
There were also voices who proposed a modification of EFSA’s format and inner 
EU-communication on orientations toward the PP. Others, again, expressed the opin-
ion that Europe-wide universalist approaches to the PP, maybe, will not work (con-
sidering that some regions see commercial benefits in being GM-free etc.). There 
will not be a single understanding and application of the PP. Particularly “ecologi-
cally sensitive” areas will have different approaches, for example. 
Eric White from the European Commission’s Legal Service claimed that the PP is 
alive and perfectly compatible even with the WTO.  
Options for action and identified future issues: 
> continue to discuss the concept of the PP in the national, EU and international 
level towards application and action 
> discuss the different national and EU wide conceptions of the PP to get to a more 
common understanding 
> elaborate mechanisms to include statements on the application of the PP in GMO 
product notifications 
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> improve, harmonize and standardize the risk assessment instruments nationally 
and EU wide (should include guidance on which kind of data should be included 
in notifications and the methodology to generate them), keeping a balance be-
tween clear guidance and case-by-case sensibility 
> in order to gain further knowledge on GMOs and to address uncertainty and igno-
rance, research projects could and should take approaches as the PP more into ac-
count 
> enter into a dialogue with stakeholders (and involve them) at the national and the 
EU level and between them; risk communication should be improved and a sys-
tem for public participation needs to be set up 
CHALLENGES IDENTIFIED IN THE PROJECT 
A considerable challenge identified is to find ways from the PP to an applicable ap-
proach and action and to define its relation to the risk assessment framework. The PP 
should not be used as a technical barrier to trade and a tool for protectionism. 
There lies a twofold challenge in the concept of PP as it is present in nowadays’ leg-
islation and practice: On the one hand, the PP has to be elaborated and discussed on 
general grounds, looking for ways to apply and regulate it. On the other hand, the 
various interpretations of the principle have to be consorted.  
The EU legislative framework has to be fine-tuned to provide for a higher degree of 
transparency and thus to fulfil the expectations on decision-making.  
It was argued that the “Sound Science” approach (firmly present in the US policies), 
with its accents on delaying safety obligations until causal chains of harmful impacts 
are fully proven, runs counter the PP – with this, originating a possible and already 
manifest conflict between the US and Europe (see the current WTO dispute). The EU 
could possibly use the “de facto coalition” with the developing countries in favour of 
the PP, to enforce its position and foster its understanding of protection.  
LITERATURE 
Federal Ministry of Health and Women (Ed) (2006): Conclusions of the conference 
"The Role of Precaution in GMO policy", 18.-19. April 2006, Vienna 
http://www.bmgfj.gv.at/cms/site/standard.html?channel=CH0810&doc=CMS1145
612477419 
AUTHOR OF THE REVIEW 
Helge Torgersen 
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DENMARK 2. 
GENETICALLY MODIFIED FOODS (1999) 2.1 
BACKGROUND OF THE PROJECT 
The DBT- project “Genetically modified foods” from 1999 was carried out due to 
the apparent scepticism among the Danish population. At that time, genetically modi-
fied foods were about to enter the Danish market, but it seemed that the Danish con-
sumers did not associate any direct advantages with them. However, it was impossi-
ble to reject that benefits would eventually emerge in step with the development of 
the technology.  
At that time, legislation on genetically modified foods had not yet been completed 
within the EU and the potential benefits and risks considering GM foods were still 
associated with much uncertainty. Thus, the aim of the project was to provide a 
multi-faceted public debate on GM foods in order to enhance the dialogue between 
decision makers and the public.  
BASIC DATA ABOUT THE PROJECT 
The project was designed as a consensus conference that took place during three 
days. The Danish Board of Technology appointed a panel of fourteen citizens who 
were asked to consider genetically modified foods. Before the actual consensus con-
ference, the citizen panel met twice and discussed GM foods based on some intro-
ductory information. At the conference, thirteen experts were invited to make a pres-
entation of their knowledge and opinion considering GM foods. During the two first 
days of the consensus conference the experts answered questions from and discussed 
with the citizen panel. Conclusively, the citizen panel created a final document con-
taining the evaluations and recommendations considering GM foods on which the 
panel could all agree.    
Through the consensus conference ten questions considering genetically modified 
foods were addressed both by the experts and the citizens. In the final document, 
each question is evaluated by the citizen panel and followed by some recommenda-
tions. The main topics that characterized the ten questions concerned amongst others: 
environmental impacts, human health, market conditions, national and international 
regulation, information, and ethics.   
MAJOR OUTCOMES OF THE PROJECT 
The consensus conference concluded that the production of genetically modified 
foods undoubtedly affects nature’s cycle. However, the experts strongly disagree 
about the seriousness of the effect and whether or not the effect is hazardous. Argu-
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ments for and against GM foods were discussed among the citizen panel and resulted 
in some recommendations. These recommendations emphasize some of the chal-
lenges that the further development of GM foods involves. 
The panel emphasized the importance of preserving the biodiversity of plants and 
animals and to protect the natural eco-systems. Thus, the citizen panel agreed that it 
should be possible to hold manufacturers of GM foods responsible for adverse ef-
fects on human health and the environment.  
The laymen panel believed that authorisations for tests and production of genetically 
modified organisms should be subjected to severe regulations for risk evaluation and 
requirements of efficient control. Further, public regulation was recommended as a 
means to offset monopolistic companies from controlling the market for GMO’s. It 
was also suggested that companies should lose their right of use for unapplied pat-
ents. The panel also supported the idea of a convention guaranteeing developing 
countries free access to utilising gene technology patents. Because biotechnological 
research to a wide extent is concentrated in the private sector, the panel recom-
mended that public funding for research in the field should be increased. 
The panel highlighted the importance of ensuring consumers still to be guaranteed a 
choice between genetically modified and non-genetically modified foods. It was fur-
ther emphasized that dissemination of information is crucial and that comprehensible 
and informative declarations of contents are necessary.  
The panel further recommended that ethical aspects should be given the same prior-
ity as purely technical aspects in relation to applications for testing, production and 
marketing of GM foods. Thus, the panel recommended that a committee charged 
with ensuring an ethical evaluation of the authorisation process should be estab-
lished.  
IMPACTS AND FOLLOW UP OF THE PROJECT 
The consensus conference kick-started a more widespread debate on genetically 
modified food in the public. The Danish Board of Technology found that the political 
interest in the field increased in the wake of the conference. Both national and EU- 
politicians showed interest in the project and were curious to know what the citizens 
worried about. 
CHALLENGES IDENTIFIED IN THE PROJECT 
Different challenges considering genetically modified foods and how to handle them 
appeared throughout the project. First of all it became clear that there is a conflict 
between experts when it comes to assessing the risks and benefits of GM foods. 
Hence, the project showed that experts disagree whether GM foods are predomi-
nantly beneficial or if they pose a threat to the environment and/or human health. 
These disagreements pose a challenge to the further discussions considering GM 
foods. Another challenge that was identified considered the question of monopoly 
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highlighting that knowledge about GM foods is only available to very few people. 
The question of responsibility was further a challenge that appeared during the con-
sensus conference; who can be held responsible if something goes wrong with GM 
foods? The challenge is to take such matters into consideration. The project further 
emphasized the importance of ethical considerations when dealing with genetically 
modified foods. Thus, the question is whether the utility value of GM foods matches 
up with the ethical issues.   
LITERATURE 
The Danish Board of Technology, (1999): Gensplejsede fødevarer. 
http://www.tekno.dk/pdf/projekter/p99_genspl.pdf; English summary: Genetically 
modified foods. http://www.tekno.dk/pdf/rtt_125_uk.pdf 
AUTHOR OF THE REVIEW 
Søren Gram 
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GENETICALLY MODIFIED CROPS IN DEVELOPING 
COUNTRIES – CHALLENGES FOR THE 
DEVELOPMENT AID (2003) 2.2 
BACKGROUND OF THE PROJECT 
The DBT project “Genetically modified crops in developing countries” were initi-
ated based on the conclusions of the UNDP’s Human Development report 2001, 
which focused on the role of ICT and biotechnology in the reduction of world pov-
erty. The report stated quite a clear position in favour of biotechnology by emphasiz-
ing an opposition to put restrictions on technological developments. Instead, the re-
port called on an examination of what it takes to control and exploit new technology 
in everybody’s interest. The UNDP report gave rise to immediate counter-reactions 
emphasizing that the problems of hunger and poverty in the third world countries are 
a matter of distribution because we already produce enough food to feed the whole 
world. Based on these counter-reactions the DBT set out to assess the pros and cons 
of using genetically modified crops to fight poverty and hunger in the third world. 
BASIC DATA ABOUT THE PROJECT 
The project ran from 2002 to 2003 and involved an interdisciplinary task force ap-
pointed by the Danish Board of Technology. The task force consisted of six experts 
all with specialist knowledge within the field of biotechnology and development aid 
respectively. The objective of the task force was to consider if, and how, dealing with 
GM crops should be an integrated part of the official, Danish development policy.  
The task force arranged three workshops where leading experts within selected areas 
presented and discussed experiences and the latest knowledge. The first workshop 
assessed the technical and environmental possibilities and risks regarding already 
existing biotechnologies. The second workshop assessed social, environmental, ethi-
cal and cultural issues. It aimed to assess the implications and desirability of using 
biotechnology in third world farming structures. The final workshop discussed the 
compatibility of GM food with the overall aims of Danish development policy in 
relation to using participatory methods, fighting poverty, the precautionary principle 
etc. During all three workshops the task force invited other leading experts to con-
tribute with comments, ideas and their expertise on the matter. 
Through the project, the task force was asked to answer a two-pronged question, 
which constituted the starting point of the DBT project; Can Danish development aid 
be used positively to 1) incorporate genetically modified crops into the work of im-
proving the living conditions of the poorest population groups in developing coun-
tries – and 2) can this be done without conflicting with existing Danish development 
policy strategies? The task force approached the questions in view of the fact that the 
dissemination of GM crops is already taking place – just not considering Danish de-
velopment aid. The first part of the question was considered to be too complex and 
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diverse to be answered by a simple yes or no, which is why the task force decided to 
take a diversified, more pragmatic and action-oriented approach. Thus, the DBT re-
port does not contain arguments for or against GM crops as such but rather provides 
a basis for the assessment of benefits and drawbacks of the possible use of GM crops 
in specific contexts. Considering the second part of the question, the task force as-
sessed that the use of GM crops in developing countries would not necessarily con-
flict with Danish development aid policy. 
The result of the project was communicated through a report targeted at institutions 
and organisations engaged in agricultural development in the poor countries of the 
world, and further at politicians, researchers, corporate staff or others who, directly 
or indirectly, influence or are involved in agricultural development, legislation, 
commerce etc. in the third world. 
MAJOR OUTCOMES OF THE PROJECT 
The project was concluded by several conclusions and recommendations, which were 
further supported by a list of premises to constitute a framework for aid organisations 
when and if a developing country needs assistance in dealing with GM crops. The 
premises were: 
> Each GM crop must be assessed individually. 
> The same yardstick cannot be applied to all developing countries. 
> Existing GM crops are primarily adapted to the needs of farmers in the rich part of 
the world. 
> Development of GM crops is slow, i.e. there are relatively few GM crops on the 
market and relatively few on the way in. 
> Safety approval of GM crops is expensive since the control procedures are ex-
tremely comprehensive. 
> Many developing countries do not have the capacity required to undertake needs 
assessment and control and would find it difficult to make their own assessment 
of whether they would benefit from the crops, and whether they could comply 
with the control and safety regulations. 
> Patents influence development, and this may cause developing countries major 
legal and economic problems when it comes to the use and development of GM 
crops. 
> GM crops may have an adverse effect on developing countries’ competitiveness 
and access to western markets. 
> The consequences of introducing GM crops are uncertain. No-one knows for sure 
what their impact will be on the environment, nutrition and biodiversity. 
The task force’s main message was that GM crops represent one among many tech-
nologies that may contribute to solving food supply problems in developing coun-
tries, but this form of agriculture is no miracle solution – at least not in the short or 
medium term. The task force assessed that Danish development aid should continue 
to focus on a broad range of technological and institutional solutions in the agricul-
tural area with focus on responding to the needs of the poor farmer. Thus, the task 
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force considered GM crops only to play a relatively limited role in the immediate 
future. The task force further emphasized that the question of how best to assist 
countries must be assessed specifically from case to case and from country to coun-
try. Besides these more general recommendations, the task force offered more spe-
cific recommendations within four focus areas: technology, political policy, institu-
tions and society. 
IMPACTS AND FOLLOW UP OF THE PROJECT 
In the wake of the project, the Ministry of Foreign Affairs of Denmark, which is in 
charge of the Danish development policy, invited the Danish Board of Technology to 
give a presentation of the project. The Ministry does not usually consult external 
organisations, which is why the interest in the DBT report must be considered quite 
an acknowledgement of the project. 
CHALLENGES IDENTIFIED IN THE PROJECT 
Conclusively, the task force emphasized that developing aid organisations will be 
failing in their responsibility if they fall short to adopt a position with regard to GM 
crops and their use in developing countries while it is necessary to examine whether 
certain GM crops might assist developing countries in ensuring sustainable agricul-
tural production and food supply in the future. Thus, the question is not whether 
Danish development aid should decide on the use of GM crops in developing coun-
tries. Instead, the challenge for the Danish development aid organisations is to help 
the developing countries prepare for the coming of the GM plants. The challenge is 
to frame some conditions that enable developing countries to deal with and decide on 
the use of GM plants. It is crucial that developing countries are assisted with the or-
ganizing so the given countries are prepared administratively for the GM crops and 
possess sufficient scientific knowledge on the matter. Further, it is important that the 
developing countries have developed the necessary control to handle GM crops.  
Such issues are exactly what development aid should focus on in relation to GM 
plants. 
LITERATURE 
The Danish Board of Technology (2003): Genmodificerede afgrøder i udviklingslande - 
udfordringer for udviklingshjælpen. 
http://www.tekno.dk/pdf/projekter/p03_genmodificerede_afgroeder.pdf; English 
summary: Genetically modified crops in developing countries - challenges for the 
development aid. 
http://www.tekno.dk/pdf/projekter/p03_gen_mod_crops_summary.pdf 
AUTHOR OF THE REVIEW 
Søren Gram 
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CO-EXISTENCE BETWEEN GM CROPS AND 
NON-GM CROPS (2004) 2.3 
BACKGROUND OF THE PROJECT 
During the summer 2003, the European Parliament and the Council decided on a 
regulation concerning the traceability and labelling of genetically modified organ-
isms and the traceability of food and feed products produced from genetically modi-
fied organisms. With this regulation the EU reopened for approvals on the growth of 
GM crops. Based on this regulation, the European Commission recommended some 
guidelines for the development of national strategies and best practices to ensure the 
co-existence of GM crops with conventional and organic farming. Thus, the Danish 
government introduced a bill on co-existence. The bill on co-existence was framed 
with references to a report from 2003 by the Danish Institute of Agricultural Sciences 
concluding that co-existence is possible in Denmark considering some crops, but that 
there are also some exceptions were co-existence seems to be problematic.  
To discuss the bill on co-existence, the Danish Parliament (Folketing) committee of 
Food, Agriculture and Fisheries and the committee of Environment decided to make 
a hearing to clarify the experiences with the growth of genetically modified crops.  
BASIC DATA ABOUT THE PROJECT 
The Danish Board of Technology arranged the hearing on the experiences of co-
existence between GM crops and non-GM crops (within the framework of BIOSAM, 
a collaborative forum addressing ethical questions considering biotechnology). The 
hearing was open to everybody and took place May 11th 2004. Around 90 people 
(mostly experts and stakeholders) attended the hearing.  
The hearing was split up into five sessions with each their theme. The first session of 
the hearing addressed the risk of GM crops spreading by a presentation of available 
knowledge on the subject. The next session moved on to discuss how to handle the 
spreading by either preventing or minimizing the spread of GM crops to fields with 
either conventional or organic crops. The third session of the day focused on the 
positive and negative consequences facing the market in connection with a growing 
of GM crops in Danish fields. The fourth session of the hearing discussed the issue 
of compensation in cases of spreading. The last session of the hearing invited differ-
ent stakeholders to present their view on the bill on co-existence. Each session con-
sisted of three short presentations by different experts. After the presentations in each 
session there were time for questions and discussions from the panel of politicians 
(committee members). Also a few questions from the audience were allowed. 
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MAJOR OUTCOMES OF THE PROJECT 
The aim of the hearing was to initiate discussions, generate knowledge, and collect 
experiences on the co-existence between GM crops and non-Gm crops. The hearing 
was recorded and later transcribed and published in a report. Due to the method of 
this project the report does not contain any overall conclusions but emphasizes, 
through the different viewpoints, the challenges that the growing of GM crops 
causes.     
Since Denmark has no actual experiences with the growing of GM crops, several 
international experts were asked to speak at the hearing to share their experiences 
with the co-existence between GM crops and non-GM crops. In Austria, the agricul-
tural structure (small farms and narrow fields) makes co-existence problematic. Fur-
ther, Austria has passed a law that prohibits growing of GM crops in the northern 
part of the country - GM-free zones. In Spain they have more experience with GM 
crops and Bt-maize have been grown since 1998. The GM crops have been grown 
without any kind of precautions, without any control considering the agricultural 
results and the environmental impacts, and without information and transparency. 
According to Friends of the Earth, there are several examples of spreading and thus 
contamination of conventional and organic crops in Spain. Experiences from Canada 
further show that the growing of GM crops will have a negative impact on organic 
farming.  
Economic potentials and costs of growing GM crops in Denmark were further dis-
cussed with reference to international experiences. So far, the growing of GM crops 
seems to bring both extra costs and savings. GM crops will no doubt become a factor 
of competitiveness, and in order for Denmark not to loose its competitive advantages 
it was broad forward that it is necessary that Denmark launch GM crops now. In the 
end, it all comes down to the individual farmer whether there are economic incen-
tives to grow GM crops. Besides the potential economic benefits that GM crops will 
bring about, other possible advantages considering GM crops were discussed. The 
effects of shifting to GM crops vary from crop to crop. Some of the advantages that 
have been identified include increased yield and productivity, a reduction in the use 
of pesticides, a more efficient weed control, less erosion and leaching, and a better 
economy for the individual farmer. If the experiences from the US are transferred to 
Europe there is thought to be great benefits for the farmer as well as the environment, 
the consumer and society.  
These claims was however dismissed by other experts who emphasized that we 
should not expect too much from the GM crops since they have not really shown any 
great potentials yet. Furthermore, some experts questioned the potential environ-
mental advantages that are often highlighted in discussion on GM crops. Thus, the 
hearing showed that there are quite contradictory opinions considering the potential 
benefits and detriments of growing GM crops.    
The Government’s suggestion for a bill on co-existence includes a system of com-
pensation that guarantees farmers whose crops are polluted by GMO’s to receive 
compensation. During the hearing both governmental systems of compensation and 
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private insurance covers were discussed in this context. It was further discussed 
whether such a system of compensation would cover all losses in a case of spreading 
from GM fields to conventional and organic fields.  
The hearing pointed to a passing of the bill on co-existence in Denmark. Throughout 
the hearing it further became clear that the provisional proposal for the co-existence 
were in need of some adjustments before the final decision to pass the bill. 
IMPACTS AND FOLLOW UP OF THE PROJECT 
Based on the discussions and experiences derived from the hearing, the original bill 
of co-existence was faced with some proposed amendments. Thus, after the hearing, 
the bill of co-existence went through two additional readings before the final bill on 
co-existence was passed in the beginning of June 2004. There were several amend-
ments employed in the final bill on co-existence and the more prominent ones in-
cluded changes considering the system of compensation in favour of organic farmers 
and the protection of their interests, and a system of publication that would make 
information (position, size and type of crop) about GM fields available to the public. 
The final bill on co-existence further enabled the minister to revoke approvals in 
cases where there is a danger that an approval might be misused.      
CHALLENGES IDENTIFIED IN THE PROJECT 
The greatest challenge considering the co-existence between GM crops and non-GM 
crops is that of spreading. To avoid the spreading of pollen it is necessary to keep a 
distance (dependent on the biology of the crop and the threshold value) between 
fields with the same kind of crops, and other cultivated plants that the crop might 
cross with. Intervals of growing are assessed as one of the most effective methods to 
avoid the spreading of seeds. However, it is impossible to secure a complete non-
spreading. In order to minimize spreading it is necessary to take some overall princi-
ples into account. First of all, the methods used to prevent spreading should depend 
on the crop being grown hereby considering the different characteristics that the dif-
ferent GM crops have. Secondly, the given system of agriculture, whereto the rules 
of co-existence should be applied, needs to be considered; e.g. geography and land-
scape. Ultimately, it is necessary to consider the scope of GM crops. Thus, co-
existence is assessed to be possible if the necessary precautions are taken. 
Conclusively, the hearing emphasized that the ultimate challenge is to make a better 
and extended system of compensation and that the rules on co-existence are ad-
dressed at a EU-level that secures that all member states have common rules consid-
ering co-existence and compensation. Considering the widespread scepticism to-
wards GM products that can be identified within the Danish population, it is crucial 
that consumers are given a genuine choice between GM products and non-GM prod-
ucts. This can be ensured through labelling of products that are genetically modified 
and through a securing of GM-free production; e.g. that organic alternatives are 
available.  
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NEW GM CROPS – NEW DEBATE (2005) 2.4 
BACKGROUND OF THE PROJECT 
The DBT-project “New GM crops – new debate” was initiated with the purpose to 
investigate how the Danish citizens assess the use of new GM crops involving plants 
producing medicine and industrial chemicals and new ornamental plants. The project 
was suggested by the Danish Forest and Nature Agency (part of the Ministry of the 
Environment). Previous projects and debates had shown a public scepticism towards 
GM food and feed crops due to the fact that the benefits of this technology are not 
obvious or directly related to the public. Thus, it became interesting to investigate the 
public’s attitude towards the use of GM plants with completely different purposes 
than those usually discussed.  
Many of these new applications of GM plants appear to bring potential benefits to 
both human health and the environment. GM plants producing medicine are expected 
to be able to reduce the production costs of certain expensive medicines, and in other 
cases to create new possibilities for treatment. For industrial use, plants are geneti-
cally modified to be little biofactories that produce raw materials and thus contribute 
to a minimization of the use of chemicals. Finally, GM ornamental plants would cre-
ate inventions such as blue roses or durable harebells. Still, these GM plants are 
grown under the same conditions as GM food and feed crops.  
Based on this, the project set out to examine how Danish citizens assess the potential 
advantages and disadvantages of the new GM plants. The aim of the project was to 
present arguments for and against: how are the plants’ potential benefits and detri-
ments considering health and environment assessed, and what are the economic pos-
sibilities and consequences – considering both the societal and the consumer level. 
BASIC DATA ABOUT THE PROJECT 
The project was addressed through the use of a citizens’ jury. 2000 Danish citizens 
were invited via the Civil Registration Number register to apply for participation in 
the citizens’ jury. On the basis of the applications received, 16 citizens were selected. 
The aim was to assemble a citizens’ jury that was relatively representative regarding 
gender, area of residence, age, education and job.  
The sixteen laymen took part in the citizens’ jury that was assembled from the 28th of 
April to the 2nd of May 2005. A planning group assisted the Danish Board of Tech-
nology in planning the project and formulating the questions that the citizens’ jury 
was presented with. During the five days of the citizens’ jury, the laymen met with 
experts and stakeholders and discussed advantages and disadvantages of the new 
crops. Based on this dialogue, the citizens’ jury formulated arguments for and against 
the new GM plants and conditions for the possible growing of GM plants in Danish 
fields and general recommendations in connection with this. 
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Ultimately, the citizens’ jury was concluded by a vote upon the arguments, condi-
tions and recommendations that expressed their attitude the best. Thus, citizens were 
not required to reach a consensus, but asked to prioritise the arguments elaborated by 
them-selves and then vote for those that they considered most important. 
The citizens were asked to consider the new uses of GM plants at three different lev-
els: what are the arguments for and against GM plants within the category in ques-
tion (medicine, industry or ornamentation); on which conditions can GM plants for 
medicine, industry or ornamentation respectively be grown in Danish markets; and 
which general recommendations are there for the future handling of new GM plants. 
These questions were addressed through 7 votes on which the recommendations and 
conclusions of the report are based. 
MAJOR OUTCOMES OF THE PROJECT 
Interpreting the voting results, the main conclusions of the report seem to be that the 
citizens’ jury assessed the new uses of GM plants to be predominantly beneficial. 
Still, the citizens’ jury had reservations considering some specific applications of the 
technology. Thus, the citizens’ jury proclaimed a conditional yes to the new GM 
plants. 
The main arguments for the GM plants included improvements with regard to the 
environment and public health, financial advantages (both for society in general and 
the individual consumer) and business opportunities. The citizens’ jury assessed that 
Denmark should tap its potential for developing GM plants due to the fact that Den-
mark has significant knowledge and experience, not to mention effective legislation. 
The most important argument against GM plants referred to the risk of unintentional 
spreading of foreign or undesirable characteristics. But the majority of the citizens’ 
jury assessed that existing regulations – including the act on co-existence – and ap-
proval procedures considers these problematic issues.  
Considering the usage of GM plants for medicine the voting results showed that the 
arguments for received more votes than the arguments against them. However, if the 
production of medicine includes the use of human or animal genes, it was a high pri-
ority for the citizens that there are strict requirements for approval of new products, 
and that the production takes place in closed environments.  
The citizens’ jury received developments of industrial GM plants as positively as 
plants producing medicine. It was especially applauded that industrial plants have the 
potential for replacing present production methods with more environmentally sus-
tainable ones.  
The attitude towards GM ornamental plants was less optimistic than the two other 
usages. The vote showed that there was slightly more arguments against than for the 
growing of GM ornamental plants in Danish fields. The citizen’s jury further empha-
sized that the main condition for the growing of GM ornamental plants is that herbi-
cide-tolerant grasses are not going to be approved due to the significant risk of 
spread to cultivated areas as well as to other vegetation.    
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An important condition for allowing the new plants that was emphasized was, that 
the environmental consequences of irresponsible practices should be assessed. Fur-
ther, the growth of the new plants should not pollute more than existing modes of 
production - particularly concerning fertilizer or pesticide usage. Thus, any negative 
impact on ground water and soil should be part of the risk assessment. However, the 
citizens’ jury did not see any reason for alarm while the present legislation and ad-
ministration is considered adequate to limit the risks. Instead, there should be more 
focus on public education and information about the new GM plants. In fact, the 
clearest message from the citizens’ jury was not about advantages, disadvantages and 
conditions with regard to GM plants, but about the necessity of informing the popu-
lation about these matters as part of an open and nuanced debate.  
Conclusively, it appears that the public’s estimation of use clearly differs depending 
on the use of GM plants. The debates on GM plants for food and feed showed that 
the public questioned these usages by asking: why? The purposes and benefits are 
not obvious to the public. On the contrary, this project on the use of new GM plants 
poses the question; why not? In general, the citizen’s jury did not see any reasons to 
impede the further development of GM plants - at least for medical and industrial use 
- as long as this does not involve environmental or health hazards, that exceed exist-
ing or alternative modes of production. 
IMPACTS AND FOLLOW UP OF THE PROJECT 
The citizens’ jury presented their results the 2nd of May 2005 at a conference at the 
Danish Parliament with the attendance of politicians, experts and various stake-
holders. After the citizens’ jury’s presentation of the results, politicians representing 
different parties and different stakeholders commented on the assessments and dis-
cussed them with the jury. The results of the conference were subsequently men-
tioned in the media.  
In November 2005 the Ministry of the Environment held a conference on the use of 
GMO’s. Whether this conference was a direct follow-up of the DBT-project is diffi-
cult to say, but the themes discussed at the conference were, in particular, concerned 
around new uses of GM plants. 
The results of the citizens’ jury were furthermore mentioned in a report on a biotech-
nology strategy considering non-food and feed published by the Directorate for 
Food, Fisheries and Agri Business in February 2006.  
In September 2005 the Danish moratorium (since 1999) on the growing and the mar-
keting of GM crops were finally revoked. The reasons for this action were grounded 
in the implementation of rules considering labelling, traceability and co-existence. 
The results of the citizens’ jury might have had an impact on these decisions, but it 
would be wrong to link the two incidents directly.  
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CHALLENGES IDENTIFIED IN THE PROJECT 
The citizens’ jury identified several challenges considering the use of GM plants for 
other purposes. One challenge is the retention of a free consumer choice in a way 
that genetically modified products are labelled. Another challenge is to strengthen 
public research to form a contrast to private research and development, as public 
research seems necessary to maintain sufficient control of the new GM plants. The 
far most obvious challenge considering these new GM plants is that usages do not 
pollute more than the corresponding traditional modes of production or better alter-
natives.  
LITERATURE 
The Danish Board of Technology, (2005): Nye GM-planter - ny debat. 
http://www.tekno.dk/pdf/projekter/p05_GM-planter_rapport.pdf; English sum-
mary: Contitional yes to new GM plants. 
http://www.tekno.dk/pdf/projekter/p05_gmp_rtt.pdf 
AUTHOR OF THE REVIEW 
Søren Gram 
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FINLAND 3. 
DEBATE BETWEEN PUBLIC ADMINISTRATION, RESEARCHERS 
AND GENERAL PUBLIC CONCERNING THE PLANT GENE 
TECHNOLOGY 
During last five years, the Finnish debate between public administration, researchers 
and general public concerning the plant gene technology can be divided in four types 
of activity: 
> General and plant gene technology focused public  hearings  
> Public administrative information of field tests and product approval processes 
> Special administrative processes which have  taken into account the public opin-
ion 
> Scenarios concerning possible implications of plant gene technology 
PUBLIC HEARINGS 
In order to discuss the ethical dimensions of genetics, Ministry of social affairs and 
health arranged a seminar "Genes and values" in Hanasaari, Espoo in 2002. The au-
dience consisted of over 100 invited participants, and the program consisted of pres-
entations by experts and a panel guided by a media professional. 
A booklet introducing in the subject had been composed in advance, and it was de-
livered for the participants. The booklet served mostly prejudices and popular beliefs 
concerning plant biology and agriculture circulated by GM critical political move-
ments. The beliefs were discussed by philosophers specialized in ethical problems of 
gene technology.  No scientific experts of plant breeding research were consulted in 
the booklet.   
The popular beliefs were the foci of the meeting, too. The sole discussant represent-
ing the science of plant biology - an associate professor in plant breeding - was of-
fered a very short time (5 minutes) to tell about new GM varieties. The media profes-
sional chairman had customarily little knowledge of science. 
The leaders of the Finnish anti-GM society were invited. Their full handful of mem-
bers trespassed in the seminar with video cameras and recorded the discussions. Such 
behaviour did not promote the free atmosphere of the discussions. As their response 
to the scientific presentations, the "activists" nailed up the ultimatum that the scien-
tist lecturing on plant breeding shall be discharged.  
It was no surprise that the seminar resulted in messages putting science under suspi-
cion. But as a trade-off it also brought important science reporters in place. The pres-
entation on plant breeding, albeit minuscule, gave many a first contact with the sub-
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ject and its true possibilities. Hence, certain media columns were opened later on for 
the first time also for scientific facts regarding modern plant breeding. 
Special contribution was made by philosophers. They analyzed also in the final re-
port of the conference the quality of typical arguments given for and against gene 
technology. Logical analysis of superficial statements made by emotional opponents 
is a good way to promote rationality in the field. Besides that it is highly important 
that with careful scientific (and not only logical) analysis prejudices and real threats 
will be separated. 
Other ministries have also arranged general seminars in the area. E.g. ministry of 
agriculture and forestry (MAF) have arranged many seminars as a part of the hearing 
process of their strategies or laws in preparation. Such seminars have been arranged 
concerning Gene Technology Strategy2 (2003, wwwb.mmm.fi/julkaisut/tyoryhma 
muistiot/2003/trm2003_18_en.pdf) and Co-existence3 (2005, wwwb.mmm.fi/julkai 
sut/tyoryhmamuistiot/2005/Trm2005_9a.pdf). The bulk of the invited participants 
have been professionals from the field of activities of the ministry, but invitations 
also cover public interest groups such as societies and other NGOs. 
In addition, seminars explaining the biological basics and topical situation regarding 
GM products in agriculture have been arranged by MAF for media people a few 
times, with fair success. Presentations are always given by top experts of science, 
legislation or administration in the field. Experiences of such focused seminars con-
nected with preparatory work of administration and authorities are in general positive 
in Finland 
PUBLIC ADMINISTRATIVE INFORMATION OF FIELD TESTS AND PROD-
UCT APPROVAL PROCESSES 
Applications for GM product approvals are decided at Community level in EU, and 
all member states participate in the process. When the information concerning a 
product application arrives in Finland, a short Finnish summary and links to official 
documents dealing with the application are made publicly available. They are in the 
Internet pages of Finnish Food Safety Authority EVIRA, the authority ordered to 
take responsibility of the information delivery in these cases. In the pages, advice is 
also given how people can give their opinion of the application to EU authorities 
using Finnish language. In addition, a press release is given in a broad delivery in 
order to activate the media. 
                                                 
2 Gene Technology Strategy and Action Plan of the Ministry of Agriculture and Forestry 
2003-2007. Working Group Memorandum 2003:18, Ministry of Agriculture and For-
estry, Helsinki, Finland, 2003. 
3 Enabling the coexistence of genetically modified crops and conventional and organic 
farming in Finland. Mid-term report. Expert Work Group on Coexistence, Ministry of 
Agriculture and Forestry, Finland, 2005 
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Finnish Gene Technology Act provides for the applications of GMO field tests to be 
communicated with public efficiently enough. The act implements Directive 
2001/18/EC. Regarding a field test with GM white birch seedlings, public informa-
tive meeting was selected as the way of action.  
The meeting was thoroughly advertised in local media, starting well beforehand. In 
spite of that, only two persons representing general public did arrive, the other of 
these was probably a local farmer. All other audience, a few scores of people, con-
sisted of (mainly local) university scientists, many of whom participated in the GM 
research program (ESGEMO), and members of the Board for Gene Technology; plus 
the handful of activists (always the same few ones) from the specialised "GM-free" 
society.  
For public discussion, far more important was the destruction of GM white birch 
seedlings made by plant GM opponents. As the result of extensive discussions in 
newspapers, the public opinion turned strongly against destructors. It was realized 
that there was no point in this destructive act because these non-flowering birches 
have no real way to diffuse their genetic material to non-GM birches or other plants. 
Instead, GM birches would have a real positive impact on town environments be-
cause of less allergic reactions. Actually based on their safety and positive impacts 
on health, an environmental organization (Ekosäätiö, Eco Foundation) gave its price 
to the developers of GM birches. Based on the destructive act, the public opinion is 
now much more favourable for the limited public information concerning the cultiva-
tion places GM plants. The irrationality of the GM opponents became much more 
evident for the general public. 
SPECIAL ADMINISTRATIVE PROCESSES WHICH HAVE TAKEN IN AC-
COUNT THE PUBLIC OPINION 
We consider that it is highly important for a rational approach concerning the plant 
gene technology that the administration does not follow prejudices of the public 
opinion. This is especially important because of the feedback to the public opinion. 
Critics of gene technology with little science expertise can use the choices of the 
administration as an evidence for their opinions. 
In Finland, the above problem was met related to restaurant criteria proposed for the 
Nordic Swan ecolabel. The aim of the ecocertificate is declared to be helping people 
"to choose the most environmentally-friendly products" and to avoid the use of the 
most environmentally burdening products (www.svanen.nu/Eng/default.asp).  
Criteria for Nordic restaurants to fulfil in order to receive the ecolabel were proposed 
(June 2006). Without any statement of reason based on facts or science, all use of 
genetically modified constituents was categorically forbidden in the restaurants with 
ecolabels. That proposition excited Finnish life scientists to express their objections 
to the misuse of such populist prejudices which only damage true efforts on envi-
ronmental protection. Among others, the traditional and most prestigious life science 
society in Finland (Societas Biochemica, Biophysica et Microbiologica Fenniae) 
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strongly criticized such anti-science attacks detrimental to environment in its state-
ment. Applications of modern biological research, including gene technology and 
genetic modification, are fundamentally required for environmental ameliorating, 
and their impacts shall be properly assessed case-by-case.  
Notable environmental benefits have already been obtained by producing the so-
called traditional GM varieties for 10 years (Sanvido et al. 20064, Brookes et Barfoot 
20065). Yet essentially greater remedies could be anticipated from "second genera-
tion" GM varieties specifically designed for environmental enhancements. Such in-
novations include resistant plant varieties with better tolerance to drought, cold, 
flooding, salt as well as pests and diseases.  
For example, blight-resistant potato was bred with gene technology by obtaining the 
resistance gene from a wild potato species. The healthy variety is in field tests for the 
third year in EU. Cultivating blight-resistant potatoes would save EU each year from 
860 million kg of yield being wasted, and 7.5 million kg of fungicides to be sprayed 
(expressed as active ingredient). Of course that also means great reductions in oil use 
and greenhouse gas emissions in agriculture (Phipps et Park 20026, Gianessi et al 
20037). Organic producers could also benefit from the use of blight resistant varie-
ties, because the risk of spreading the disease from other plantations to the fields 
used for organic production would be smaller. 
                                                 
4 Olivier Sanvido, Michèle Stark, Jörg Romeis and Franz Bigler (2006). Ecological im-
pacts of genetically modified crops. Experiences from ten years of experimental field re-
search and commercial cultivation. ART-Schriftenreihe 1. Fed. Dep. Econ. Aff. DEA, 
Switzerland, 108 p. 
5 Graham Brookes and Peter Barfoot (2006). Global Impact of Biotech Crops: Socio-
Economic and Environmental  
Effects in the First Ten Years of Commercial Use. Agbioforum 9: 139-151.  
Abstract:  Genetically modified (GM) crops have now been grown commercially on a 
substantial scale for ten years. This paper assesses the impact this technology is having 
on global agriculture from both economic and environmental perspectives. It examines 
specific global economic impacts on farm income and environmental impacts of the 
technology with respect to pesticide usage and greenhouse gas emissions for each of the 
countries where GM crops have been grown since 1996. The analysis shows that there 
have been substantial net economic benefits at the farm level amounting to $5 billion in 
2005 and $27 billion for the ten year period. The technology has reduced pesticide 
spraying by 224 million kg (equivalent to about 40% of the annual volume of pesticide 
active ingredient applied to arable crops in the European Union) and as a result, de-
creased the environmental impact associated with pesticide use by more than 15%. GM 
technology has also significantly reduced the release of greenhouse gas emissions from 
agriculture, which, in 2005, was equivalent to removing 4 million cars from the roads.  
6 Phipps & Park (2002). J Animal Feed Sci.11: 1–18.  
7 Leonard Gianessi, Sujatha Sankula and Nathan Reigner (2003). Plant biotechnology: 
Potential impact for improving pest management in European agriculture. Potato case 
study. NCFAP  
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The objections of the scientific community were accepted by the administration re-
sponsible for the Nordic Swan ecolabel. It was decided in autumn 2006 that geneti-
cally modified constituents are allowed in Nordic Swan ecolabeled restaurants. 
SCENARIOS CONCERNING POSSIBLE IMPLICATIONS OF (PLANT) GENE 
TECHNOLOGY 
Based on assessment project concerning social impacts of the human genome and 
stem cell research by the Committee for the Future, a scenario book was made. The 
aim of the book was to inform the general public about most important results of the 
assessment project. Beside that it illustrated possible future impacts of gene technol-
ogy with three scenarios. The scenario book (Kuusi 2004)8 got considerable publicity 
in media.  
The names of the scenarios characterize their content: 
> Safety first of all 
> Wealth and employment from gene technology 
> Gene information belongs to everybody  
All scenarios were discussed as reasonable choices making different assumptions 
concerning future developments. After the presentation of the scenario story its prob-
ability was discussed. For example, in the first scenario the blight-resistant potato 
resulted in a lagged serious health problem. In the discussion part, the probability of 
that problem was discussed. It was considered that even taking into account the risk 
it is reasonable to accept the blight-resistant potato.  The conclusion was the same as 
in the third scenario: Also in order to solve possible problems related to gene tech-
nology, the best choice is to make it commonplace.  
Like the information technology, gene technology should belong to everybody. It 
requires an internet based “Gene Information Centre” providing its services to every-
body. In a safe environment (compare banking services), it makes sense to integrate 
this type of personal gene information with one’s personal electronic patient records.   
AUTHORS OF THE REVIEW 
DSc(Agr&For) Jussi Tammisola 
PhD Osmo Kuusi 
                                                 
8 Osmo Kuusi (2004)  Geenitieto kuuluu kaikille (Gene information belongs to every-
body), Edita, Helsinki  
 50 
FLANDERS 4. 
PUBLIC FORUM »NEW IMPULSES FOR THE DEBATE 
ON GENETICALLY MODIFIED FOOD« (2003) 4.1 
BACKGROUND OF THE PROJECT 
On September 25th 2001 a hearing was held in the Flemish Parliament to discuss the 
advices published by five Flemish advisory bodies9, by request of the Flemish Par-
liament10, on the topic of genetically modified organisms(GM organisms). A recur-
ring element in the five reports was the importance of organizing a public debate on 
this topic. 
The Flemish Institute for Science and Technology Assessment, viWTA, established 
by Decree on 17/07/2000 provided the opportunity to respond to this advice. The 
Board of the viWTA decided in December 2001 to organise a pilot project on this 
topic. In Spring 2002 this topic was narrowed down to ‘genetically modified food’.  
The project was officially launched in May 2002 with a pre-study.  The goal of this 
study was to map the existing debate on genetically modified food in Flanders (ac-
tors, positions, legal situation,…).  The report of this study was published in Novem-
ber 2002, in December 2002 the Public Forum was launched.  On the 26th of May 
2003, the 15 members of the citizens panel submitted their final report to Mr. Nor-
bert de Batselier, President of the Flemish parliament. 
MAJOR OUTCOMES OF THE PROJECT 
The report of the Flemish lay panel contained 28 recommendations, centred around 
six major themes: 
> Legislation, control and consultation 
> Information 
> Ethics 
> Health issues 
> Global and economic issues 
> Environmental consequences 
Most important of these recommendations, also in the light of European legislation, 
are: 
                                                 
9 De Sociaal Economische Raad van Vlaanderen (SERV), de Milieu en Natuurraad van 
Vlaanderen (Mina-raad), de Vlaamse Raad voor wetenschapsbeleid (VRWB), de 
Vlaamse Land- en Tuinbouwraad (VLTR) en de Vlaamse Gezondheidsraad. 
10 Adviesvraag van 11/02/2001 van Trees Merckx-Van Goey houdende raadpleging van 
diverse adviesorganen over de problematiek van genetisch gemodificeerde organismen. 
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Legislation, control and consultation: 
> Even after the discussion it is still not clear who is liable in case of problem 
(product liability as well as environmental liability). The reference persons did not 
know the answer. This leaves the initiative to politicians. The liability has to be 
regulated so as to be legally binding. It has to be unambiguous, leaving little room 
for interpretation and for dodging responsibilities. 
> It is hard to choose between genetically modified foodstuffs or food without GM 
organisms: you cannot choose for something that is not available yet. But when 
genetically modified food arrives, there is a real danger that non-genetically modi-
fied food will be under pressure. The choice has wider implications than mere la-
bels. If you want to sell both (labelled) genetically modified food and non-
modified food, you need two completely separate circuits. Freedom of choice has 
to be guaranteed. This is a complex issue. Both those who want to purchase ge-
netically modified food as those who do not, need to be able to make a choice. If 
nothing changes, the situation will not improve. 
> The introduction of genetically modified food on the market might lead to increas-
ing production costs for non-GM food, a.o. because of extra checks. The sector of 
genetically modified food will be able to compensate this extra cost because of 
cheaper production techniques. 
> The European rules for permits are not bad; they are the result of hard work. The 
E.U has a procedure for quickly recalling GM products in case of problems. But 
the rules are not watertight: the evaluation of permits is left to scientists and poli-
ticians. The evaluation of permits ought not to be restricted to scientists, but ex-
tended to other areas of expertise (economists, sociologists, philosophers). 
Information: 
> The new EU legislation allows for public consultations, but the form in which this 
will happen is  still vague (active or passive approach?) A large majority of the 
Flemish laypanel believes the government ought to provide clear and neutral in-
formation. A majority thinks the existing website of the Belgian Biosafety Server 
(http://biosafety.ihe.be) can fulfil this role, but is must be translated from English. 
The site can be expanded into a portal site. 
> Labels must be uniform throughout Europe (using clear icons) 
> Citizens prefer an active consultation of the public under EU legislation. This al-
lows the citizen to voice his opinion. Participation can only be useful after an 
awareness-raising campaign. 
Ethics: 
> There is no universally accepted ethical position, but there are nevertheless clear 
ethical limits. The different scope of arguments (based on risks vs. based on du-
ties) makes an ethical debate difficult. However, ethical considerations must play 
a role in allowing genetically modified foodstuffs. 
 52 
Health issues: 
> The health risk of genetically modified foodstuffs that are introduced in the mar-
ket are negligible. Strict and reliable checks have convinced the lay panel that the 
health risks of regulated genetically modified food are negligible. Consumers can 
regain their confidence if they are informed in a reliable way about the health is-
sues related to genetically modified food. But permanent checks and controls stay 
necessary for genetically modified food. Because of the complexity of the issues, 
this debate must be conducted in public. 
Global and economic issues: 
> The authorities have to provide a framework and the means for the transfer of 
knowledge and technology between North and South, and for establishing local 
research facilities in the South. 
> The authorities should continue to support fundamental research and the techno-
logical development of genetically modified organisms. But the subsidies have to 
be made dependent on promises to share the relevant knowledge with the Third 
World.  
> Research into traditional and biological agriculture must not be neglected, but 
should continue to exist as a full area of research.  
Environmental consequences: 
> Evaluation of the environmental hazards is extremely important. Each case has to 
be thoroughly investigated. 
> Biotechnology must make a responsible choice, respecting biodiversity, the bio-
tope of the crop and the ecosystem. These elements must be taken into account 
during risk analysis. 
> Once genetically modified food is brought to market, environmental risks still 
need to be monitored. The present post-marketing plan does not provide for ade-
quate control. The costs for more systematic controls have to be borne by the bio-
tech industry. 
CHALLENGES IDENTIFIED IN THE PROJECT 
Potentially problematic issues, that could be further explored in the questionnaire, 
seem very generally: 
> Ways to engage the public in decision making processes on GMO’s: ac-
tive/passive? 
> Importance of understandable, down to earth communication about GMO’s 
> Freedom of choice/possibility of creating complete separate circuits 
> Effect on introduction GM-food on production costs for non GM food (extra 
checks and quality control systems) 
> Multi-disciplinary evaluation of risks 
> Challenges to labelling 
> How to involve ethical considerations in future approvel procedures? 
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> How can the south benefit from European research? 
AUTHOR OF THE REVIEW 
Els van den Cruyce and Stef Steyaart 
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FUNCTIONAL FOODS. STATE OF THE ART (2006) 4.2 
BACKGROUND OF THE PROJECT 
Functional foods represent one of the most intensively investigated and promoted 
area in the food and nutrition sciences today. Functional foods are fortified or en-
riched foods that provide health benefits beyond the provision of essential nutrients, 
when they are consumed at efficacious levels as part of a varied diet on a regular 
basis. Linking the consumption of functional foods with health claims should be 
based on scientific evidence. However, not all foods on the market today that are 
claimed to be functional foods are supported by enough solid data to merit such 
claims. What are the benefits and what are the risks? 
In this comprehensive study, the consortium Food2Know (University of Ghent) and 
Flanders’ FOOD (knowledge centre for the Flemish Food Industry) made an over-
view of different functional food products on the market in Flanders. Using a ques-
tionnaire, the societal issues were elaborated by 30 experts in this field (diet and nu-
trition experts, retailers, consumer and patient organisations, regulatory bodies, aca-
demic researchers and stakeholders from the Flemish food industry). Information 
was gathered on issues such as the scientific evidence linked to the health claims, the 
regulation in Flanders and Europe and the role of functional foods in the Flemish 
health policy. 
The results were summarized in a report (only available in Dutch) and were pre-
sented during a debate with experts and policymakers in the Flemish Parliament. The 
project had no further impact on policy making. 
MAJOR OUTCOMES OF THE PROJECT 
The study focused on the following issues: 
Scientific evidence for health claims: 
There is a need for stricter control of the scientific basis of health claims on func-
tional food products. Today, health claims are not reliable enough. More precise un-
derstanding of the mechanisms of actions of functional food and more scientific evi-
dence is required. 
Functional foods and health policy: 
A frequently asked question is if functional food can be a part of the disease risk-
reduction public health program? This study concluded that government policy and 
action must keep focussing on healthy lifestyle, balanced food intake and sport. 
Functional food cannot solve what has been damaged by ignoring these points. 
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Safety: 
The products that are on the market today, are considered to be safe. Nevertheless, 
enrichment of food products with specific nutrients can imply much higher doses of 
intake by consumers. The experts in this study supported the idea of mentioning a 
maximum dose on the label of each functional food product. Another important risk 
is that functional food can give a false feeling of safety. Functional food could be-
come an excuse to give less attention to sport and food habits. 
Price of functional foods: 
Functional food products are quite expensive. Experts recommend actions to make 
the possible advantages of functional food available for everybody. 
Information overload: 
News articles are often contradictory. It is very difficult for consumers to select the 
relevant and scientific based information.  
Food and medicine: 
Experts see a clear trend towards the use of food for medical purposes. 
CHALLENGES IDENTIFIED IN THE PROJECT 
Potentially problematic aspects of functional food, that could be useful to the subject 
of GMO’s, seem very generally: 
> Scientific evidence for benefits of these type of food products 
> Safety of the products 
> Price of the products: Who can benefit? Who will pay for GM food? 
> Challenges to labelling: information overload for consumer 
> Consumers attitude towards GM food: experience of food, food culture. 
AUTHOR OF THE REVIEW 
Els van den Cruyce and Stef Steyaart 
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INDUSTRIAL BIOTECHNOLOGY IN FLANDERS: 
STATE OF THE ART (2006) 4.3 
BACKGROUND OF THE PROJECT 
Industrial or white biotechnology is the application of biotechnology for the process-
ing and production of chemicals, materials and energy. White biotechnology uses 
enzymes and micro-organisms, such as yeast and bacteria, to make products in chem-
istry, food, paper and pulp, textiles and energy. White biotechnology uses biomass as 
an alternative to fossil resources for the production of biochemicals such as biofuels 
and biopolymers. In the future, genetically modified crops could be developed, as a 
renewable source for non-food applications. 
In this comprehensive study, the Laboratory for Industrial Microbiology and Biocata-
lysis (University of Ghent) made an overview of the applications and fields of exper-
tise in Flanders. Using a questionnaire, the societal issues were elaborated by 30 ex-
perts in the field of industrial biotechnology. Information was gathered on issues 
such as Flanders’ chances to evolve to a bio-based economy, the opportunities for a 
more sustainable production, the implications for the economy in Flanders, and more 
specific for the agricultural sector. 
The results were summarized in a report (only available in Dutch) and were pre-
sented during a debate with experts and policymakers in the Flemish Parliament. The 
project had no further impact on policy making. 
MAJOR OUTCOMES OF THE PROJECT 
The study focused on the following issues: 
> Sustainability: 
Industrial biotechnology offers opportunities for a more sustainable production. 
Enzymes can drive chemical reactions towards the desired end product in a very 
effective and efficient way, under circumstances of normal temperature and pres-
sure. Less energy is consumed and waste production is reduced. However, only a 
complete life cycle analysis can asses whether the use of industrial biotechnology 
is more eco-efficient.  
Secondly, instead of fossil fuels, agricultural raw materials, such as cereals and 
coleseed are used. This reduces the emission of  greenhouse gasses. Some experts 
expect that production of crops will be more geographically spread, in contrast to 
the concentration of  power within the limited amount of petroleum producing 
countries. 
Thirdly, the agricultural raw material must be produced in a sustainable way, 
avoiding deforesting, erosion and soil impoverishment. 
> Safety of the use of micro-organisms for industrial applications: 
The (genetically modified) micro-organisms are bred in a closed reactor. After 
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use, the micro-organisms are separated from the product and killed. This is called 
“contained use”. 
> Perception of the public: 
Recent Eurobarometer results show that more than half of the interviewees be-
lieve that biotechnology can improve the life standard. Especially the medical ap-
plications receive a lot of support. However, the European citizen is still very 
critical towards the modification of agricultural crops or green biotechnology. Ex-
perts fear that this negative attitude will also involve genetic modification of crops 
for non-food applications. 
> Implications for the agricultural sector: 
The agricultural sector of the future will not only produce food, but will more and 
more become a producer of chemicals, industrial raw materials and biofuels. Be-
cause the area of land in Flanders used for the agricultural production is limited, 
some experts fear that this competition will threaten the production of food. Pro-
ponents argue that the Belgian and European agriculture suffer from overproduc-
tion and that the European agriculture requires a high proportion of the overall EU 
budget to subsidise it. Another argument is that a lot of area is available in the 
member states that integrated the EU in 2004. 
In the future green biotechnology could make a substantial contribution in the 
production of agricultural production such as cereals for non-food uses. 
> Can Flanders evolve to a biobased economy: 
In a biobased economy, an increasing number of chemicals and materials will be 
produced in biorefineries using renewable resources. Biomass derived energy is 
expected to cover an increasing amount of the energy consumption.  
The agricultural sector in Flanders will be unable to meet the demand for biomass. 
Import from neighbouring countries, Eastern Europe, America and even Africa 
will be necessary. Because of its central location and extensive transport infra-
structure, Flanders is well placed for import and transport of these raw materials.  
> Financial investment in research and development of industrial biotechnology: 
The biotechnological research in Flanders is mainly focused on green and red bio-
technology. Therefore the experts from the questionnaire propose to invest more 
in the research and development of industrial biotechnology in Flanders.  
CHALLENGES IDENTIFIED IN THE PROJECT 
Potentially problematic issues, that could be further explored in the questionnaire, 
seem very generally: 
> Sustainability of GM crops for non-food issues 
> Perception of the public towards GM crops for non-food issues 
> Implications for the European agricultural sector 
> Europe and the biobased economy 
AUTHOR OF THE REVIEW 
Els van den Cruyce and Stef Steyaart 
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FRANCE 5. 
INRA PROJECT »CO-CONSTRUCTION OF A RESEARCH 
PROGRAMME« (2002) 
BACKGROUND OF THE PROJECT 
The French National Institute for agronomic research (INRA) has been working for 
many years on the elaboration of a transgenic  rootstock potentially resistant to 
Grapevine Fanleaf Virus (GFLV), together with a private partner. In 1999, the pri-
vate partner decided to stop its participation to this research, because of the hatred 
public discussion on GM grapevine. INRA decided to continue its research and 
passed on all material to its laboratory in Colmar.  
However, in 2001, and because the public debate on transgenic was still going on, 
INRA decided to suspend the ongoing experiments and to initiate a discussion on 
their pursuit within a working group integrating researchers, professionals and con-
sumers, using a participatory process.  
The initial question the working group had to answer was about the opportunity to 
realise field trials of rootstock potentially resistant to Grapevine Fanleaf Virus 
(GFLV). However, the working group reformulated the demand in the following 
direction: 
> Which are the philosophical, social, economical and technical aspects at stake in 
this field trial? Knowing that there are many research needs related to grapevine 
diseases, how to define priorities et how to choose the types of arbitration. 
> Should INRA continue to research on GM-grapevine and, if yes, which conditions 
have to be met in order to pass to the stage of field trials? 
BASIC DATA ABOUT THE PROJECT 
The selected method was based on the so-called “Technology assessment through 
interaction”11. It consists in putting together various worldviews, so that deliberations 
are nourished from a variety of arguments and standpoints.  
The number of participants was limited to 14, so as to allow deliberation on complex 
problems and heterogeneous questions. Whereas some participants had no special 
expertise in the topic (so-called “laypersons”’), the group also comprised researchers 
and wine-professionals. The selection process was based on the results of a socio-
logical study, which displayed a social cartography of worldviews around the topics 
of grapevine, wine and GMOs. The conceptions of science have also been considered 
                                                 
11 See Grin, J., van de Graaf, H., Hoppe, R., (1997). Technology assessment through in-
teraction. A guide. Den Hag, Rathenau Institute (available at http://www.rathenau.nl). 
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in the selection process, as well as attitudes towards research on a transgenic root-
sock for grapevine.  Based on this analysis, the organisers invited: 
> Four researchers working on research on grapevine diseases, but who hold differ-
ent worldviews. 
> Six grapevine and wine professionals, stemming from different geographical re-
gions and holding different worldviews. 
> Four citizens, also invited for the variety of their worldviews. 
The working group met 7 times, from April to September 2002. 
Various instances were part of the experiment: 
> The General Direction of INRA, which initiated the project. 
> 2 project managers.  
> One research assistant. 
> A steering group (comité de pilotage), composed of the project managers and the 
INRA Direction. 
> An evaluation committee, composed of personalities external to INRA, special-
ized in the analysis of controversies and of participation. 
> A moderator for the working group sessions. 
MAJOR OUTCOMES OF THE PROJECT 
The working group came to the following conclusions: 
> Wine has a strong symbolic dimension. As a consequence, a genetic modification 
done on grapevine dedicated to the fabrication of "wine-food" could have a nega-
tive impact on "wine-pleasure" and on high quality wines. 
> There is a strong attachment to a system production based on biological, technical 
and cultural variety. With respect to the threats related to grapevine diseases, vari-
ous fighting methods should be developed, so as to contribute to the various pro-
duction modes of vinegrape.  
> Considering research activities, there is a lack of integrated and transversal ap-
proaches. There is a necessity for a better understanding of the interaction be-
tween the plant and its environment.  
> INRA should continue to do research on genetically modified vinegrape in labora-
tory and green house. Field trials should also be implemented. But, on this last 
point, all group members did not agree on the opportunity to have field trials (2 
persons against). Opponents to the field trials considered that even the solution 
may be technically satisfactory, it is not socially acceptable. In this respect, it 
could prejudice the status and image of French wine. The other 12 members con-
sidered as acceptable field trials with transgenic grapevine. But their positive 
opinion is limited to a given experiment and no opinion has been formulated on a 
possible commercialisation. 
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IMPACTS AND FOLLOW UP OF THE PROJECT 
The report of the working group has been passed on to the INRA Direction in Sep-
tember 2002. In January 2003, INRA decided to ask for an authorization for the im-
plantation of field trials in Colmar, to set up a local follow-up committe and to create 
a mix commission in charge of defining the major orientations of wine and vinegrape 
research.  
CHALLENGES IDENTIFIED IN THE PROJECT 
> role of public research. 
> transgenic wine and vinegrape 
> dialogue and interaction 
> The issue of trust 
> Ability of public resarch institutions to set a boundary between research and its 
applications 
LITERATURE 
Co-construction d'un programme de recherche : une expérience pilote sur les vignes 
transgéniques. Rapport final du groupe de travail et réponse de la direction de l'IN-
RA.2003. INRA: Paris. http://www.inra.fr/genomique/rapport-final-ogm-vigne.html 
AUTHOR OF THE REVIEW 
Danielle Bütschi 
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GERMANY 6. 
GENETIC ENGINEERING, BREEDING AND BIODIVERSITY  
(1998) 6.1 
BACKGROUND OF THE PROJECT 
The TAB-project "Genetic engineering and breeding from the viewpoint of biodiver-
sity in agriculture" (short title: “Genetic engineering, breeding and biodiversity”) was 
based on a recommendation by the Committee on Food, Agriculture and Forestry and 
was approved in Autumn 1996 by the Committee for Education, Science, Research, 
Technology and Technology Assessment of the German Parliament. 
Background for the project was the 4. International Technical Conference on Plant 
Genetic Resources of the FAO at Leipzig in June 1996, which approved the Global 
Action Plan and the Leipzig Declaration for the “Conservation and Sustainable Utili-
zation of Plant Genetic Resources for Food and Agriculture”. Further, the Conven-
tion on Biological Diversity – ratified by Germany in 1993 – had defined objectives 
for the protection and use of the global biodiversity. These international commit-
ments, to be implemented on national level, were one starting point. The other start-
ing point was the questions, which impacts on biodiversity results from modern bio-
technology. 
The goal of the TA-project was to investigate what negative influences the use of 
genetic engineering in plant breeding can have on biodiversity, what contributions 
breeding and genetic engineering can make to conserving biodiversity and finally, 
what potentials can be derived for policy-making. A restricted, technology-centred 
perspective was not adequate for this theme. Particularly for the issue of potentials 
for conserving plant genetic resources and biodiversity in general, the approach was 
expanded in order to cover the significance of genetic engineering and breeding in 
the overall context. 
BASIC DATA ABOUT THE PROJECT 
The TA-project was executed in one and a half year, and finished in 1998. Four sci-
entific studies were awarded in the project. The draft final report of TAB was based 
mainly on these studies and was evaluated by a number of experts from science, gov-
ernment and stakeholders. 
The investigation area was limited to the field of plant breeding and - as far as possi-
ble - was restricted to the agricultural sector in Germany, taking into account Euro-
pean framework conditions. The topics of the project were: 
> biodiversity and plant genetic resources – status and development, 
> plant breeding – its goals, economic development and legal regulation, 
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> direct and indirect impacts of new (conventional and genetically engineered) va-
rieties on biodiversity – systematic analysis of impact chains, 
> biodiversity conservation measures – ex-situ, in-situ and on farm measures, 
> international agreements and implementation of international obligations, 
> options for action in the areas of research, agricultural, environmental and devel-
opment politics. 
MAJOR OUTCOMES OF THE PROJECT 
The results of the project showed that modern agriculture has made a considerable 
contribution to reducing the biodiversity of many crops and wild plants in Germany 
through intensification, rationalisation, specialisation and concentration of produc-
tion. Impacts on biodiversity have in particular been generated by changes in fertili-
sation, plant protection, rotation and land reallocation and consolidation. Plant breed-
ing and modern plant varieties are all part of the changed agricultural production 
system and their impact on biodiversity is more of an indirect one. The central con-
clusion of the project was that in Germany and Central Europe the use of genetic 
engineering procedures in plant breeding will not have a specific, significantly nega-
tive influence on biodiversity compared to conventional breeding practices in the 
short to medium term. On the other hand, however, genetic engineering in plant 
breeding will not make any significant contribution to conserving or extending plant 
genetic resources. 
To achieve the goal of "conserving biodiversity", there was seen a particular need for 
action on direct conservation measures. To this end the ex-situ, in-situ and on-farm 
conservation measures must be improved and developed. As Germany did not have a 
coordinated procedure on the conservation of plant genetic resources which incorpo-
rates all conservation measures, it was recommended to develop a combined conser-
vation strategy. This would simultaneously be a major contribution to conserving 
biodiversity in Germany. In order to implement international agreements at national 
level and to develop and apply a national strategy to conserve biodiversity (including 
plant genetic resources (PGR)), close coordination and cooperation was regarded as 
necessary between the various policy fields and levels affected. Interested and af-
fected societal groups should be incorporated into the national strategy development 
and implementation process. 
A matter of central importance for the sustainable conservation of biodiversity was 
seen in a full-coverage change towards sustainable agriculture, in which the promo-
tion of agricultural diversity and the protection of wild flora and fauna is a major 
component. The principles of organic farming which, in contrast to the still predomi-
nant conventional farming, involve more extensive and diversified farming practices, 
could therefore provide significant guides. It was pointed out that changes in basic 
framework conditions for agricultural and environmental policy do not make specific 
conservation measures (as discussed in the project) become superfluous, but their 
scope and urgency would take on a relative basis. 
A broad spectrum of options for action in the different areas of the project was iden-
tified and discussed. As future issues were identified: 
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> monitoring of the impacts of patenting on plant breeding and variety protection; 
> research on the impacts of the introduction of new varieties (conventional and 
transgenic plant varieties) on biodiversity of agro eco-systems and adjacent eco-
systems, with special attention to the issues of changes in cropping systems, resis-
tance development and resistance management; 
> long-term ecological impacts require comprehensive post-marketing monitoring, 
coordinated and combined with fundamental research activities on biodiversity 
and plant genetic resources. 
IMPACTS AND FOLLOW UP OF THE PROJECT 
The report was published as parliamentary document (Bundestagsdrucksache 
13/11253). In the following electoral term, the report was deliberated in the leading 
Committee for Nutrition, Agriculture and Forestry and two consulting committees. 
The result of the deliberation in the committees was a recommendation and report for 
the plenary (Bundestagsdrucksache 14/1716), with a detailed catalogue of actions 
based on the options for action in the TAB-report. This recommendation was ap-
proved in the plenary meeting of the German Bundestag on 16th December 1999, by 
the governmental majority and the PDS. 
In the federal agricultural report 2000 (Bundestagsdrucksache 14/2672), the Federal 
Government had pointed out that measures for the national programme on plant ge-
netic resources and a research programme on biodiversity has been prepared, in order 
to implement the above mentioned decision of the German Bundestag. 
CHALLENGES IDENTIFIED IN THE PROJECT 
In the project identified (future) challenges which are still valid (conclusions of the 
reviewer): 
> preservation of plant genetic resources 
> impacts of patenting on plant breeding and variety protection 
> uncertain future of small and medium seed producers 
> impacts of the introduction of new varieties (conventional and gm varieties) on 
biodiversity of agro eco-systems and adjacent eco-systems 
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RISK ASSESSMENT AND POST-MARKETING 
MONITORING OF TRANSGENIC PLANTS (2000) 6.2 
BACKGROUND OF THE PROJECT 
The TAB-project "Risk assessment and post-marketing monitoring of transgenic 
plants" was demanded by the Committee on Food, Agriculture and Forestry of the 
German Parliament. 
Background for the project was the ongoing debate in the EU on the authorisation of 
transgenic varieties and the amendment of the Deliberate Release Directive 
90/220/EEC. The development culminated in the summer of 1999 in a de facto mora-
torium on approval of transgenic plants for marketing by the Council of Environ-
mental Ministers, combined with the demand that the reforms in progress be com-
pleted before any new approvals are issued. 
During the project execution, the German marketing approval for the maize variety 
Bt176/ "Windsor" (about to receive variety approval from the "Bundessortenamt" – 
German Federal Plant Variety Agency) was suspended in February 2000 under Arti-
cle 16 of the Release Directive, which constitutes a safeguard clause. This event has 
sparked off forceful political and scientific controversy in Germany, which has also 
involved the German Bundestag and its committees on a number of occasions. In 
June 2000 the German Chancellor announced an initiative seeking to agree a three-
year transitional phase with the companies involved during which commercial culti-
vation of transgenic plants would be possible only on a limited scale and in combina-
tion with increased research into safety aspects, and particularly an intensive moni-
toring programme. This was not implemented due to the emerging of the BSE crisis 
in Germany. 
The goal of the TA-project was to give a focused overview of the status of the scien-
tific and political debate. It was not the purpose of the project to provide novel an-
swers to the outstanding questions on biosafety or develop separate proposals for the 
post-marketing monitoring. 
BASIC DATA ABOUT THE PROJECT 
The TA-project was executed in fifteen months (July 1999 – November 2000). Five 
scientific studies were awarded in the project. The draft final report of TAB was 
based mainly on these studies and was evaluated by a number of experts from sci-
ence and government. 
The investigation was limited to a status report on risk assessment and post-
marketing monitoring of transgenic agricultural crop plants. The main topics of the 
project were: 
> the status in safety research (inc. post-marketing monitoring) and the debate on 
risks, 
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> the state of regulation and treatment of authorisation procedures in the EU for the 
release, marketing and variety licensing of gm agricultural crop plants, 
> the state of implementation of the Novel Food Directive (licensing and labelling). 
MAJOR OUTCOMES OF THE PROJECT 
For the scientific debate on risks, it was worked out that controversies regarding 
both general and specific impacts relate primarily to three different levels: 
> first, the fundamental likeliness of occurrence (e.g. of outcrossing or development 
of resistance by insect pests),  
> second, the degree of possible damage (e.g. reducing biological diversity or ad-
versely affecting organic farming), and  
> third, the possible or necessary measures to avert risk (e.g. size of the protective 
zones around fields with transgenic plants or design of resistance management).  
Generally, the state of data appeared deficient in many respects, as while there had 
been over 1,300 release experiments in Europe alone, fewer than 1 % of release ex-
periments worldwide have been linked with accompanying ecological research (al-
though in Germany the figure was 15 %). Another reason why there was virtually no 
"real knowledge about risk" is the safety requirements needed for the accompanying 
ecological research. Critical voices pointed out that the lack of evidence of adverse 
ecological impacts suggests more that the wrong questions are being asked (with a 
resulting lack of corresponding studies) than the absence of any risk. Conversely, it is 
true that conventionally bred plants (i.e. not using genetic engineering) have never 
been subjected to biological safety testing, so that the impacts of transgenic varieties 
are always more thoroughly researched than those of conventional varieties. Many 
scientists also stressed that the new characteristics of transgenic plants are in princi-
ple much more clearly defined – and hence more easily documented and researched – 
than the results of conventional breeding. 
However, a whole series of questions will in any event be impossible to answer in 
research projects with a limited life. First, the results of scientific research always 
generate not only answers but also new questions, and second because long-term 
indirect effects can generally only be observed in the course of longer-term cultiva-
tion of transgenic plants on a significant scale. This realisation had led to virtual una-
nimity among all involved on the development and implementation of long-term 
monitoring of transgenic plants under cultivation. 
For the risk assessment in the approval procedures, the report looked in detail at 
how far the status of the scientific risk debate, and specifically the ecological aspects, 
were taken into account in the opinions in the framework of the approval procedures 
for marketing under Directive 90/220/EEC of both the EU scientific committees and 
national agencies (in Germany, Austria, the UK and – in part – Sweden), and how 
differences identified in the opinions can be explained. The result was that 
> scientific contributions and arguments have been very much selectively used and 
variously interpreted,  
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> diverging conclusions have been drawn from gaps and areas of uncertainty in our 
knowledge, and  
> above all, the possible consequences have been very differently evaluated in terms 
of the scale of damage and resulting implications.  
Even after the amendment, there is still no definition of damaging impacts, so that 
there will still be considerable scope for different assessments. Not least, the question 
will be which agricultural paradigm the impacts of transgenetic agricultural plants 
are measured against. It will not be possible to derive a normative framework for this 
paradigm simply from the debate about GE applications: instead, this will require a 
serious definition and specification of the term "sustainable agriculture" as a stated 
goal of European agricultural policy. 
For the post-marketing monitoring was pointed out that three dimensions or dis-
tinctions have special relevance: 
> monitoring based on cause-and-effect hypotheses (even if partly unexplained or 
uncertain) versus unexpected or rare events,  
> surveys of the agricultural ecosystem (and adjoining marginal structures) versus 
surveys of the environment generally,  
> monitoring for limited periods versus long-term or unlimited monitoring.  
The overall main conclusions of the report were: 
No excessive expectations should be raised for the amended Deliberate Release Di-
rective 90/220/EEC and the introduction of post-marketing monitoring. Their poten-
tial for resolving problems will inevitably remain limited until such time as funda-
mental agreement is reached on definitions of damage and desirable agricultural 
practice.  
Both the amended Deliberate Release Directive and the Novel Food Regulation re-
quire operationalisation and specific guidelines for implementing the safety assess-
ment and approval procedures. This is the only way to reduce discussions about the 
scope, coverage, methodology and interpretation of the safety assessments. This 
should build on the current state of the scientific risk debate. To this extent it will be 
an ongoing task, rather than a one-time exercise.  
New instruments – such as post-marketing monitoring or revised labelling regula-
tions – should only be introduced when their integration into existing statutory provi-
sions and their implications have been carefully considered and widely discussed. To 
avoid new areas of conflict and controversy, e.g. in post-marketing monitoring a dis-
tinction should be made as early as possible between this and pre-marketing safety 
research and risk assessment and the criteria for incorporating information from 
monitoring in the approval procedure should be clarified.  
Finally, new areas of conflict should be identified at the earliest possible state and 
investigated in advance. Attention is drawn particularly to the announced second-
generation transgenic plants, which are e.g. supposed to have a health-promoting 
effect as "functional food". These will probably result in a shift in the debate from 
possible ecological impacts towards potential health impacts and also pose entirely 
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new and possibly even greater problems in safety assessment than the current trans-
genic plants.  
IMPACTS AND FOLLOW UP OF THE PROJECT 
The report was published as a parliamentary document (Bundestagsdrucksache 
14/5492). The report was deliberated in the leading Committee on Consumer Protec-
tion, Food and Agriculture and two consulting committees. Thereby, the report was 
discussed controversial. The governmental majority presented a motion which in-
cluded the whole spectrum of the report issues, proposed a further development of 
the concept sustainable agriculture and demanded a consequent application of the 
precautionary principle. In contrast, the motion of the opposition (CDU/CSU) con-
centrated on the rapid implementation of the new Deliberate Release Directive 
2001/18/EC and was demanding a strengthened research and use of transgenic crop 
plants. 
The result of the deliberation in the committees was a recommendation (of the gov-
ernmental majority of SPD and the Greens) and report for the plenary which was 
approved in the plenary meeting of the German Bundestag on 14th June 2002. The 
TAB report was once again unanimously noticed by the plenary. 
The part on post-marketing monitoring of the report was used in a documentation of 
the Federal Environmental Agency (UBA 2001) which summarise the state of debate 
at that time. 
The report had pointed out that TA should be started on the new generations of 
transgenic plants at the earliest state as possible because these will probably result in 
a shift in the debate from possible ecological impacts towards potential health im-
pacts and also pose entirely new and possibly even greater problems in safety as-
sessment than the current transgenic plants. Following this recommendation, TAB 
was commissioned with a project on transgenic plants of the second and third genera-
tion in 2003. 
CHALLENGES IDENTIFIED IN THE PROJECT 
In the project identified (future) challenges which are still valid (conclusions of the 
reviewer): 
> need for more accompanying ecological research to assess possible risks of gm 
plants 
> missing definition of damaging impacts, so that there is still a considerable scope 
for different assessments 
> missing normative framework for desirable agricultural practice or sustainable 
agriculture, against which impacts of gm plants can be measured 
> insufficient implementation of post-marketing monitoring 
> need for clear distinction between post-marketing monitoring and pre-marketing 
safety research 
 68 
> development of criteria for the feed-back of information from the post-marketing 
monitoring to the authorisation agencies and for impacts on running approvals or 
re-approvals 
> importance of the second and third generation of gm plants (in particular plant-
made-pharmaceuticals, plant-made-industrials, functional food) with potentially a 
shift in the debate from ecological impacts towards health impacts and new prob-
lems in risk assessment 
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DISKURS GRÜNE GENTECHNIK (GREEN BIOTECHNOLOGY 
DISCOURSE) (2002) 6.3 
BACKGROUND OF THE PROJECT 
The so-called “Diskurs Grüne Gentechnik” (“Green Biotechnology Discourse” was 
initiated by the federal Ministry of Consumer Protection, Nutrition and Agriculture 
(Bundesministerium für Verbraucherschutz, Ernährung und Landwirtschaft, 
BMVEL) in 2001. 
The situation in the starting year was characterised by the worldwide growing com-
mercialisation of gm crops, the amendment of the EU regulation on genetic engineer-
ing, the abandonment of the three-year transitional trial phase of introducing gm 
crops in agriculture due to the BSE crisis (see review on the TAB project 2000), and 
the new direction of the German agricultural policy (so-called “Agrarwende”). 
The goal was to “establish a forum for clarification of facts and for debate among all 
relevant societal groups” (BMVEL 2003, p. 5). 
BASIC DATA ABOUT THE PROJECT 
The “Green Biotechnology Discourse” was started in December 2001 and finalised 
in September 2002. 30 stakeholder groups – industry, agricultural organisations, en-
vironmental and consumer groups, churches, trade unions – took part in the dis-
course. Further, representatives of different other ministries were present. The steer-
ing committee of the discourse consisted of representatives of the stakeholder groups 
and was chaired by a representative of the BMVEL. 
The discourse was split in two phases, the starting phase (with a kick-of meeting, the 
selection of the moderator, the constitution of the steering committee and a hearing) 
und the phase of so called “discourse rounds”. The stakeholder and representatives of 
the ministry met in five “discourse rounds” of two days duration und in a conference. 
At these meetings opinions of 53 experts were heard and discussed by the partici-
pants. Care was taken to have an equal proportion of “pro-GM” and “anti-GM” ex-
perts. The moderator had prepared in the starting phase a “basic reader” which gave 
an overview on scientific, economic, ethic, social and legal issues. 
The steering committee agreed on the main topics to be discussed in the five “dis-
course rounds”: 
> preservation of biodiversity, 
> innovation potential and future chances of green biotechnology, 
> benefits and risks for consumer and producer, 
> preconditions, chances and consequences of an abandonment of green biotechnol-
ogy, 
> information, participation of the public and freedom of choice. 
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The results were published in a final report written by the steering committee 
(BMVEL 2002). The BMVEL published in addition a booklet in which the results 
are resumed as seen by the ministry (BMVEL 2003). 
MAJOR OUTCOMES OF THE PROJECT 
For major points, a consensus was not achieved. The final report lists for the differ-
ent topics the points of consensus and dissent, and open questions. Some major out-
comes are (BMVEL 2002): 
> Biodiversity: Consensus on the importance of preservation the biodiversity, but 
dissent on what is a negative impact on biodiversity (e.g. out-crossing); important 
open questions are seen in the definition of ecological damage and in the respon-
sibility for damages on biodiversity; 
> Risk assessment: Fundamental disagreement on the deliberate release and use of 
gm plants; as most important open question was identified the understanding of 
the precautionary principle; 
> Benefits of GM plants: Consensus about the importance of plant breeding, the 
potentials of conventional breeding and the need of molecular-genetic and ecosys-
tem research for successful plant breeding, but dissent on specific benefits from 
GM plants; important open questions are seen in the clarification of potential fun-
damental differences between conventional breeding and genetic engineering and 
in the regulation of intellectual property rights; 
> Benefits of GM foods: Consensus on the high standards of food security and qual-
ity in the industrial countries, but disagreement on the consumer benefits from 
product innovation in the past and from gm food; as prior open questions are re-
garded the definition of improved foods and the possibilities of healthier nutrition 
through gm food; 
> Freedom of choice and coexistence: Consensus on the freedom of choice for pro-
ducer and consumer, the labelling of gm foods and that with zero tolerance coex-
istence is not possible, but dissent on thresholds, measurements and accountabil-
ity; to the identified open questions belong feasibility of coexistence, coexistence 
rules and liability; 
> Labelling: Clear and practicable regulation for labelling is demanded; a consensus 
for seed thresholds was not achieved. 
IMPACTS AND FOLLOW UP OF THE DISCOURSE 
All important stakeholders in the field of green biotechnology have participated in 
the discourse. But no changes in the German discussion on gm plants and foods re-
sulted from this exercise – there was no successful mediation across the GM divide. 
The discourse is extensively documented on the “transgen” website 
(www.transgen.de). This official website declares: “In the end the discourse had little 
effect. The various views continue to stand opposed to each other. A number of ques-
tions that were discussed at the time have meanwhile been settled politically, but this 
has hardly calmed down the controversies.” (Transgen 2007) For the in 2002 re-
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elected red-green coalition government, freedom of choice and coexistence remained 
the leading policy goals for the area of biotechnology and food. Following the new 
EU regulation, an amendment of the German regulation on genetic engineering took 
place in 2004 [?]. Pro-GM participants regarded this new regulation as blocking the 
use of gm plants. 
It has been suggested that the discourse had a built-in design to cement rather than to 
mitigate the controversy. A fundamental divide between two sides appeared due to 
the requirement of the pro/contra proportionality in the selection of experts. This 
arrangement offered organisations with more outspoken views greater leverage on 
the kind of expertise that would be presented. Any substantive debate between dif-
ferent experts was frustrated. Experts were used as strategic resources by the partici-
pating organisations. One effect of the discourse was apparently that cooperation and 
coordination within each side of the GM controversy was strengthened (Paula/van 
den Belt 2006, p. 32).  
CHALLENGES IDENTIFIED IN THE DISCOURSE 
In the discourse identified (future) challenges which are still valid (conclusions of the 
reviewer): 
> definition of ecological damage 
> definition and operationalisation of the precautionary principle 
> regulation and impacts of intellectual property rights and patenting 
> consumer benefits from gm foods as improved food products and healthier nutri-
tion 
> feasibility of coexistence, coexistence rules and liability 
> working labelling regime for gm food 
> thresholds for labelling of seeds 
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GENETIC ENGINEERING AND ORGANIC FARMING (2003) 6.4 
BACKGROUND OF THE PROJECT 
In December 2000, the German Federal Environmental Agency (Umweltbundesamt 
– UBA) held a professional conference on the subject of “Green genetic engineering 
and organic farming”. During this conference, possible approaches for protecting 
organic production sites as the use of genetically modified plants increase in conven-
tional agriculture were discussed with persons representing organic farming from the 
research, production and administration sector. 
The experts participating in the conference agreed that the only way to minimise con-
tamination due to introgression from genetically modified plants is to use suitable 
prescribed distances between organic farming areas and fields containing genetically 
modified plants. Additionally, the establishment of zones that are free of GMOs 
should be considered within protected areas. 
At the starting time of the project, there was no basic legal stipulations in Germany 
or in Europe with regard to these calls for minimum prescribed distances and GMO-
free protected areas. 
The objective of the “Green genetic engineering and organic farming” project was 
thus to present different legal scenarios for establishing regulations on minimum pre-
scribed distances between organic farming areas and fields containing genetically 
modified plants within the German und European legal systems. 
BASIC DATA ABOUT THE PROJECT 
The specialist report entitled “Green genetic engineering and organic farming” 
(Barth et al. 2003) was prepared on behalf of the German Federal Environmental 
Agency by the Forschungsinstitut für biologischen Landbau Berlin e.V. and the Öko-
Institut e.V. in the time between June 2001 and August 2002. The report includes the 
results of two workshops held on 29 October 2001 and 16 January 2002 in Berlin 
during which the initial results were discussed with various experts. 
MAJOR OUTCOMES OF THE PROJECT 
There is a world wide consensus among organic farmers not to use genetically engi-
neered organism (GMO). Initially implemented through the guidelines of organic 
farming associations, this rule now gained accession to consumer protection legisla-
tion in the USA, Japan and the European Union. 
EU LAW PERMITS PROTECTIVE MEASURES FOR ORGANIC FARMING 
At the European level neither the EU regulation on organic agriculture nor the seeds 
directives prescribe mandatory measures for the protection of organic crops against 
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pollination by GMO pollen. An evaluation of EU Directive 2001/18/EC on the De-
liberate Release of GMO shows, however, that the permission to market GMO may 
include an order to take measures to avoid property damage through pollination as 
one of the “specific conditions of use and handling” of the GMO. This results from a 
systematic and parallel interpretation of the EU Directive on the release of GMO and 
the EU regulation on organic agriculture. Only inasmuch as the interpretation of the 
Directive on the release of GMO takes into account the legislative targets of the EU 
regulation on organic agriculture will a balance of interests between organic agricul-
ture and the cultivation of GMO be accomplished. 
PROPOSALS FOR ISOLATION DISTANCES 
Currently the most widely discussed option for affording protection against property 
damages is to provide isolation distances between cultures with GMO plants and 
organically managed cultures; another is to demarcate GMO-free regions. 
Isolation distances have for a long time been used in seed production to maintain 
purity of breed. The goal is to keep impurity to a minimum. Statutory minimum iso-
lation distances are based on past experience with seed production and they do not 
completely rule out hybridisation. Nevertheless, the imposition of safety distances 
does offer itself as one possible way of protecting organic agriculture. 
An analysis of empirical data with a view of defining isolation distances revealed 
many gaps and hence an urgent need for further research. Despite this shortcoming, 
and for pragmatic purposes, the present survey was based on what data were avail-
able to derive first recommendations for isolation distances. 
Measures for protection against property damages through GMO pollination in or-
ganic agriculture, such as the declaration of isolation distances on commercial pack-
aging of GMO seeds, could be imposed by way of commercialisation permits. Im-
plemented through commercialisation permits such measures could even today have 
an effect on civil-law relationships between organic farmers and GMO farmers, un-
der certain conditions entitling organic farmers to claims for damages caused by ge-
netic introgression. 
PATHS TOWARD CONCILIATION BETWEEN NEIGHBOURS 
In Germany the private legal rights and spheres of interest of organic farmers and 
users of transgenic varieties are defined and delimited by civil law. The borderline is 
drawn by a system of legal claims governing neighbourly relationships. § 906 of the 
German Civil Code is the central norm of private environmental law. Under this 
paragraph users of transgenic plants can be required to avoid or minimise genetic 
modifications in neighbouring cultures. When an organic farmer suffers market 
losses due to the pollination of organic cultures by GMO pollen, the owner of the 
neighbouring transgenic cultures can be ordered to pay damages. At present it is dif-
ficult to assess the level of enforceable claims. The complex intercalating system of 
claims to desist or to compensate will have an inhibitory impact on the use of trans-
genic seeds, and the economic burden of having to avoid GMO pollination of 
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neighbouring cultures or pay compensation, will not be calculable in advance. How-
ever, organic farmers are so burdened with having to secure cogent proofs of causal-
ity that many will see this as an intolerable manacle. Under these conditions there 
will be little hope of arriving at a state of peaceful coexistence. 
The idea of a self-organised mediation system for temporal and spatial isolation in 
connection with a compensation scheme financed by GMO producers and users is 
introduced. 
PUBLIC REGISTER OF PRODUCTION SITES 
All member states of the European Union are required by the Directive 2001/18/EC 
to establish public registers documenting GMO cultivation sites and the identity of 
cultivated GMO varieties for the purpose of monitoring environmental effects. This 
register could at the same time serve as a production register for GMO. The directive 
leaves it up to the member states to determine the details of register management. 
The directive contains no impediment to requiring farmers to provide precise infor-
mation on the location of their GMO cultures for the register. Information concerning 
the precise design of the GMO and the analytic measures to detect it could be in-
cluded along the lines of the draft of the EU regulation concerning traceability and 
labelling. However, this draft only requires that the codes of GMO sequences be pub-
lished. Since organic farmers must be in a position to reliably detect GMO se-
quences, the cultivation register would need to contain precise information on their 
identity. 
INTRODUCTION OF GOOD PRODUCTION PRACTICE IN GMO CULTIVATION 
Protective measures to avoid GMO pollination could be imposed on users of GMO 
seeds through the introduction of a code of “Good Production Practice in GMO cul-
tivation” (GPP). Such measures could include, for example, defensive cultivation 
planning and the maintenance of specific distances between transgenic and suscepti-
ble organic cultures. For the implementation of the GPP code the administration must 
be empowered to impose specific single protective measures. Non-observance of 
such an order must be penalised as a regulatory offence. GPP could be introduced by 
an amendment to the Gentechnikgesetz (German act on genetic engineering) or the 
Saatgutverkehrsgesetz (German act on the marketing of seed). Alternatively, it could 
be introduced through an amendment to a specific (organic) agriculture statute. 
DAMAGE FUND FOR GMO POLLINATION 
For pollination by GMO from non-determinable sources a system for compensating 
organic farmers for market losses is necessary and indeed feasible. Compensation 
could be provided by a governmental compensation system or a fund model based on 
a statutory regulation or a voluntary self-commitment of producers and users of 
GMO. 
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PROTECTION OF ORGANIC SEED PRODUCTION 
The protection of organic seed production necessitates closed regional production 
areas. This requires the development of an appropriate legal basis. 
IMPACTS AND FOLLOW UP OF THE PROJECT 
Some points are incorporated in the amended German legislation on genetic engi-
neering, but many other points are still discussed controversial. 
CHALLENGES IDENTIFIED IN THE DISCOURSE 
In the project identified (future) challenges which are still valid (conclusions of the 
reviewer): 
> definition of isolation distances and Good Production Practice 
> liability and compensation fund 
> protection of organic seed production 
> coexistence which does justice to consumers’ right to freedom of choice is not 
easily to be arrived 
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GREEN GENETIC ENGINEERING – TRANSGENIC PLANTS 
OF THE SECOND AND THIRD GENERATION (2005) 6.5 
BACKGROUND OF THE PROJECT 
The TAB-project “transgenic plants of the second and third generation” was de-
manded by the Committee for Education, Research and Technology Assessment. The 
term "second generation" was used to describe those genetically modified plants 
(GMP) which are in the pipeline (i.e. in industrial development and shortly before 
licensing), while “third generation” is applied to those in research or a very early 
stage of development. 
The origin of this project can be clearly traced back to the previous TAB project 
"Risk assessment and post-marketing monitoring of transgenic plants", where the 
investigation of this topic was brought up as an important recommendation concern-
ing future TA need (see review 6.2). 
A second motivation was the (as well since a long time especially in the political 
debate repeated) assumption, that a shift in the European consumers' hostile attitude 
towards GMP can't be expected as long as no products from GMP with a convincing 
benefit are on the market. The TAB project to study the potential and risks of future 
transgenic plants was limited to the subset of GMP with modified use properties for 
the consumer (so-called “output traits”). The TA project aimed to answer the follow-
ing questions: 
> how the targeted additional benefits of these GMP are defined, 
> how they are supposed to be achieved, 
> what economic potential can be expected, 
> what new (types of) risks should be assumed, 
> what new questions of safety assessment result from these, 
> whether existing safety measures appear adequate, or whether they need to be 
modified, expanded or supplemented, 
> what regulatory challenges result, and also 
> what effects on consumer acceptance are to be expected. 
BASIC DATA ABOUT THE PROJECT 
The TA-project was executed in 21 months (November 2003 – July 2005), subdi-
vided into two phases. Eight scientific studies (expert opinions) were commissioned 
during the project. In the first phase (until August 2004), based on three of the expert 
opinions, an overview of research and development as well as concerning the eco-
nomic potentials and the international debate on risk evaluation and assessment was 
worked out. The second phase of the project was devoted to an in-depth analysis of 
"molecular farming" which means the use of GMP for the production of industrial 
materials (so-called PMI or plant made industrials) and especially as a source of 
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pharmaceutical substances for human and animal medicine (so-called PMP, or plant 
made pharmaceuticals). The draft final report of TAB was based mainly on the 
commissioned scientific studies and was evaluated by a number of experts from sci-
ence and government. 
The main topics of the final report were: 
> a detailed description of GMP for functional foods, for PMI and PMP12 
> including an in-depth discussion of their economic potentials and 
> their possible ecological and health risks; 
> the possible performance of biological and physical confinement measures; 
> the regulation of molecular farming (in the EU, compared to the U.S. and Can-
ada):  
> areas for action (with regard to the German national and the EU level). 
MAJOR OUTCOMES OF THE PROJECT 
OVERVIEW OF RESEARCH AND DEVELOPMENT – LICENSING AND RELEASE 
GMP with output traits were divided into six groups: 
1. improved contents in plants which are a source of food (functional foods - FF); 
2. improved contents in plants which are a source of animal feed; 
3. optimised or modified plants for production of industrial materials (PMI) or 
4. for production of pharmaceutical substances (PMP); 
5. GMP for phytoremediation (plants for the treatment of contaminated soils); 
6. modified properties of decorative flowers (colour) or plants (e.g. lawn). 
GMP with output traits play no role in global cultivation, which is still completely 
dominated by herbicide and insect resistance. Until 2005 eleven GMP with modified 
output traits have been licensed in various countries (2006: plus one), nine of them 
without relevance for the TAB report (tomatoes with longer shelf life, modified 
decorative flowers, tobacco with reduced nicotine content). The two remaining varie-
ties, a rapeseed with high lauric acid content and a soy bean with increased oleic acid 
content, have been unsuccessful on the US market, and are accordingly not grown to 
any effective extent. In the EU, only the three modified carnations have been li-
censed (since 1997/98). The licensing pipeline contains (since 1997) 21 applications, 
including one PMI GMP, the "famous" potato with modified starch composition. 
Among the releases in the U.S. (1988-2003), GMP with modified output traits ac-
count for c. 20% of the c. 10,000 applications, equivalent to 150-230 a year since 
1994. In the EU, GMP with modified output traits account for c. 15% of all releases 
in 1988-2003 (over 270 of 1,850 applications). In line with the trend for GMP gener-
                                                 
12GMP for animal feedstuff were not dealt with in depth, as their uses are more com-
parable with agronomically modified GMP, and hence do not open up new prospects 
for use in the same way as the other three groups, and because they play only a minor 
role in Europe, quantitatively speaking. 
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ally, there has been a very definite decrease in release applications since 1996/97. A 
breakdown by individual groups shows a much smaller significance of the feedstuff 
sector than in the USA. 
GMP FOR THE PRODUCTION OF FUNCTIONAL FOODS OR THEIR INGREDIENTS 
The range of functional ingredients produced or (to be) modified in plants by genetic 
engineering is still very manageable. The GMP developed so far are predominantly 
prototypes to demonstrate fundamental feasibility, which need further development 
for commercial use and must be tested not only in the field but also on humans in 
nutrition studies.  
For most functional ingredients, the current genetic engineering approaches – over-
expressing or reducing the activity of individual genes directly involved in the rele-
vant metabolic pathways – are not sufficient to achieve commercially attractive con-
tent of the functional ingredients in the GMP. Hopes involve conceptual and meth-
odological further developments in metabolic engineering, which seeks to affect en-
tire metabolic pathways and regulatory networks in a coordinated way. Whether FF 
GMP can be established in the medium term as a source of functional food raw mate-
rials and ingredients depends crucially on whether the assumed cheaper production 
of functional ingredients in GMP can be actually achieved. This is not easy, as there 
are established production platforms already in existence (e.g. chemical synthesis, 
microbial production, isolation from natural sources) for most of the ingredients cur-
rently being researched in GMP, which FF GMP will have to compete with. The re-
source-intensive and comparatively long development period for new GMP varieties 
and the functional foods or ingredients produced from them represent a comparative 
disadvantage, as the regulatory requirements mean tying up resources in the long 
term in a dynamic market which actually requires a rapid and flexible response. In 
addition, GMP approaches generally have to be supplemented by other food technol-
ogy options, as functional GMP for direct consumption can only meet a small seg-
ment of the possible entire supply of and demand for functional foods, for reasons of 
shelf life, seasonal availability, convenience and bioavailability. 
PLANT MADE PHARMACEUTICALS 
GMPs have been discussed for many years as a highly promising new production 
platform for drug production. The hope is particularly for low-cost production in 
large quantities. Products produced using genetic engineering methods account for 
the overwhelming part of pharmaceutically effective proteins and peptides, which are 
also called “biopharmaceuticals”. Significantly less important (and also in very early 
stages of development) are genetic approaches to influencing pharmaceutically effec-
tive so-called secondary metabolites, which were not discussed in the report. 
To date, no PMP GMP has been licensed for placing on the market anywhere in the 
world. There are intensive research and release activities in the USA and Canada, 
while the activities in the EU come predominantly from two French firms (Meristem 
Therapeutics and Biocem). The plant species used are predominantly maize and to-
bacco, followed by rapeseed and soy bean. No PMP has yet been given “real” ap-
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proval as a drug. Several proteins which also have pharmaceutical uses are already 
on the market, although so far they can only be sold as research or diagnostic re-
agents. They come from experimental releases (in the USA). 
Of those PMP in development, so far only two have been recognised as having so-
called orphan drug status (for treating rare diseases). In the EU orphan drug status 
(for use with mucoviscidosis sufferers) was granted in 2003 to a so-called gastric 
lipase (from maize). To date the protein comes from experimental releases in France, 
and could be the first PMP for application for approval as a drug in the EU. In the 
USA a so-called galacosidase was granted orphan drug status in the same year. 15 
PMP were identified in various phases of clinical testing. In addition to gastric lipase, 
an antibody for caries prophylaxis and patient-specific antibodies for treating non-
Hodgkin lymphomas are in an advanced stage of testing. Several PMP are currently 
being developed for veterinary use, with the option of extending these to human in-
dications later if successful. Besides these concrete examples, there is a vast number 
of PMP in preclinical R&D stages. A key area is developing antibodies, presumably 
because possible specific advantages of production in GMP seem most within reach. 
To assess the future potential of PMP GMP, comparison with competing production 
platforms is needed. To date, biopharmaceuticals have almost entirely been produced 
microbially or in animal cell cultures, and transgenic animals are rather more ad-
vanced than PMP approaches (although here again no drug has yet been approved). 
The various production platforms are briefly presented and described in the report. 
Possible specific advantages of PMP GMP were considered in terms of freedom 
from human-pathogenic agents, correct glycosylation and of investment and produc-
tion costs including scalability. These were found to be predominantly dependent on 
the product. For example, it is clear that glycosylation closer to mammalian cells 
(modification of the protein in the cell) from PMP has an advantage over microbial 
systems for many drugs, although this may also prove a pharmacological disadvan-
tage for others. It is fairly certain that general cost advantages cannot be assumed for 
production from PMP – these are only plausible on the unrealistic assumption of only 
slightly regulated open cultivation (plus ideal yields). An in-depth investigation of 
the foreseeable potential of possible oral vaccines showed that oral vaccines do not 
seem very important for vaccine development, and particularly that the idea of inges-
tion in the form of unprocessed fruits (still frequently cited) is entirely unrealistic. 
An overall assessment of the currently foreseeable economic potential  concluded 
that in view of the major and growing importance of biopharmaceuticals generally, 
there is probably also growing potential for production in PMP, without the general 
cost advantages generally assumed. Their competitiveness is decisively determined 
by advances in competing production systems and development of specific regula-
tions for cultivation and corresponding risk management measures. 
PLANT MADE INDUSTRIALS 
Use of PMI GMP seems comparatively further away. This is a little surprising, given 
the intensive work on relevant GMP concepts over many years, and the fact that the 
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first two such GMP were approved and commercialised years ago. The only cur-
rently foreseeable example here in the EU is the starch potato, which has been in the 
approval pipeline for years. 
For all other approaches (whether in “designer oils” or “designer starches”, produc-
tion of industrial enzymes, biopolymers or other special ingredients) it is virtually 
impossible to assess how far the work has come in concrete terms. In some cases, 
this is in-house work, in other cases the development work – e.g. on bioplastics from 
GMP – seems to be taking significantly longer than hoped. The reasons for this dif-
fer, depending on the development goal and plant species, but the examples pre-
sented suggest possible general assessments (which also apply e.g. to development of 
FF GMP). 
> In several cases, expectations particularly of attainable product yields have been 
not been satisfied even after many years of development. In the course of maxi-
mising content, apparently undesired side effects have emerged (are emerging) in 
many cases which then result in lower yields. While this does not make the con-
cept (economically) unusable, it does affect the range of substances which can be 
produced on a commercially competitive basis. 
> In several cases, the transition from the highly promising model plants to specifi-
cally usable ones did not proceed as hoped, as the genes failed to “function” ac-
cordingly. 
> In other products, the alternative production systems (cell-based systems, trans-
genic animals) developed faster or more efficiently. 
An assessment of the prospects for PMI concepts is accordingly (even) more difficult 
than for PMP. Production of bulk products seems unlikely in the foreseeable future, 
the production of renewable raw materials is more likely to be optimised through 
breeding of non-genetically-modified plants. Industry sees realistic prospects for 
high-price special applications, if these can only be produced in GMP and not in 
conventional varieties or the cultured varieties otherwise used. Dual use (e.g. bio-
plastic and feedstuff) depends on relevant approval, which is only conceivable for 
selected approaches. Transgenic trees for plantation farming could become more 
significant worldwide, but cultivation in the EU is unlikely for a long time. 
POSSIBLE ECOLOGICAL AND HEALTH RISKS 
Given the early stage of GMP modified for output traits, no risk discussion has de-
veloped for most sub-aspects, so that no presentation in detail was possible. This 
applied particularly to the possible ecological risks of FF GMP and the possible 
health risks of PMI GMP. The risk discussion for FF GMP is focusing on the basic 
question of safety evaluation of innovative and primarily functional foods, while for 
PMP GMP the emphasis is on possible release into the environment and food and 
preventing this. Therefore the risk debate on molecular farming (of PMP and PMI) 
generally has so far concentrated almost entirely on the question of reliable seques-
tration and containment of GMP. 
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Basically, GMP modified for output traits fundamentally change the situation for risk 
regulation (i.e. risk assessment, risk evaluation and risk management), because at 
least PMP GMP as well as some PMI GMP have an inherent risk because of the 
medical and physiological impact of their ingredients. 
The current goal of risk regulation is to approve only GMP which are risk free as 
compared to "conventionally" bred plants. This concept must be at least modified by 
developing comprehensive and rigorous safety requirements for cultivation and proc-
essing e.g. for PMP GMP with their potential environmental and health risks (as is 
the case in Canada and the USA). It will probably be necessary to impose group-
specific measures which imply moving away from the pure case-by-case principle, or 
at least supplementing it. 
At the same time, the discussion of benefits is taking on new priority compared with 
the 1st generation of GMP, including risk evaluation and regulation. So far, it has 
been possible to ignore doubts about the benefits of the genetically introduced prop-
erties from the regulatory point of view (because no concrete risks to health and the 
environment were established as a prerequisite for approval), and to leave evaluation 
to market forces. In future, the desired benefit (e.g. production of life-saving drugs) 
is likely to play a greater role – at least in some cases – in risk evaluation, including 
in the approval decision. 
BIOLOGICAL AND PHYSICAL CONFINEMENT MEASURES 
In considering possible risk management measures for GMP modified for output 
traits, it is necessary to distinguish between two groups of GMP which pose very 
different requirements for regulation, namely those which can be regarded as just as 
safe as the approved 1st generation GMP, and all others. 
The first group could include several of the conceivable PMI applications, e.g. if 
these involve modified food plants which are currently being used for industrial pur-
poses in their conventional form. At least if the relevant GMP has explicit approval 
for food and feed, large scale cultivation is conceivable subject to the prevailing va-
riety-specific coexistence regulations, and would not differ substantially in quality 
from the food sector. The second group presumably includes most PMP, together 
with a range of conceivable PMI plants for which special containment/confinement 
will be required. In the event of open cultivation, and possibly greenhouse cultiva-
tion, particularly strict biological and physical confinement measures must apply, as 
the current regulations in Canada and the U.S. require. 
The report discusses in detail the question how reliable the various methods in pre-
venting undesired dissemination of GMP are. The overall conclusion was that the 
present state of science and technology is unable to offer any system for confinement 
of transgenic nonfood plants which permits coexistence in open cultivation of GMO 
and non-GMO species completely free of any influence. But it was emphatically 
stressed that the extent to which such influence can be tolerated and under what con-
ditions are matters for society to decide. 
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Only few biological confinement methods have reached a state of development 
where substantial studies on integrity and leak tightness can be carried out. An (al-
most) complete prevention of the escape of a transgene is up to now only possible in 
closed systems. 
REGULATION ISSUES IN MOLECULAR FARMING 
Consideration of the state of regulation of genetic engineering showed that the pre-
sent regulations and procedures for molecular farming are not entirely appropriate or 
adequate. For molecular farming of “high price” products or ingredients on compara-
tively small areas, approval for release under Part B of European Directive 
2001/18/EC is inadequate in many cases (because the relevant products may not be 
placed on the market), although approval for placing on the market under Part C 
would actually not be required, because free trade and unlimited cultivation are not 
goals of GMP development. At least in the medium term, there will accordingly be a 
need for change, particularly in the regulation of genetic engineering. By contrast, 
there is currently hardly any need for change apparent in drug and chemical regula-
tion. 
Activities and discussions in the EU (until summer 2005) showed that very little at-
tention had been paid to the issue of molecular farming so far, particularly in com-
parison with Canada and the U.S. [this has changed a little bit since then, as EFSA 
and IPTS have started several activities, both of them taking notice of the TAB re-
port; see below]. This implies a need at EU and national level for more intensive 
consideration of the opportunities and potential risks of GMP modified for output 
traits. 
AREA FOR ACTION: OPERATIONALISATION OF VISIONS AND SCENARIOS 
Although molecular farming has been described as a future option for many years in 
the debate on genetic engineering, it has mostly been presented in very vague terms, 
either as largely unsupported assumptions about possible benefits (and/or risks) or as 
visions of the future. The relevant documents typically focus on scenarios for the use 
of possible products from GMP modified for output traits, describing scenarios for 
production and cultivation which have little contact with reality, and completely ig-
nore regulatory aspects and realistic coexistence scenarios. Such operationalisation 
accompanied by greater social opening seems very important for the coming debates 
on possible future use of transgenic plants. These tasks should be addressed with a 
view to the coming Framework Programme 7, together with more substantial links to 
the relevant policy areas, strategies and goals (including more extensive use of re-
newable raw materials, development of rural areas, sustainability of agriculture, 
healthier nutrition). 
AREA FOR ACTION: GERMAN RESEARCH POLICY 
Facing the new and complex questions regarding the benefit as well as novel risks 
and their management, for German research policy the development of interminis-
terial promotional R&D measures for research into molecular farming was assessed 
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as being adequate. A viable and societally acceptable approach would require not 
only bringing together the ministries' technical points of view but also including 
various interest groups in developing such promotional programmes and projects. 
No assessment was performed for R&D approaches in detail, e.g. deserving promo-
tion or safety issues requiring particularly urgent investigation. However, a specific 
proposal was made for a “Progress report by the Federal Government on the status of 
publicly funded activities in connection with research, approval, cultivation and mar-
keting of GMP”, which should in detail review the aims and outcomes of the last 10 
to 15 years and draw conclusions for the future promotion and funding of R&D de-
voted to biotechnology and plant sciences (a proposal, which seems to be suited for 
every other country as well as the EU level). Such a report could possibly offer a 
basis or at least a point of reference for more constructive and sustainable further 
development of research policy on green genetic engineering and alternative strate-
gies. 
AREA FOR ACTION: MODIFICATION OF REGULATION AT EU LEVEL 
The need for action concerning modification of regulation was clearly located at EU 
level. The regulation has to come under review if it is suited for the production of 
PMP and PMI (which seems not so; see results above). With regard to national regu-
lations, it was concluded that they have to be revised in a second step according to 
the EU regulation. 
IMPACTS AND FOLLOW UP OF THE PROJECT 
Parliamentary debate and/or decision:  
The proposal of the "Progress Report" was picked up several times in parliamentary 
debates (on GMOs, but not directly connected with the TAB report) and has been 
integrated in the official statement of the (together with the christian democrats gov-
erning) social democrats concerning the current amendment of the gene technology 
law. 
Public perception: 
Compared to other TAB projects, a relatively broad press coverage in print and web-
based media began directly after the acceptance by the Committee for Education, 
Research and Technology Assessment and publication of the report in February 
2006. In June 2006, TAB together with the Committee for Education, Research and 
Technology Assessment organized a public workshop in the German Parliament and 
invited stakeholders from industry, regulatory authorities and academia to answer to 
and to discuss the report's view. The workshop was very well attended, by all kinds 
of stakeholders. The usual heavily polarized debate was astonishingly moderate, in 
our view the outcomes of the report were completely validated, although "the indus-
try" tried to proof a too negative judgement concerning the economic potentials (but 
failed to show any other perspective than was discussed by TAB). 
Scientific recognition: 
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The performance of the report was appreciated a lot (there is up to now no publica-
tion of comparable comprehensiveness in Germany, maybe in Europe?), accompa-
nied by heavy criticism from scientists who refuse to concede that the results of mo-
lecular farming up to now are in many respects of a poor nature (and probably are 
opposing the proposal of the reviewing "Progress Report"). The websites on GMOs 
and biosafety of the German research ministry refer to the report (especially concern-
ing the risk regulation of PMP) and integrated links to TAB. IPTS invited TAB to a 
workshop on molecular farming which was then attended by Armin Spök from IFZ 
(Graz, Austria) who was responsible for two of the expert opinions on risk regula-
tion, and who has published its results recently in TRENDs in Biotechnology. 
CHALLENGES IDENTIFIED IN THE PROJECT 
Due to the up to now very limited presence of the topic "molecular farming" in the 
debate on GMOs (at least in a detailed manner), an overall need at EU and national 
level for more intensive consideration of the opportunities and potential risks of 
GMP modified for output traits is obvious. 
> Technical dimension: The possible performance of future GMP could be assessed 
in a more realistic way (via an in-depth "Progress Report"); with respect to the 
cultivation of PMP and PMI GMP, the development and assessment of biological 
and physical confinement measures are of special and fundamental importance; 
> Social dimension: The possible acceptance of PMI and PMP GMP will (in my 
opinion, A. Sauter) depend on an early and transparent participation already in the 
R&D phase, beyond promotional communication activities like "Plants for the Fu-
ture" (see "operationalisation of visions and scenarios"); 
> Political / regulatory dimension: The whole EU regulation has to be checked for 
appropriateness for molecular farming (EFSA has started a self tasking activity, 
IPTS is also working by order of the Commission). 
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GENTECHNOLOGIEBERICHT 
(GENE TECHNOLOGY REPORT) (2007) 6.6 
BACKGROUND OF THE PROJECT 
The “Gentechnologiebericht” (Gene Technology Report) of the Berlin-Brandenburg 
Academy of Sciences and Humanities is a monitoring project that focuses not only 
on GM plants or GM foods but includes also medical applications. The report as-
sesses the entire field of gene technology, because unlike other technologies this par-
ticular field is affecting the basic principles of life, human existence and that of all 
other living beings.   
The report surveys carefully all present facts and the latest developments in the field 
of gene technology and presents a critical study from an impartial viewpoint. 
BASIC DATA ABOUT THE PROJECT 
The report is edited by an interdisciplinary study group consisting of several mem-
bers of the Berlin-Brandenburg Academy of Sciences and Humanities. The partici-
pating authors are impartial. They are experts on different disciplines of the subject, 
and they observe the subject beyond their own specific discipline as well. Acknowl-
edged external experts are involved additionally for further detailed questions. 
The report was published for the first time in 2005 (Hucho et al.). It consisted of four 
main chapters representing different case studies, which were chosen following pub-
lic controversies at that time. One of these case studies is on gene technology applied 
to plant breeding, farming and foods (green gene technology). A separate supplement 
published in March 2007 updates the data and adds news topics (Müller-Röber et al., 
2007).  
MAJOR OUTCOMES OF THE PROJECT 
The monitoring of the report consists of three parts: The first part is a documentation 
of today's state of technological development including scientific progress and the 
recent range of applications. The second part is a detailed overview of economic, 
ecological, social, political, legal, and ethical aspects. The third part is a system of 
indicators that are suitable to unravel and describe the topics connected with the ap-
plication of gene technology to plant breeding, farming and foods. 
The first part of the monitoring report, the documentation of technological develop-
ments, gives a detailed view on recent research and describes the aims of this re-
search as well as the applied techniques. Cisgenic plants and smart breeding are ex-
amples for two newly invented techniques that were presented in the media as alter-
natives to transgenic plants, which is the “classic” way of modifying plants. The re-
port draws the conclusion that both techniques could be useful extensions of the sci-
entific methods. But they will not be able to replace the methods of genetic engineer-
 87 
ing transferring foreign DNA from other species since the available genes are re-
stricted to closely related species.  
Further topics are the DNA sequencing of plant genome, the use of genetic engineer-
ing in research on biodiversity and ecosystems, enabling technologies in modern 
plant breeding, new methods of selection and both the creation and phenotyping of 
genetic diversity. On top of giving an overview over current scientific progress, the 
monitoring report includes an overview of the input and output traits that are worked 
on in the field of GM plants. Several examples are being examined, including insect 
resistant maize, the cultivation of which has been started in Germany recently, 
“golden rice” that could arouse a great deal of interest especially for poorer people in 
developing countries, and “energy plants” which gain high yield of biomass and are 
being discussed in public as an alternative form of energy production. 
The second part of the monitoring report examines different topics concerning GM 
plants and GM foods, which are debated controversially in the general public. Public 
opinion on GM plants and GM foods is a major factor and has to be taken into ac-
count, not only in Germany but in the whole European Union. The scepticism about 
these particular applications of gene technology is much higher in Europe than in the 
US, Canada or Argentina, where GM plants have been cultivated for almost ten years 
now. The report investigates the background to this poor acceptance. On the one 
hand, GM plants meet with criticism because of possible unforeseen negative eco-
logical side effects, on the other hand GM foods are criticized because of the risk of 
unpredictable health effects. The report examines both argumentations. GM plants 
that are resistant against herbicides or insects are used as two examples to document 
the recent scientific findings on ecological and health effects. Furthermore, the report 
focuses on economic aspects being of particular interest to political debates. An 
overview over several studies on the economic potential of GM plants is being pre-
sented. The topics being discussed are the development of the areas cultivated with 
GM plants, the question who will profit from GM plants, the preconditions for bene-
fiting of today's GM plants, the potential benefits of GM plants for the future, and the 
number of jobs being connected with the use of GM plants in agriculture and food 
production. Furthermore, a portrayal of the current situation of European and Ger-
man laws on GM plants and GM foods is presented, which includes the topics coex-
istence and liability. Despite the fact that ethical questions might be less important 
for the agricultural use of gene technology than for medical use, the report even ex-
amines ethical problems that could be associated with the use of gene technology 
during the process of plant breeding. 
The third part presents indicators that allow to describe the different current devel-
opments in the field of green gene technology clearly and easily to understand. A 
single indicator stands for a “measuring device” which allows to depict complex is-
sues that cannot be measured directly and to assess these issues representatively. An 
indicator reduces complexity through which developments at long and at short inter-
vals are less difficult to spot. A set of indicators makes it possible to back up subjec-
tive perceptions of developments or to falsify them. Proven developments can be 
analysed and interpreted with the help of further data. A misleading concentration on 
certain details frequently produces wrong results or misleading interpretations. The 
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report tries to prevent this serious risk by relating the indicators to one of the specifi-
cally defined problems that are connected strongly or weakly with the subject. All 
these defined problems seen as a whole should describe the issue of green gene tech-
nology entirely. This methodological step prevents observation loopholes if no suit-
able indicator could be found. In detail, the several defined problems take up again 
the different economic, ecological, social, political, legal, and ethical questions and 
also latest scientific research and current applications, which are presented in the 
second part of the report. In addition, connections between these aspects are pointed 
out and even problems connected to GM plants and GM foods less obviously are part 
of the overall picture. The definition of the problems is an important task of its own. 
The definition of what is seen as a problem is based on the public point of view on 
chances and risks, which might be diametrically opposed to an experts viewpoint. 
Nevertheless, this guarantees that the report does not deal with an experts debate 
only.  
The following indicators represent some examples: The number of traits, the number 
of field trials and the number of traits in these field trials are used to examine the 
potential that green gene technology has developed currently. The sales and profits 
being made with genetically modified seeds, the worldwide area under cultivation 
with GM plants and several cultivation data for Germany are some of the indicators 
being used to determine the current economic relevance of GM plants and GM foods. 
The amount of money being spent on research on GM plants and the number of ap-
plied patents are two of the indicators that try to measure the scientific and economic 
importance of green gene technology. Ecological effects are observed for example by 
the number of proven cases, when a GM plant interbreeds with another plant outside 
the field, and the use of pesticides on GM plants compared to the amount used on 
non-GM plants. The dissemination of GM foods can be described for example by the 
number of GM plants being approved for food use in the EU and by the market share 
of these products. The consumers' and the farmers' acceptance of GM plants and GM 
foods are two indicators being used to measure the intensity of conflicts that the in-
troduction of these products might cause. Generally, the indicators are used to de-
scribe the situation in Germany. The data is updated yearly. The report makes use of 
appropriate and valid sources like scientific studies or official databases of the gov-
ernment. The particular scientific work of the monitoring report is the selection of 
the indicators that has to base on intelligible criteria and that should cover all differ-
ent aspects of green gene technology. Single results are linked with each other to 
achieve a more precise assessment and a balanced interpretation. Finally, the report 
publishes recommendations based on this work. 
IMPACTS AND FOLLOW UP OF THE PROJECT 
The monitoring report is not only addressed to the policy makers in parties, govern-
ment, administration, non-profit organisations, scientific societies etc. but also to the 
general public interested in this particular issue. The report would like to make a 
good case for public discussions without taking a position for one side or the other. 
Thus the report wants to achieve a more objective public debate.  
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The next report is going to be published in 2008. Therein the issue of genetically 
modified animals will be dealt with additionally. Further and current information can 
be found at www.gentechnologiebericht.de. 
CHALLENGES IDENTIFIED IN THE PROJECT 
The annual update of the indicators does not only include the presentation and the 
interpretation of the recent data. It includes also a discussion if the indictors them-
selves. The main stress within the complex topics could have changed during the 
time and new additional data could be necessary for a conclusive interpretation. New 
topics have to be recognized as well, for example the debate about the consequences 
of the recent discoveries in the field of epigenomics.  
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NORWAY 7. 
RECONVENING THE LAY PEOPLES PANEL ON 
GM FOOD 4 YEARS AFTER (2000) 7.1 
BACKGROUND OF THE PROJECT 
The lay people’s panel was commissioned in 1996, by the Norwegian Biotechnol-
ogy Advisory Board (NBAB) and The National Committees for Research Ethics 
(NCRE), based on government grants. It consisted of 15 persons randomly chosen 
among 400 applicants. None of these had particular affiliations concerning the ques-
tion of genetically modified food. 
After several meetings to develop internal reflection on the issue of GM-food, the 
panel teamed up with a panel of experts to discuss central challenges regarding GM-
food. After the conference, the lay people’s panel delivered a consensus report with 
advice for action. 
In 2000, the panel reconvened to discuss the issue with a new panel of experts, under 
the auspices of NBAB, NCRE and the Norwegian Board of Technology (NBT). In 
the meanwhile, some members of the panel had continued their involvement in the 
issue, thus establishing themselves as experts on the issue. Again, the lay people’s 
panel delivered a consensus report.  
The conference had the following aims: 
> give a summary of central developments on research and use of GM food since 
the conference in 1996 
> present a consensus report with advice on whether a moratorium on importing and 
marketing GM-food should be imposed and eventually on other relevant topics 
> to strengthen the emphasis on lay people’s insights in technology assessment and 
management 
BASIC DATA ABOUT THE PROJECT 
The project was a consensus conference based on a hearing of experts. The confer-
ence was undertaken on 15th-16th of November 2000. Participants included 15 lay 
people, 18 experts took part in the hearing. In addition there were a number of facili-
tators.  
The hearing focused on the following topics: 
> Status of knowledge about effects on health and environment 
> Status of regulations and control: Are present regulations comprehensive and effi-
cient? 
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> Is a moratorium feasible and legitimate? 
> What are the interests of consumers, retailers, processors and producers? 
MAJOR OUTCOMES OF THE PROJECT 
The panel gave the following conclusions: 
A moratorium should be imposed, prohibiting cultivation of GM food and feed with 
the exception for test purposes. Imports and marketing of GM food and feed should 
also be prohibited. The moratorium should only be lifted when certain criteria are 
met: 
> - Knowledge of the long-range consequences of the technology should be im-
proved 
> - Laws and regulations should be coordinated internationally 
> - Monitoring, control and traceability should be strengthened 
A group representing broad interests should be convened to elaborate these criteria 
and evaluate when these are met. 
Within health, no evidence of harm is given, but this cannot be excluded. Further, the 
technology has not contributed within promising fields of increased nutrition or 
lower allergenic effects.  
There is no evidence that use of pesticides or herbicides have been reduced as a re-
sult of GM-cultivation. On the other hand, GM-agriculture has accentuated the use of 
monocultures and industrial approaches, which is harmful. There are indications that 
GMOs can disturb ecosystems, thus causing irreversible harm. There is an urgent 
need for better knowledge about effects on the environment. 
Although the GM-plants marketed so far are not useful for Norway, they could prove 
advantageous in other regions of the world. However, despite promises that GM 
would especially benefit the poor, such applications have not been delivered. On the 
other hand, the development towards monocultures cannot be seen as serving the 
poor.  
There is a mismatch between regulations on living matter and regulations on food 
and feed. While, according to the Norwegian Gene Technology Act, living matter is 
evaluated on criteria such as societal benefit, ethics and sustainability, these criteria 
are not considered in the Food Act which regulates food. Thus, food imports are not 
evaluated on the same criteria as domestic products. 
The panel expressed disappointment that some members of the expert panel pre-
sented their own judgment of the consensus report, and that they were not able to 
distinguish between normative and factual topics/discussions. 
Insights from experts: 
There is no evidence of adverse health effects of GM food, but knowledge is insuffi-
cient. On environmental effects, knowledge is almost non-existent. Views on the 
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appropriateness of a moratorium vary, the strongest arguments against a moratorium 
is that it would challenge WTO rules. Further, the risk for GM contamination is lim-
ited to imports, and controlling this is dependent on systems for screening and trac-
ing, rather than legal restrictions. 
Acceptance of GMOs can be seen as a combination of risk, benefit and moral accep-
tance. While risk and benefit are quantitative factors, moral acceptance is a qualita-
tive factor, constituting a veto. Opposition to GMOs up to 2000 can be based on per-
ceptions of low benefits, rather than perceptions of high risk. 
The Norwegian agricultural sector, including farmer unions and cooperatives, are 
sceptical towards GMOs, and practice a self-imposed restriction. This is based both 
on internal attitudes, but also on the lack of confidence among consumers. Although 
certain producers may be tempted to consider GM products, experiences with growth 
hormones and foreign cattle breeds indicate that producers are generally sceptical to 
growth-enhancing technologies.  
Norwegians became more sceptical towards bio- and gene technology from 1996 to 
2000, and are relatively more sceptical than the average European. As long as the 
consumers are sceptical, both retailers and food processing businesses try to avoid 
such products – also from imports. Thus, GM production is disadvantageous to Nor-
wegian interests. Regulations that can be trusted by all parties will be advantageous. 
To control products, methodology to reveal GM contamination is necessary. It is also 
necessary to establish a system of traceability to control products based on GM but 
where there are no trace of transgenes in the end-product. However, who shall pay 
for a system of traceability? If the businesses shall cover such expenses, can this be 
something that only the major actors can afford? 
IMPACT AND FOLLOW UP OF THE PROJECT 
The project got overall good coverage by the press and mass media and was looked 
upon as a valuable contribution in the further public debate. The project was de-
scribed in detail in the Norwegian biotechnology journal “Genialt”, published by the 
Norwegian Biotechnology Advisory Board. Furthermore the facilitators were invited 
to present the major conclusions and recommendations from the project in the Nor-
wegian Parliament on January 18th 2001.  
In recent years, several of the challenges identified during the project (see under-
neath) have been met by the Norwegian Government. At present, routines for analys-
ing imported food and feed for GM content are in place and running, legislation for 
traceability and labelling are established and there is a high degree of legislative 
harmonization. 
CHALLENGES IDENTIFIED IN THE PROJECT 
(The panel identified a number of challenges. The reviewer is not in a position to 
judge to what extent these challenges have been met through recent developments.) 
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> Systems for screening GMOs for adverse effects must be developed 
> Systems for controlling GM-contamination must be developed. Existing schemes 
often only indicate GM-contamination, they cannot prove such contamination. 
> Systems for labelling and traceability must be developed.  
> Laws and regulations must be coordinated at the international level. 
While health effects can be expected to be the same across regions, environmental 
effects may vary. Therefore, there is a higher need for independent Norwegian stud-
ies on environmental effects. 
LITERATURE 
Bioteknologinemnda, Forskningsetiske komiteer and Teknologirådet (2000): 
Oppfølgingskonferansen om Genmodifisert mat. Genialt nr. 4/2000. Web: 
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PUBLIC MEETING ON COEXISTENCE (2004) 7.2 
BACKGROUND OF THE PROJECT 
The Norwegian Biotechnology Advisory Board (NBAB) arranges a number of 
meetings and seminars to strengthen public reflection and debate on GMOs and 
to prepare hearings and statements on policies. 
BASIC DATA ABOUT THE PROJECT 
The meeting was held on 29th of April 2004. There were 94 participants, including a 
mixture of stakeholders, government officials and experts, with only a few lay peo-
ple. The project did not intend to build consensus. Thus, outcomes presented under-
neath do not represent common understandings. 
The debate covered the following topics: 
> Case-study on gene flow between GM crops and their relatives – the case of ca-
nola 
> Potential for gene flow in important crops for Norwegian agriculture 
> Possible practical measures to reduce gene flow 
> Possible political measures to minimize gene flow 
> Specific co-existence challenges for organic agriculture 
> Co-existence: strategies in a feed company 
> How to ensure GM-free feed imports 
> How to ensure GM-free seed 
The presentations and key comments are documented in a report based partly on 
documents submitted by participants, and partly on transcripts from recordings. 
MAJOR OUTCOMES OF THE PROJECT 
Closing remarks: 
> New regulatory frameworks for co-existence should not be used as a political in-
strument to introduce GM crops, but also to secure GM-free production. 
> Co-existence is not only about biology, but also a question of commercial inter-
ests and economic compensation. Central stakeholders believe that the “polluter 
pays-principle” should apply and that the burden of proof should be placed on the 
producer.  
Comments from participants (given without consensus): 
> EU-regulation on co-existence is tailored to give consumers a choice. However, 
believing that GM may allow for choice may prove naïve. Separation measures ei-
ther in cultivation or in transport and processing may be prohibitively expensive, 
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thus one type of farming will be harmed if the other is allowed. Which side to 
loose is a political question – and this should be what regulation is all about. 
> Producers, feed industries etc. want to follow a restrictive line, but these sectors 
are dependent on imports of seed and feed. Imports from countries outside EEA 
raises particular challenges: Which can guarantee GM-free products? Can there be 
conflicts b/w objective of avoiding GM and other objectives such as contributing 
to income generation in developing countries? 
> Norwegian producers, including fish farmers, avoid using GM feed because of 
consumer demand. However, this is not displayed on the final products. Wouldn’t 
it be to farmers own interest to establish systems of labelling? 
Perspectives on gene flow 
The challenge of separation is not entirely new as organic products are already han-
dled separately from conventional. However, the challenge of handling gene flow 
between crops/crop rotations is new. 
There are a number of criteria on which the likelihood of gene flow can be evaluated. 
Gene flow through pollen is related to degree of out-crossing. The likelihood of gene 
transfer vary, dependent, inter alia, on the occurrence of related crops nearby. It also 
depends on whether the traits give a fitness advantage (for instance pest tolerance). 
Further, pollen flow is of highest concern when the seeds are the harvest of interest. 
For many vegetables, grasses etc., pollen flow is less relevant. Mitochondrial and 
chloroplastic DNA is not transferred with pollen, so transgenes within will be less 
susceptible to gene flow.  
Particular challenges to particular sectors, some are also particular to Norway:  
> For aquaculture, there is a challenge that soy meal and oils is gaining importance 
but GM-free soy is limited. On the other hand, the combination of fatty acids of 
today’s soy is not entirely suitable for aquaculture – a challenge that could be 
solved by GM. Aquaculture therefore faces particular challenges in relation to 
GM feed, first by securing GM-free soy, and second by being tempted to adopt 
GM feed. 
> In conventional agriculture, the strong position of agricultural cooperatives, 
alongside a high degree of regulation, favour a standard approach shared by 
neighbouring farms. 
> Organic agriculture may have a higher diversity – both intentional and uninten-
tional (weeds). This may allow them to be sinks of GM-volunteers – especially for 
Bt-crops and other GM-crops that may have a fitness advantage. 
IMPACTS AND FOLLOW UP OF THE PROJECT 
Insights from the meeting have been communicated in relation both to the develop-
ment of general regulation, and in relation to specific submissions for deliberate re-
lease. The meeting marked the opening of the debate on co-existence in Norway. 
After the meeting, researchers and experts have been mandated to draft a bill for co-
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existence, addressing crucial issues such as the risk for gene flow in different crop 
species, systems for compensation, and the right to information about GM fields. 
CHALLENGES IDENTIFIED IN THE PROJECT 
(Remaining challenges, based on judgments by the reviewer)  
> What are the defining differences between GMOs and non-GMOs? The tech-
nology that is applied, or the traits that the organisms carry? While it is the 
(potentially harmful) traits that one wants to control, the regulations are de-
fined by the techniques employed. 
> Which properties/practical measures can reduce risk for gene flow? Can for 
instance mitochondrial/chloroplastic transgenes pose lower risk, thus be 
treated differently from regular transgenes? 
> Systems for accountability, liability and compensation. 
> The issue of organic farming becoming a sink of transgenes must be examined, 
including legal and economic aspects. 
> Imports of meat, and of feed from 3rd party countries, increase likelihood of 
meat based on GM feed. This could create an urge for a labeling system for 
such products. However, should this be a mandatory labeling of meat based 
on GM feed, or should it be voluntary labeling of non-GM meat? 
LITERATURE 
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EVALUATING THE CRITERIA OF SUSTAINABILITY AND 
SOCIETAL IMPACTS IN RELATION TO GM FOOD –  
THE WORK OF THE NORWEGIAN BIOTECHNOLOGY 
ADVISORY BOARD 7.3 
BACKGROUND AND BASIC DATA 
GM food on the market today is partly consisting of living entities, for instance intact 
corn grains or entire fruits or vegetables (containing viable seed). In Norway, such 
commodities must be evaluated not only in the food legislation context, but also in 
relation to the act relating to the production and use of genetically modified organ-
isms. This act strongly emphasizes that the deliberate release of genetically modified 
organisms (GMOs) should have no detrimental effects on either health or the envi-
ronment (at the same taking into account that we are not living in a risk-free society). 
This emphasis is fully in line with the legislation of other nations concerning the 
regulation of GMOs. Distinct from the regulations of most other nations, however, 
the Norwegian Gene Technology Act also stresses that the deliberate release of such 
organisms should represent a “benefit to the community” and enable “sustainable 
development”. In general, the GM applications under directive 2001/18/EC or regu-
lation 1829/2003 do not contain information that makes such a comprehensive GMO 
evaluation process possible. 
It is not self-evident how “sustainability” and “benefit to the community” should be 
considered in terms of the practical application of the Act. The Norwegian Biotech-
nology Advisory Board is appointed by the Norwegian government with a mandate 
to give advice on these additional requirements.  
The Norwegian Biotechnology Advisory Board 
The Norwegian Biotechnology Advisory Board (NBAB) is an independent body 
established in 1991. The Board is founded in the Act relating to the application of 
biotechnology in medicine and the Act relating to the production and use of geneti-
cally modified organisms. The Board consists of 21 members, including 13 persons 
mandated by the government, and 8 persons mandated by different organisations. 
Representatives of six ministries have observer status. The Board’s secretariat has 
seven to eight employees. 
The main tasks of the NBAB are to identify and examine the ethical questions raised 
by applications of modern biotechnology on humans, animals, plants and microor-
ganisms and to provide advice that can assist policy-making and stimulate public 
debates on the issues. The Board gives recommendations both concerning the devel-
opment of general regulation, and in relation to specific submissions for deliberate 
release. 
The work of NBAB can be described as a form of technology assessment done by a 
standing expert committee, with a specific emphasis on sustainability and societal 
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impacts. The activities involve meetings, dissemination, statements etc. Statements 
and advice are generally not based on consensus, but on majority votes. 
This document explores how the NBAB interprets and addresses the issues of sus-
tainability and societal impacts. The text is based primarily on conclusions from ac-
tivities that were dedicated to discuss these issues broadly. However, insights from 
statements and advice in specific cases are also included. 
MAJOR OUTCOMES OF THE PROJECT 
The Norwegian Biotechnology Advisory Board finds that it is not clear whether the 
provisions relating to “benefit to the community” and “sustainable development” are 
to be considered as additional requirements or as a softening-up of the requirement 
for non-detrimental effects on either health or the environment. “Sustainable devel-
opment” and “benefit to the community” can be understood as either: 
> additional requirements to the absence of detrimental effects on health and the 
environment; or 
> a softening-up of the requirement of non-detrimental effects; or 
> an additional requirement that alone could be sufficient grounds for refusing ap-
proval or for a softening-up of the requirement of non-detriment. 
According to the first alternative, the requirement would be that, in addition to hav-
ing no detrimental effects on health and the environment, the “deliberate release 
represents a benefit to the community and a contribution to sustainable develop-
ment”. If the deliberate release fails to fulfil this requirement, the recommendation 
would be to reject an application for approval. Under this alternative, any softening-
up of the requirement of non-detriment would be impossible.  
The second alternative does allow for the approval of deliberate releases even when 
the possibility of detrimental effects on health and the environment have been estab-
lished, if it can be demonstrated or argued that the “deliberate release represents a 
benefit to the community and a contribution to sustainable development”. Conse-
quently, the requirements of “sustainable development” and “benefit to the commu-
nity” are being used as an opportunity for softening up or counterbalancing the re-
quirement of non-detriment, but may not be applied as an additional requirement that 
alone could be sufficient grounds for rejecting an application for approval. 
In the third alternative, the requirement of “benefit to the community” and/or “sus-
tainable development” could constitute independent grounds for rejecting an applica-
tion for approval. Furthermore, “sustainable development” and “benefit to the com-
munity” can be used to soften up the requirement of non-detriment. This could be 
considered as a combination of the first two alternatives and is the alternative the 
NBAB judges to be the best interpretation of the Act. 
In the opinion of the NBAB, the Norwegian Gene Technology Act should be inter-
preted to mean that the requirements of “sustainable development”, “benefit to the 
community” and other “ethical and social considerations” represent prerequisites that 
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alone could carry decisive weight against granting an application, but that should 
also be considered in relation to, and weighed against the risk of detrimental effects, 
when such risk is low. 
Hence, an assessment of an individual GM application (also GM food, se above) will 
have the following structure: 
1) Danger of detrimental effects on health and the environment: 
> what are the possible negative consequences? 
> what is the likelihood of such consequences occurring? 
2) The precautionary principle: 
> is the risk assessment associated with justified uncertainty? 
> is there a possibility of substantial or irreversible harm? 
3) Is it: 
> in compliance with the principle of “sustainable development”? 
> of “benefit to the community”? 
> “ethically and socially justifiable”? 
Sustainable development 
“Sustainable development” could be said to build on a series of ideas, including the 
following: 
> the idea of the global effects of human activities; 
> the idea of ecological limits and that these limits have been exceeded in several 
areas; 
> the idea of meeting basic human needs; 
> the idea of just distribution between generations; 
> the idea of just distribution between wealthy and poor nations; 
> the idea of a new form of economic growth. 
This final point indicates that it is not a matter of just any form of economic growth. 
On the contrary, two types of qualification are required. Firstly, it should be eco-
nomic growth involving an absolute – and not only a relative – efficiency improve-
ment in the use of energy and other natural resources. Secondly, this economic 
growth must entail a more balanced distribution between poor and wealthy nations. 
The six points listed above can serve as a structure for assessing whether the deliber-
ate release of a genetically modified organism is in compliance with the requirements 
of “sustainable development”. The same type of checklist questions could be asked 
for each of these points as those considered when assessing health and environmental 
risks and the precautionary principle. The responses to and the discussion of all the 
questions would, in this case, provide an overall picture of the extent to which there 
is compliance or non-compliance with the requirements set. 
Furthermore, a clarification of the relationship between biodiversity (i.e. diversity of 
genes, species and ecosystems) and ecological sustainability is needed. Effects on 
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biodiversity would be assessed in relation to detrimental effects on health and the 
environment and the precautionary principle, thus be included in standard assess-
ments also within the EU. However, relating biodiversity to the question of “sustain-
able development” implies a shift of focus in time and space. Assessments of the 
possible detrimental effects on health and the environment refer primarily to local, 
regional and national contexts. Assessments of the issue of “sustainable develop-
ment” apply globally and also, to a longer time span (generations). When diversity is 
reduced, humankind’s opportunities of promoting “sustainable development” are 
reduced accordingly. Preserving biodiversity represents a form of long-term life in-
surance – for the existence of species, ecosystems and humankind. Another aspect 
worth underlining is the type of ethical assessments associated with the notion of 
intrinsic value. The concept of “sustainable development” encompasses two different 
types of intrinsic value. The first is nature’s own intrinsic value; the second applies to 
certain forms of humankind’s absolute intrinsic value. In the opinion of the NBAB, 
assessments of this kind might be more usefully made in relation to the issue of 
“other ethical and social considerations” and not in relation to the issue of “sustain-
able development”. 
Global effects 
> Is biodiversity affected on a global scale? 
> Is the functional capacity of ecosystems affected? 
> Do these effects differ between production and use? 
Ecological limits 
> Is the efficiency of energy use affected? 
> Is the efficiency of other natural resource use affected? 
> Is the distribution between the use of renewable and non-renewable natural re-
sources affected? 
> Are discharges of pollutants with a global/transboundary range affected? 
> Are emissions of greenhouse gases especially affected? 
> Do these effects differ between production and use? 
Basic human needs 
> Is the fulfilment of basic human needs affected? 
> Do these effects differ between production and use? 
Distribution between generations 
> Is the distribution of benefits between generations affected? 
> Is the distribution of burdens between generations affected? 
> Do these effects differ between production and use? 
Distribution between rich and poor 
> Is the distribution of benefits between rich and poor countries affected? 
> Is the distribution of burdens between rich and poor countries affected? 
> Do these effects differ between production and use? 
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Economic growth 
> Is economic growth’s demands on energy and other natural resources affected? 
> Are economic growth’s global/transboundary environmental impacts affected? 
> Is economic growth’s distribution between rich and poor countries affected? 
> Do these effects differ between production and use? 
Comment 
Compliance with the requirements of “sustainable development” will have to be 
based on an overall assessment and discussion of all these questions. However, not 
all the questions above may be relevant in all cases. 
Benefit to the community 
As mentioned above, the concept of “benefit to the community” appears in the Gene 
Technology Act as one of several criteria for granting an application. It is, in any 
case, a complex concept, for which neither the Act itself nor its legislative history 
provides any clear guidance as to how it should be understood. In the current context, 
the NBAB has opted for a relatively pragmatic approach, and try to ask some “check-
list questions” that may be relevant: 
Product characteristics 
> Is it reasonable to say that there is a need for the product in terms of demand or 
otherwise? 
> Is it reasonable to say that the product will solve or possibly contribute to solving 
a societal problem? 
> Is it reasonable to say that the product is significantly better than equivalent prod-
ucts already on the market? 
> Is it reasonable to say that there are alternatives that are better than the product in 
terms of solving or possibly contributing to solving the societal problem in ques-
tion? 
Production and use of the product 
Among the relevant aspects to be considered are: 
> Does the product contribute to creating new employment opportunities in general 
and in rural areas in particular? 
> Does the product contribute to creating new employment opportunities in other  
> countries? 
> Does the product create problems for existing production whose existence should 
otherwise be preserved? 
> Does the product create problems for existing production in other countries? 
(This list of questions is not meant to be exhaustive, but is meant primarily to serve 
as an indication of the type of questions that should be considered). 
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Comment 
Any assessment of benefit to the community must be based on a discussion of the 
responses as a whole. However, it should be emphasized that every question may not 
be equally relevant in all instances. 
IMPACTS AND FOLLOW UP OF THE PROJECT 
The statements made by the NBAB are generally regarded as high impact contribu-
tions by the competent authorities. Such statements are publicly available and quite 
often they spark a public debate. The statements are communicated to the decision-
makers both through letters and by regular meetings, as the decision-makers have 
status as observers during the relevant NBAB discussions. NBAB is planning a con-
ference on sustainability and GMOs late in 2007.  
CHALLENGES IDENTIFIED IN THE PROJECT 
Operationalizing the criteria of sustainability and societal benefit in relation, for in-
stance, to specific submissions for deliberate release, remains challenging. Even 
more challenging than defining the “checklists”, is to access relevant information 
regarding the products. As Norway appears to be unique in using these criteria, sub-
missions within the EU do not generally include relevant data. And so far, applicants 
do not seem to find it worthwhile to provide such data just for Norway. Without 
relevant documentation, Norway cannot fully undertake the relevant assessments, 
and thus, based on this lack of information, Norwegian authorities may end up not 
authorising a given product. However, the EU might not consider such terms legiti-
mate to reject an authorisation, which could be necessary under Norway’s commit-
ment as member of the EEA. Thus, a number of questions regarding the harmoniza-
tion of regulation within the EU/EEA remain. 
As described above, there also remains a question of whether criteria of sustainability 
and societal impacts should be interpreted as additional requirements to the absence 
of detrimental effects on health and the environment; or as a softening-up of the re-
quirement of non-detrimental effects. 
LITERATURE: 
Linnestad, Casper (ed) (2003): Sustainability, benefit to the community and ethics in the 
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SWITZERLAND 8. 
PUBLIFORUM »GENETIC TECHNOLOGY AND NUTRITION«  
(1999) 8.1 
BACKGROUND OF THE PROJECT 
The PubliForum on Genetic Technology and Nutrition took place in 1999, under the 
lead of the Swiss Centre for Technology Assessment, referred to below as TA-
SWISS. This centre has been set up in 1992 by the Swiss Parliament and is attached 
to the Swiss Council for Science and Technology. Its mission is to support the politi-
cal decision-making process, firstly by carrying out expert analyses, and secondly by 
canvassing the opinions of the citizens themselves through participatory projects. 
The PubliForum on Genetic Technology and Nutrition was the second participatory 
project ever organised by TA-SWISS13. 
The aim of the PubliForum on Genetic Technology and Nutrition was to set up an 
encounter between the people actively involved in the development of genetic tech-
nology (i.e. scientists, but also industry, public authorities and NGOs) and the public. 
Genetically modified organisms (GMOs) had already been extensively discussed 
about a year before, as Swiss citizens had to vote on an initiative demanding a halt to 
genetic engineering in Switzerland (the “initiative for genetic protection”). During 
the political campaign preceding the vote, all of the interested parties involved de-
bated the issue at great length, but the fact that the rules of the game did not allow for 
a win-win situation (voters had to answer “yes” or “no”) meant that it was difficult to 
get a real dialogue going. For the PubliForum on genetic technology in nutrition, the 
rules of the game were changed, to allow for win-win situations. The inclusion of 
ordinary citizens in the process would then provide greater awareness of their wishes, 
alternative solutions and needs. It would also provide an opportunity to learn about 
their argumentation patterns: how did they perceive and understand the implications 
of genetic technology in nutrition, what were their hopes and fears, and on which 
basic values and standards did they judge the issue?  
Discussing these questions was considered as crucial, as the debate on GMOs was, at 
that time, far from being closed. As a matter of fact, when the Initiative for Genetic 
Protection had been first discussed by Parliament in 1996 and 1997, the Federal As-
sembly charged the government to fill all juridical gaps regarding genetic engineer-
ing in the non-human domain (Motion GENLEX). At the time of the PubliForum, 
government was working on this adaptation of the legislation14. 
                                                 
13 TA-SWISS has been undertaking participatory projects since 1998.  
14 The Swiss government presented its conclusions regarding the GENLEX motion in 
2000, in form of a modification of the Law on environmental protection. This govern-
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BASIC DATA ABOUT THE PROJECT 
The PubliForum on Genetic Technology and Nutrition is a participatory project, us-
ing the “consensus conference” model developed by the Danish Board of Technol-
ogy. This model has been adapted for the multilingual reality of Switzerland: instead 
of 15 citizens being invited to discuss the effects of new technologies, about 30 citi-
zens from all parts of the country were invited to discuss and an interpretation ser-
vice has been offered so that each participant could use their own language. All in 
all, the citizens met three times: 
> In a first preparatory week-end, participants could meet and get to know each 
other, familiarize with the working method and inform themselves about the sub-
ject implications of genetic technology in food and plants. They also selected 
those aspects which they wanted to investigate more closely during the PubliFo-
rum. 
> At the second preparatory weekend, the panel members defined their questions 
more clearly and chose the information persons who were to reply to these ques-
tions during the main PubliForum session. Their questions were related to re-
search, environment, health, ethics and economics.  
> The actual PubliForum lasted three days. During the first two days, which was 
open to the public, the information persons answered the questions of the citizen 
panel. Then the panel went behind closed doors and had 24 hours to draw up a re-
port.  
In order to create an as neutral as possible framework for the PubliForum, an accom-
panying group had been formed consisting of representatives from industry, research, 
administration, media, politics and various non-governmental organisations (NGOs). 
This accompanying group had the task of putting the content of the PubliForum into 
concrete terms and to make sure that the preparation and realisation of the event took 
place in an as balanced as possible way. The accompanying group was also responsi-
ble for the preparation of information sheets meant to help the Citizen Panel familiar-
ise themselves with the subject. Another assignment was that of helping find refer-
ence persons to answer the questions and, finally, influence could be made on the 
composition of the Citizen Panel. 
MAJOR OUTCOMES OF THE PROJECT 
In its report, the Citizens’ Panel acknowledged that today's level of scientific knowl-
edge does not permit the existence of specific risks resulting from genetically modi-
fied organisms to be ruled out. And, as one cannot quantify these risks, the Panel was 
not in a position to make any judgement on their acceptability. Half of the Panel, 
                                                                                                                                          
mental proposal addressed many issues, such as biodiversity preservation, civil responsi-
bility regarding GM crops, authorization procedures and the introduction of a declara-
tion for GM products. But the Parliament, after having examined this proposal, decided 
to write a specific law on genetic engineering. It took more than two years of political 
debate for the Parliament to come to a final text. 
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however, was of the opinion that genetic technology is an encroachment on life-
processes, whereas the other half saw no difference between genetic technology and 
traditional production methods. This gap could be seen in the notion of imposing a 
moratorium on the production and marketing of genetically modified organisms15, 
which was endorsed only by a slender majority of the Panel. Despite these differ-
ences of opinion, the Citizens’ Panel agreed that freedom of choice for consumers 
should be maintained and that GMOs should thus be clearly labelled. It also de-
manded more research on risks and monitoring studies and showed some concern 
about the financial independence of public research. 
IMPACTS AND FOLLOW UP OF THE PROJECT 
The PubliForum on genetic engineering in nutrition caught a great deal of attention 
of the media and political groups, mainly for its proposal of a moratorium made by 
the Citizens’ Panel. TA-SWISS could also present the PubliForum’s results in the 
Parliamentary commission for science, education and culture. Many articles also 
were published in specialized magazines and journals. 
Interestingly, what was a minority position at the time of the publication of the re-
sults of the PubliForum (the idea of a moratorium was in fact only defended by 
ecologists groups) became, with time and the support of farmers’ representatives 
(who became conscious, through the PubliForum and other surveys, that consumers 
didn’t want to consume GMO crops), a potentially majority position. Indeed, during 
the discussions on the new law on genetic engineering by the relevant Parliamentary 
Commission, a slender majority amended the law with a moratorium of 5 years (ex-
cluding field trials for scientific purposes). This proposal was ultimately rejected in 
the final vote in Parliament, where the Commission’s slender majority was unable to 
gain enough support for its proposal. Interestingly, groups in favour of a moratorium 
tried a second time to anchor a 5-year moratorium on GMOs in Swiss legislation. 
This time, they tried to integrate it in the agriculture law, which was revised in 2003. 
And for a second time, they just failed16. Parallel to all these parliamentary debates, 
environmental groups, consumer associations and farmers group have launched an 
Initiative demanding a five-year moratorium on the farming GM crops for use in 
food (the use of GM crops for research purposes would be authorized under strict 
conditions). The group collected over 120’000 signatures in only seven months17. 
This initiative was contested by the government and Parliament (whereas a minority 
of the representatives had been supporting it), as well as by research and industry 
                                                 
15 Clearly defined field trials (specifically by public institutions) should, however, be per-
mitted and supervised in order to obtain extended knowledge on any risks. 
16 The proposal was in fact accepted by the lower chamber of the Parliament (National 
Council), but rejected by the upper chamber (State Council). In an ultimate vote, the 
lower chamber decided to align its position to that of the State Council in order not to 
bring down the whole revision. 
17 To be valid, an initiative must be supported by 100’000 citizens and have to be found in 
a period of 18 monthes. 
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representatives. In November 2005, 55.7% of the Swiss citizens accepted the initia-
tive demanding the five-year moratorium18.  
CHALLENGES IDENTIFIED IN THE PROJECT 
In its report, the Citizen’s Panel gave its opinion on several topics and formulated 
several recommendations. From these, we can consider that the challenges for GM 
plants and food, seen from a citizen perspective, are the following: 
> The freedom of public research must be guaranteed and public funding should 
remain assured. 
> The current supervisory mechanisms are sufficient, but citizens call for an intensi-
fied dialog between the general public and research. 
> GMO-specific risks cannot be ruled out. Therefore, monitoring is absolutely nec-
essary, in order to be able to estimate risk potential in a better way. 
> Switzerland needs to have trained personnel, able to carry out monitoring research 
into GMOs.  
> Backing out of genetic technology in the sense of a unilateral Swiss policy doesn’t 
seem to be an option any more, since this would lead to important economic dis-
advantages, primarily in the Swiss research area and secondarily because of the 
dependence of Switzerland on imported raw materials, which could in the future 
contain GMO-components. Nevertheless, the question on how far a need for the 
use of genetically modified organisms exists in Switzerland must be answered. 
> The existence of traditional, genetic-technology-free agriculture as well as organic 
farming must be guaranteed, in order to provide consumers with a free choice, 
both today and in the future. Moreover, instead of GMO production, organic 
farming could be a chance for Switzerland, as at the moment of the PubliForum 
no contamination is to be feared. 
> The smaller seed producers may disappear in the long term because they will not 
be able to compete with large multi-national industry, which would mean that de-
pendence could develop.  
> The patenting of living organisms is for many of the members of the panel not 
acceptable. On the other hand, patenting creates more transparency, as the appli-
cant has to publish his research results before the patent is granted. It is also un-
derstandable that the high costs of research have to be made to pay for themselves 
somehow. 
> The unequivocal tracing of damage back to a GMO is very difficult. If such evi-
dence exists, it must in all cases be possible to prosecute those responsible (e.g. 
the producer). 
                                                 
18 A survey conducted just after the vote showed that among those who voted against the 
initiative, 13% were actually convinced to vote against gene technology. In other 
words, these persons didn’t correctly understand that the question they had to answer 
(“do you agree or not with the initiative and, eventually, the initiative should have been 
accepted by about 68% of the voters – an extremely high score for a popular initiative 
(Hirter and Linder 2006). 
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RIBIOS FORUM »THE FUTURE OF PLANT 
BIOTECHNOLOGY IN SWITZERLAND« (2003) 8.2 
Excerpts from the report: “The Future of Plant Biotechnology in Switzerland”, Les 
Cahiers du RIBios, No7 
BACKGROUND OF THE PROJECT 
The Forum entitled « The future of plant biotechnology in Switzerland » took place 
at the University of Lausanne on November 3rd, 2003. It was jointly organised by 
the RIBios (Biosafety Interdisciplinary Network, based at the Graduate Institute for 
Development Studies of the University of Geneva) and by the Interface sciences-
société of the University of Lausanne.  
The aim of this Forum was to bring together stakeholders involved in the decisions 
about experimental field releases of transgenic plants in Switzerland.  
BASIC DATA ABOUT THE PROJECT 
The participants of the Forum were representatives of three main groups of stake-
holders: public scientists involved in plant biotechnology research, the governmental 
bodies involved in the decision-making process, and other institutions directly in-
volved in science policy at the national level. All the participants had been invited 
personally, in order to make clear that they should speak in their own name rather 
than in their institution’s name. This sensitive issue was dealt with by agreeing with 
the participants that no material would be published on the content of the debates 
without their prior review of the documents. 
Before the forum, the participants received a position paper written by the organisers. 
This paper was divided into six sections corresponding to important topics that 
would be discussed during the forum. It was aimed at giving some factual informa-
tion, but also some analytical overview to stimulate the debate.  
The forum lasted one day. The debates were organised by topics. In the morning, 
three questions were discussed: «Risk negotiation», «Coordination at the level of 
assessment and decision» and «Coherence between research and environment poli-
cies». In the afternoon the debates focused on «“Socially robust” research policies», 
«Biotechnological research in Switzerland» and «Decision-making under uncer-
tainty: the controversial implementation of precaution». 
The organisers decided to adopt a non-directive strategy for the debate regulation. 
Three persons were assigned to that task. One was in charge of handing over to the 
participants and to keep the schedule. The two other persons acted as facilitators by 
introducing factual or analytical elements pertinent to the debate, and by redirecting 
the discussion when it was clearly out of the topic of this forum. 
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MAJOR OUTCOMES OF THE PROJECT 
Following the forum, a document restituting the main discussed points have been 
published in the “Les Cahiers du Ribios”. The core of the text is made of partici-
pants’ quotations, which are introduced by a short summary. 
CHALLENGES IDENTIFIED IN THE PROJECT 
The richness and diversity of the discussions during the forum show that many open 
questions are remaining with respect to research on GMOs. The lecture of the report 
shows that there is a certain frustration from the side of researchers, or at least a dif-
ficulty to cope with the social and political dimension of the issue. 
CHALLENGES IDENTIFIED WITH RESPECT TO PUBLIC RESEARCH: 
> To regain the public’s confidence, it is necessary to define research priorities that 
correspond to agronomical problems which have been clearly identified and 
which benefit from political support. 
> The distinction between fundamental and applied research must be taken into con-
sideration. There is a sharp difference between commercialisation and experimen-
tal releases. The frontier between these two facets of research is nevertheless dif-
ficult to draw. This distinction is however important as soon as risk assessment is 
concerned. The standards and procedures used in the assessment do indeed de-
pend on the nature of the trials, experimental or commercial.  
> The position of Switzerland on the international scene in terms of knowledge and 
competitiveness in plant biotechnology is an issue to consider. There is a risk to 
see the competitiveness of Switzerland in the field of plant biotechnology de-
crease, as a result of industrial delocalisations and disinterest on behalf of stu-
dents. While Switzerland has still a good knowledge base in the field of plant bio-
technology, research is locked in, in part because of the difficulty to make field 
tests experiments. 
> Research is facing important economical, political or administrative constraints. 
These difficulties have prevented researchers from accumulating the knowledge 
needed to perform an adequate risk assessment of the plants under development. 
> The time lag between the application for an experimental release and the decision 
of the authority may be incompatible with the scientific rationale. 
CHALLENGES IDENTIFIED WITH RESPECT TO RISKS: 
> Rather than talking about the risks of doing research, one should also take into 
account the potential benefits, namely benefits that will derive from this research 
in the future but are still not known. In other words, the risks of doing research 
should be balanced with the risks of not doing it. 
> Risks related to a new technology such as GMOs must not be discussed in isola-
tion but rather in comparison with the risks of the technology it is replacing. 
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CHALLENGES IDENTIFIED WITH RESPECT TO PUBLIC DEBATE: 
> The perception of risk by the public may sometimes be irrational. Risks related to 
GM food are typically over-estimated in comparison to other risks. 
> Some participants pointed out the fact that communication policies have not been 
able until now to reverse this trend, and thus generate a positive picture of plant 
biotechnology in the public. 
> It is more difficult to find support in the public for innovation, than to exploit the 
fears of the public related to these innovations. 
> There is clearly a lack of communication in the field of plant biotechnology. The 
scientific community should do more grassroot work. However, the social accept-
ability of GMOs does not onlydepend on the level of information. In other words, 
more information does not necessarily end up with more people accepting the 
technology: 
> There is a need to find new forms of public debate. Moreover, people and groups 
concerned by new technologies shoudl be included upstream (i.e.when a technol-
ogy is still at the stage of research), so as to make research policies “socially more 
robust”. 
CHALLENGES IDENTIFIED WITH RESPECT TO DECISION-MAKING PROC-
ESSES: 
> There is a risk that scientific arguments are “instrumentalised” by political au-
thorities in the decision-making process. 
> Science should be more able to recognize the limits of its knowledge. This would 
surely be a way to improve society’s confidence in science. 
> Any decision in the field of risk mangement is somehow political, since a zero 
risk level is not achievable. Political decisions consist therefore in determining an 
acceptable level of risk: 
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REPORT ON THE COEXISTENCE OF DIFFERENT GM 
 AND NON-GM AGRICULTURAL CULTIVATION SYSTEMS 
(AGROSCOPE RECKENHOLZ-TÄNIKON RESEARCH 
 STATION ART, 2005) 8.3 
BACKGROUND OF THE PROJECT 
Worldwide GM0 cultivation is increasing year by year. Even though there is little 
likelihood of such cultivation in Switzerland at present, cultivation of GMOs in the 
future cannot be excluded. According to the Gene Technology Law (GTL), when 
GMOs are grown, non-GMO production and consumer’s freedom of choice must be 
safeguarded. So-called “coexistence” must be guaranteed by segregating production 
flows (Warenflussstrennung) during the whole productions chain (from the field to 
shelves of the stores), by regulations and by technical measures. In this respect, legal 
threshold values were defined because it is impossible to rule out mixing completely 
no matter how much care is taken. They specify the percentage of genetically modi-
fied material which can be included in food and animal feeds without having to label 
them as «genetically modified». In line with the EU, a threshold limit of 0.9% is set 
in Switzerland. This limit is for approved GM crops. For non-approved GM crops 
there is, theoretically, a zero-tolerance.  
Agroscope Reckenholz-Tänikon Research Station ART was commissioned by the 
Federal Office for Agriculture (FOAG) to carry out a study on whether GM and non-
GM agricultural systems in Swit-zerland can coexist from a scientific and technical 
point of view within the present legislative framework. Maize, wheat and oilseed 
rape were selected as model crops.  
BASIC DATA ABOUT THE PROJECT 
The aim of the project was to present a concept for a coexistence of GM and non-
GM cropping systems in Switzerland. In a first step mechanisms were analysed 
which can lead to a mixture of agricultural products during cropping. Subsequently, 
technical and organisational measures were listed which can minimize or prevent 
mixing. The study was limited to the agricultural production, i.e. from planting to the 
delivery of the harvest to storing or processing facilities. The cost of segregation of 
different cropping systems varies according to the specific biological characteristics 
of the crops and according to the level of segregation required. Three model crops 
(maize, wheat and oilseed rape) have been chosen as case studies to show what 
specific measures are needed in order to maintain the legally binding GMO threshold 
for food and feed.  
The study was entirely funded from the Agroscope Reckenholz-Tänikon Research 
Station own resources, with no third party funding that could have cast doubts upon 
their independence. The scientists based their statements on objective foundations.  
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MAJOR OUTCOMES OF THE PROJECT 
The investigations on the possibilities and limits of the «coexistence of GM and non-
GM cultivation systems in Switzerland» reached the conclusion that, with the requi-
site crop-specific distances, discussion and agreement between farmers, and careful 
segregation during product handling on the farm, the cultivation of GM maize, GM 
wheat and GM oilseed rape in Switzerland would be technically possible.  
This assessment was based on the threshold limit of 0.9 % GM content and covered 
cultivation up to the delivery of the harvested material at the collection point. Addi-
tional time and costs related to coexistence was not examined. The measures neces-
sary for coexistence are detailed in the “Schriftenreihe der FAL” No 5519. They are 
for example: 
> Usge of certified seed 
> Optimal soil preparation after the harvest and cultivation of non-GM crops before 
subsequent  GM planting. 
> The degree of out-crossing between fields with GM and fields with non-modified 
plants of the same species can be reduced through isolation distances and “buffer 
zones” between GM an non-modified crops.. Moreover, it is possible to avoid that 
cross-pollination happens at the same time. 
> The intermingling of GM and non-modified crops in various machines can be 
avoided by carefully cleaning them after having used them for GM-crop fields. 
> Segragation during harvest, transport, storage and processing of the crops, as well 
as a documentation of these processes is essential to minimize intermingling.  
IMPACT AND FOLLOW UP OF THE PROJECT 
In June 2005, a conference named "Coexistence of GM and non-GM crops - scien-
tific data, practical applications and perspectives for the next decade has been organ-
ised by the authors of the study. About 120 Swiss and international experts discussed 
the issue of coexistence (more info on the conference on: www.coexistence.ethz.ch/). 
The group took part in many other conferences dedicated to the issue of coexistence, 
in Switzerland or at the European level. But, at the time being, it doesn’t carry any 
project on the theme. 
In June 2006, The Federal Office for Agriculture adapted the legislation on coexis-
tence (ordinance on coexistence) and considered some elements analysed in the 
study. There is, however, no evidence on how far the study influenced the legislative 
process. 
                                                 
19 Study summary as pdf (http://www.reckenholz.ch/doc/en/publ/schrift/sr55vz.html): To 
order Study (http://www.reckenholz.ch/cgi-bin/sql/order.pl?ref=4&lang=en&sort=-
feld_0).  
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CHALLENGES IDENTIFIED IN THE PROJECT 
> How to guarantee coexistence? This implies regulatory, technical and organisa-
tional aspects. 
> The probability of intermingling depends on the biological properties of the vari-
ous plants. The necessity for coexistence measures must then be separately as-
sessed, for each cultivated plant. 
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COORDINATION MEETING OF INSTITUTIONS OFFERING 
BIOSAFETY-RELATED TRAINING AND EDUCATION 
PROGRAMS (2004) 8.4 
Excerpts from the “REPORT OF THE COORDINATION MEETING OF INSTI-
TUTIONS OFFERING BIOSAFETYRELATED TRAINING AND EDUCATION 
PROGRAMS”,(http://www.biodiv.org/doc/meetings/bs/bscmet-01/official/bscmet-
01-01-en.pdf) 
BACKGROUND OF THE PROJECT 
The first Coordination Meeting of institutions offering biosafety-related training and 
education programs was held 4-6 October 2004 in Geneva, Switzerland. It was or-
ganized by the Swiss Agency for Environment, Forests and Landscape (SAEFL) in 
collaboration with the CBD Secretariat, the UNEP/GEF Biosafety Unit and the Ge-
neva Environment Network.  
Thirty-seven (37) participants from 28 institutions attended the meeting, including 
representatives from academic and other organizations. The participants came from 
all over the world (Belgium, Namibia, Switzerland, Mexico, New Zealand, USA, 
England, Netherlands, China, Kenya, Norway, Cuba, Thailand, Canada, Austria, 
Chile, Italy, Japan). 
The meeting was a follow-up to the offer made by the Government of Switzerland at 
the first meeting of the Conference of the Parties serving as the meeting of the Parties 
to the Cartagena Protocol on Biosafety (COP MOP). In its decision BS-I/5 on capac-
ity-building, the COP-MOP emphasized the need for a coordinated approach towards 
capacity-building at all levels and accordingly established a Coordination Mecha-
nism to promote partnerships and maximize complementarities and synergies be-
tween various capacity-building initiatives contributing to the effective implementa-
tion of the Protocol. In this regard, the Government of Switzerland offered to sponsor 
a coordination meeting for representatives of academic and research institutions ac-
tively involved in education, training and research programs in biotechnology and 
biosafety in the autumn of 2004. The Swiss Government contracted RIBios – Réseau 
Interdisciplinaire Biosécurité – (Biosafety Interdisciplinary Research Network), 
which is part of Institut Universitaire d’Études du Développement (IUED), to organ-
ize the meeting. 
The primary objective of this meeting was to bring together representatives of insti-
tutions involved in biosafety training and education to share information and com-
pare notes regarding their ongoing programs and to learn more about the about the 
Protocol and the capacity-building needs and priorities for its effective implementa-
tion. The specific objectives of the meeting were: 
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> To review the current status (“state of the art”) regarding training and education 
programs in biosafety, including consideration of the draft compendium of exist-
ing programs; 
> To review the needs and priorities of countries and discuss ways and means for 
enhancing training and education programs to respond to those needs and support 
effective implementation of the Protocol; 
> To identify and discuss key components of biosafety training and education pro-
grams; 
> To explore mechanisms to enhance coordination, networking and collaboration 
among institutions offering biosafety training and education programs. 
BASIC DATA ABOUT THE PROJECT 
The agenda of the meeting consisted of two parts. The first part (day one) included 
presentations on: overview of the Cartagena Protocol and the COP-MOP decisions; 
the capacity building needs of countries and the role of training institutions in ad-
dressing those needs; the experience from the UNEP-GEF projects on capacity-
building in biosafety and overview of the draft compendium. These were followed by 
short presentations by participants on their ongoing and planned programs. 
The second part of the meeting included three plenary session discussions and one 
session of group discussions. The deliberations focused on the compendium; ways 
and means to improve biosafety training and education programs to address the 
needs of different target audiences; possible mechanisms for future networking/ col-
laboration and the next steps. 
MAJOR OUTCOMES OF THE PROJECT 
Overall, the meeting was a big success. It provided the first opportunity for institu-
tions offering training and education in biosafety to meet and interact and laid a good 
foundation for their future collaboration and active involvement in biosafety proc-
esses at international, regional and national levels. 
The meeting represented an important first step in preparing education and training 
institutions to play an effective role in building capacity for effective implementation 
of the Cartagena Protocol on Biosafety and other relevant instruments. It provided 
them with an insight into what the key training need are from the point of view of the 
countries that are now in the process of establishing and implementing their national 
frameworks and an the opportunity to learn more about what other institutions are 
offering and develop ideas for improving their programs. 
The main outcome of the meeting was the development of a common format (ques-
tionnaire) for the compendium of existing biosafety training and education programs. 
The meeting also developed a set of draft recommendations for consideration by 
COP-MOP, governments, education and training institutions and other stakeholders 
in order to enhance biosafety training and education in support of the Protocol im-
plementation.  
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IMPACT AND FOLLOW UP OF THE PROJECT 
No concrete action has been implemented after the coordination meeting. Neverthe-
less, the meeting created a dynamic, in the sense that Malaisia University decided to 
organise a second meeting in April 2007, in Kuala Lumpur. The RIBios network 
(which organised the first meeting) will be participating and hopes that it will be able 
to interact and create synergies with african universities, so as to establish education 
programmes on biosecurity. 
CHALLENGES IDENTIFIED IN THE PROJECT 
While the meeting had resulted in fruitful deliberations, it also raised many new im-
portant questions. For example, questions were raised regarding: 
> how to effectively to involve the newly trained experts in biosafety activities of 
their own countries;  
> how to insure the sustainability of the biosafety training and education programs,  
> how to mobilize adequate funding for biosafety training programs and for scholar-
ships to support students from developing countries;  
> how to insure the availability of technical infrastructure in all countries for the 
effective delivery of biosafety education and training programs and  
> how to fill the gaps in the existing courses. All these questions underline the ardu-
ous challenge ahead. 
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UNITED KINGDOM 9. 
PROJECTS SINCE 2000 
BACKGROUND 
The most important activities concerning GM crops and food carried out in the UK 
since 2000 are 
> the government commissioned dialogue on GM issues (GM dialogue) 
> the Farm-scale evaluations (FSEs) of GM crops 
As the latter study is scientific, this review will focus on the GM dialogue. However 
it should be noted that the FSE’s were one of the pieces of information used by the 
government to inform its policy on GM crops in 2004 – see section on Impact and 
follow-up. POSTnote 211 GM crops in the UK (2004) gives an overview of the GM 
dialogue and the FSEs and discusses the issues raised. It was published prior to the 
Government setting out its policy on GM in March 2004. Other POSTnotes in this 
area published since 2000 are POSTnote 172 Labelling GM foods (2002) and POST-
note 146 GM farm trials (2000). 
GM DIALOGUE 
The GM dialogue ran from May 2002 to January 2004 and consisted of three main 
strands: 
> GM science review –an assessment of the state of current scientific knowledge on 
GM crops and foods; 
> economics review - an evaluation of the potential costs and benefits of GM crops 
in the UK; 
> GM Nation? - a nationwide public debate to find out what people really think 
about GM. 
Information on each strand and its outcome is discussed below. 
GM SCIENCE REVIEW20  
The science review was led by the Government's Chief Scientific Adviser working 
with the Chief Scientific Adviser to the Secretary of State for the Environment, Food 
and Rural Affairs, and with independent advice from the Food Standards Agency. 
The science review was carried out by a 26-member panel comprised of leading sci-
entists from a spectrum of disciplines and perspectives, two lay representatives, a 
social scientist and a leading scientist with cross membership with the Public Debate 
Steering Board. It considered peer-reviewed published scientific literature and was 
                                                 
20 http://www.gmsciencedebate.org.uk/ 
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focused on science-based issues identified by the public and the scientific commu-
nity.  
In July 2003 the panel concluded that for current GM crops and GM food:  
> the risk to human health is very low; 
> these crops are unlikely to invade the countryside and become problematic plants; 
> it is unlikely that these crops, if consumed, would be toxic to wildlife; 
> there is insufficient information to predict the long-term impact of the herbicide 
regimes associated with herbicide-tolerant GM crops on wildlife; 
> the balance of risks and benefits will vary for each GM crop, therefore case-by 
case regulation is appropriate. 
The panel reconvened to consider comments on its July report and the results of the 
FSEs, reporting in January 2004 that:- 
> none of the new research published since the first Report significantly altered the 
earlier conclusions;  
> the FSEs were of high scientific calibre. The panel found that if GM herbicide 
tolerant (GMHT) crops are managed as in the FSEs, a significant reduction would 
be expected in weeds with GMHT beet and spring oilseed rape, whereas the oppo-
site would be found with maize. These effects arise from the herbicides and are 
not a direct consequence of the GM process. The different findings for different 
GM crops reinforced the conclusion of the first Science Review that GM crops 
must be assessed on a case-by-case basis. 
ECONOMICS21 
An evaluation of the costs and benefits of the possible commercial cultivation of GM 
crops in the UK, published in July 2003, was conducted by the Prime Minister’s 
Strategy Unit (SU). The SU performs long term strategic reviews of major areas of 
policy, studies of cross-cutting policy issues, strategic audits and joint work with 
Departments to promote strategic thinking and improve policy-making across White-
hall. It reports directly to the Prime Minister. The study focused on the GM crops 
that were currently available, as well as possible developments in the next 10-15 
years, and developed five scenarios to explore a range of possible futures. The study 
was informed by experts, the public, science and the best available economic data.  
The study concluded that although existing GM crops could offer some advantages 
to UK farmers, at least in the short-term, any economic benefit is likely to be limited 
by negative public attitudes and retailer policies. Over the next 10-15 years, the SU 
considered that there is significant potential for benefits from future developments in 
GM crop technology as well as potential for impacts on wider science and industry. 
The key conclusion of the study was that the future of GM crops will depend on the 
nature of the regulatory system and public attitudes.  
                                                 
21 www.number-10.gov.uk/su/gm/index.htm 
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GM NATION? THE PUBLIC DEBATE22 
A public debate, organised by a steering board independent of government, took 
place in summer 2003. The aim was to promote a programme of debate on GM is-
sues, framed by the public, against the background of the possible cultivation of GM 
crops in the UK.  
> The debate was overseen by a Steering board which comprised of people with 
different perspectives on GM and people with expertise in public engagement. A 
number of external contractors were appointed to manage the debate programme 
and deliver the different strands of the programme. Foundation Discussion work-
shops  -nine workshops of 18-20 participants from different backgrounds/age -
groups held in different regional locations.  
> Public events - a series of public events organized in three ‘tiers’ at na-
tional/regional, county and local levels. These events included different methods - 
round-table discussions, expert speaker Q&A, debating a motion – but were in-
formed by stimulus material approved by the steering  board. Participants were 
self-selecting. 
> Narrow-but-deep element – series of reconvened discussion groups that involved 
a selected cross-section of the wider population, who would be exposed to GM is-
sues over a period of two weeks. 
Over 37,000 people provided feedback from this range of activities which including 
more than 600 meetings and visits to the GM Nation? website. Key messages emerg-
ing from the debate include: 
> people are generally uneasy about GM crops; 
> there is little support for early commercialisation; 
> there is a widespread mistrust of government and multi-national companies; 
> there is a broad desire to know more and for further research to be done; 
> the debate was welcomed and valued. 
IMPACT AND FOLLOW-UP 
The Government considered the reports from all three strands of the GM dialogue 
and published both a detailed response and a Parliamentary statement in March 
200423. In these the Government set out its policy on GM crops and said it would: 
> assess GM crops on a case-by-case basis, taking a precautionary and evidence-
based approach, and making the protection of human health and the environment 
the top priority  
• provide choice for consumers through mandatory labelling of GM food products  
> consult on measures to facilitate the co-existence of GM and non-GM crops, and 
on options to provide compensation to non-GM farmers who suffer a financial 
loss through no fault of their own  
                                                 
22 www.gmnation.org.uk/docs/GMNation_FinalReport.pdf  
23 http://www.defra.gov.uk/corporate/ministers/statements/mb040309.htm 
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There are currently no GM crops being grown in the UK and no commercial cultiva-
tion is expected before 2009 at the earliest. However GM crops have been grown for 
research and development purposes at a number of sites, for example in the FSEs. 
Co-existence 
When GM crops are grown commercially measures will need to be applied to ensure 
that they can coexist with non-GM production. The Department for Environment, 
Food and Rural Affairs (Defra) consulted on proposed coexistence measures for Eng-
land between July and October 2006.  A summary of responses to the consultation 
should be available by the end of this year. Defra expects to have measures in place 
before GM crops are grown commercially. 
CHALLENGES IDENTIFIED IN THE PROJECTS 
> Generally the UK public is uneasy about GM crops. How will consumer attitudes 
develop over the next 5-10 years? This is likely to be key to any future success of 
GM crops. 
> Which future developments in GM technology will offer economic benefits? 
> Assessment and monitoring of the long-term impact of GM crops on the environ-
ment. 
> Co-existence of GM crops with non-GM crop production. Particular problems 
include (1) no legal threshold for the presence of GM crops in organic crops. In 
practice the organic sector works to the limit of detection of the presence of GM. 
(2) EU seed purity levels (less than 0.9%) will challenge the seed industry, who 
work to 1-2% seed purity, while the organic sector would like a level of less than 
0.1%. 
> Liability – who will pay if there is any environmental damage as a result of GM 
crops being grown? 
> WTO – how will the EU respond to the WTO dispute panel’s findings on the im-
plementation of GM crop regulations in Europe. 
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JOINT EPTA PROJECT 
”GENETICALLY MODIFIED PLANTS AND FOODS” 
QUESTIONNAIRE 
– FINAL VERSION – 
 
INTRODUCTION 
Although GM crops and food can be considered an established technology and regula-
tion is in place in many parts of the world, the issue still gives rise to controversy. 
Different countries have taken different approaches to regulating GM crops and foods. 
In the USA, product regulation does not imply any mandatory requirement to tell con-
sumers if a product contains GM material. In contrast, it is a central tenet of the EU ap-
proach that consumers should be made aware that a product contains, or has been pro-
duced using, GM material. This has required the EU to introduce regulations on label-
ling and traceability so that GM and non-GM products can be segregated through the 
entire production and marketing chain.  
The difference in regulatory philosophy across continents has already created some ten-
sion in international trade relations. In 2003 the WTO was asked to rule on the legality 
of the EU’s failure to process marketing applications for new GM agricultural products 
between 1998 and 2001.  
In addition to the possibility of similar challenges in the future, a range of other factors 
might bring pressure to bear on the current EU regulatory approach to GM foods and 
crops. These include inconsistencies among EU Member States on the way that they 
have implemented EU regulations or have dealt with the issue of co-existence.  
So far, the EU regulatory framework has not entailed that all aspects of the regulation of 
GMOs are dealt with uniformly throughout the EU. Member States have been left to 
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devise and implement their own regulations concerning the co-existence of GM and 
non-GM crops and approaches vary considerably across the EU. 
Another key factor may be technological developments particularly if these introduce 
new traits with perceived benefits to consumers or if they render the traditional distinc-
tion between GM and non-GM products less clear-cut. Such factors could influence 
public attitudes towards GM foods and crops within the EU in an unforeseeable way.  
Whatever happens, the future development of the debate on how best to regulate GM 
crops and foods in the EU is undetermined and the current regulatory system may face 
new challenges. 
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I. FACTORS INFLUENCING THE FUTURE OF GM PLANTS IN EUROPE 
I.1 GENERAL ASSESSMENT 
 
Question 1: 
a) Many factors will influence the future of GM plants and food in Europe. Below 
is a list of frequently cited major factors. Please indicate for each factor whether 
you think it will encourage or discourage the demand for GM plants and foods. 
Please feel free to add other important factors not listed.  
major factors Encour-
age  
demand
Discour-
age  
demand
Neither Don’ t 
know 
World food demand     
Attitudes to health      
Attitudes to the environment     
Use of bio-energy and biomass     
Global trade of food products     
Structures and power relations in the food 
chain (for instance increasing retailer power)
    
Differentiation of food products  
(consider developments such as food label-
ling and use of processed foods)  
    
International trade regulation     
Increased use of for pharmaceuticals      
Pest pressure     
Trend towards more efficient agricultural 
production methods 
    
………….     
………….     
b) Overall, would you think that the demand to introduce new GM plants in the 
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European agriculture will increase or decrease?  
(Please select one possibility)  
Increase  
Decrease  
No net effect  
Don’t know  
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Question 2: 
Do you think that the "first generation" of GM plants (as insect resistant (IR), her-
bicide resistant (HR) and virus resistant (VR) plants) will be grown in Europe to a 
noticeable extent (say more than 5 % of the available agricultural crop land) in 
the next 15 years? 
Time scale of introduction in Europe in your country 
Within the next 5 years   
Within 6 – 10 years   
Within 11 - 15 years   
Not within the next 15 years   
Don’t know   
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I.2 NEW GM PLANTS, NEW APPLICATIONS 
Question 3: 
a) Currently there are several classes of new GM plants in development. Please 
check if you believe the following statements are valid for the different classes of 
crops. 
Please feel free to add other classes of new gm plants not listed.  
Statement: "Such crops will become avail-
able within the coming 10 years." 
Valid  Not valid Don’ t 
know 
GM plants with new agricultural input traits 
(e.g. reduced need for fertilizer, water) 
   
GM plants with consumer benefits  
(e.g. improved nutritional value, taste, less allergens) 
   
GM plants for bioenergy 
(e.g. higher biomass yield, new plants) 
   
GM plants for plant made industrials 
(e.g. starch, fibre, plastics) 
   
GM trees designed for industrial/energy purposes    
GM plants for plant made pharmaceuticals 
(e.g. haemo-proteins, vaccines) 
   
GM plants for phytoremediation 
(e.g. plants for extracting toxics from the soil) 
   
New GM flowers etc. 
(e.g. new flower colours, grasses for lawns and golf 
courses) 
   
…………………...    
…………………...    
…………………...    
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Statement: "Such crops will be authorised 
for cultivation in Europe." 
Valid  Not valid Don’ t 
know 
GM plants with new agricultural input traits 
(e.g. reduced need for fertilizer, water) 
   
GM plants with consumer benefits  
(e.g. improved nutritional value, taste, less allergens) 
   
GM plants for bioenergy 
(e.g. higher biomass yield, new plants) 
   
GM plants for plant made industrials 
(e.g. starch, fibre, plastics) 
   
GM trees designed for industrial/energy purposes    
GM plants for plant made pharmaceuticals 
(e.g. haemo-proteins, vaccines) 
   
GM plants for phytoremediation 
(e.g. plants for extracting toxics from the soil) 
   
New GM flowers etc. 
(e.g. new flower colours, grasses for lawns and golf 
courses) 
   
…………………...    
…………………...    
…………………...    
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Statement: "Such crops will find significant 
demand from farmers." 
Valid  Not valid Don’ t 
know 
GM plants with new agricultural input traits 
(e.g. reduced need for fertilizer, water) 
   
GM plants with consumer benefits  
(e.g. improved nutritional value, taste, less allergens) 
   
GM plants for bioenergy 
(e.g. higher biomass yield, new plants) 
   
GM plants for plant made industrials 
(e.g. starch, fibre, plastics) 
   
GM trees designed for industrial/energy purposes    
GM plants for plant made pharmaceuticals 
(e.g. haemo-proteins, vaccines) 
   
GM plants for phytoremediation 
(e.g. plants for extracting toxics from the soil) 
   
New GM flowers etc. 
(e.g. new flower colours, grasses for lawns and golf 
courses) 
   
…………………...    
…………………...    
…………………...    
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Statement: "Products from such crops will 
find acceptance with consumers." 
Valid  Not valid Don’ t 
know 
GM plants with new agricultural input traits 
(e.g. reduced need for fertilizer, water) 
   
GM plants with consumer benefits  
(e.g. improved nutritional value, taste, less allergens) 
   
GM plants for bioenergy 
(e.g. higher biomass yield, new plants) 
   
GM plants for plant made industrials 
(e.g. starch, fibre, plastics) 
   
GM trees designed for industrial/energy purposes    
GM plants for plant made pharmaceuticals 
(e.g. haemo-proteins, vaccines) 
   
GM plants for phytoremediation 
(e.g. plants for extracting toxics from the soil) 
   
New GM flowers etc. 
(e.g. new flower colours, grasses for lawns and golf 
courses) 
   
…………………...    
…………………...    
…………………...    
 
Please feel free to give explanations or comments concerning your answers to these 
questions.  
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
…………………………………………………………………………………………… 
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Question 4: 
a) In future, technical developments such as "cisgenic" GM technology may be-
come more important. While traditional “transgenic” plants result from gene 
transfers which use recombined DNA from other species, "cisgenic" plants result 
from gene transfers which use only recombined DNA from the same species. 
Please indicate if you agree or disagree with the following statements.  
Statement Agree Disagree Don’ t know 
"Cisgenic" GM technology will gain high 
importance in the future. 
   
Such technologies will lead to blurring the 
boundaries between GM and non-GM 
plants in the future. 
   
Products derived from such technologies 
will be regarded as "less hazardous" by the 
public. 
   
"Cisgenic" GM technology will undermine 
the demand for transgenic GM technology. 
   
In the light of these developments, existing 
regulation will have to be adapted. 
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b) “Smart breeding” is another new technical development. "Smart breeding" 
derives from traditional methods of plant breeding but includes tools on the basis 
of modern recombinant DNA technology such as molecular markers. Please indi-
cate if you agree or disagree with the following statements.  
Statement Agree Disagree Don’ t know
“Smart breeding” will gain high importance 
in the future. 
   
"Smart breeding" will have a good public 
image. 
   
"Smart breeding" will overcome the demand 
for currently regulated GM technologies. 
   
"Smart breeding" will overcome the current 
need to regulate GM technologies. 
   
 
Please feel free to give explanations or comments concerning your answer on 
these questions.  
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
…………………………………………………………………………………………… 
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I.3 Public Attitude and Acceptance 
 
Question 5: 
Currently the consumer acceptance of gm plants and food varies across Europe. 
Many factors have been associated with public acceptance. Please rank the fac-
tors in the list below in their importance for consumer acceptance over the next 
10 to 15 years. 
Please feel free to add other factors not listed.  
Factors Not 
impor-
tant  
Little 
impor-
tant  
Important Very 
impor-
tant  
Don’ t 
know 
Risk issues related to environment       
Environmental upsides (e.g. reduced need 
for fertilizer, pesticides or tillage) 
     
Risk issues related to health      
Price benefits for consumers      
Consumer benefits related to food quality 
and health  
     
 functioning risk management       
Perspectives on global food security      
Quality of information to citizens      
Getting accustomed to GM products      
Opportunity for public participation in  
decision making 
     
Efficient and transparent labelling and free 
consumer choice 
     
Global distribution of risks and benefits      
…………..      
…………..      
13 
 
…………..      
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Question 6: 
Will public attitudes to GM crops and food change in the next 10 to 15 years? 
 
Issues More nega-
tive 
No change More posi-
tive 
Acceptance of GM technology in general    
Acceptance of new GM food products    
Acceptance of new GM non-food products    
 
Please feel free to give explanations or comments concerning your answer on this 
question.  
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
…………………………………………………………………………………………… 
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II. CHALLENGES FOR EUROPEAN POLICY 
II.1 CHALLENGES LINKED TO FREEDOM OF CHOICE, LABELLING AND CO-
EXISTENCE 
 
Question 7: 
Co-existence measures are a central part of risk management under GM-
cultivation. Co-existence is also a central prerequisite for freedom of choice. Co-
existence may be a challenge, depending on type of crop and location. Do you 
think that co-existence will work for the "first generation" of gm plants (e.g. in-
sect resistant, herbicide resistant  and virus resistant (VR) plants) in the next 15 
years?  
(Please tick one possibility)  
Yes, for the cultivation of GM plants on a large scale 
for almost every crop 
 
Yes, for the cultivation of GM plants on a large scale 
for some specific crops 
 
Yes, but only for the cultivation of GM plants on a 
small scale for almost every crop 
 
Yes, but only for the cultivation of GM plants on a 
small scale for some specific crops 
 
No, not at all  
Don’t know  
 
Please feel free to give explanations or comments concerning your answer on this 
question.  
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
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……………………………………………………………………………………………
…………………………………………………………………………………………… 
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Question 8: 
a) For the cultivation of GM crops some experts have discussed whether there 
could be relevant environmental or economic risks (e.g. to farmers not applying 
gm crops) that would not be contained by current risk assessment and co-
existence schemes. Please tick the statement that comes closest to your opinion. 
 
Relevant risks do not exist at all  
Relevant risks exist for a few particular GM crops  
Relevant risks exist for all GM crops  
Don’t know  
 
 
If you think that relevant risks do not exist at all, or if you don’t know, proceed to Ques-
tion 9. 
 
b) If you think that relevant risks might exist, please tick those statements that 
come closest to your opinion (multiple answers possible). 
In general, risks are negligible  
Environmental risks are balanced by benefits to society and accept-
able 
 
Economic risks to other farmers can be negotiated between parties 
involved 
 
Such risks are unacceptable and need regulatory intervention   
Don’t know  
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c) Do you think that current regulatory provisions are sufficient to deal with such 
risks, today or for the foreseeable future?  
Yes, in the current situation and in the foreseeable future  
Yes in the current situation, but not in the foreseeable future  
No, not at all  
Don’t know  
 
 
d) If you ticked “No, not at all” or “not in the foreseeable future”, how do you 
think these risks should be addressed? Please indicate the measure you consider 
most appropriate to address such risks (multiple answers possible).  
New criteria for risk assessment  
More stringent litigation schemes  
Stronger liability of gm producer and user  
New regulation  
………..  
………..  
Don’t know  
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Question 9: 
Co-existence and labelling of GM food are closely connected. There are different 
opinions over how well the current EU regulations would cope with the extended 
use and growing of gm plants in Europe. Please indicate which scenario in your 
opinion is most likely.  
(Please tick one scenario)  
Scenario  
Successful coexistence:  
The labelling of GM food is generally correct 
(including occasional mishap), non GM food is 
also available. 
 
Misapplication of labelling:  
All food is labelled as “may contain GM”, also 
non GM food. 
 
Failure of labelling regime:  
GM food is on the market, but not labelled cor-
rectly. 
 
Failure of coexistence:  
More or less all food is GM or contains GM com-
ponents, and is labelled as GM food. 
 
Blockade of GM food: 
Very little GM food on the market so that label-
ling is of little relevance. 
 
Don’t know  
 
Please feel free to give explanations or comments concerning your answer on this 
question.  
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
…………………………………………………………………………………………… 
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II.2 CHALLENGES LINKED TO NEW GENERATION GM CROPS 
 
Question 10: 
a) Newly developed GM plants for the non-food sector (e.g. gm plants for plant 
made pharmaceuticals, for industrial raw materials, and for bio-energy) are 
sometimes said to have new properties compared to gm plants for food and 
therefore pose new regulatory challenges. Do you or don’ t you agree with the 
following statement? 
 Yes No Don’ t know 
New GM plants for the 
non-food sector will 
pose new regulatory 
challenges 
   
 
 
If you ticked "No" or "Don’t know", proceed to question 11. 
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b) If you ticked "Yes", please assess which regulatory challenges non-food GM 
plants will raise in the next 10-15 years, and whether this will be very likely, 
likely, unlikely or highly unlikely.  
 
Please feel free to add other regulatory challenges not listed.  
Type of regulatory  
challenge 
Very likely Likely Unlikely Highly 
unlikely 
Don’t know
New parameters for risk  
assessment and manage-
ment 
     
Confinement / containment 
measures 
     
Regulation of coexistence      
Labelling      
Liability      
……….       
……….      
……….      
 
 
Please feel free to give explanations or comments concerning your answer on this 
question.  
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
…………………………………………………………………………………………… 
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Question 11: 
So far, the assessment procedures for GM plants and food only takes into account 
potential risks. Some actors have advocated that also potential benefits should 
be taken into consideration as applied in areas such as pharmaceuticals.  
Below is a list of potential benefits that could be included in such considerations. 
Please assess how likely it is that in future different benefits will be considered 
for GM approvals. 
Please feel free to add other groups not listed.  
Aspect Very likely Likely Unlikely Highly 
unlikely  
Don’ t 
know 
Environmental benefit      
Economic return      
Food safety       
Food quality      
Nutritional benefit      
…………….      
…………….      
…………….      
 
Please feel free to give explanations or comments concerning your answer on this 
question.  
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
…………………………………………………………………………………………… 
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Question 12: 
In order to assess risks and benefits of GM cultivation, it must be compared to 
established practices in agriculture. In Europe, these practices vary according to 
climate or soil, but also to the tasks assigned to agriculture. For example, and 
apart from efficiently producing crops or providing jobs, agriculture should also 
protect the traditional landscape and the natural environment, among others.  
Thus, agriculture must pursue different aims, against which the performance of 
GM cultivation will be measured. Please rank the aims in the list below in their 
importance over the next 10 to 15 years. 
 
Aims in agriculture Not im-
portant 
Little 
impor-
tant 
Impor-
tant 
Very 
impor-
tant 
Don’ t 
know 
Achieving high yields in crop 
production 
     
Reducing inputs in crop pro-
duction 
     
Efficient crop production under 
difficult agricultural conditions 
(erosion, pest pressure etc.) 
     
Staying competitive in times of 
market liberalisation and re-
duced subsidies 
     
Crop production with least 
possible environmental impact 
     
Producing high quality food in 
great variety 
     
Providing jobs for the rural 
population 
     
Protecting the traditional cul-
tivated landscape 
     
Promoting organic farming      
 
 
24 
 
II.3 GLOBAL ASPECTS OF GM REGULATION 
 
Question 13: 
a) It is probable that more types of GM crops will be released both in export coun-
tries and in Europe. The current EU regulation, based on the precautionary princi-
ple and case-by-case risk assessment and authorisation, might be challenged by 
the US and other countries also in the future. Please give your judgement on how 
robust the EU regulatory system will turn out to be to challenges for example at 
the WTO in the next 10 to 15 years. 
(Please tick one possibility)  
Robustness of the  
current EU regulatory system 
 
The general principles and approaches of the EU regulation and 
the varying implementation of the EU Member States can with-
stand challenges through the WTO. 
 
The general principles and approaches of the EU regulation can 
be maintained. However, the most restrictive practices of indi-
vidual EU Member States will have to be changed. 
 
The general principles and approaches of the EU regulation can 
be maintained, but a more substantial harmonisation among 
the EU Member States will be necessary. 
 
The EU regulatory system can not be maintained due to chal-
lenges through the WTO. 
 
Don’t know  
 
b) The EU legalisation has been a model for regulations in some other countries. 
Will the EU regulation continue to be influential in the future? 
(Please tick one possibility)  
Yes  
No  
Don’t know  
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Please feel free to give explanations or comments concerning your answer on this 
question.  
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
…………………………………………………………………………………………… 
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III. CHALLENGES FOR RESEARCH POLICY 
 
Question 14: 
In view of new developments in the research on GM plants, what will be the ob-
jectives of publicly-funded research in your country in the coming years? 
Please feel free to add other objectives not listed.  
 
Objectives of R&D Very li-
kely  
Likely Unlikely Highly 
unlikely 
Don’ t 
know 
Risk assessment and management 
 
     
Development of products/solutions 
responding to agronomic problems not 
covered by private research 
     
Development of innovative products 
with the intent to improve economic 
competitiveness 
     
……………      
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IV. AREAS OF ACTION 
 
Question 15: 
In order to meet challenges that have been explored in this questionnaire, it 
could be necessary for government institutions to take further action. Please pri-
oritise the areas below in which you consider action needs to be taken. 
Please feel free to add areas of action not listed. 
Area of action Very low 
priority 
Low prio-
rity 
High prio-
rity 
Very high 
priority 
Don’ t 
know 
Research funding      
Better implementation of exist-
ing regulation 
     
Amendment of existing regula-
tion  
     
Adaptation to international 
ruling (e.g. WTO) 
     
Reform of competent  
authorities/institutions 
     
Subsidiarity / change in the 
level of decision making 
     
Expert involvement in decision 
making 
     
Stakeholder involvement in 
decision making 
     
Public involvement in decision 
making 
     
None, let the system work as it 
is  
     
…………………………………      
…………………………………      
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…………………………………      
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Question 16: 
In order to further explore new challenges, within which areas do you consider 
further investigations (for example technology assessment projects) to be most 
relevant. 
(Please give key words)  
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
…………………………………………………………………………………………… 
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ANNEX 5: TABLES OF RESULTS 
FIGURE 1: INFLUENCING FACTORS FOR THE FUTURE OF  
 GM PLANTS AND FOOD IN EUROPE (Question 1A; n = 71) 
Question: Many factors will influence the future of GM plants and food in Europe. Be-
low is a list of frequently cited major factors. Please indicate for each factor 
whether you think it will encourage or discourage the demand for GM 
plants and foods. Please feel free to add other important factors not listed. 
 
Nei ther Don’t know Total
% % % % % n
World food demand 50.7% 8.5% 33.8% 7.0% 100.0% 71
Attitudes to health 31.0% 43.7% 15.5% 9.9% 100.0% 71
Attitudes to the environment 28.2% 54.9% 12.7% 4.2% 100.0% 71
Use of bio-energy and biomass 74.6% 1.4% 19.7% 4.2% 100.0% 71
Global trade of food products 50.7% 8.5% 29.6% 11.3% 100.0% 71
9.9% 49.3% 23.9% 16.9% 100.0% 71
22.5% 33.8% 31.0% 12.7% 100.0% 71
International trade regulation 52.1% 8.5% 25.4% 14.1% 100.0% 71
Increased use of for pharmaceuticals 52.1% 5.6% 31.0% 11.3% 100.0% 71
Pest pressure 53.5% 11.3% 28.2% 7.0% 100.0% 71
66.2% 8.5% 19.7% 5.6% 100.0% 71
Encourage 
demand
Discourage 
demand
Structures and power relations in the 
food chain (for instance increasing 
retailer power)
Differentiation of food products 
(consider developments such as food 
labelling and use of processed foods)
Trend towards more efficient 
agricultural production methods  
FIGURE 2: FUTURE DEMAND FOR NEW GM PLANTS IN EUROPEAN  
 AGRICULTURE (Question 1B; n = 71) 
Question: Overall, would you think that the demand to introduce new GM plants in 
the European agriculture will increase or decrease? 
ABB. 2  
 Column % Count
Increase 62.0% 44
Decrease 14.1% 10
No net effect 18.3% 13
Don’t know 5.6% 4
Total 100.0% 71
g
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FIGURE 3: FUTURE CULTIVATION OF FIRST GENERATION GM PLANTS IN EUROPE  
 (Question 2; n = 71) 
Question: Do you think that the "first generation" of GM plants (as insect resistant (IR), 
herbicide resistant (HR) and virus resistant (VR) plants) will be grown in 
Europe to a noticeable extent (say more than 5 % of the available agricul-
tural crop land) in the next 15 years)? 
 
Don't know Tot al
% % % % % % n
in Europe 21.1% 35.2% 15.5% 19.7% 8.5% 100.0% 71
in your country 1.4% 23.9% 21.1% 40.8% 12.7% 100.0% 71
Within the next 
5 years
Within 6 – 10 
years
Within 11 -  15 
years
Not within the 
next 15 years
 
FIGURE 4: AVAILABILITY OF NOVEL GM PLANTS  
 (Question 3A; n = 71) 
Question: Currently there are several classes of new GM plants in development. Please 
check if you believe the statement: “Such crops will become available within 
the coming 10 years.” 
Valid Not valid 
Don’t 
know Total 
 % % % % n 
GM plants with new agricultural 
input traits (e.g. reduced need for 
fertiliser, water) 
54,9% 22,5% 22,5% 100,0% 71 
GM plants with consumer benefits 
(e.g. improved nutritional value, 
taste, less allergens) 
50,7% 32,4% 16,9% 100,0% 71 
GM plants for bioenergy (e.g. 
higher biomass yield, new plants) 
60,6% 15,5% 23,9% 100,0% 71 
GM plants for plant made industri-
als (e.g. starch, fibre, plastics) 
78,9% 4,2% 16,9% 100,0% 71 
GM trees designed for indus-
trial/energy purposes 
25,4% 46,5% 28,2% 100,0% 71 
GM plants for plant made pharma-
ceuticals (e.g. haemo-proteins, 
vaccines) 
64,8% 14,1% 21,1% 100,0% 71 
GM plants for phytoremediation 
(e.g. plants for extracting toxins 
from the soil) 
23,9% 39,4% 36,6% 100,0% 71 
New GM flowers etc. (e.g. new 
flower colours, grasses for lawns 
and golf courses) 
60,6% 14,1% 25,4% 100,0% 71 
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FIGURE 5: AUTHORISATION OF NOVEL GM PLANTS (Question 3B; n = 71) 
Question: Currently there are several classes of new GM plants in development. Please 
check if you believe the statement: “Such crops will be authorised for culti-
vation in Europe.” 
Valid Not valid Don’t 
know 
Total  
% % % % n 
GM plants with new agricultural input 
traits (e.g. reduced need for fertiliser, 
water) 
57,7% 22,5% 19,7% 100,0% 71 
GM plants with consumer benefits (e.g. 
improved nutritional value, taste, less 
allergens) 
53,5% 26,8% 19,7% 100,0% 71 
GM plants for bioenergy (e.g. higher 
biomass yield, new plants) 
62,0% 18,3% 19,7% 100,0% 71 
GM plants for plant made industrials 
(e.g. starch, fibre, plastics) 
70,4% 14,1% 15,5% 100,0% 71 
GM trees designed for industrial/energy 
purposes 
32,4% 38,0% 29,6% 100,0% 71 
GM plants for plant made pharmaceuti-
cals (e.g. haemo-proteins, vaccines) 
43,7% 29,6% 26,8% 100,0% 71 
GM plants for phytoremediation (e.g. 
plants for extracting toxins from the 
soil) 
32,4% 31,0% 36,6% 100,0% 71 
New GM flowers etc. (e.g. new flower 
colours, grasses for lawns and golf 
courses) 
50,7% 16,9% 32,4% 100,0% 71 
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FIGURE 6: DEMAND FROM FARMERS FOR NOVEL GM PLANTS (Question 3C; n = 71) 
Question: Currently there are several classes of new GM plants in development. Please 
check if you believe the statement: “Such crops will find significant demand 
from farmers.” 
Valid Not valid Don’t 
know 
Total  
% % % % n 
GM plants with new agricultural input 
traits (e.g. reduced need for fertiliser, 
water) 
66,2% 19,7% 14,1% 100,0% 71 
GM plants with consumer benefits (e.g. 
improved nutritional value, taste, less 
allergens) 
39,4% 36,6% 23,9% 100,0% 71 
GM plants for bioenergy (e.g. higher 
biomass yield, new plants) 
64,8% 16,9% 18,3% 100,0% 71 
GM plants for plant made industrials 
(e.g. starch, fibre, plastics) 
57,7% 23,9% 18,3% 100,0% 71 
GM trees designed for industrial/energy 
purposes 
26,8% 43,7% 29,6% 100,0% 71 
GM plants for plant made pharmaceuti-
cals (e.g. haemo-proteins, vaccines) 
22,5% 45,1% 32,4% 100,0% 71 
GM plants for phytoremediation (e.g. 
plants for extracting toxins from the soil) 
16,9% 53,5% 29,6% 100,0% 71 
New GM flowers etc. (e.g. new flower 
colours, grasses for lawns and golf 
courses) 
32,4% 38,0% 29,6% 100,0% 71 
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FIGURE 7: ACCEPTANCE WITH CONSUMERS OF NOVEL GM PLANTS (Question 3D; n = 71) 
Question: Currently there are several classes of new GM plants in development. Please 
check if you believe the statement: “Products from such crops will find ac-
ceptance with consumers.” 
Valid Not 
valid 
Don’t 
know 
Total  
% % % % n 
GM plants with new agricultural input traits 
(e.g. reduced need for fertiliser, water) 
31,0% 43,7% 25,4% 100,0% 71 
GM plants with consumer benefits (e.g. im-
proved nutritional value, taste, less allergens) 
56,3% 29,6% 14,1% 100,0% 71 
GM plants for bioenergy (e.g. higher biomass 
yield, new plants) 
50,7% 29,6% 19,7% 100,0% 71 
GM plants for plant made industrials (e.g. 
starch, fibre, plastics) 
50,7% 26,8% 22,5% 100,0% 71 
GM trees designed for industrial/energy pur-
poses 
35,2% 38,0% 26,8% 100,0% 71 
GM plants for plant made pharmaceuticals 
(e.g. haemo-proteins, vaccines) 
47,9% 26,8% 25,4% 100,0% 71 
GM plants for phytoremediation (e.g. plants 
for extracting toxins from the soil) 
47,9% 25,4% 26,8% 100,0% 71 
New GM flowers etc. (e.g. new flower colours, 
grasses for lawns and golf courses) 
39,4% 28,2% 32,4% 100,0% 71 
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FIGURE 8: FUTURE IMPORTANCE OF “CISGENIC” GM TECHNOLOGY (Question 4A; n = 71) 
Question: In the future, technical developments such as “cisgenic” GM technology 
may become more important. While traditional “transgenic” plants result 
from gene transfers which use recombined DNA from other species, “cis-
genic” plants result from gene transfers which use only recombined DNA 
from the same species. Please indicate if you agree or disagree with the fol-
lowing statements. 
Agree Disagree Don’t know Total  
% % % % n 
“Cisgenic” GM technology will gain high 
importance in the future. 
33,8% 14,1% 52,1% 100,0% 71 
Such technologies will lead to blurring the 
boundaries between GM and non-GM 
plants in the future. 
50,7% 31,0% 18,3% 100,0% 71 
Products derived from such technologies 
will be regarded as “less hazardous” by 
the public. 
35,2% 39,4% 25,4% 100,0% 71 
“Cisgenic” GM technology will undermine 
the demand for transgenic GM technol-
ogy. 
16,9% 50,7% 32,4% 100,0% 71 
In the light of these developments, exist-
ing regulation will have to be adapted. 
57,7% 22,5% 19,7% 100,0% 71 
 
FIGURE 9: FUTURE IMPORTANCE OF “SMART BREEDING” (Question 4B; n = 71) 
Question: “Smart breeding” is another new technical development. "Smart breeding" 
derives from traditional methods of plant breeding but includes tools on the 
basis of modern recombinant DNA technology such as molecular markers. 
Please indicate if you agree or disagree with the following statements. 
Agree Disagree Don’t know Total  
% % % % n 
“Smart breeding” will gain high impor-
tance in the future. 
69,0% 7,0% 23,9% 100,0% 71 
“Smart breeding” will have a good 
public image. 
56,3% 14,1% 29,6% 100,0% 71 
“Smart breeding” will overcome the 
demand for currently regulated GM 
technologies. 
15,5% 54,9% 29,6% 100,0% 71 
“Smart breeding” will overcome the 
current need to regulate GM technolo-
9,9% 74,6% 15,5% 100,0% 71 
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FIGURE 10: NEW REGULATORY CHALLENGES CAUSED BY NOVEL GM PLANTS? 
 (Question 10A; n = 71) 
Question: Newly developed GM plants for the non-food sector (e.g. gm plants for 
plant made pharmaceuticals, for industrial raw materials, and for bio-
energy) are sometimes said to have new properties compared to gm plants 
for food and therefore pose new regulatory challenges. Do you or don’t you 
agree with the following statement? 
 Column % Count 
Yes 62,0% 44 
No 35,2% 25 
Don’t know 2,8% 2 
New GM plants for the non-food sector 
will pose new regulatory challenges  
Total 100,0% 71 
 
FIGURE 11: AREAS OF NEW REGULATORY CHALLENGES OF NOVEL GM PLANTS  
 (Question 10B; n = 44) 
Question: If you ticked "Yes" [in question 10B], please assess which regulatory chal-
lenges non-food GM plants will raise in the next 10-15 years, and whether 
this will be very likely, likely, unlikely or highly unlikely. Please feel free to 
add other regulatory challenges not listed. 
Very 
likely 
Likely Unlikely Highly 
unlikely 
Don’t 
know 
Total Type of regulatory chal-
lenge 
% % % % % % n 
New parameters for risk 
assessment and man-
agement 
45,5% 45,5% 6,8% 0,0% 2,3% 100,0% 44 
Confinement/contain-
ment measures 
52,3% 36,4% 6,8% 0,0% 4,6% 100,0% 44 
Regulation of coexistence 56,8% 36,4% 4,5% 0,0% 2,3% 100,0% 44 
Labelling 25,0% 43,2% 29,5% 0,0% 2,3% 100,0% 44 
Liability 34,1% 54,5% 2,3% 0,0% 9,1% 100,0% 44 
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FIGURE 12: PUBLIC ATTITUDES (Question 6; n = 71) 
Question: Will public attitudes to GM crops and food change in the next 10 to 15 
years? 
 More 
negative 
No change More 
positive 
Total 
 % % % % n 
Acceptance of GM technology in general 5,6% 36,6% 57,7% 100,0% 71 
Acceptance of new GM food products 9,9% 52,1% 38,0% 100,0% 71 
Acceptance of new GM non-food products 2,8% 22,5% 74,6% 100,0% 71 
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FIGURE 13: FACTORS INFLUENCING PUBLIC ATTITUDES (Question 5; n = 71) 
Question: Currently the consumer acceptance of gm plants and food varies across Eu-
rope. Many factors have been associated with public acceptance. Please 
rank the factors in the list below in their importance for consumer accep-
tance over the next 10 to 15 years. Please feel free to add other factors not 
listed. 
Factors 
Not im-
portant 
Little 
impor-
tant 
Impor-
tant 
Very 
impor-
tant 
Don’t 
know 
Total   
% % % % % % n 
Risk issues related to environ-
ment 
4,2% 12,7% 45,1% 35,2% 2,8% 100,0% 71
Environmental upsides (e.g. 
reduced need for fertiliser, 
pesticides or tillage) 
4,2% 47,9% 28,2% 16,9% 2,8% 100,0% 71
Risk issues related to health 1,4% 5,6% 35,2% 54,9% 2,8% 100,0% 71
Price benefits for consumers 8,5% 23,9% 31,0% 35,2% 1,4% 100,0% 71
Consumer benefits related to 
food quality and health 
2,8% 12,7% 33,8% 49,3% 1,4% 100,0% 71
Performance of risk manage-
ment systems 
2,8% 23,9% 43,7% 25,4% 4,2% 100,0% 71
Perspectives on global food 
security 
16,9% 38,0% 25,4% 15,5% 4,2% 100,0% 71
Quality of information to citi-
zens 
2,8% 18,3% 42,3% 35,2% 1,4% 100,0% 71
Getting accustomed to GM 
products 
8,5% 15,5% 42,3% 29,6% 4,2% 100,0% 71
Opportunity for public partici-
pation in decision making 
8,5% 40,8% 36,6% 11,3% 2,8% 100,0% 71
Efficient and transparent label-
ling and free consumer choice 
2,8% 9,9% 43,7% 42,3% 1,4% 100,0% 71
Global distribution of risks and 
benefits 
8,5% 45,1% 32,4% 8,5% 5,6% 100,0% 71
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FIGURE 14: WILL COEXISTENCE WORK FOR FIRST GENERATION GM PLANTS?  
 (Question 7; n = 71) 
Question: Co-existence measures are a central part of risk management under GM-
cultivation. Co-existence is also a central prerequisite for freedom of choice. 
Co-existence may be a challenge, depending on type of crop and location. 
Do you think that co-existence will work for the "first generation" of gm 
plants (e.g. insect resistant, herbicide resistant and virus resistant (VR) 
plants) in the next 15 years? (Please tick one possibility). 
   Percentage Count
Yes, for the cultivation of GM plants on a large scale for almost every
crop 
15,5% 11 
Yes, for the cultivation of GM plants on a large scale for some spe-
cific crops 
31,0% 22 
Yes, but only for the cultivation of GM plants on a small scale for 
almost every crop 
5,6% 4 
Yes, but only for the cultivation of GM plants on a small scale for 
some specific crops 
25,4% 18 
No, not at all 15,5% 11 
Don’t know 7,0% 5 
Total 100,0% 71 
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FIGURE 15: CAN CONSUMERS’  CHOICE BE MAINTAINED? (Question 9; n = 71) 
Question: Co-existence and labelling of GM food are closely connected. There are dif-
ferent opinions over how well the current EU regulations would cope with 
the extended use and growing of gm plants in Europe. Please indicate 
which scenario in your opinion is most likely. (Please tick one scenario) 
   Percentage Count
Successful coexistence: The labelling of GM food is generally correct 
(including occasional mishap), non GM food is also available. 
52,1% 37 
Misapplication of labelling: All food is labelled as “may contain GM”, 
also non GM food. 
5,6% 4 
Failure of labelling regime: GM food is on the market, but not labelled 
correctly. 
14,1% 10 
Failure of coexistence: More or less all food is GM or contains GM com-
ponents, and must be labelled as GM food. 
7,0% 5 
Blockade of GM food: Very little GM food on the market so that label-
ling is of little relevance. 
16,9% 12 
Don’t know 4,2% 3 
Total 100,0% 71 
 
FIGURE 16: DO COEXISTENCE SCHEMES ADDRESS RISKS? (Question 8A; n = 71) 
Question: For the cultivation of GM crops some experts have discussed whether there 
could be relevant environmental or economic risks (e.g. to farmers not ap-
plying gm crops) that would not be contained by current risk assessment 
and co-existence schemes. Please tick the statement that comes closest to 
your opinion. 
 Percentage Count 
Relevant risks do not exist at all 15,5% 11 
Relevant risks exist for a few particular GM crops 29,6% 21 
Relevant risks exist for all GM crops 49,3% 35 
Don’t know 5,6% 4 
Total 100,0% 71 
 
12 
FIGURE 17: HOW TO MEET RISKS? (Question 8B; n = 56) 
Question: If you think that relevant risks might exist [in question 8A], please tick those 
statements that come closest to your opinion (multiple answers possible). 
 Respondents Responses Percentage (n=71)
In general, risks are negligible 9 13 % 
Environmental risks are balanced by bene-
fits to society and acceptable 
17 24 % 
Economic risks to other farmers can be 
negotiated between parties involved 
23 32 % 
Such risks are unacceptable and need 
regulatory intervention 
26 37 % 
Don’t know 2 3 % 
Total 56 78 
 
FIGURE 18: ARE REGULATORY PROVISIONS SUFFICIENT? (Question 8C; n = 56) 
Question: Do you think that current regulatory provisions are sufficient to deal with 
such risks [see question 8B], today or for the foreseeable future? 
 Count Percentage 
Yes, in the current situation and in the foreseeable future 19 27 % 
Yes in the current situation, but not in the foreseeable future 16 23 % 
No, not at all 20 28 % 
Don’t know 1 1 % 
Total 56  
 
13 
FIGURE 19: BENEFIT ASSESSMENT (Question 11; n = 71) 
Question: So far, the assessment procedures for GM plants and food only takes into 
account potential risks. Some actors have advocated that also potential 
benefits should be taken into consideration as applied in areas such as 
pharmaceuticals.  
Below is a list of potential benefits that could be included in such considera-
tions. Please assess how likely it is that in future different benefits will be 
considered for GM approvals. Please feel free to add other groups not listed. 
Highly 
unlikely 
Unlikely Likely Very 
likely 
Don’t 
know 
Total  
% % % % % % n 
Environmental benefit 15,5% 25,4% 38,0% 16,9% 4,2% 100,0% 71 
Economic return 29,6% 28,2% 23,9% 12,7% 5,6% 100,0% 71 
Food safety 16,9% 25,4% 33,8% 18,3% 5,6% 100,0% 71 
Food quality 16,9% 31,0% 31,0% 15,5% 5,6% 100,0% 71 
Nutritional benefit 15,5% 31,0% 35,2% 12,7% 5,6% 100,0% 71 
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FIGURE 20: AIMS IN AGRICULTURE (Question 12; n = 71) 
Question: In order to assess risks and benefits of GM cultivation, it must be compared 
to established practices in agriculture. In Europe, these practices vary ac-
cording to climate or soil, but also to the tasks assigned to agriculture. For 
example, and apart from efficiently producing crops or providing jobs, agri-
culture should also protect the traditional landscape and the natural envi-
ronment, among others. Thus, agriculture must pursue different aims, 
against which the performance of GM cultivation will be measured. Please 
rank the aims in the list below in their importance over the next 10 to 15 
years. 
Not 
impor
tant 
Little 
impor-
tant 
Impor-
tant 
Very 
impor-
tant 
Don’t 
know 
Total  
% % % % % % n 
Achieving high yields in crop 
production 
5,6% 19,7% 36,6% 31,0% 7,0% 100,0% 71 
Reducing inputs in crop produc-
tion 
2,8% 5,6% 46,5% 36,6% 8,5% 100,0% 71 
Efficient crop production under 
difficult agricultural conditions 
(erosion, pest pressure etc.) 
2,8% 14,1% 42,3% 33,8% 7,0% 100,0% 71 
Staying competitive in times of 
market liberalisation and re-
duced subsidies 
1,4% 15,5% 39,4% 33,8% 9,9% 100,0% 71 
Crop production with least pos-
sible environmental impact 
0,0% 4,2% 39,4% 52,1% 4,2% 100,0% 71 
Producing high quality food in 
great variety 
1,4% 7,0% 35,2% 50,7% 5,6% 100,0% 71 
Providing jobs for the rural 
population 
7,0% 21,1% 45,1% 19,7% 7,0% 100,0% 71 
Protecting the traditional culti-
vated landscape 
7,0% 12,7% 40,8% 33,8% 5,6% 100,0% 71 
Promoting organic farming 8,5% 32,4% 23,9% 26,8% 8,5% 100,0% 71 
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FIGURE 21: ROBUSTNESS OF THE EU REGULATORY SYSTEM (Question 13A; n = 71) 
Question: It is probable that more types of GM crops will be released both in export 
countries and in Europe. The current EU regulation, based on the precau-
tionary principle and case-by-case risk assessment and authorisation, might 
be challenged by the US and other countries also in the future. Please give 
your judgement on how robust the EU regulatory system will turn out to be 
to challenges for example at the WTO in the next 10 to 15 years. (Please tick 
one possibility) 
Answers % of answers Number of answers 
The general principles and approaches of the EU 
regulation and the varying implementation of 
the EU Member States can withstand challenges 
through the WTO. 
22,5 16 
The general principles and approaches of the EU 
regulation can be maintained. However, the 
most restrictive practices of individual EU Mem-
ber States will have to be changed. 
32,4 23 
The general principles and approaches of the EU 
regulation can be maintained, but a more sub-
stantial harmonisation among the EU Member 
States will be necessary. 
23,9 17 
The EU regulatory system can not be maintained
due to challenges through the WTO. 
14,1 10 
Don’t know 7,0 5 
Total 100,0 71 
 
FIGURE 22: THE FUTURE ROLE OF THE EU LEGISLATION (Question 13B; n = 71) 
Question: The EU legalisation has been a model for regulations in some other coun-
tries. Will the EU regulation continue to be influential in the future? (Please 
tick one possibility) 
Answers % of answers Number of answers 
Yes 69,0 49 
No 12,7 9 
Don’t know 18,3 13 
Total 100,0 71 
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FIGURE 23: PRIORITISATION OF POLICY FIELDS (Question 15; n = 71) 
Question: In order to meet challenges that have been explored in this questionnaire, it 
could be necessary for government institutions to take further action. 
Please prioritise the areas below in which you consider action needs to be 
taken. Please feel free to add areas of action not listed 
Very 
low 
priority 
Low 
priority 
High 
priority 
Very 
high 
priority 
Don’t 
know 
Total  
% % % % % % n 
Research funding 0,0% 9,9% 46,5% 38,0% 5,6% 100,0% 71 
Better implementation of 
existing regulation 
5,6% 29,6% 39,4% 16,9% 8,5% 100,0% 71 
Amendment of existing 
regulation 
2,8% 33,8% 32,4% 21,1% 9,9% 100,0% 71 
Adaptation to international 
ruling (e.g. WTO) 
9,9% 33,8% 28,2% 16,9% 11,3% 100,0% 71 
Reform of competent au-
thorities/institutions 
12,7% 25,4% 33,8% 21,1% 7,0% 100,0% 71 
Subsidiarity/change in the 
level of decision making 
4,2% 39,4% 35,2% 7,0% 14,1% 100,0% 71 
Expert involvement in 
decision making 
2,8% 19,7% 36,6% 35,2% 5,6% 100,0% 71 
Stakeholder involvement 
in decision making 
8,5% 26,8% 42,3% 16,9% 5,6% 100,0% 71 
Public involvement in deci-
sion making 
11,3% 31,0% 33,8% 19,7% 4,2% 100,0% 71 
None, let the system work 
as it is 
56,3% 15,5% 5,6% 1,4% 21,1% 100,0% 71 
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FIGURE 24: OBJECTIVES OF PUBLICLY FUNDED RESEARCH (Question 14; n = 71) 
Question: In view of new developments in the research on GM plants, what will be the 
objectives of publicly-funded research in your country in the coming years? 
Please feel free to add other objectives not listed. 
Highly 
unlikely 
Unlikely Likely Very 
likely 
Don’t 
know 
Total  
% % % % % % n 
Risk assessment and man-
agement 
2,8% 23,9% 35,2% 31,0% 7,0% 100,0% 71 
Development of prod-
ucts/solutions responding to 
agronomic problems not 
covered by private research 
5,6% 28,2% 39,4% 16,9% 9,9% 100,0% 71 
Development of innovative 
products with the intent to 
improve economic competi-
tiveness 
7,0% 31,0% 32,4% 18,3% 11,3% 100,0% 71 
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AUSTRIA 1. 
ECOLOGICAL MONITORING OF GENETICALLY MODIFIED 
ORGANISMS (2000) 1.1 
BACKGROUND OF THE PROJECT 
Context 
On March 12th, 2001, the European Union (the Parliament and the Council by the co-
decision procedure) adopted Directive 2001/18/EC on the deliberate release into the 
environment of genetically modified organisms. As a significant part of this Direc-
tive there is a Monitoring Plan sketched to be further elaborated in Guidance Notes. 
These supplementing Guidance Notes have been adopted by decision of the Council 
on October 3rd, 2002. 
The present research was realised and finished between these two dates and ad-
dresses the need for further elaboration of the monitoring system, presenting prelimi-
nary proposals to be discussed on a national Austrian basis and EU-wide, afterwards.  
The Austrian situation in the domain of green biotechnologies is characterised by a 
quite restrictive legislation, regional efforts to completely forbid GMOs and a broad 
GM-critical consensus between the political parties, farmers, interest groups, NGOs 
and the public. Already in the 1990s with the Directive 90/220/EEC in force, Austria 
pushed for a monitoring instrument. Basically, there were and there are two funda-
mental positions on the EU-level: those who demand an extensive monitoring of the 
approved GMOs, arguing that it is impossible to know every relevant effect of the 
product in a risk assessment ex ante; and those who understand a product which is 
approved after an exhaustive risk assessment as fully admitted. The critique of the 
latter on monitoring is that it is not affordable and even if it would be one cannot 
know what parameters exactly to trace – one cannot detect and measure anything 
which possibly could be of relevance. Austria maintained its pro-monitoring attitude 
and the present paper has to be read in this stable policy-line.  
Demanding institutions 
This study was financed by the Austrian Federal Ministry of Agriculture, Forestry, 
Environment and Water Management. As documented in the Third Report of the 
Austrian Genetic Engineering Commission (Gentechnikkommission), the study was 
also demanded and partly financed by the Austrian Federal Ministry of Health and 
Women. The paper was published in the monograph series of the Austrian Federal 
Environment Agency. The authors are, partly, from this agency and, partly, scientists 
from outside (University of Vienna, Austrian Federal Office and Research Centre of 
Agriculture). The main author Andreas Traxler has no institutional affiliation.  
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Guiding questions 
How can we deal with the uncertainty about potential environmental effects of 
GMOs? What proposals can be made for the guidance notes to amend and complete 
Annex VII of the Directive 2001/18/EC with a framework concept for ecological 
monitoring that satisfies the needs of the EU and the Member States? 
BASIC DATA ABOUT THE PROJECT 
Type of project: 
This project is a survey on ecological monitoring and the translation (to present it to 
a larger audience) of an abridged version of a more extensive monography (contain-
ing more Austrian-specific details) of the Austrian Federal Environment Agency 
(published in 2000). The methods used are basically a review of the legislative texts 
and scientific publications on the subject, and an exposition of Austrian ecological 
protection targets. Two case studies (GM maize and GM oilseed rape) were used in 
the original German version to delineate the requisites of an ecological monitoring 
device. However, the focus lies on the elaboration of a method, more than on apply-
ing already established methods.  
Topics: 
At first, the survey presents the EU-wide legal provisions on GMO monitoring. 
Then, the framework concept and the guidelines for monitoring of GMOs are 
sketched. There are criteria elaborated, the questions of financing and public partici-
pation are addressed and a terminology is elaborated. In a next step, the authors in-
troduce the monitoring parameters and test methods they recommend.. After sugges-
tions for Austrian specific ecological protection targets, the authors conclude with 
some words on biogeographical regions in Austria.  
Duration: 
The longer version in German language was published and presented in the year 
2000, this paper in 2001. The project work took approximately a year.  
MAJOR OUTCOMES OF THE PROJECT 
Central findings 
The study’s analysis of the respective legislative acts on GMOs brought the authors 
to the conviction that ecological monitoring is one of the few methods to increase 
GMOs’ environmental safety. It is the only way to detect unforeseen effects, to pos-
sibly prevent adverse effects in time, and to get to learn about the ecological risks of 
GMOs. There is a broad agreement, also in the EU (see directive 2001/18/EC) and 
between the interest groups, that it is a necessary instrument to control possible risks 
of the release of GMOs. However, there is uncertainty on how to implement it. Rep-
resentatives of the industry, on the one hand, and ecologists, on the other, have quite 
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divergent views on the nature, extent and duration of the investigations to be carried 
out in a monitoring tool. 
From the authors’ point of view, ecological monitoring must be planned and carried 
out by ecologists in co-operation with molecular biologists and cannot be accepted as 
a burdensome necessity involved in the release of a GMO.  
In line with the EU directive’s indications, there should be a case-specific monitoring 
(limited in time, hypothesis-based) and general surveillance (nation-wide long-term 
monitoring without time restrictions, designed to observe the effects of all consented 
GMOs). The present monography also suggests a monitoring of the state-of-the-art 
(collect and structure international monitoring results; periodically adjust current 
monitoring plans in terms of methodology and subject matter) and an ecosystem 
monitoring (because of the high costs, it would be feasible only at few locations; 
however, this could unearth important findings and initiate interdisciplinary envi-
ronmental monitoring on an integrated basis). A list of guidelines for ecological 
monitoring for releases and for the placing on the market is compiled in the study. 
The paper votes for the participation of the public (to improve acceptance and in-
crease objectivity) and a broader and interdisciplinary integration of scientific fields 
and interest groups. 
There is a great amount of monitoring parameters and test methods proposed by the 
contributors, which reflect the inconvenience of not knowing what to detect and as-
sess, exactly. It seems that with the recommended ensemble, there should be reached 
an integrated, holistic vision able to catch problematic effects on the ecobiological 
system on various points and as fast as possible: There are standard parameters (bio-
mass, phenology, cover values, vegetation structure, etc.) and methods of plant ecol-
ogy proposed, furthermore biochemical, ornithological and entomological monitor-
ing methods, and soil analyses.  
The ecological protection targets should be stipulated by each individual Member 
State – the present survey attempts this for Austria.  
Options for action 
Amend Directive 2001/18/EC in line with the aspects prompted by the Austrian posi-
tion. Each notification for the deliberate release or placing on the market of GMOs 
must contain a detailed monitoring plan on a case-by-case basis.  
Identified future issues 
The survey claims that the following points have to be clarified for future GMO noti-
fications with regard to efficient ecological monitoring: 
> determination of the executing institutions 
> definition of threshold values 
> definition of ecological damage (the term is not sufficiently defined: is it “dam-
age” if a native plant population is suppressed or already if there is a GMO-
occurrence in ruderal biotops?) 
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> establishment of a national and international information network (with a central 
coordination office for the GMO-monitoring as collector and administrator of 
monitoring data and findings) 
These issues should be discussed at the earliest possible stage: 
> planning of a nation-wide, representative monitoring network for animals and 
plants 
> definition of the ecological targets likely to be affected by GMOs 
> financing  
IMPACTS AND FOLLOW UP OF THE PROJECT 
According to the press release of the Austrian Federal Environment Agency, the 
frame monitoring concept was developed to be placed at the EU-level in the discus-
sion on the monitoring guidelines complementing directive 2001/18/EC. These 
guidelines were published in 2002 by decision of the Council of the European Union. 
Only a comparative study of the two documents and the positions of other Member 
States and the relevant interest groups could clarify the concrete influence of the 
Austrian proposal.  
CHALLENGES IDENTIFIED 
The development of this monitoring concept, according to the authors, does by no 
means give a “clean bill of health” for releasing or placing GMOs on the market. 
Moreover, ecological monitoring is necessary and a useful tool – however, it does 
not work wonders: it is expensive, time-consuming, and methodologically limited. 
LITERATURE 
Traxler, A., Heissenberger, A., Frank, G., Lethmayer, C., Gaugitsch, H. (2000): Durch-
führung von Untersuchungen zu einem ökologischen Monitoring von gentechnisch 
veränderten Organismen. Umweltbundesamt, Monographien Band 126, Wien 
http://www.bmgfj.gv.at/cms/site/standard.html?channel=CH0810&doc=CMS1085
490251342 
English version (2001): Ecological Monitoring of Genetically Modified Organisms. Aus-
trian Federal Environment Agency, Wien 
http://www.umweltbundesamt.at/fileadmin/site/publikationen/M147.pdf 
AUTHOR OF THE REVIEW 
Helge Torgersen 
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PRECAUTIONARY EXPERTISE FOR GM CROPS (2004) 1.2 
BACKGROUND OF THE PROJECT 
Demanding institution (initiator): 
The research project "Precautionary Expertise for GM Crops" was funded by the 
European Commission, Quality of Life programme. It was the third in a series of EU 
funded projects on policy problems associated with the regulation of GMOs in sev-
eral EU member states, co-ordinated by the Open University, Milton Keynes. 
Context: 
Background for this project was the increasing need of changes in regulatory proce-
dures regarding GM crops. When Member States blocked the EU–level regulatory 
procedure in 1999, new legislations were adopted to meet their demands. New pro-
cedures were supposed to provide a mechanism to ensure full traceability and label-
ling of GMO crops and to enhance the application of the precautionary principle on a 
national level. Although the precautionary principle was widely invoked for dealing 
with uncertain risks by Member states, criticism remained considering the principle 
as a pretext for political agendas. One important reason was that largely, a generally 
accepted coherent view on the scope and modes of application of the principle was 
considered to be lacking. 
The project analysed the different approaches to the precautionary principle and their 
consequences for regulatory measures as they appeared from regulatory actions by 
some Member States as well as from statements made by various stakeholders. Par-
ticularly the broader accounts leave the scope wide open for different interpretations. 
As a result, disagreements about the practical meaning emerged. The main goal of 
the study was to accommodate different views and give guidelines for the implemen-
tation of the principle. Thus it was an attempt to construct a comprehensive concept 
of the precautionary principle in the context of agricultural biotechnology. 
The main guiding questions were: 
> How do current European practices compare with different accounts of the pre-
cautionary principle? 
> How are risk research, risk assessment and risk management linked in practice?   
> How do stakeholder groups attempt to influence regulatory measures within or 
> beyond formal procedures? 
> How do expert advisory bodies mediate between regulatory science and public-
scientific controversy? 
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BASIC DATA ABOUT THE PROJECT 
Type of project: 
The project was performed as an inter-disciplinary policy research exercise, aiming 
at comparative evaluations of national policy events, investigated by the national 
partners, and developments on the EU level researched by the co-ordinator. 
The research activities mainly consisted of an analysis of relevant documents as well 
as interviews and workshops with key actors, involving a wide range of stakeholders.  
Duration / start and closing date: 
Work was performed within the years 2002 -2004, with the final report in 2004. 
Topics of the project: 
The investigation focused on the practical application of the precautionary principle 
in the member states with respect to transgenic crops.  
Participants: 
> D. Wield, S. Carr, L. Levidow, S. Oreszczyn, Open University, Milton Keynes, 
UK (Co-ordinators);  
> H. Torgersen, A. Bogner, Institute of Technology Assessment; Austrian Academy 
of Sciences, Vienna, Austria; 
> B. Gill, K. Boschert. Ludwig-Maximilians-Universität München, Germany; 
> J. Toft, Roskilde University Library, Copenhagen, Denmark; 
> C. Marris, P.-B. Joly, St. Ronda, Institut National de la Recherche Agonomique, 
Ivry, France; Ch. Bonneuil, Centre Koyré d'Histoire des Sciences et des Techni-
ques, Grenable; 
> L. Lemkow, D. Tàbara, D. Polo, Universitat Autònoma de Barcelona, Spain.  
Subcontracts (consultants): 
> P. Schenkelaars, Schenkelaars Biotechnology Consultancy, The Netherlands; 
> J. Tait, University of Edinburgh, UK. 
Events: 
> National stakeholder workshops were held in all participating countries (UK, A, 
D, DK, F, SP, NL) and on the EU level. Workshops proceedings were distributed 
and, in part, published. 
MAJOR OUTCOMES OF THE PROJECT 
Central findings 
The project places emphasis on the different understandings of the concept of pre-
caution. As the different reports of the member states show, the concept is very con-
tentious in its details and led to many conflicts among experts. In practise, the differ-
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ent accounts have a strong impact on regulatory procedures. Narrow and broader 
accounts differ in three general respects – uncertainties in risk assessment, the trigger 
for management measures, and the scope of action (including alternative solutions). 
Despite institutional reforms regulatory disagreements continue, for instance, over 
the criteria for evidence, definitions of harms and means to manage uncertain risks. 
One main outcome of the project is that different accounts should not be seen as 
fixed types but as dynamic tensions within the regulatory procedures. It is important 
to note that precaution has obtained its practical meanings through regulatory con-
flicts, more than by explicit interpretation or application of an a priori principle.  
The project draws the conclusion that the diversity of views of member states is not 
considered impeding coherent policy or decisions. Through dynamic tensions among 
different accounts regulatory expert-procedures identified and addressed more scien-
tific uncertainties than before. Thus, the precautionary principle helps to raise new 
questions about various unknowns in risk assessment. It shall be a flexible policy 
framework offering stronger means for shifting and clarifying regulatory criteria.  
Options for action 
The project analysed the need of common regulatory standards on EU level in order 
to handle existing expert conflicts. The establishment of the EFSA was an important 
step towards harmonizing the different understandings trough objective scientific 
advice. It is designed to override and reconcile national regulatory differences. How-
ever, the project made clear that on the EU-level different views are not being re-
spected unless they are based on relevant scientific arguments. According to EFSA, 
Member States shall supply the necessary data and explain their scientific basis for 
different options within their risk management. 
Identified future issues: 
In future, this might stimulate more transparency in framing uncertainty and assign-
ing a burden of evidence. Since many risks are not clarified yet, a great burden is 
born on science and expert judgements. Consequently common regulatory standards 
shall provide a more rigorous and transparent basis to deal with legitimacy problems.  
Another future issue identified by this project is the broader participation of the pub-
lic and stakeholders. The involvement of diverse stakeholders, including critical sci-
entists and NGOs, can help to ensure that as many relevant questions as possible are 
addressed. 
IMPACTS AND FOLLOW UP OF THE PROJECT 
In every participating country as well as on the EU level a workshop with stake-
holders such as regulators, scientists, industry and NGO representatives was held, 
where comments were collected and incorporated into the final report. These work-
shops took on different shapes in every country; in Austria, it was held as a “meeting 
on neutral grounds” between regulators from different ministries and scientists in 
order to explore policy future options. 
 12 
The results of the project were published in a special issue of the scientific journal 
Science and Public Policy (32/4, 2005) and, individually, in various other scientific 
journals by several project team members. 
CHALLENGES IDENTIFIED 
The relation between scientific advice and political decision making on GM plants 
remains precarious despite agreed policy principles such as precaution. Rather than 
suggesting a once-and-for-all procedure with fixed and scientifically unambiguous 
criteria for the assessment of new GM plants, the authorisation, application and mar-
keting of such plants and their products remain politically sensitive and open for ne-
gotiation. The issue turns out not to be able to be dealt with on the basis of science 
and law only, so that changes in the decision making due to political considerations 
will have to be taken into consideration in the future as well. 
LITERATURE 
Special issue on precautionary expertise for EU agbiotech regulation. Science and Public 
Policy 32(4), August 2005 
AUTHOR OF THE REVIEW 
Helge Torgersen 
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RISK ASSESSMENT OF GMO PRODUCTS IN THE EUROPEAN 
UNION. TOXICITY ASSESSMENT, ALLERGENICITY 
ASSESSMENT AND SUBSTANTIAL EQUIVALENCE 
IN PRACTICE AND PROPOSALS FOR IMPROVEMENT 
AND STANDARDISATION (2004) 1.3 
BACKGROUND OF THE PROJECT 
Context 
Toxic and allergenic properties are considered focal aspects in the assessment of po-
tential health risks of GM food. In contrast to other regulatory contexts such as che-
micals, plant pesticides and food additives, detailed requirements for toxicity and 
allergenicity assessment have not been put into concrete terms until recently. During 
the time this study was carried out there was no detailed guidance available at all1. 
However, a number of genetically modified plants (GMPs) had already been author-
ised under Directive 90/220/EEC and the Novel Food Regulation. The authors state a 
distortion between the provided guidance for risk assessment and the complex situa-
tion characterised by rapid scientific progress, varying interpretation of EU regula-
tion by the national authorities, and pressures from industry and public interest 
groups. The assessment practice resulting from this constellation is described as be-
ing time-consuming and inconsistent. 
Demanding institution 
The present monograph was funded by the Austrian Federal Ministry for Agriculture, 
Forestry, Environment and Water Economy and the Austrian Federal Ministry for 
Health and Women. The research that provided the basis for this document (two pre-
ceding studies in German language) was financed by the Austrian Federal Ministry 
for Work and Labour and by the Austrian Federal Ministry for Health and Women. 
Parliamentary documentation states that this compilation was carried out by order of 
the Austrian Federal Ministry for Health and Women.  
Guiding questions 
Which risk assessment practices exist regarding potential toxic and allergenic proper-
ties of GMPs? How would a consistent toxicity and allergenicity risk assessment 
approach look like? Which shortcomings can be identified in current risk assess-
ment? Out of this review of the state-of-the-art, which proposals may be given in the 
context of recent regulatory developments for guidance documents etc.? 
                                                 
1 The authors mentioned the guidance document of EU’s Scientific Steering Committee 
(SSC) that lists toxicity and allergenicity of gene products as issues to be considered. At 
present, there is the EFSA GMO panel’s Guidance Document for the assessment of 
GMPs published in April 2004 (as an updated version of the SSC document) and actu-
alized in 2006. This document more extensively addresses the aspects of toxicity and al-
lergenicity. 
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BASIC DATA ABOUT THE PROJECT 
Type of the project, methods 
The present monograph is an abridged and condensed but updated English version of 
the content, conclusions and recommendations of two earlier research projects car-
ried out in German language with the main goal to review the practice of risk as-
sessment procedures on GMPs in the EU.  
The practice of toxicity and allergenicity assessment was scrutinised in a range of 
Directive 90/220/EEC and Novel Food Regulation dossiers. Relevant dossiers were 
selected, investigated and their respective assessment procedure described. The dif-
ferent approaches to risk assessment were compared and evaluated. A literature re-
view on the concept of substantial equivalence was also implemented. Based on this, 
the study elaborates proposals aiming at improvement and standardisation of risk 
assessment procedures. Surveys on toxicity and allergenicity assessment in regula-
tory documents covering GMPs in Europe and the US provided information which 
was included in the conclusions and proposals. 
Topics 
> current practice of toxicity and allergenicity assessment 
> its shortcomings 
> requirements for a comprehensive toxicity and allergenicity assessment 
> proposals for improvement and standardisation of risk assessment regulation and 
practice 
Duration 
The two studies that form the basis of the present English version were conducted 
between 2000 and 2003. The English paper was first published in July 2004. 
Participants 
The current English version is authored by a subset of the original project team 
which consisted of scientists from the Austrian Federal Environment Agency, the 
Inter-University Research Centre for Technology, Work and Culture (IFZ) Graz, the 
ARC Seibersdorf Research GmbH, the Research Center for Biotechnology, Society 
and the Environment at the University of Hamburg and a range of individually con-
tracted experts. 
The subset of this team and, hence, the authors of the updated English version are: 
Armin Spök (IFZ), Heinz Hofer (ARC Seibersdorf), Petra Lehner and Rudolf Valen-
ta (contracted), Susanne Stirn (University of Hamburg), and Helmut Gaugitsch (Aus-
trian Federal Environment Agency). 
Events 
In the course of the investigation, various internal project workshops were held. 
 15 
Prior to publishing the English version an international conference was held in au-
tumn 2003 in Vienna, where the outcomes of the two preceding studies were dis-
cussed and a fundament for the updated English version was laid. Besides some of 
the studies’ authors, a representative of the European Commission (Andreas 
Klepsch) and a member of the environmental NGO Global2000 gave lectures. 
MAJOR OUTCOMES OF THE PROJECT 
Central findings 
With regard to the toxicity and allergenicity assessment procedures and the use of the 
concept of substantial equivalence, the study points out significant shortcomings in 
the dossiers based on Directive 90/220/EEC, as well as in the Novel Food Regulation 
dossiers: 
> The formal structure of the risk assessment approach is not based on and does not 
clearly distinguish between exposure assessment and hazard assessment (which 
are both necessary). The claims of substantial equivalence are frequently based on 
trials and analysis that are not properly designed. 
> Assessments and conclusions drawn often cannot be entirely verified given the 
lack of details. 
> Although the overall approaches in risk assessment are similar in the dossiers, 
differences became evident at the level of details – this fact points to a lack of de-
tails in the guidance documents. 
> Safety conclusions are often based on indirect evidence and/or assumption based 
reasoning, and they are partly based on questionable methods, approaches and as-
sumptions. 
> Unintended effects of genetic modification are usually not investigated and even 
dismissed. Significant differences found in compositional analysis are disre-
garded.  
Options for action 
Proposals were developed aiming at further improvement and standardisation of risk 
assessment: 
> The structure of risk assessment approaches and dossiers should be standardised. 
> The role of substantial equivalence for risk assessment should be further clarified. 
> Significant differences in the results of analysis of the same GMPs should at least 
trigger repetition of the analysis. 
> Dossiers should be “stand-alone” documents, including full reports of available 
safety studies, quoted literature, statistical evaluation sheets for compositional 
analysis, and thorough description of methods applied. 
> The direct testing of toxic or allergenic properties should be preferred compared 
to indirect testing and assumption based reasoning. 
> Testing should be extended to include whole-plant/whole-food testing. 
 16 
Identified future issues 
The authors mention that some of these proposals have already been included in most 
recent guidance documents. Others might require further discussion and even addi-
tional studies – the particular minimum set of toxicity endpoints, for example. Some 
proposals might require further improvement of testing methods or even the devel-
opment of new methods. 
IMPACTS AND FOLLOW UP OF THE PROJECT 
Parliamentary debate 
Austria refers to the study in an EU meeting of the Standing Committee on the Food 
Chain and Animal Health, claiming a comprehensive toxicological risk assessment as 
described in the study. In the Austrian Parliament there is no immediate discussion of 
the study. However, it details and shapes the Austrian position on GMP risk assess-
ment issues. 
Scientific recognition and public perception 
An article based on the present study and written by some of its authors (together 
with other scientists) was published in the International Archives of Allergy and Im-
munology (137/2005). 
Furthermore, the work is cited in Science, Technology & Human Values (32/1), in a 
Press Release of the Institute of Science in Society, and in a Nature Biotechnology 
correspondence. It was presented on the Third World Network’s website and men-
tioned as additional material by the Third Meeting of the UNEP Ad Hoc Technical 
Expert Group on Risk Assessment. 
CHALLENGES IDENTIFIED IN THE PROJECT 
At the time of this English paper’s publication, the 2003 SSC guidance document 
was the state-of-the-art standards on GMP risk assessment. As mentioned, it contains 
some of the proposals made by this study, as, for example, the need of complete dos-
siers containing all information required for a full risk assessment. Other aspects, 
however, remain unclear, ambiguous, or disregarded: Good Laboratory Practice is 
only demanded for toxicological studies. The SSC guidance is ambiguous with re-
gard to the toxicological testing of the introduced proteins. The possibility of secon-
dary effects is acknowledged, but in a more limited way than in this monograph. Fur-
ther guidance for homology studies than the indications given by the SSC document 
is needed. Unlike the case-by-case basis favoured by the SSC guidance notes, this 
paper proposes compositional analysis for all processed products. 
Taking into account these differences, this monograph sees the challenges in address-
ing the shortcomings still remaining. If this is not accomplished by further and better 
regulation, risk assessment practice on toxicity and allergenicity is still to be called 
deficient. 
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LITERATURE 
Spök, A., Hofer, H., Lehner, P., Valenta, R., Stirn, S., Gaugitsch, H. (2004): Risk As-
sessment of GMO Products in the European Union. Toxicity assessment, allergenic-
ity assessment and substantial equivalence in practice and proposals for improve-
ment and standardisation. Austrian Federal Environment Agency. Wien 
AUTHOR OF THE REVIEW 
Helge Torgersen 
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FEASIBILITY STUDY ON »GMO-FREE« CLAIMS AND 
THE AVOIDANCE OF GMOS IN FOOD (2005) 1.4 
BACKGROUND OF THE PROJECT 
Context 
The study bases its predications regarding to the feasibility of a correct use of the label 
“GMO‐free”, on  the one hand, on  the definition according  to  the Codex Alimentarius 
Austriacus and, on the other hand, on the EU‐regulation 1829/2003 concerning the (not 
required) labelling of animal feed and comestibles as GMO.  
The public debate on GMOs  in Austria was a more critical one compared  to other EU 
Member States. Moreover,  it was characterised by an unusual common understanding 
between political representatives, social movements and significant parts of the agricul‐
tural sector. This constellation led to a more restrictive handling of the label “GMO‐free” 
in Austria. For example, the Austrian label requires additional standards concerning the 
application of production facilities, the fabrication of additives, and feeding.  
The study was carried out while the use of GM‐seeds in Austria and other EU Member 
States was prohibited by regulations of  the EU‐Council. Hence,  the possibility was ex‐
cludable that in Austria and large parts of the EU there would be GM‐seeds employed. 
In case of additives, the situation in the year 2005 was already different: some of them 
were almost exclusively accessible from sources involving GM‐micro‐organisms. 
Demanding institution 
The Austrian Federal Ministry of Health and Women, the Austrian Federal Ministry of 
Economics and Labour and the AMA Marketing GesmbH assigned the Austrian Agency 
for  Health  and  Food  Safety  with  the  realisation  and  coordination  of  this  feasibility 
study. 
The  study was  realised  in cooperation with  the University  for Natural Resources and 
Applied  Life  Sciences  and was  continuously  evaluated  by  Prof. Maurer,  head  of  the 
former Ludwig‐Boltzmann‐Institute for Organic Farming and Applied Ecology and now 
chairman of the new Bio Research Austria Institute. 
Guiding questions 
> Is there a transfer of GMOs from animal feed to derived food products? 
> Are the raw materials and additives for feed production available? 
> From the viewpoint of nutritional requirements, is the use of GMO-free feeds fea-
sible? 
> Does a GMO transfer happen via bee products? 
> What strategies and efficient monitoring exist to avoid GMO contamination? 
> From an economical viewpoint, is the use of GMO-free feeds feasible? 
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BASIC DATA ABOUT THE PROJECT 
Type of project 
The present project is a feasibility study that tries to estimate the existing possibilities 
(taking into account nutritional requirements, economical factors and constraints, 
etc.) to accomplish the requirements established in the legal frameworks in Austria 
and the EU. A broad inquiry into Austrian and international scientific studies and 
publications forms the basis of this study. The study investigates legislative texts and 
economical measures (market prices; amounts of consume and production of seeds, 
etc.), and undertakes some basic calculations to estimate the differential costs for the 
production of food applying GMO-free feeds.  
Topics 
The topics addressed by the study are basically the legal situation for the denomina-
tion of a product as “GMO-free” in Austria and the EU, the necessities to meet the 
legal requirements and control their compliance (monitoring) and the additional costs 
of gaining the “GMO-free” label. Besides, the world agricultural product market is 
taken into consideration regarding the availability of indispensable import products.  
With these concrete topics the main problematic of the feasibility of GMO-free pro-
ducts appropriate to the current legal frameworks is addressed. 
Duration 
The study was commissioned in late autumn 2004, finished and published in No-
vember 2005. 
Participants 
> Austrian Agency for Health and Food Safety: Leopold Girsch (project manage-
ment),  
> Institute for Seeds: Natascha Balarezo (internal project coordination), Christine 
Kargl 
> Institute for Animal Feed: Veronika Kolar, Thomas Kickinger, Herbert Würzner 
> Vienna Institute for Comestible Testing: Rainer Bernhart, Klaus Riediger 
> Risk Assessment: Roland Grossgut, Daniela Hofstädter 
> Institute for Apiology: Rudolf Moosbeckhofer 
> Biochemistry Competence Centre: Hermann Hoertner, Rupert Hochegger 
Subcontracts 
> University for Natural Resources and Applied Life Sciences (Institute for Market-
ing and Innovation): Siegfried Pöchtrager, Josef Penzinger, Stefan Großauer 
> Evaluation: Ludwig Maurer 
Events 
The study was presented to a broad range of interest groups at the end of 2005. On 
November 2nd, 2005, there was a press conference at the Austrian Agency of Health 
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and Food Safety in Vienna. In the following weeks until February 2006 there were 
presentations, for example, for the Chambers of Agriculture of Austria, Upper Aus-
tria, Styria and Lower Austria and other communities of the agricultural sector.  
MAJOR OUTCOMES OF THE PROJECT 
Central findings 
> No evidence was found in the international scientific literature stating that even 
traces of transgenic DNA were detectable in foods derived from animal produc-
tion after feeding GM-feed.  
> 90% of the imported soy used for feeding in Austria is transgenic. The global 
share of GM-soy is still increasing. However, following the requirements from the 
EU directive 1829/2003, in a short- and medium-term raw materials for animal 
feed production which do not have to be labelled as GMOs will be available. With 
respect to the provisions established by the Austrian Codex, protein substitutes for 
soybean extraction meal produced in Austria and the EU will be available. It has 
to be said that these substitutes can only be used to a certain limit and no forecast 
can be given for the development of the raw material markets. In terms of the ad-
ditives for animal feed production, there are products available which do not re-
quire labelling in accordance with the EU-directive but would so according to the 
Austrian law.  
> Feasibility of the usage of feed labelled as GMO-free: following the EU directive, 
it is feasible in a short- and medium term; following the Austrian Codex, it is fea-
sible only for cattle but not for pigs, poultry and turkey (because of the necessary 
additives) 
> The content of pollen in honey is usually noticeably below the labelling threshold 
levels in accordance with the EU-directive.  
> Monitoring and strategies to avoid contamination: self-control of the companies; 
separated and closed production processes; appropriate cleaning; more provisions 
in monitoring and surveillance for the Austrian label 
> The use of animal feed containing soybean extraction meal labelled as GMO-free 
or not requiring labelling leads to additional costs of up to over 8%. These costs 
vary considerably depending on the line of production (beef, pigs, etc.). In the fu-
ture, by-products from bio-fuel production that contain protein and are available 
in Austria and the EU will be commercially employable as a protein supplying 
substitute for soybean extraction meal.  
Options for action 
> enhance the production of substitutes for soybean (for example, from bio-fuel 
production) 
> try to assure a reliable labelling in the world market’s production chains 
> try to safeguard Austria’s share of Brazilian and US GMO-free soybeans 
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Identified future issues 
> monitor the world raw material market’s development and the share of available 
and affordable GMO-free products 
> integrate more aspects into the calculations of the additional costs 
IMPACTS AND FOLLOW UP OF THE PROJECT 
Parliamentary debate 
The Federal Minister of Agriculture, Forestry, Environment and Water Management 
mentioned in a parliamentary inquiry presented by the Green Party in the year 2006 
that the present study was presented to the ministerial working group on genetic en-
gineering. Moreover, he cited the study’s insights into the additional costs and tech-
nical needs for contamination prevention. In another parliamentary inquiry in 2004, 
also presented by the Greens, the same Minister explains the financing and planning 
of the study. He says, inter alia, that there was (as usual) an interchange on the plan-
ned contents with the relevant experts, on beforehand. Also in the regional Parlia-
ment of Salzburg the study was subject of a parliamentary inquiry. 
Interestingly, the study was cited in a parliamentary debate in the German Bundestag 
by Christel Happach-Kasan (FDP). She exposed and interpreted the study’s finding 
that GM-free pig and poultry breeding is quite impossible because of the additives 
needed. Not using genetic engineering technologies would lead to a higher mortality 
in the animal stocks. There was disagreement expressed by the German Greens.  
Public perception 
After the press conference on November 2nd, 2005, there was ample recognition of 
the study in local media and partially in the German-speaking world. The Austrian 
Press Agency published an article delivered by the Agrarian Information Centre. The 
ORF (the Austrian public news channel) reported, too. 
Furthermore, the study was mentioned by the Austrian Federal Chamber of Com-
merce. Details were cited by the Austrian Chamber of Labour, Greenpeace, Austrian 
agricultural communities such as BioAustria, the German Information Service on 
Genetic Engineering (Informationsdienst Gentechnik) and other German citizen’s 
action committees. 
The public perception of the study is characterised by the conclusion that GMO-free 
production of comestibles is feasible, principally, but there are some costs to take 
into account. However, there are also new opportunities for the Austrian agriculture, 
especially concerning the production of GMO-free substitutes for soy from bio-fuel.  
Scientific recognition 
A research paper of the Austrian Federal Ministry of Health and Women on the need 
to label GMOs already pointed to the study in 2005, before its finishing.  
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CHALLENGES IDENTIFIED IN THE PROJECT 
The development of the international market for reliable GM-free seeds and feed can 
not be predicted and lies outside the Austrian room for manoeuvre. The availability 
of GM-free additives is already quite limited.  
LITERATURE 
Austrian Agency for Health and Food Safety/University for Natural Resources and Ap-
plied Life Sciences, Vienna (2005): Feasibility Study on “GMO-free” claims and the 
avoidance of GMOs in food. 
AUTHOR OF THE REVIEW 
Helge Torgersen 
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COEXISTENCE (2005) 1.5 
BACKGROUND OF THE PROJECT 
The cultivation of genetically modified crops is growing steadily and fast in the ulti-
mate years, mostly in North and Latin America. In the EU there is already an exten-
sive set of legislation on the regulation, admission and limitation of GMO cultiva-
tion, import etc.  
In 2003, the European Commission released the Recommendation No. 2003/556/EC 
on guidelines for the development of national strategies and best practices to ensure 
the coexistence of genetically modified crops with conventional and organic farming. 
The Commission underlined that these guidelines should focus on economic conse-
quences of GMO cultivation given that ecological and health aspects are already 
taken into account in the GMO admission procedure. The scope of the guidelines 
spans from the agricultural production to the first point of sale – higher levels of 
elaboration are not considered. In addition, national catalogues of measures, as to be 
defined by the member states, should allow for every country’s specificities regard-
ing topography, climate, the agricultural structures and the production systems. The 
Commission’s Recommendation together with the country’s implementation strate-
gies should ensure that the compliance with the threshold values for non-GMOs is 
not impeded by the diversity of the producing regions, the productive systems and 
technical matters. 
The Austrian situation in the domain of green biotechnologies is characterised by a 
quite restrictive legislation and a broad GM-critical consensus between the political 
parties, farmers, interest groups, NGOs and the public. Seeds in the initial examina-
tion have to be free of GM contaminations to be authorised in Austria. In the follow-
up examination a threshold value of 0,1% is fixed. 
BASIC DATA ABOUT THE PROJECT 
The present study was conducted (under the guidance of Prof. Georg Grabherr) by 
Kathrin Pascher and Marion Dolezel from Vienna University’s Department of Con-
servation Biology, Vegetation Ecology and Landscape Ecology between the end of 
2003 and March 2005 on behalf of the Austrian Federal Ministry for Health and 
Women (Section IV). The overall goal of the document is to define rules and meas-
ures providing a general framework for coexistence of GM-, conventional and bio-
logical crops for the specific Austrian case as demanded by the Commission’s Rec-
ommendation. The authors argue that measures for the cultivation of GM-crops 
would assure the farmers the possibility of planting just the crops they want to, as 
well as the consumers the security and freedom of choice they look for.  
Following the Commission Guidelines which establish that the measures have to be 
crop-specific, the study focuses on maize, oilseed rape and sugar beet – for the au-
thors primarily expect these crops to be commercially cultivated as GMOs in Europe. 
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Sources of GM-contaminations are outlined and evaluated, then the measure propos-
als for the reduction of these contaminations are given and experiences from other 
countries with coexistence of the mentioned crops are incorporated.  
The project was realised in terms of a scientific study from an eco-biological per-
spective. In the course of the project, the authors attended a series of conferences and 
lectures, amongst others the 1st European Conference on the Coexistence in Den-
mark, a conference on GMO Risk Assessment in Vienna, other forums on coexis-
tence in Austria and a Conference of the European network of GMO-free Regions. 
There were basically two methods applied: Firstly, a theoretical evaluation of the 
problematic of coexistence and contamination by means of a review of existing stud-
ies of a European and non-European institutions and authorities (FiBL, Union of 
Concerned Scientists, BUWAL, JRC, MAFF, MAF), literature databases, organisa-
tional websites (saveourseeds.orf, transgen.de, biosicherheit.de, ucsa.org, etc.), per-
sonal contacts to Austrian authorities, organisations and firms (AGES, Saatbau Linz, 
ZAMG, Chambers of Agriculture, etc.), and conference attendance. Secondly, GMO-
crop growing was simulated for different Austrian regions. The amount of field 
losses due to the necessary belts of isolation (to avoid exogamy) was simulated for 
random and clustered repartition of GM-crop fields in the cases of maize, oilseed 
rape and sugar beet.  
MAJOR OUTCOMES OF THE PROJECT 
The study’s outcome is a catalogue of measures to prevent contamination with 
GMOs and to delineate the exigencies of a reasonable coexistence.  
In the case of maize, the use of barriere-plants or of varieties with different flowering 
dates will not be sufficient to reduce GMO contamination rates to 0,9%. Isolation 
distances of at least 200m seem to be the only viable measure to guarantee this quota. 
However, if GM proportions grow beyond 10% and if a threshold value of 0,1% in 
the harvest is to be realised, cultivation, harvest and post-harvest processes have to 
be thoroughly separated and cross fertilisation completely avoided. Not even isola-
tion distances of one to several kilometres could assure this due to other factors that 
until now couldn’t be exhaustively studied – the establishment of large-scale GMO 
free zones would be the only possible way to guarantee these low threshold values. 
Imports of basis seeds and possible cross fertilisation are the crucial points for con-
tamination control in oilseed rape. Necessary measures for the consumption produc-
tion are, therefore, a purity control of the imported basis seeds, long growing inter-
vals of at least 8 to 12 years (to reduce volunteers of oilseed rape) and isolation dis-
tances of 4 kilometres (allowing for the flying distances of pollinating insects). Re-
gional and continuous examinations of their effectiveness could facilitate more flexi-
ble isolation distances. The management of the segetal weed flora, barriers with non-
GM oilseed rape and the removal of bee hives near the fields seem to be viable 
measures, too. Transportation routes should be as short as possible. However, the 
creation of a closed seed production area would be the most effective measure. Con-
sidering the specificities of agronomic and topographic structures, climatic particu-
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larities, the necessary extent of the isolation zones, regional occurrence of volunteers, 
etc., the authors argue that coexistence of oilseed rape will not be feasible in Austria.  
Sugar beet for consumption is not flowering. Hence, the unwanted hybridisation 
events affect seed production areas. To achieve a threshold value for GM contamina-
tion of 0,5% much larger isolation distances than the currently widespread 300, 600 
or 1000m would be needed. The highest risk is currently posed by imported seed. 
Reliable choice and control is needed; moreover, suitable cultivars, coordination of 
farmers, at least 2 kilometres of isolation distance, control of bolters, weed beets, 
volunteer beets and Beta-forms. Pollen barriers should be used and a crop rotation of 
at least eight years guaranteed. 
Beyond these crop specific arguments the study presents measures to avoid technical 
contamination at cultivation and harvest. The technical processes of GM and con-
ventional or organic field crops should either be completely separated or strict guide-
lines for adjustment, operation and cleaning measures should be provided and de-
manded. Seeding and harvesting machines have to be cleaned before and after their 
application for GM crops. Losses during the transport must be prevented, hoppers 
cleaned and controlled, contracts established (e.g. between vicinal farmers on loca-
tion of their fields or on the requirements and criteria for a joint use of machines), 
etc. 
IMPACTS AND FOLLOW UP OF THE PROJECT 
A Green Party’s delegate to the National Assembly asked the Federal Minister of 
Health and Women and the Federal Minister of Agriculture, Forestry, Environment 
and Water Management in a written parliamentary request about the costs of coexis-
tence in Austria. As an initial point he cited the present study which, in his interpreta-
tion, comes to the conclusion that the coexistence of GMOs and conventional and 
biological products is possible, if at all, only with high technical and organisational 
efforts.  
The study is also cited by further studies of the Federal Ministry of Health and 
Women and the Austrian Agency for Health and Food Security, the network of 
GMO-free regions and an Upper-Austrian text introducing this region’s characteris-
tics and the structure of its economy. In a slightly different reading some of the 
study’s findings are presented in an information letter of Les Professionels des 
Semences et de la Protection des Plantes, a French syndicate of the seeding indus-
tries. They mention that the study posits the possibility of coexistence always re-
specting the right isolation distances. It is just rape where coexistence doesn’t seen 
viable in Austria. 
CHALLENGES IDENTIFIED IN THE PROJECT 
The study’s tenor is that coexistence is possible in some cases but not in all. And 
even if it is possible this would lead to economical and social costs and much regula-
tory work on a national base. The mentioned feasible measures to assure coexistence 
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are presented in a sceptical light. The whole issue of coexistence seems to be a prob-
lematic one since it is at least an expensive endeavour and potentially impossible, at 
the end. The reader could get the impression that the study provides and tries to pro-
vide scientific arguments underpinning GM-critical positions.  
LITERATURE 
Pascher, K., Dolezel, M. (2005): Koexistenz von gentechnisch veränderten, konventio-
nellen und biologisch angebauten Kulturpflanzen in der Österreichischen Landwirt-
schaft – Handlungsempfehlungen aus ökologischer Sicht. Bundesministerium für 
Gesundheit und Frauen, Sektion IV, Band 2/05, Wien 
http://www.bmgfj.gv.at/cms/site/standard.html?channel=CH0810&doc=CMS1113
391269254 English summary: 
http://www.bmgfj.gv.at/cms/site/attachments/6/4/4/CH0810/CMS1113391269254/
summary_-_coexistenz.pdf 
AUTHOR OF THE REVIEW 
Helge Torgersen 
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THE ROLE OF PRECAUTION IN GMO POLICY (2006) 1.6 
BACKGROUND OF THE PROJECT 
Context 
In the year 2000, the European Commission published the so called Communication 
on the Precautionary Principle. This document proposed guidelines for the handling 
of scientific uncertainty. Since then, precautionary language and criteria have been 
integral part of the respective legislation, for instance, in the Deliberate Release Di-
rective concerning GM crops or the Biosafety Protocol. Today, the Precautionary 
Principle (PP) is firmly established in European law. 
Notwithstanding, the principle has not ceased to be contentious and much less to be 
interpreted in different ways. Besides the narrow account of the European Commis-
sion’s document, there are broader ones from other sources like the European Par-
liament, experts, member states and stakeholders. The project “Precautionary Exper-
tise for GM crops” (see section 1.2) studied varying understandings and applications 
of the PP within and between 7 European States. The scenario in Austria could be 
sketched as characterised by a wide GMO-critical political consensus between gov-
ernment, stakeholders and the public, despite divergent concepts of precaution.  
Demanding institution 
The present conference was initiated jointly by the Austrian Federal Ministries of 
Agriculture, Forestry, the Environment and Water Management and of Health and 
Women. The Federal Environment Agency was responsible for realisation. The con-
ference took place in the frame of the Austrian EU-Presidency in the first half year of 
2006. The actual and possible development of the PP in GMO policy was examined 
from legal, scientific, and political perspectives as well as on the basis of case studies 
at national, EU and international levels.  
Guiding questions 
> What different interpretations of the PP exist? 
> Is there room for the principle in the EU legislative framework and how is it spe-
cified? 
> What are practical experiences with the principle? 
> What is the scientific background to be taken into account? 
BASIC DATA ABOUT THE PROJECT 
Type of project and duration 
The project was an international and interdisciplinary expert conference held at the 
Hofburg in Vienna with the participation of experts and stakeholders from a scien-
tific and a political background. It took place on the 18th and 19th of April 2006.  
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Topics 
Relevant aspects of the precautionary approach towards regulation of GMOs were 
addressed. The main topics discussed were possibilities and limits of precautionary 
measures within the existing legal framework, the scientific background of precau-
tionary approaches, as well as the practical experiences of putting to use the princi-
ple.  
Some of the contributions’ subject areas were how EU legislation on GMOs relates 
to and gives room for the PP, how and where it is discussed controversially, how it is 
interpreted in the CEE countries and what were practical experiences with the use of 
the principle, as well as the question of risk assessment. 
Participants 
Approximately 135 scientists, state and interest group representatives  
Speakers: (in order of appearance): 
> Hugo-Maria Schally (Chairperson), DG Environment, European Commission 
> Christine von Weizsäcker, Germany 
> Kathryn Tierney, DG Environment, European Commission 
> Liina Eek, Ministry of the Environment, Estonia 
> David Wield, Open University, UK 
> Eric White, Legal Service, European Commission 
> Thomas Jakl (Chairperson), Ministry for Agriculture, Forestry, Environment and 
Water Management, Austria 
> Brian Wynne, Centre for the Study of Environmental Change, Lancaster Univer-
sity, UK 
> Jürgen Zentek, Freie Universität Berlin, Germany 
> Christopher Pollock, Institute for Grassland and Environmental Research, UK 
> Margaret Mellon, Union of Concerned Scientists, USA 
> Katja Moch, Öko-Institut Freiburg, Germany 
> Michel Haas (Chairperson), Ministry for Health and Women, Austria 
> Brian Wynne on behalf of David Gee, European Environment Agency 
> Harry Kuiper, GMO-Panel EFSA, RIKILT – Institute of Food Safety, The Nether-
lands 
> Jan Husby, Norwegian Institute of Gene Ecology, Norway 
> Simon Barber, Plant Biotechnology Unit, EuropaBio 
> Helmut Gaugitsch, Federal Environment Agency, Austria 
IMPACTS AND FOLLOW UP OF THE PROJECT 
It was concludingly addressed by Helmut Gaugitsch that there is a need for a follow-
up. A good starting-point would be the discussion on the PP and ways towards its 
application. Kathryn Tierney (EU Commission) enunciated that the debate on GMOs 
and the PP would continue at the EU Environmental Council in Luxembourg in June 
2006. 
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There was no parliamentary debate on the conference. However, it was presented by 
the authorities as an asset in the Austrian EU-presidency 2006 to address the issue in 
such an international expert conference, bringing forward the respective EU-wide 
discussion. The national press (Der STANDARD, 20.4.2006) reported in a short 
statement. The Institute for Applied Ecology (Freiburg/Germany), the USDA For-
eign Agricultural Service, biotrin.cz and the Biosafety Information Centre mentioned 
the conference on its website. 
MAJOR OUTCOMES OF THE PROJECT 
Central findings 
As Helmut Gaugitsch in his closing remarks points out, there is broad consensus 
around an understanding of the PP as one of the central aspects of European GMO 
legislation. It was described as a tool that allows countries to adopt the level of pro-
tection that was felt necessary, even in the absence of scientific certainty. However, 
it remains questionable whether there is a common understanding of the PP and the 
way it can or should be implemented.  
Regarding the question whether the PP is a risk management issue only, it became 
clear that risk assessment on its own is an important prerequisite for decision making 
but not enough as it is inadequate to assess uncertainty, by definition cannot assess 
ignorance and also falls short of acknowledging any benefits. As Bryan Wynne ex-
pressed it, precaution should rest on the recognition that knowledge is always lim-
ited. The assumption that the need for precautionary policy can be subjugated to pre-
liminary risk assessment is misconceived. 
The PP should contribute to protection and not protectionism and should be used to 
gain further scientific knowledge. It was stated that the PP can be a possible instru-
ment of scientific innovation. 
There were also voices who proposed a modification of EFSA’s format and inner 
EU-communication on orientations toward the PP. Others, again, expressed the opin-
ion that Europe-wide universalist approaches to the PP, maybe, will not work (con-
sidering that some regions see commercial benefits in being GM-free etc.). There 
will not be a single understanding and application of the PP. Particularly “ecologi-
cally sensitive” areas will have different approaches, for example. 
Eric White from the European Commission’s Legal Service claimed that the PP is 
alive and perfectly compatible even with the WTO.  
Options for action and identified future issues: 
> continue to discuss the concept of the PP in the national, EU and international 
level towards application and action 
> discuss the different national and EU wide conceptions of the PP to get to a more 
common understanding 
> elaborate mechanisms to include statements on the application of the PP in GMO 
product notifications 
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> improve, harmonize and standardize the risk assessment instruments nationally 
and EU wide (should include guidance on which kind of data should be included 
in notifications and the methodology to generate them), keeping a balance be-
tween clear guidance and case-by-case sensibility 
> in order to gain further knowledge on GMOs and to address uncertainty and igno-
rance, research projects could and should take approaches as the PP more into ac-
count 
> enter into a dialogue with stakeholders (and involve them) at the national and the 
EU level and between them; risk communication should be improved and a sys-
tem for public participation needs to be set up 
CHALLENGES IDENTIFIED IN THE PROJECT 
A considerable challenge identified is to find ways from the PP to an applicable ap-
proach and action and to define its relation to the risk assessment framework. The PP 
should not be used as a technical barrier to trade and a tool for protectionism. 
There lies a twofold challenge in the concept of PP as it is present in nowadays’ leg-
islation and practice: On the one hand, the PP has to be elaborated and discussed on 
general grounds, looking for ways to apply and regulate it. On the other hand, the 
various interpretations of the principle have to be consorted.  
The EU legislative framework has to be fine-tuned to provide for a higher degree of 
transparency and thus to fulfil the expectations on decision-making.  
It was argued that the “Sound Science” approach (firmly present in the US policies), 
with its accents on delaying safety obligations until causal chains of harmful impacts 
are fully proven, runs counter the PP – with this, originating a possible and already 
manifest conflict between the US and Europe (see the current WTO dispute). The EU 
could possibly use the “de facto coalition” with the developing countries in favour of 
the PP, to enforce its position and foster its understanding of protection.  
LITERATURE 
Federal Ministry of Health and Women (Ed) (2006): Conclusions of the conference 
"The Role of Precaution in GMO policy", 18.-19. April 2006, Vienna 
http://www.bmgfj.gv.at/cms/site/standard.html?channel=CH0810&doc=CMS1145
612477419 
AUTHOR OF THE REVIEW 
Helge Torgersen 
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DENMARK 2. 
GENETICALLY MODIFIED FOODS (1999) 2.1 
BACKGROUND OF THE PROJECT 
The DBT- project “Genetically modified foods” from 1999 was carried out due to 
the apparent scepticism among the Danish population. At that time, genetically modi-
fied foods were about to enter the Danish market, but it seemed that the Danish con-
sumers did not associate any direct advantages with them. However, it was impossi-
ble to reject that benefits would eventually emerge in step with the development of 
the technology.  
At that time, legislation on genetically modified foods had not yet been completed 
within the EU and the potential benefits and risks considering GM foods were still 
associated with much uncertainty. Thus, the aim of the project was to provide a 
multi-faceted public debate on GM foods in order to enhance the dialogue between 
decision makers and the public.  
BASIC DATA ABOUT THE PROJECT 
The project was designed as a consensus conference that took place during three 
days. The Danish Board of Technology appointed a panel of fourteen citizens who 
were asked to consider genetically modified foods. Before the actual consensus con-
ference, the citizen panel met twice and discussed GM foods based on some intro-
ductory information. At the conference, thirteen experts were invited to make a pres-
entation of their knowledge and opinion considering GM foods. During the two first 
days of the consensus conference the experts answered questions from and discussed 
with the citizen panel. Conclusively, the citizen panel created a final document con-
taining the evaluations and recommendations considering GM foods on which the 
panel could all agree.    
Through the consensus conference ten questions considering genetically modified 
foods were addressed both by the experts and the citizens. In the final document, 
each question is evaluated by the citizen panel and followed by some recommenda-
tions. The main topics that characterized the ten questions concerned amongst others: 
environmental impacts, human health, market conditions, national and international 
regulation, information, and ethics.   
MAJOR OUTCOMES OF THE PROJECT 
The consensus conference concluded that the production of genetically modified 
foods undoubtedly affects nature’s cycle. However, the experts strongly disagree 
about the seriousness of the effect and whether or not the effect is hazardous. Argu-
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ments for and against GM foods were discussed among the citizen panel and resulted 
in some recommendations. These recommendations emphasize some of the chal-
lenges that the further development of GM foods involves. 
The panel emphasized the importance of preserving the biodiversity of plants and 
animals and to protect the natural eco-systems. Thus, the citizen panel agreed that it 
should be possible to hold manufacturers of GM foods responsible for adverse ef-
fects on human health and the environment.  
The laymen panel believed that authorisations for tests and production of genetically 
modified organisms should be subjected to severe regulations for risk evaluation and 
requirements of efficient control. Further, public regulation was recommended as a 
means to offset monopolistic companies from controlling the market for GMO’s. It 
was also suggested that companies should lose their right of use for unapplied pat-
ents. The panel also supported the idea of a convention guaranteeing developing 
countries free access to utilising gene technology patents. Because biotechnological 
research to a wide extent is concentrated in the private sector, the panel recom-
mended that public funding for research in the field should be increased. 
The panel highlighted the importance of ensuring consumers still to be guaranteed a 
choice between genetically modified and non-genetically modified foods. It was fur-
ther emphasized that dissemination of information is crucial and that comprehensible 
and informative declarations of contents are necessary.  
The panel further recommended that ethical aspects should be given the same prior-
ity as purely technical aspects in relation to applications for testing, production and 
marketing of GM foods. Thus, the panel recommended that a committee charged 
with ensuring an ethical evaluation of the authorisation process should be estab-
lished.  
IMPACTS AND FOLLOW UP OF THE PROJECT 
The consensus conference kick-started a more widespread debate on genetically 
modified food in the public. The Danish Board of Technology found that the political 
interest in the field increased in the wake of the conference. Both national and EU- 
politicians showed interest in the project and were curious to know what the citizens 
worried about. 
CHALLENGES IDENTIFIED IN THE PROJECT 
Different challenges considering genetically modified foods and how to handle them 
appeared throughout the project. First of all it became clear that there is a conflict 
between experts when it comes to assessing the risks and benefits of GM foods. 
Hence, the project showed that experts disagree whether GM foods are predomi-
nantly beneficial or if they pose a threat to the environment and/or human health. 
These disagreements pose a challenge to the further discussions considering GM 
foods. Another challenge that was identified considered the question of monopoly 
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highlighting that knowledge about GM foods is only available to very few people. 
The question of responsibility was further a challenge that appeared during the con-
sensus conference; who can be held responsible if something goes wrong with GM 
foods? The challenge is to take such matters into consideration. The project further 
emphasized the importance of ethical considerations when dealing with genetically 
modified foods. Thus, the question is whether the utility value of GM foods matches 
up with the ethical issues.   
LITERATURE 
The Danish Board of Technology, (1999): Gensplejsede fødevarer. 
http://www.tekno.dk/pdf/projekter/p99_genspl.pdf; English summary: Genetically 
modified foods. http://www.tekno.dk/pdf/rtt_125_uk.pdf 
AUTHOR OF THE REVIEW 
Søren Gram 
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GENETICALLY MODIFIED CROPS IN DEVELOPING 
COUNTRIES – CHALLENGES FOR THE 
DEVELOPMENT AID (2003) 2.2 
BACKGROUND OF THE PROJECT 
The DBT project “Genetically modified crops in developing countries” were initi-
ated based on the conclusions of the UNDP’s Human Development report 2001, 
which focused on the role of ICT and biotechnology in the reduction of world pov-
erty. The report stated quite a clear position in favour of biotechnology by emphasiz-
ing an opposition to put restrictions on technological developments. Instead, the re-
port called on an examination of what it takes to control and exploit new technology 
in everybody’s interest. The UNDP report gave rise to immediate counter-reactions 
emphasizing that the problems of hunger and poverty in the third world countries are 
a matter of distribution because we already produce enough food to feed the whole 
world. Based on these counter-reactions the DBT set out to assess the pros and cons 
of using genetically modified crops to fight poverty and hunger in the third world. 
BASIC DATA ABOUT THE PROJECT 
The project ran from 2002 to 2003 and involved an interdisciplinary task force ap-
pointed by the Danish Board of Technology. The task force consisted of six experts 
all with specialist knowledge within the field of biotechnology and development aid 
respectively. The objective of the task force was to consider if, and how, dealing with 
GM crops should be an integrated part of the official, Danish development policy.  
The task force arranged three workshops where leading experts within selected areas 
presented and discussed experiences and the latest knowledge. The first workshop 
assessed the technical and environmental possibilities and risks regarding already 
existing biotechnologies. The second workshop assessed social, environmental, ethi-
cal and cultural issues. It aimed to assess the implications and desirability of using 
biotechnology in third world farming structures. The final workshop discussed the 
compatibility of GM food with the overall aims of Danish development policy in 
relation to using participatory methods, fighting poverty, the precautionary principle 
etc. During all three workshops the task force invited other leading experts to con-
tribute with comments, ideas and their expertise on the matter. 
Through the project, the task force was asked to answer a two-pronged question, 
which constituted the starting point of the DBT project; Can Danish development aid 
be used positively to 1) incorporate genetically modified crops into the work of im-
proving the living conditions of the poorest population groups in developing coun-
tries – and 2) can this be done without conflicting with existing Danish development 
policy strategies? The task force approached the questions in view of the fact that the 
dissemination of GM crops is already taking place – just not considering Danish de-
velopment aid. The first part of the question was considered to be too complex and 
 35 
diverse to be answered by a simple yes or no, which is why the task force decided to 
take a diversified, more pragmatic and action-oriented approach. Thus, the DBT re-
port does not contain arguments for or against GM crops as such but rather provides 
a basis for the assessment of benefits and drawbacks of the possible use of GM crops 
in specific contexts. Considering the second part of the question, the task force as-
sessed that the use of GM crops in developing countries would not necessarily con-
flict with Danish development aid policy. 
The result of the project was communicated through a report targeted at institutions 
and organisations engaged in agricultural development in the poor countries of the 
world, and further at politicians, researchers, corporate staff or others who, directly 
or indirectly, influence or are involved in agricultural development, legislation, 
commerce etc. in the third world. 
MAJOR OUTCOMES OF THE PROJECT 
The project was concluded by several conclusions and recommendations, which were 
further supported by a list of premises to constitute a framework for aid organisations 
when and if a developing country needs assistance in dealing with GM crops. The 
premises were: 
> Each GM crop must be assessed individually. 
> The same yardstick cannot be applied to all developing countries. 
> Existing GM crops are primarily adapted to the needs of farmers in the rich part of 
the world. 
> Development of GM crops is slow, i.e. there are relatively few GM crops on the 
market and relatively few on the way in. 
> Safety approval of GM crops is expensive since the control procedures are ex-
tremely comprehensive. 
> Many developing countries do not have the capacity required to undertake needs 
assessment and control and would find it difficult to make their own assessment 
of whether they would benefit from the crops, and whether they could comply 
with the control and safety regulations. 
> Patents influence development, and this may cause developing countries major 
legal and economic problems when it comes to the use and development of GM 
crops. 
> GM crops may have an adverse effect on developing countries’ competitiveness 
and access to western markets. 
> The consequences of introducing GM crops are uncertain. No-one knows for sure 
what their impact will be on the environment, nutrition and biodiversity. 
The task force’s main message was that GM crops represent one among many tech-
nologies that may contribute to solving food supply problems in developing coun-
tries, but this form of agriculture is no miracle solution – at least not in the short or 
medium term. The task force assessed that Danish development aid should continue 
to focus on a broad range of technological and institutional solutions in the agricul-
tural area with focus on responding to the needs of the poor farmer. Thus, the task 
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force considered GM crops only to play a relatively limited role in the immediate 
future. The task force further emphasized that the question of how best to assist 
countries must be assessed specifically from case to case and from country to coun-
try. Besides these more general recommendations, the task force offered more spe-
cific recommendations within four focus areas: technology, political policy, institu-
tions and society. 
IMPACTS AND FOLLOW UP OF THE PROJECT 
In the wake of the project, the Ministry of Foreign Affairs of Denmark, which is in 
charge of the Danish development policy, invited the Danish Board of Technology to 
give a presentation of the project. The Ministry does not usually consult external 
organisations, which is why the interest in the DBT report must be considered quite 
an acknowledgement of the project. 
CHALLENGES IDENTIFIED IN THE PROJECT 
Conclusively, the task force emphasized that developing aid organisations will be 
failing in their responsibility if they fall short to adopt a position with regard to GM 
crops and their use in developing countries while it is necessary to examine whether 
certain GM crops might assist developing countries in ensuring sustainable agricul-
tural production and food supply in the future. Thus, the question is not whether 
Danish development aid should decide on the use of GM crops in developing coun-
tries. Instead, the challenge for the Danish development aid organisations is to help 
the developing countries prepare for the coming of the GM plants. The challenge is 
to frame some conditions that enable developing countries to deal with and decide on 
the use of GM plants. It is crucial that developing countries are assisted with the or-
ganizing so the given countries are prepared administratively for the GM crops and 
possess sufficient scientific knowledge on the matter. Further, it is important that the 
developing countries have developed the necessary control to handle GM crops.  
Such issues are exactly what development aid should focus on in relation to GM 
plants. 
LITERATURE 
The Danish Board of Technology (2003): Genmodificerede afgrøder i udviklingslande - 
udfordringer for udviklingshjælpen. 
http://www.tekno.dk/pdf/projekter/p03_genmodificerede_afgroeder.pdf; English 
summary: Genetically modified crops in developing countries - challenges for the 
development aid. 
http://www.tekno.dk/pdf/projekter/p03_gen_mod_crops_summary.pdf 
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Søren Gram 
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CO-EXISTENCE BETWEEN GM CROPS AND 
NON-GM CROPS (2004) 2.3 
BACKGROUND OF THE PROJECT 
During the summer 2003, the European Parliament and the Council decided on a 
regulation concerning the traceability and labelling of genetically modified organ-
isms and the traceability of food and feed products produced from genetically modi-
fied organisms. With this regulation the EU reopened for approvals on the growth of 
GM crops. Based on this regulation, the European Commission recommended some 
guidelines for the development of national strategies and best practices to ensure the 
co-existence of GM crops with conventional and organic farming. Thus, the Danish 
government introduced a bill on co-existence. The bill on co-existence was framed 
with references to a report from 2003 by the Danish Institute of Agricultural Sciences 
concluding that co-existence is possible in Denmark considering some crops, but that 
there are also some exceptions were co-existence seems to be problematic.  
To discuss the bill on co-existence, the Danish Parliament (Folketing) committee of 
Food, Agriculture and Fisheries and the committee of Environment decided to make 
a hearing to clarify the experiences with the growth of genetically modified crops.  
BASIC DATA ABOUT THE PROJECT 
The Danish Board of Technology arranged the hearing on the experiences of co-
existence between GM crops and non-GM crops (within the framework of BIOSAM, 
a collaborative forum addressing ethical questions considering biotechnology). The 
hearing was open to everybody and took place May 11th 2004. Around 90 people 
(mostly experts and stakeholders) attended the hearing.  
The hearing was split up into five sessions with each their theme. The first session of 
the hearing addressed the risk of GM crops spreading by a presentation of available 
knowledge on the subject. The next session moved on to discuss how to handle the 
spreading by either preventing or minimizing the spread of GM crops to fields with 
either conventional or organic crops. The third session of the day focused on the 
positive and negative consequences facing the market in connection with a growing 
of GM crops in Danish fields. The fourth session of the hearing discussed the issue 
of compensation in cases of spreading. The last session of the hearing invited differ-
ent stakeholders to present their view on the bill on co-existence. Each session con-
sisted of three short presentations by different experts. After the presentations in each 
session there were time for questions and discussions from the panel of politicians 
(committee members). Also a few questions from the audience were allowed. 
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MAJOR OUTCOMES OF THE PROJECT 
The aim of the hearing was to initiate discussions, generate knowledge, and collect 
experiences on the co-existence between GM crops and non-Gm crops. The hearing 
was recorded and later transcribed and published in a report. Due to the method of 
this project the report does not contain any overall conclusions but emphasizes, 
through the different viewpoints, the challenges that the growing of GM crops 
causes.     
Since Denmark has no actual experiences with the growing of GM crops, several 
international experts were asked to speak at the hearing to share their experiences 
with the co-existence between GM crops and non-GM crops. In Austria, the agricul-
tural structure (small farms and narrow fields) makes co-existence problematic. Fur-
ther, Austria has passed a law that prohibits growing of GM crops in the northern 
part of the country - GM-free zones. In Spain they have more experience with GM 
crops and Bt-maize have been grown since 1998. The GM crops have been grown 
without any kind of precautions, without any control considering the agricultural 
results and the environmental impacts, and without information and transparency. 
According to Friends of the Earth, there are several examples of spreading and thus 
contamination of conventional and organic crops in Spain. Experiences from Canada 
further show that the growing of GM crops will have a negative impact on organic 
farming.  
Economic potentials and costs of growing GM crops in Denmark were further dis-
cussed with reference to international experiences. So far, the growing of GM crops 
seems to bring both extra costs and savings. GM crops will no doubt become a factor 
of competitiveness, and in order for Denmark not to loose its competitive advantages 
it was broad forward that it is necessary that Denmark launch GM crops now. In the 
end, it all comes down to the individual farmer whether there are economic incen-
tives to grow GM crops. Besides the potential economic benefits that GM crops will 
bring about, other possible advantages considering GM crops were discussed. The 
effects of shifting to GM crops vary from crop to crop. Some of the advantages that 
have been identified include increased yield and productivity, a reduction in the use 
of pesticides, a more efficient weed control, less erosion and leaching, and a better 
economy for the individual farmer. If the experiences from the US are transferred to 
Europe there is thought to be great benefits for the farmer as well as the environment, 
the consumer and society.  
These claims was however dismissed by other experts who emphasized that we 
should not expect too much from the GM crops since they have not really shown any 
great potentials yet. Furthermore, some experts questioned the potential environ-
mental advantages that are often highlighted in discussion on GM crops. Thus, the 
hearing showed that there are quite contradictory opinions considering the potential 
benefits and detriments of growing GM crops.    
The Government’s suggestion for a bill on co-existence includes a system of com-
pensation that guarantees farmers whose crops are polluted by GMO’s to receive 
compensation. During the hearing both governmental systems of compensation and 
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private insurance covers were discussed in this context. It was further discussed 
whether such a system of compensation would cover all losses in a case of spreading 
from GM fields to conventional and organic fields.  
The hearing pointed to a passing of the bill on co-existence in Denmark. Throughout 
the hearing it further became clear that the provisional proposal for the co-existence 
were in need of some adjustments before the final decision to pass the bill. 
IMPACTS AND FOLLOW UP OF THE PROJECT 
Based on the discussions and experiences derived from the hearing, the original bill 
of co-existence was faced with some proposed amendments. Thus, after the hearing, 
the bill of co-existence went through two additional readings before the final bill on 
co-existence was passed in the beginning of June 2004. There were several amend-
ments employed in the final bill on co-existence and the more prominent ones in-
cluded changes considering the system of compensation in favour of organic farmers 
and the protection of their interests, and a system of publication that would make 
information (position, size and type of crop) about GM fields available to the public. 
The final bill on co-existence further enabled the minister to revoke approvals in 
cases where there is a danger that an approval might be misused.      
CHALLENGES IDENTIFIED IN THE PROJECT 
The greatest challenge considering the co-existence between GM crops and non-GM 
crops is that of spreading. To avoid the spreading of pollen it is necessary to keep a 
distance (dependent on the biology of the crop and the threshold value) between 
fields with the same kind of crops, and other cultivated plants that the crop might 
cross with. Intervals of growing are assessed as one of the most effective methods to 
avoid the spreading of seeds. However, it is impossible to secure a complete non-
spreading. In order to minimize spreading it is necessary to take some overall princi-
ples into account. First of all, the methods used to prevent spreading should depend 
on the crop being grown hereby considering the different characteristics that the dif-
ferent GM crops have. Secondly, the given system of agriculture, whereto the rules 
of co-existence should be applied, needs to be considered; e.g. geography and land-
scape. Ultimately, it is necessary to consider the scope of GM crops. Thus, co-
existence is assessed to be possible if the necessary precautions are taken. 
Conclusively, the hearing emphasized that the ultimate challenge is to make a better 
and extended system of compensation and that the rules on co-existence are ad-
dressed at a EU-level that secures that all member states have common rules consid-
ering co-existence and compensation. Considering the widespread scepticism to-
wards GM products that can be identified within the Danish population, it is crucial 
that consumers are given a genuine choice between GM products and non-GM prod-
ucts. This can be ensured through labelling of products that are genetically modified 
and through a securing of GM-free production; e.g. that organic alternatives are 
available.  
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NEW GM CROPS – NEW DEBATE (2005) 2.4 
BACKGROUND OF THE PROJECT 
The DBT-project “New GM crops – new debate” was initiated with the purpose to 
investigate how the Danish citizens assess the use of new GM crops involving plants 
producing medicine and industrial chemicals and new ornamental plants. The project 
was suggested by the Danish Forest and Nature Agency (part of the Ministry of the 
Environment). Previous projects and debates had shown a public scepticism towards 
GM food and feed crops due to the fact that the benefits of this technology are not 
obvious or directly related to the public. Thus, it became interesting to investigate the 
public’s attitude towards the use of GM plants with completely different purposes 
than those usually discussed.  
Many of these new applications of GM plants appear to bring potential benefits to 
both human health and the environment. GM plants producing medicine are expected 
to be able to reduce the production costs of certain expensive medicines, and in other 
cases to create new possibilities for treatment. For industrial use, plants are geneti-
cally modified to be little biofactories that produce raw materials and thus contribute 
to a minimization of the use of chemicals. Finally, GM ornamental plants would cre-
ate inventions such as blue roses or durable harebells. Still, these GM plants are 
grown under the same conditions as GM food and feed crops.  
Based on this, the project set out to examine how Danish citizens assess the potential 
advantages and disadvantages of the new GM plants. The aim of the project was to 
present arguments for and against: how are the plants’ potential benefits and detri-
ments considering health and environment assessed, and what are the economic pos-
sibilities and consequences – considering both the societal and the consumer level. 
BASIC DATA ABOUT THE PROJECT 
The project was addressed through the use of a citizens’ jury. 2000 Danish citizens 
were invited via the Civil Registration Number register to apply for participation in 
the citizens’ jury. On the basis of the applications received, 16 citizens were selected. 
The aim was to assemble a citizens’ jury that was relatively representative regarding 
gender, area of residence, age, education and job.  
The sixteen laymen took part in the citizens’ jury that was assembled from the 28th of 
April to the 2nd of May 2005. A planning group assisted the Danish Board of Tech-
nology in planning the project and formulating the questions that the citizens’ jury 
was presented with. During the five days of the citizens’ jury, the laymen met with 
experts and stakeholders and discussed advantages and disadvantages of the new 
crops. Based on this dialogue, the citizens’ jury formulated arguments for and against 
the new GM plants and conditions for the possible growing of GM plants in Danish 
fields and general recommendations in connection with this. 
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Ultimately, the citizens’ jury was concluded by a vote upon the arguments, condi-
tions and recommendations that expressed their attitude the best. Thus, citizens were 
not required to reach a consensus, but asked to prioritise the arguments elaborated by 
them-selves and then vote for those that they considered most important. 
The citizens were asked to consider the new uses of GM plants at three different lev-
els: what are the arguments for and against GM plants within the category in ques-
tion (medicine, industry or ornamentation); on which conditions can GM plants for 
medicine, industry or ornamentation respectively be grown in Danish markets; and 
which general recommendations are there for the future handling of new GM plants. 
These questions were addressed through 7 votes on which the recommendations and 
conclusions of the report are based. 
MAJOR OUTCOMES OF THE PROJECT 
Interpreting the voting results, the main conclusions of the report seem to be that the 
citizens’ jury assessed the new uses of GM plants to be predominantly beneficial. 
Still, the citizens’ jury had reservations considering some specific applications of the 
technology. Thus, the citizens’ jury proclaimed a conditional yes to the new GM 
plants. 
The main arguments for the GM plants included improvements with regard to the 
environment and public health, financial advantages (both for society in general and 
the individual consumer) and business opportunities. The citizens’ jury assessed that 
Denmark should tap its potential for developing GM plants due to the fact that Den-
mark has significant knowledge and experience, not to mention effective legislation. 
The most important argument against GM plants referred to the risk of unintentional 
spreading of foreign or undesirable characteristics. But the majority of the citizens’ 
jury assessed that existing regulations – including the act on co-existence – and ap-
proval procedures considers these problematic issues.  
Considering the usage of GM plants for medicine the voting results showed that the 
arguments for received more votes than the arguments against them. However, if the 
production of medicine includes the use of human or animal genes, it was a high pri-
ority for the citizens that there are strict requirements for approval of new products, 
and that the production takes place in closed environments.  
The citizens’ jury received developments of industrial GM plants as positively as 
plants producing medicine. It was especially applauded that industrial plants have the 
potential for replacing present production methods with more environmentally sus-
tainable ones.  
The attitude towards GM ornamental plants was less optimistic than the two other 
usages. The vote showed that there was slightly more arguments against than for the 
growing of GM ornamental plants in Danish fields. The citizen’s jury further empha-
sized that the main condition for the growing of GM ornamental plants is that herbi-
cide-tolerant grasses are not going to be approved due to the significant risk of 
spread to cultivated areas as well as to other vegetation.    
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An important condition for allowing the new plants that was emphasized was, that 
the environmental consequences of irresponsible practices should be assessed. Fur-
ther, the growth of the new plants should not pollute more than existing modes of 
production - particularly concerning fertilizer or pesticide usage. Thus, any negative 
impact on ground water and soil should be part of the risk assessment. However, the 
citizens’ jury did not see any reason for alarm while the present legislation and ad-
ministration is considered adequate to limit the risks. Instead, there should be more 
focus on public education and information about the new GM plants. In fact, the 
clearest message from the citizens’ jury was not about advantages, disadvantages and 
conditions with regard to GM plants, but about the necessity of informing the popu-
lation about these matters as part of an open and nuanced debate.  
Conclusively, it appears that the public’s estimation of use clearly differs depending 
on the use of GM plants. The debates on GM plants for food and feed showed that 
the public questioned these usages by asking: why? The purposes and benefits are 
not obvious to the public. On the contrary, this project on the use of new GM plants 
poses the question; why not? In general, the citizen’s jury did not see any reasons to 
impede the further development of GM plants - at least for medical and industrial use 
- as long as this does not involve environmental or health hazards, that exceed exist-
ing or alternative modes of production. 
IMPACTS AND FOLLOW UP OF THE PROJECT 
The citizens’ jury presented their results the 2nd of May 2005 at a conference at the 
Danish Parliament with the attendance of politicians, experts and various stake-
holders. After the citizens’ jury’s presentation of the results, politicians representing 
different parties and different stakeholders commented on the assessments and dis-
cussed them with the jury. The results of the conference were subsequently men-
tioned in the media.  
In November 2005 the Ministry of the Environment held a conference on the use of 
GMO’s. Whether this conference was a direct follow-up of the DBT-project is diffi-
cult to say, but the themes discussed at the conference were, in particular, concerned 
around new uses of GM plants. 
The results of the citizens’ jury were furthermore mentioned in a report on a biotech-
nology strategy considering non-food and feed published by the Directorate for 
Food, Fisheries and Agri Business in February 2006.  
In September 2005 the Danish moratorium (since 1999) on the growing and the mar-
keting of GM crops were finally revoked. The reasons for this action were grounded 
in the implementation of rules considering labelling, traceability and co-existence. 
The results of the citizens’ jury might have had an impact on these decisions, but it 
would be wrong to link the two incidents directly.  
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CHALLENGES IDENTIFIED IN THE PROJECT 
The citizens’ jury identified several challenges considering the use of GM plants for 
other purposes. One challenge is the retention of a free consumer choice in a way 
that genetically modified products are labelled. Another challenge is to strengthen 
public research to form a contrast to private research and development, as public 
research seems necessary to maintain sufficient control of the new GM plants. The 
far most obvious challenge considering these new GM plants is that usages do not 
pollute more than the corresponding traditional modes of production or better alter-
natives.  
LITERATURE 
The Danish Board of Technology, (2005): Nye GM-planter - ny debat. 
http://www.tekno.dk/pdf/projekter/p05_GM-planter_rapport.pdf; English sum-
mary: Contitional yes to new GM plants. 
http://www.tekno.dk/pdf/projekter/p05_gmp_rtt.pdf 
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Søren Gram 
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FINLAND 3. 
DEBATE BETWEEN PUBLIC ADMINISTRATION, RESEARCHERS 
AND GENERAL PUBLIC CONCERNING THE PLANT GENE 
TECHNOLOGY 
During last five years, the Finnish debate between public administration, researchers 
and general public concerning the plant gene technology can be divided in four types 
of activity: 
> General and plant gene technology focused public  hearings  
> Public administrative information of field tests and product approval processes 
> Special administrative processes which have  taken into account the public opin-
ion 
> Scenarios concerning possible implications of plant gene technology 
PUBLIC HEARINGS 
In order to discuss the ethical dimensions of genetics, Ministry of social affairs and 
health arranged a seminar "Genes and values" in Hanasaari, Espoo in 2002. The au-
dience consisted of over 100 invited participants, and the program consisted of pres-
entations by experts and a panel guided by a media professional. 
A booklet introducing in the subject had been composed in advance, and it was de-
livered for the participants. The booklet served mostly prejudices and popular beliefs 
concerning plant biology and agriculture circulated by GM critical political move-
ments. The beliefs were discussed by philosophers specialized in ethical problems of 
gene technology.  No scientific experts of plant breeding research were consulted in 
the booklet.   
The popular beliefs were the foci of the meeting, too. The sole discussant represent-
ing the science of plant biology - an associate professor in plant breeding - was of-
fered a very short time (5 minutes) to tell about new GM varieties. The media profes-
sional chairman had customarily little knowledge of science. 
The leaders of the Finnish anti-GM society were invited. Their full handful of mem-
bers trespassed in the seminar with video cameras and recorded the discussions. Such 
behaviour did not promote the free atmosphere of the discussions. As their response 
to the scientific presentations, the "activists" nailed up the ultimatum that the scien-
tist lecturing on plant breeding shall be discharged.  
It was no surprise that the seminar resulted in messages putting science under suspi-
cion. But as a trade-off it also brought important science reporters in place. The pres-
entation on plant breeding, albeit minuscule, gave many a first contact with the sub-
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ject and its true possibilities. Hence, certain media columns were opened later on for 
the first time also for scientific facts regarding modern plant breeding. 
Special contribution was made by philosophers. They analyzed also in the final re-
port of the conference the quality of typical arguments given for and against gene 
technology. Logical analysis of superficial statements made by emotional opponents 
is a good way to promote rationality in the field. Besides that it is highly important 
that with careful scientific (and not only logical) analysis prejudices and real threats 
will be separated. 
Other ministries have also arranged general seminars in the area. E.g. ministry of 
agriculture and forestry (MAF) have arranged many seminars as a part of the hearing 
process of their strategies or laws in preparation. Such seminars have been arranged 
concerning Gene Technology Strategy2 (2003, wwwb.mmm.fi/julkaisut/tyoryhma 
muistiot/2003/trm2003_18_en.pdf) and Co-existence3 (2005, wwwb.mmm.fi/julkai 
sut/tyoryhmamuistiot/2005/Trm2005_9a.pdf). The bulk of the invited participants 
have been professionals from the field of activities of the ministry, but invitations 
also cover public interest groups such as societies and other NGOs. 
In addition, seminars explaining the biological basics and topical situation regarding 
GM products in agriculture have been arranged by MAF for media people a few 
times, with fair success. Presentations are always given by top experts of science, 
legislation or administration in the field. Experiences of such focused seminars con-
nected with preparatory work of administration and authorities are in general positive 
in Finland 
PUBLIC ADMINISTRATIVE INFORMATION OF FIELD TESTS AND PROD-
UCT APPROVAL PROCESSES 
Applications for GM product approvals are decided at Community level in EU, and 
all member states participate in the process. When the information concerning a 
product application arrives in Finland, a short Finnish summary and links to official 
documents dealing with the application are made publicly available. They are in the 
Internet pages of Finnish Food Safety Authority EVIRA, the authority ordered to 
take responsibility of the information delivery in these cases. In the pages, advice is 
also given how people can give their opinion of the application to EU authorities 
using Finnish language. In addition, a press release is given in a broad delivery in 
order to activate the media. 
                                                 
2 Gene Technology Strategy and Action Plan of the Ministry of Agriculture and Forestry 
2003-2007. Working Group Memorandum 2003:18, Ministry of Agriculture and For-
estry, Helsinki, Finland, 2003. 
3 Enabling the coexistence of genetically modified crops and conventional and organic 
farming in Finland. Mid-term report. Expert Work Group on Coexistence, Ministry of 
Agriculture and Forestry, Finland, 2005 
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Finnish Gene Technology Act provides for the applications of GMO field tests to be 
communicated with public efficiently enough. The act implements Directive 
2001/18/EC. Regarding a field test with GM white birch seedlings, public informa-
tive meeting was selected as the way of action.  
The meeting was thoroughly advertised in local media, starting well beforehand. In 
spite of that, only two persons representing general public did arrive, the other of 
these was probably a local farmer. All other audience, a few scores of people, con-
sisted of (mainly local) university scientists, many of whom participated in the GM 
research program (ESGEMO), and members of the Board for Gene Technology; plus 
the handful of activists (always the same few ones) from the specialised "GM-free" 
society.  
For public discussion, far more important was the destruction of GM white birch 
seedlings made by plant GM opponents. As the result of extensive discussions in 
newspapers, the public opinion turned strongly against destructors. It was realized 
that there was no point in this destructive act because these non-flowering birches 
have no real way to diffuse their genetic material to non-GM birches or other plants. 
Instead, GM birches would have a real positive impact on town environments be-
cause of less allergic reactions. Actually based on their safety and positive impacts 
on health, an environmental organization (Ekosäätiö, Eco Foundation) gave its price 
to the developers of GM birches. Based on the destructive act, the public opinion is 
now much more favourable for the limited public information concerning the cultiva-
tion places GM plants. The irrationality of the GM opponents became much more 
evident for the general public. 
SPECIAL ADMINISTRATIVE PROCESSES WHICH HAVE TAKEN IN AC-
COUNT THE PUBLIC OPINION 
We consider that it is highly important for a rational approach concerning the plant 
gene technology that the administration does not follow prejudices of the public 
opinion. This is especially important because of the feedback to the public opinion. 
Critics of gene technology with little science expertise can use the choices of the 
administration as an evidence for their opinions. 
In Finland, the above problem was met related to restaurant criteria proposed for the 
Nordic Swan ecolabel. The aim of the ecocertificate is declared to be helping people 
"to choose the most environmentally-friendly products" and to avoid the use of the 
most environmentally burdening products (www.svanen.nu/Eng/default.asp).  
Criteria for Nordic restaurants to fulfil in order to receive the ecolabel were proposed 
(June 2006). Without any statement of reason based on facts or science, all use of 
genetically modified constituents was categorically forbidden in the restaurants with 
ecolabels. That proposition excited Finnish life scientists to express their objections 
to the misuse of such populist prejudices which only damage true efforts on envi-
ronmental protection. Among others, the traditional and most prestigious life science 
society in Finland (Societas Biochemica, Biophysica et Microbiologica Fenniae) 
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strongly criticized such anti-science attacks detrimental to environment in its state-
ment. Applications of modern biological research, including gene technology and 
genetic modification, are fundamentally required for environmental ameliorating, 
and their impacts shall be properly assessed case-by-case.  
Notable environmental benefits have already been obtained by producing the so-
called traditional GM varieties for 10 years (Sanvido et al. 20064, Brookes et Barfoot 
20065). Yet essentially greater remedies could be anticipated from "second genera-
tion" GM varieties specifically designed for environmental enhancements. Such in-
novations include resistant plant varieties with better tolerance to drought, cold, 
flooding, salt as well as pests and diseases.  
For example, blight-resistant potato was bred with gene technology by obtaining the 
resistance gene from a wild potato species. The healthy variety is in field tests for the 
third year in EU. Cultivating blight-resistant potatoes would save EU each year from 
860 million kg of yield being wasted, and 7.5 million kg of fungicides to be sprayed 
(expressed as active ingredient). Of course that also means great reductions in oil use 
and greenhouse gas emissions in agriculture (Phipps et Park 20026, Gianessi et al 
20037). Organic producers could also benefit from the use of blight resistant varie-
ties, because the risk of spreading the disease from other plantations to the fields 
used for organic production would be smaller. 
                                                 
4 Olivier Sanvido, Michèle Stark, Jörg Romeis and Franz Bigler (2006). Ecological im-
pacts of genetically modified crops. Experiences from ten years of experimental field re-
search and commercial cultivation. ART-Schriftenreihe 1. Fed. Dep. Econ. Aff. DEA, 
Switzerland, 108 p. 
5 Graham Brookes and Peter Barfoot (2006). Global Impact of Biotech Crops: Socio-
Economic and Environmental  
Effects in the First Ten Years of Commercial Use. Agbioforum 9: 139-151.  
Abstract:  Genetically modified (GM) crops have now been grown commercially on a 
substantial scale for ten years. This paper assesses the impact this technology is having 
on global agriculture from both economic and environmental perspectives. It examines 
specific global economic impacts on farm income and environmental impacts of the 
technology with respect to pesticide usage and greenhouse gas emissions for each of the 
countries where GM crops have been grown since 1996. The analysis shows that there 
have been substantial net economic benefits at the farm level amounting to $5 billion in 
2005 and $27 billion for the ten year period. The technology has reduced pesticide 
spraying by 224 million kg (equivalent to about 40% of the annual volume of pesticide 
active ingredient applied to arable crops in the European Union) and as a result, de-
creased the environmental impact associated with pesticide use by more than 15%. GM 
technology has also significantly reduced the release of greenhouse gas emissions from 
agriculture, which, in 2005, was equivalent to removing 4 million cars from the roads.  
6 Phipps & Park (2002). J Animal Feed Sci.11: 1–18.  
7 Leonard Gianessi, Sujatha Sankula and Nathan Reigner (2003). Plant biotechnology: 
Potential impact for improving pest management in European agriculture. Potato case 
study. NCFAP  
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The objections of the scientific community were accepted by the administration re-
sponsible for the Nordic Swan ecolabel. It was decided in autumn 2006 that geneti-
cally modified constituents are allowed in Nordic Swan ecolabeled restaurants. 
SCENARIOS CONCERNING POSSIBLE IMPLICATIONS OF (PLANT) GENE 
TECHNOLOGY 
Based on assessment project concerning social impacts of the human genome and 
stem cell research by the Committee for the Future, a scenario book was made. The 
aim of the book was to inform the general public about most important results of the 
assessment project. Beside that it illustrated possible future impacts of gene technol-
ogy with three scenarios. The scenario book (Kuusi 2004)8 got considerable publicity 
in media.  
The names of the scenarios characterize their content: 
> Safety first of all 
> Wealth and employment from gene technology 
> Gene information belongs to everybody  
All scenarios were discussed as reasonable choices making different assumptions 
concerning future developments. After the presentation of the scenario story its prob-
ability was discussed. For example, in the first scenario the blight-resistant potato 
resulted in a lagged serious health problem. In the discussion part, the probability of 
that problem was discussed. It was considered that even taking into account the risk 
it is reasonable to accept the blight-resistant potato.  The conclusion was the same as 
in the third scenario: Also in order to solve possible problems related to gene tech-
nology, the best choice is to make it commonplace.  
Like the information technology, gene technology should belong to everybody. It 
requires an internet based “Gene Information Centre” providing its services to every-
body. In a safe environment (compare banking services), it makes sense to integrate 
this type of personal gene information with one’s personal electronic patient records.   
AUTHORS OF THE REVIEW 
DSc(Agr&For) Jussi Tammisola 
PhD Osmo Kuusi 
                                                 
8 Osmo Kuusi (2004)  Geenitieto kuuluu kaikille (Gene information belongs to every-
body), Edita, Helsinki  
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FLANDERS 4. 
PUBLIC FORUM »NEW IMPULSES FOR THE DEBATE 
ON GENETICALLY MODIFIED FOOD« (2003) 4.1 
BACKGROUND OF THE PROJECT 
On September 25th 2001 a hearing was held in the Flemish Parliament to discuss the 
advices published by five Flemish advisory bodies9, by request of the Flemish Par-
liament10, on the topic of genetically modified organisms(GM organisms). A recur-
ring element in the five reports was the importance of organizing a public debate on 
this topic. 
The Flemish Institute for Science and Technology Assessment, viWTA, established 
by Decree on 17/07/2000 provided the opportunity to respond to this advice. The 
Board of the viWTA decided in December 2001 to organise a pilot project on this 
topic. In Spring 2002 this topic was narrowed down to ‘genetically modified food’.  
The project was officially launched in May 2002 with a pre-study.  The goal of this 
study was to map the existing debate on genetically modified food in Flanders (ac-
tors, positions, legal situation,…).  The report of this study was published in Novem-
ber 2002, in December 2002 the Public Forum was launched.  On the 26th of May 
2003, the 15 members of the citizens panel submitted their final report to Mr. Nor-
bert de Batselier, President of the Flemish parliament. 
MAJOR OUTCOMES OF THE PROJECT 
The report of the Flemish lay panel contained 28 recommendations, centred around 
six major themes: 
> Legislation, control and consultation 
> Information 
> Ethics 
> Health issues 
> Global and economic issues 
> Environmental consequences 
Most important of these recommendations, also in the light of European legislation, 
are: 
                                                 
9 De Sociaal Economische Raad van Vlaanderen (SERV), de Milieu en Natuurraad van 
Vlaanderen (Mina-raad), de Vlaamse Raad voor wetenschapsbeleid (VRWB), de 
Vlaamse Land- en Tuinbouwraad (VLTR) en de Vlaamse Gezondheidsraad. 
10 Adviesvraag van 11/02/2001 van Trees Merckx-Van Goey houdende raadpleging van 
diverse adviesorganen over de problematiek van genetisch gemodificeerde organismen. 
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Legislation, control and consultation: 
> Even after the discussion it is still not clear who is liable in case of problem 
(product liability as well as environmental liability). The reference persons did not 
know the answer. This leaves the initiative to politicians. The liability has to be 
regulated so as to be legally binding. It has to be unambiguous, leaving little room 
for interpretation and for dodging responsibilities. 
> It is hard to choose between genetically modified foodstuffs or food without GM 
organisms: you cannot choose for something that is not available yet. But when 
genetically modified food arrives, there is a real danger that non-genetically modi-
fied food will be under pressure. The choice has wider implications than mere la-
bels. If you want to sell both (labelled) genetically modified food and non-
modified food, you need two completely separate circuits. Freedom of choice has 
to be guaranteed. This is a complex issue. Both those who want to purchase ge-
netically modified food as those who do not, need to be able to make a choice. If 
nothing changes, the situation will not improve. 
> The introduction of genetically modified food on the market might lead to increas-
ing production costs for non-GM food, a.o. because of extra checks. The sector of 
genetically modified food will be able to compensate this extra cost because of 
cheaper production techniques. 
> The European rules for permits are not bad; they are the result of hard work. The 
E.U has a procedure for quickly recalling GM products in case of problems. But 
the rules are not watertight: the evaluation of permits is left to scientists and poli-
ticians. The evaluation of permits ought not to be restricted to scientists, but ex-
tended to other areas of expertise (economists, sociologists, philosophers). 
Information: 
> The new EU legislation allows for public consultations, but the form in which this 
will happen is  still vague (active or passive approach?) A large majority of the 
Flemish laypanel believes the government ought to provide clear and neutral in-
formation. A majority thinks the existing website of the Belgian Biosafety Server 
(http://biosafety.ihe.be) can fulfil this role, but is must be translated from English. 
The site can be expanded into a portal site. 
> Labels must be uniform throughout Europe (using clear icons) 
> Citizens prefer an active consultation of the public under EU legislation. This al-
lows the citizen to voice his opinion. Participation can only be useful after an 
awareness-raising campaign. 
Ethics: 
> There is no universally accepted ethical position, but there are nevertheless clear 
ethical limits. The different scope of arguments (based on risks vs. based on du-
ties) makes an ethical debate difficult. However, ethical considerations must play 
a role in allowing genetically modified foodstuffs. 
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Health issues: 
> The health risk of genetically modified foodstuffs that are introduced in the mar-
ket are negligible. Strict and reliable checks have convinced the lay panel that the 
health risks of regulated genetically modified food are negligible. Consumers can 
regain their confidence if they are informed in a reliable way about the health is-
sues related to genetically modified food. But permanent checks and controls stay 
necessary for genetically modified food. Because of the complexity of the issues, 
this debate must be conducted in public. 
Global and economic issues: 
> The authorities have to provide a framework and the means for the transfer of 
knowledge and technology between North and South, and for establishing local 
research facilities in the South. 
> The authorities should continue to support fundamental research and the techno-
logical development of genetically modified organisms. But the subsidies have to 
be made dependent on promises to share the relevant knowledge with the Third 
World.  
> Research into traditional and biological agriculture must not be neglected, but 
should continue to exist as a full area of research.  
Environmental consequences: 
> Evaluation of the environmental hazards is extremely important. Each case has to 
be thoroughly investigated. 
> Biotechnology must make a responsible choice, respecting biodiversity, the bio-
tope of the crop and the ecosystem. These elements must be taken into account 
during risk analysis. 
> Once genetically modified food is brought to market, environmental risks still 
need to be monitored. The present post-marketing plan does not provide for ade-
quate control. The costs for more systematic controls have to be borne by the bio-
tech industry. 
CHALLENGES IDENTIFIED IN THE PROJECT 
Potentially problematic issues, that could be further explored in the questionnaire, 
seem very generally: 
> Ways to engage the public in decision making processes on GMO’s: ac-
tive/passive? 
> Importance of understandable, down to earth communication about GMO’s 
> Freedom of choice/possibility of creating complete separate circuits 
> Effect on introduction GM-food on production costs for non GM food (extra 
checks and quality control systems) 
> Multi-disciplinary evaluation of risks 
> Challenges to labelling 
> How to involve ethical considerations in future approvel procedures? 
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> How can the south benefit from European research? 
AUTHOR OF THE REVIEW 
Els van den Cruyce and Stef Steyaart 
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FUNCTIONAL FOODS. STATE OF THE ART (2006) 4.2 
BACKGROUND OF THE PROJECT 
Functional foods represent one of the most intensively investigated and promoted 
area in the food and nutrition sciences today. Functional foods are fortified or en-
riched foods that provide health benefits beyond the provision of essential nutrients, 
when they are consumed at efficacious levels as part of a varied diet on a regular 
basis. Linking the consumption of functional foods with health claims should be 
based on scientific evidence. However, not all foods on the market today that are 
claimed to be functional foods are supported by enough solid data to merit such 
claims. What are the benefits and what are the risks? 
In this comprehensive study, the consortium Food2Know (University of Ghent) and 
Flanders’ FOOD (knowledge centre for the Flemish Food Industry) made an over-
view of different functional food products on the market in Flanders. Using a ques-
tionnaire, the societal issues were elaborated by 30 experts in this field (diet and nu-
trition experts, retailers, consumer and patient organisations, regulatory bodies, aca-
demic researchers and stakeholders from the Flemish food industry). Information 
was gathered on issues such as the scientific evidence linked to the health claims, the 
regulation in Flanders and Europe and the role of functional foods in the Flemish 
health policy. 
The results were summarized in a report (only available in Dutch) and were pre-
sented during a debate with experts and policymakers in the Flemish Parliament. The 
project had no further impact on policy making. 
MAJOR OUTCOMES OF THE PROJECT 
The study focused on the following issues: 
Scientific evidence for health claims: 
There is a need for stricter control of the scientific basis of health claims on func-
tional food products. Today, health claims are not reliable enough. More precise un-
derstanding of the mechanisms of actions of functional food and more scientific evi-
dence is required. 
Functional foods and health policy: 
A frequently asked question is if functional food can be a part of the disease risk-
reduction public health program? This study concluded that government policy and 
action must keep focussing on healthy lifestyle, balanced food intake and sport. 
Functional food cannot solve what has been damaged by ignoring these points. 
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Safety: 
The products that are on the market today, are considered to be safe. Nevertheless, 
enrichment of food products with specific nutrients can imply much higher doses of 
intake by consumers. The experts in this study supported the idea of mentioning a 
maximum dose on the label of each functional food product. Another important risk 
is that functional food can give a false feeling of safety. Functional food could be-
come an excuse to give less attention to sport and food habits. 
Price of functional foods: 
Functional food products are quite expensive. Experts recommend actions to make 
the possible advantages of functional food available for everybody. 
Information overload: 
News articles are often contradictory. It is very difficult for consumers to select the 
relevant and scientific based information.  
Food and medicine: 
Experts see a clear trend towards the use of food for medical purposes. 
CHALLENGES IDENTIFIED IN THE PROJECT 
Potentially problematic aspects of functional food, that could be useful to the subject 
of GMO’s, seem very generally: 
> Scientific evidence for benefits of these type of food products 
> Safety of the products 
> Price of the products: Who can benefit? Who will pay for GM food? 
> Challenges to labelling: information overload for consumer 
> Consumers attitude towards GM food: experience of food, food culture. 
AUTHOR OF THE REVIEW 
Els van den Cruyce and Stef Steyaart 
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INDUSTRIAL BIOTECHNOLOGY IN FLANDERS: 
STATE OF THE ART (2006) 4.3 
BACKGROUND OF THE PROJECT 
Industrial or white biotechnology is the application of biotechnology for the process-
ing and production of chemicals, materials and energy. White biotechnology uses 
enzymes and micro-organisms, such as yeast and bacteria, to make products in chem-
istry, food, paper and pulp, textiles and energy. White biotechnology uses biomass as 
an alternative to fossil resources for the production of biochemicals such as biofuels 
and biopolymers. In the future, genetically modified crops could be developed, as a 
renewable source for non-food applications. 
In this comprehensive study, the Laboratory for Industrial Microbiology and Biocata-
lysis (University of Ghent) made an overview of the applications and fields of exper-
tise in Flanders. Using a questionnaire, the societal issues were elaborated by 30 ex-
perts in the field of industrial biotechnology. Information was gathered on issues 
such as Flanders’ chances to evolve to a bio-based economy, the opportunities for a 
more sustainable production, the implications for the economy in Flanders, and more 
specific for the agricultural sector. 
The results were summarized in a report (only available in Dutch) and were pre-
sented during a debate with experts and policymakers in the Flemish Parliament. The 
project had no further impact on policy making. 
MAJOR OUTCOMES OF THE PROJECT 
The study focused on the following issues: 
> Sustainability: 
Industrial biotechnology offers opportunities for a more sustainable production. 
Enzymes can drive chemical reactions towards the desired end product in a very 
effective and efficient way, under circumstances of normal temperature and pres-
sure. Less energy is consumed and waste production is reduced. However, only a 
complete life cycle analysis can asses whether the use of industrial biotechnology 
is more eco-efficient.  
Secondly, instead of fossil fuels, agricultural raw materials, such as cereals and 
coleseed are used. This reduces the emission of  greenhouse gasses. Some experts 
expect that production of crops will be more geographically spread, in contrast to 
the concentration of  power within the limited amount of petroleum producing 
countries. 
Thirdly, the agricultural raw material must be produced in a sustainable way, 
avoiding deforesting, erosion and soil impoverishment. 
> Safety of the use of micro-organisms for industrial applications: 
The (genetically modified) micro-organisms are bred in a closed reactor. After 
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use, the micro-organisms are separated from the product and killed. This is called 
“contained use”. 
> Perception of the public: 
Recent Eurobarometer results show that more than half of the interviewees be-
lieve that biotechnology can improve the life standard. Especially the medical ap-
plications receive a lot of support. However, the European citizen is still very 
critical towards the modification of agricultural crops or green biotechnology. Ex-
perts fear that this negative attitude will also involve genetic modification of crops 
for non-food applications. 
> Implications for the agricultural sector: 
The agricultural sector of the future will not only produce food, but will more and 
more become a producer of chemicals, industrial raw materials and biofuels. Be-
cause the area of land in Flanders used for the agricultural production is limited, 
some experts fear that this competition will threaten the production of food. Pro-
ponents argue that the Belgian and European agriculture suffer from overproduc-
tion and that the European agriculture requires a high proportion of the overall EU 
budget to subsidise it. Another argument is that a lot of area is available in the 
member states that integrated the EU in 2004. 
In the future green biotechnology could make a substantial contribution in the 
production of agricultural production such as cereals for non-food uses. 
> Can Flanders evolve to a biobased economy: 
In a biobased economy, an increasing number of chemicals and materials will be 
produced in biorefineries using renewable resources. Biomass derived energy is 
expected to cover an increasing amount of the energy consumption.  
The agricultural sector in Flanders will be unable to meet the demand for biomass. 
Import from neighbouring countries, Eastern Europe, America and even Africa 
will be necessary. Because of its central location and extensive transport infra-
structure, Flanders is well placed for import and transport of these raw materials.  
> Financial investment in research and development of industrial biotechnology: 
The biotechnological research in Flanders is mainly focused on green and red bio-
technology. Therefore the experts from the questionnaire propose to invest more 
in the research and development of industrial biotechnology in Flanders.  
CHALLENGES IDENTIFIED IN THE PROJECT 
Potentially problematic issues, that could be further explored in the questionnaire, 
seem very generally: 
> Sustainability of GM crops for non-food issues 
> Perception of the public towards GM crops for non-food issues 
> Implications for the European agricultural sector 
> Europe and the biobased economy 
AUTHOR OF THE REVIEW 
Els van den Cruyce and Stef Steyaart 
 58 
FRANCE 5. 
INRA PROJECT »CO-CONSTRUCTION OF A RESEARCH 
PROGRAMME« (2002) 
BACKGROUND OF THE PROJECT 
The French National Institute for agronomic research (INRA) has been working for 
many years on the elaboration of a transgenic  rootstock potentially resistant to 
Grapevine Fanleaf Virus (GFLV), together with a private partner. In 1999, the pri-
vate partner decided to stop its participation to this research, because of the hatred 
public discussion on GM grapevine. INRA decided to continue its research and 
passed on all material to its laboratory in Colmar.  
However, in 2001, and because the public debate on transgenic was still going on, 
INRA decided to suspend the ongoing experiments and to initiate a discussion on 
their pursuit within a working group integrating researchers, professionals and con-
sumers, using a participatory process.  
The initial question the working group had to answer was about the opportunity to 
realise field trials of rootstock potentially resistant to Grapevine Fanleaf Virus 
(GFLV). However, the working group reformulated the demand in the following 
direction: 
> Which are the philosophical, social, economical and technical aspects at stake in 
this field trial? Knowing that there are many research needs related to grapevine 
diseases, how to define priorities et how to choose the types of arbitration. 
> Should INRA continue to research on GM-grapevine and, if yes, which conditions 
have to be met in order to pass to the stage of field trials? 
BASIC DATA ABOUT THE PROJECT 
The selected method was based on the so-called “Technology assessment through 
interaction”11. It consists in putting together various worldviews, so that deliberations 
are nourished from a variety of arguments and standpoints.  
The number of participants was limited to 14, so as to allow deliberation on complex 
problems and heterogeneous questions. Whereas some participants had no special 
expertise in the topic (so-called “laypersons”’), the group also comprised researchers 
and wine-professionals. The selection process was based on the results of a socio-
logical study, which displayed a social cartography of worldviews around the topics 
of grapevine, wine and GMOs. The conceptions of science have also been considered 
                                                 
11 See Grin, J., van de Graaf, H., Hoppe, R., (1997). Technology assessment through in-
teraction. A guide. Den Hag, Rathenau Institute (available at http://www.rathenau.nl). 
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in the selection process, as well as attitudes towards research on a transgenic root-
sock for grapevine.  Based on this analysis, the organisers invited: 
> Four researchers working on research on grapevine diseases, but who hold differ-
ent worldviews. 
> Six grapevine and wine professionals, stemming from different geographical re-
gions and holding different worldviews. 
> Four citizens, also invited for the variety of their worldviews. 
The working group met 7 times, from April to September 2002. 
Various instances were part of the experiment: 
> The General Direction of INRA, which initiated the project. 
> 2 project managers.  
> One research assistant. 
> A steering group (comité de pilotage), composed of the project managers and the 
INRA Direction. 
> An evaluation committee, composed of personalities external to INRA, special-
ized in the analysis of controversies and of participation. 
> A moderator for the working group sessions. 
MAJOR OUTCOMES OF THE PROJECT 
The working group came to the following conclusions: 
> Wine has a strong symbolic dimension. As a consequence, a genetic modification 
done on grapevine dedicated to the fabrication of "wine-food" could have a nega-
tive impact on "wine-pleasure" and on high quality wines. 
> There is a strong attachment to a system production based on biological, technical 
and cultural variety. With respect to the threats related to grapevine diseases, vari-
ous fighting methods should be developed, so as to contribute to the various pro-
duction modes of vinegrape.  
> Considering research activities, there is a lack of integrated and transversal ap-
proaches. There is a necessity for a better understanding of the interaction be-
tween the plant and its environment.  
> INRA should continue to do research on genetically modified vinegrape in labora-
tory and green house. Field trials should also be implemented. But, on this last 
point, all group members did not agree on the opportunity to have field trials (2 
persons against). Opponents to the field trials considered that even the solution 
may be technically satisfactory, it is not socially acceptable. In this respect, it 
could prejudice the status and image of French wine. The other 12 members con-
sidered as acceptable field trials with transgenic grapevine. But their positive 
opinion is limited to a given experiment and no opinion has been formulated on a 
possible commercialisation. 
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IMPACTS AND FOLLOW UP OF THE PROJECT 
The report of the working group has been passed on to the INRA Direction in Sep-
tember 2002. In January 2003, INRA decided to ask for an authorization for the im-
plantation of field trials in Colmar, to set up a local follow-up committe and to create 
a mix commission in charge of defining the major orientations of wine and vinegrape 
research.  
CHALLENGES IDENTIFIED IN THE PROJECT 
> role of public research. 
> transgenic wine and vinegrape 
> dialogue and interaction 
> The issue of trust 
> Ability of public resarch institutions to set a boundary between research and its 
applications 
LITERATURE 
Co-construction d'un programme de recherche : une expérience pilote sur les vignes 
transgéniques. Rapport final du groupe de travail et réponse de la direction de l'IN-
RA.2003. INRA: Paris. http://www.inra.fr/genomique/rapport-final-ogm-vigne.html 
AUTHOR OF THE REVIEW 
Danielle Bütschi 
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GERMANY 6. 
GENETIC ENGINEERING, BREEDING AND BIODIVERSITY  
(1998) 6.1 
BACKGROUND OF THE PROJECT 
The TAB-project "Genetic engineering and breeding from the viewpoint of biodiver-
sity in agriculture" (short title: “Genetic engineering, breeding and biodiversity”) was 
based on a recommendation by the Committee on Food, Agriculture and Forestry and 
was approved in Autumn 1996 by the Committee for Education, Science, Research, 
Technology and Technology Assessment of the German Parliament. 
Background for the project was the 4. International Technical Conference on Plant 
Genetic Resources of the FAO at Leipzig in June 1996, which approved the Global 
Action Plan and the Leipzig Declaration for the “Conservation and Sustainable Utili-
zation of Plant Genetic Resources for Food and Agriculture”. Further, the Conven-
tion on Biological Diversity – ratified by Germany in 1993 – had defined objectives 
for the protection and use of the global biodiversity. These international commit-
ments, to be implemented on national level, were one starting point. The other start-
ing point was the questions, which impacts on biodiversity results from modern bio-
technology. 
The goal of the TA-project was to investigate what negative influences the use of 
genetic engineering in plant breeding can have on biodiversity, what contributions 
breeding and genetic engineering can make to conserving biodiversity and finally, 
what potentials can be derived for policy-making. A restricted, technology-centred 
perspective was not adequate for this theme. Particularly for the issue of potentials 
for conserving plant genetic resources and biodiversity in general, the approach was 
expanded in order to cover the significance of genetic engineering and breeding in 
the overall context. 
BASIC DATA ABOUT THE PROJECT 
The TA-project was executed in one and a half year, and finished in 1998. Four sci-
entific studies were awarded in the project. The draft final report of TAB was based 
mainly on these studies and was evaluated by a number of experts from science, gov-
ernment and stakeholders. 
The investigation area was limited to the field of plant breeding and - as far as possi-
ble - was restricted to the agricultural sector in Germany, taking into account Euro-
pean framework conditions. The topics of the project were: 
> biodiversity and plant genetic resources – status and development, 
> plant breeding – its goals, economic development and legal regulation, 
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> direct and indirect impacts of new (conventional and genetically engineered) va-
rieties on biodiversity – systematic analysis of impact chains, 
> biodiversity conservation measures – ex-situ, in-situ and on farm measures, 
> international agreements and implementation of international obligations, 
> options for action in the areas of research, agricultural, environmental and devel-
opment politics. 
MAJOR OUTCOMES OF THE PROJECT 
The results of the project showed that modern agriculture has made a considerable 
contribution to reducing the biodiversity of many crops and wild plants in Germany 
through intensification, rationalisation, specialisation and concentration of produc-
tion. Impacts on biodiversity have in particular been generated by changes in fertili-
sation, plant protection, rotation and land reallocation and consolidation. Plant breed-
ing and modern plant varieties are all part of the changed agricultural production 
system and their impact on biodiversity is more of an indirect one. The central con-
clusion of the project was that in Germany and Central Europe the use of genetic 
engineering procedures in plant breeding will not have a specific, significantly nega-
tive influence on biodiversity compared to conventional breeding practices in the 
short to medium term. On the other hand, however, genetic engineering in plant 
breeding will not make any significant contribution to conserving or extending plant 
genetic resources. 
To achieve the goal of "conserving biodiversity", there was seen a particular need for 
action on direct conservation measures. To this end the ex-situ, in-situ and on-farm 
conservation measures must be improved and developed. As Germany did not have a 
coordinated procedure on the conservation of plant genetic resources which incorpo-
rates all conservation measures, it was recommended to develop a combined conser-
vation strategy. This would simultaneously be a major contribution to conserving 
biodiversity in Germany. In order to implement international agreements at national 
level and to develop and apply a national strategy to conserve biodiversity (including 
plant genetic resources (PGR)), close coordination and cooperation was regarded as 
necessary between the various policy fields and levels affected. Interested and af-
fected societal groups should be incorporated into the national strategy development 
and implementation process. 
A matter of central importance for the sustainable conservation of biodiversity was 
seen in a full-coverage change towards sustainable agriculture, in which the promo-
tion of agricultural diversity and the protection of wild flora and fauna is a major 
component. The principles of organic farming which, in contrast to the still predomi-
nant conventional farming, involve more extensive and diversified farming practices, 
could therefore provide significant guides. It was pointed out that changes in basic 
framework conditions for agricultural and environmental policy do not make specific 
conservation measures (as discussed in the project) become superfluous, but their 
scope and urgency would take on a relative basis. 
A broad spectrum of options for action in the different areas of the project was iden-
tified and discussed. As future issues were identified: 
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> monitoring of the impacts of patenting on plant breeding and variety protection; 
> research on the impacts of the introduction of new varieties (conventional and 
transgenic plant varieties) on biodiversity of agro eco-systems and adjacent eco-
systems, with special attention to the issues of changes in cropping systems, resis-
tance development and resistance management; 
> long-term ecological impacts require comprehensive post-marketing monitoring, 
coordinated and combined with fundamental research activities on biodiversity 
and plant genetic resources. 
IMPACTS AND FOLLOW UP OF THE PROJECT 
The report was published as parliamentary document (Bundestagsdrucksache 
13/11253). In the following electoral term, the report was deliberated in the leading 
Committee for Nutrition, Agriculture and Forestry and two consulting committees. 
The result of the deliberation in the committees was a recommendation and report for 
the plenary (Bundestagsdrucksache 14/1716), with a detailed catalogue of actions 
based on the options for action in the TAB-report. This recommendation was ap-
proved in the plenary meeting of the German Bundestag on 16th December 1999, by 
the governmental majority and the PDS. 
In the federal agricultural report 2000 (Bundestagsdrucksache 14/2672), the Federal 
Government had pointed out that measures for the national programme on plant ge-
netic resources and a research programme on biodiversity has been prepared, in order 
to implement the above mentioned decision of the German Bundestag. 
CHALLENGES IDENTIFIED IN THE PROJECT 
In the project identified (future) challenges which are still valid (conclusions of the 
reviewer): 
> preservation of plant genetic resources 
> impacts of patenting on plant breeding and variety protection 
> uncertain future of small and medium seed producers 
> impacts of the introduction of new varieties (conventional and gm varieties) on 
biodiversity of agro eco-systems and adjacent eco-systems 
LITERATURE 
Meyer, R.; Revermann, C.; Sauter, A. (1998): Biologische Vielfalt in Gefahr? Gentech-
nik in der Pflanzenzüchtung. Studien des Büros für Technikfolgen-Abschätzung 
beim Deutschen Bundestag Band 6. Edition sigma: Berlin 
English summary: http://www.tab.fzk.de/en/projekt/zusammenfassung/ab55.htm 
AUTHOR OF THE REVIEW 
Rolf Meyer 
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RISK ASSESSMENT AND POST-MARKETING 
MONITORING OF TRANSGENIC PLANTS (2000) 6.2 
BACKGROUND OF THE PROJECT 
The TAB-project "Risk assessment and post-marketing monitoring of transgenic 
plants" was demanded by the Committee on Food, Agriculture and Forestry of the 
German Parliament. 
Background for the project was the ongoing debate in the EU on the authorisation of 
transgenic varieties and the amendment of the Deliberate Release Directive 
90/220/EEC. The development culminated in the summer of 1999 in a de facto mora-
torium on approval of transgenic plants for marketing by the Council of Environ-
mental Ministers, combined with the demand that the reforms in progress be com-
pleted before any new approvals are issued. 
During the project execution, the German marketing approval for the maize variety 
Bt176/ "Windsor" (about to receive variety approval from the "Bundessortenamt" – 
German Federal Plant Variety Agency) was suspended in February 2000 under Arti-
cle 16 of the Release Directive, which constitutes a safeguard clause. This event has 
sparked off forceful political and scientific controversy in Germany, which has also 
involved the German Bundestag and its committees on a number of occasions. In 
June 2000 the German Chancellor announced an initiative seeking to agree a three-
year transitional phase with the companies involved during which commercial culti-
vation of transgenic plants would be possible only on a limited scale and in combina-
tion with increased research into safety aspects, and particularly an intensive moni-
toring programme. This was not implemented due to the emerging of the BSE crisis 
in Germany. 
The goal of the TA-project was to give a focused overview of the status of the scien-
tific and political debate. It was not the purpose of the project to provide novel an-
swers to the outstanding questions on biosafety or develop separate proposals for the 
post-marketing monitoring. 
BASIC DATA ABOUT THE PROJECT 
The TA-project was executed in fifteen months (July 1999 – November 2000). Five 
scientific studies were awarded in the project. The draft final report of TAB was 
based mainly on these studies and was evaluated by a number of experts from sci-
ence and government. 
The investigation was limited to a status report on risk assessment and post-
marketing monitoring of transgenic agricultural crop plants. The main topics of the 
project were: 
> the status in safety research (inc. post-marketing monitoring) and the debate on 
risks, 
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> the state of regulation and treatment of authorisation procedures in the EU for the 
release, marketing and variety licensing of gm agricultural crop plants, 
> the state of implementation of the Novel Food Directive (licensing and labelling). 
MAJOR OUTCOMES OF THE PROJECT 
For the scientific debate on risks, it was worked out that controversies regarding 
both general and specific impacts relate primarily to three different levels: 
> first, the fundamental likeliness of occurrence (e.g. of outcrossing or development 
of resistance by insect pests),  
> second, the degree of possible damage (e.g. reducing biological diversity or ad-
versely affecting organic farming), and  
> third, the possible or necessary measures to avert risk (e.g. size of the protective 
zones around fields with transgenic plants or design of resistance management).  
Generally, the state of data appeared deficient in many respects, as while there had 
been over 1,300 release experiments in Europe alone, fewer than 1 % of release ex-
periments worldwide have been linked with accompanying ecological research (al-
though in Germany the figure was 15 %). Another reason why there was virtually no 
"real knowledge about risk" is the safety requirements needed for the accompanying 
ecological research. Critical voices pointed out that the lack of evidence of adverse 
ecological impacts suggests more that the wrong questions are being asked (with a 
resulting lack of corresponding studies) than the absence of any risk. Conversely, it is 
true that conventionally bred plants (i.e. not using genetic engineering) have never 
been subjected to biological safety testing, so that the impacts of transgenic varieties 
are always more thoroughly researched than those of conventional varieties. Many 
scientists also stressed that the new characteristics of transgenic plants are in princi-
ple much more clearly defined – and hence more easily documented and researched – 
than the results of conventional breeding. 
However, a whole series of questions will in any event be impossible to answer in 
research projects with a limited life. First, the results of scientific research always 
generate not only answers but also new questions, and second because long-term 
indirect effects can generally only be observed in the course of longer-term cultiva-
tion of transgenic plants on a significant scale. This realisation had led to virtual una-
nimity among all involved on the development and implementation of long-term 
monitoring of transgenic plants under cultivation. 
For the risk assessment in the approval procedures, the report looked in detail at 
how far the status of the scientific risk debate, and specifically the ecological aspects, 
were taken into account in the opinions in the framework of the approval procedures 
for marketing under Directive 90/220/EEC of both the EU scientific committees and 
national agencies (in Germany, Austria, the UK and – in part – Sweden), and how 
differences identified in the opinions can be explained. The result was that 
> scientific contributions and arguments have been very much selectively used and 
variously interpreted,  
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> diverging conclusions have been drawn from gaps and areas of uncertainty in our 
knowledge, and  
> above all, the possible consequences have been very differently evaluated in terms 
of the scale of damage and resulting implications.  
Even after the amendment, there is still no definition of damaging impacts, so that 
there will still be considerable scope for different assessments. Not least, the question 
will be which agricultural paradigm the impacts of transgenetic agricultural plants 
are measured against. It will not be possible to derive a normative framework for this 
paradigm simply from the debate about GE applications: instead, this will require a 
serious definition and specification of the term "sustainable agriculture" as a stated 
goal of European agricultural policy. 
For the post-marketing monitoring was pointed out that three dimensions or dis-
tinctions have special relevance: 
> monitoring based on cause-and-effect hypotheses (even if partly unexplained or 
uncertain) versus unexpected or rare events,  
> surveys of the agricultural ecosystem (and adjoining marginal structures) versus 
surveys of the environment generally,  
> monitoring for limited periods versus long-term or unlimited monitoring.  
The overall main conclusions of the report were: 
No excessive expectations should be raised for the amended Deliberate Release Di-
rective 90/220/EEC and the introduction of post-marketing monitoring. Their poten-
tial for resolving problems will inevitably remain limited until such time as funda-
mental agreement is reached on definitions of damage and desirable agricultural 
practice.  
Both the amended Deliberate Release Directive and the Novel Food Regulation re-
quire operationalisation and specific guidelines for implementing the safety assess-
ment and approval procedures. This is the only way to reduce discussions about the 
scope, coverage, methodology and interpretation of the safety assessments. This 
should build on the current state of the scientific risk debate. To this extent it will be 
an ongoing task, rather than a one-time exercise.  
New instruments – such as post-marketing monitoring or revised labelling regula-
tions – should only be introduced when their integration into existing statutory provi-
sions and their implications have been carefully considered and widely discussed. To 
avoid new areas of conflict and controversy, e.g. in post-marketing monitoring a dis-
tinction should be made as early as possible between this and pre-marketing safety 
research and risk assessment and the criteria for incorporating information from 
monitoring in the approval procedure should be clarified.  
Finally, new areas of conflict should be identified at the earliest possible state and 
investigated in advance. Attention is drawn particularly to the announced second-
generation transgenic plants, which are e.g. supposed to have a health-promoting 
effect as "functional food". These will probably result in a shift in the debate from 
possible ecological impacts towards potential health impacts and also pose entirely 
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new and possibly even greater problems in safety assessment than the current trans-
genic plants.  
IMPACTS AND FOLLOW UP OF THE PROJECT 
The report was published as a parliamentary document (Bundestagsdrucksache 
14/5492). The report was deliberated in the leading Committee on Consumer Protec-
tion, Food and Agriculture and two consulting committees. Thereby, the report was 
discussed controversial. The governmental majority presented a motion which in-
cluded the whole spectrum of the report issues, proposed a further development of 
the concept sustainable agriculture and demanded a consequent application of the 
precautionary principle. In contrast, the motion of the opposition (CDU/CSU) con-
centrated on the rapid implementation of the new Deliberate Release Directive 
2001/18/EC and was demanding a strengthened research and use of transgenic crop 
plants. 
The result of the deliberation in the committees was a recommendation (of the gov-
ernmental majority of SPD and the Greens) and report for the plenary which was 
approved in the plenary meeting of the German Bundestag on 14th June 2002. The 
TAB report was once again unanimously noticed by the plenary. 
The part on post-marketing monitoring of the report was used in a documentation of 
the Federal Environmental Agency (UBA 2001) which summarise the state of debate 
at that time. 
The report had pointed out that TA should be started on the new generations of 
transgenic plants at the earliest state as possible because these will probably result in 
a shift in the debate from possible ecological impacts towards potential health im-
pacts and also pose entirely new and possibly even greater problems in safety as-
sessment than the current transgenic plants. Following this recommendation, TAB 
was commissioned with a project on transgenic plants of the second and third genera-
tion in 2003. 
CHALLENGES IDENTIFIED IN THE PROJECT 
In the project identified (future) challenges which are still valid (conclusions of the 
reviewer): 
> need for more accompanying ecological research to assess possible risks of gm 
plants 
> missing definition of damaging impacts, so that there is still a considerable scope 
for different assessments 
> missing normative framework for desirable agricultural practice or sustainable 
agriculture, against which impacts of gm plants can be measured 
> insufficient implementation of post-marketing monitoring 
> need for clear distinction between post-marketing monitoring and pre-marketing 
safety research 
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> development of criteria for the feed-back of information from the post-marketing 
monitoring to the authorisation agencies and for impacts on running approvals or 
re-approvals 
> importance of the second and third generation of gm plants (in particular plant-
made-pharmaceuticals, plant-made-industrials, functional food) with potentially a 
shift in the debate from ecological impacts towards health impacts and new prob-
lems in risk assessment 
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DISKURS GRÜNE GENTECHNIK (GREEN BIOTECHNOLOGY 
DISCOURSE) (2002) 6.3 
BACKGROUND OF THE PROJECT 
The so-called “Diskurs Grüne Gentechnik” (“Green Biotechnology Discourse” was 
initiated by the federal Ministry of Consumer Protection, Nutrition and Agriculture 
(Bundesministerium für Verbraucherschutz, Ernährung und Landwirtschaft, 
BMVEL) in 2001. 
The situation in the starting year was characterised by the worldwide growing com-
mercialisation of gm crops, the amendment of the EU regulation on genetic engineer-
ing, the abandonment of the three-year transitional trial phase of introducing gm 
crops in agriculture due to the BSE crisis (see review on the TAB project 2000), and 
the new direction of the German agricultural policy (so-called “Agrarwende”). 
The goal was to “establish a forum for clarification of facts and for debate among all 
relevant societal groups” (BMVEL 2003, p. 5). 
BASIC DATA ABOUT THE PROJECT 
The “Green Biotechnology Discourse” was started in December 2001 and finalised 
in September 2002. 30 stakeholder groups – industry, agricultural organisations, en-
vironmental and consumer groups, churches, trade unions – took part in the dis-
course. Further, representatives of different other ministries were present. The steer-
ing committee of the discourse consisted of representatives of the stakeholder groups 
and was chaired by a representative of the BMVEL. 
The discourse was split in two phases, the starting phase (with a kick-of meeting, the 
selection of the moderator, the constitution of the steering committee and a hearing) 
und the phase of so called “discourse rounds”. The stakeholder and representatives of 
the ministry met in five “discourse rounds” of two days duration und in a conference. 
At these meetings opinions of 53 experts were heard and discussed by the partici-
pants. Care was taken to have an equal proportion of “pro-GM” and “anti-GM” ex-
perts. The moderator had prepared in the starting phase a “basic reader” which gave 
an overview on scientific, economic, ethic, social and legal issues. 
The steering committee agreed on the main topics to be discussed in the five “dis-
course rounds”: 
> preservation of biodiversity, 
> innovation potential and future chances of green biotechnology, 
> benefits and risks for consumer and producer, 
> preconditions, chances and consequences of an abandonment of green biotechnol-
ogy, 
> information, participation of the public and freedom of choice. 
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The results were published in a final report written by the steering committee 
(BMVEL 2002). The BMVEL published in addition a booklet in which the results 
are resumed as seen by the ministry (BMVEL 2003). 
MAJOR OUTCOMES OF THE PROJECT 
For major points, a consensus was not achieved. The final report lists for the differ-
ent topics the points of consensus and dissent, and open questions. Some major out-
comes are (BMVEL 2002): 
> Biodiversity: Consensus on the importance of preservation the biodiversity, but 
dissent on what is a negative impact on biodiversity (e.g. out-crossing); important 
open questions are seen in the definition of ecological damage and in the respon-
sibility for damages on biodiversity; 
> Risk assessment: Fundamental disagreement on the deliberate release and use of 
gm plants; as most important open question was identified the understanding of 
the precautionary principle; 
> Benefits of GM plants: Consensus about the importance of plant breeding, the 
potentials of conventional breeding and the need of molecular-genetic and ecosys-
tem research for successful plant breeding, but dissent on specific benefits from 
GM plants; important open questions are seen in the clarification of potential fun-
damental differences between conventional breeding and genetic engineering and 
in the regulation of intellectual property rights; 
> Benefits of GM foods: Consensus on the high standards of food security and qual-
ity in the industrial countries, but disagreement on the consumer benefits from 
product innovation in the past and from gm food; as prior open questions are re-
garded the definition of improved foods and the possibilities of healthier nutrition 
through gm food; 
> Freedom of choice and coexistence: Consensus on the freedom of choice for pro-
ducer and consumer, the labelling of gm foods and that with zero tolerance coex-
istence is not possible, but dissent on thresholds, measurements and accountabil-
ity; to the identified open questions belong feasibility of coexistence, coexistence 
rules and liability; 
> Labelling: Clear and practicable regulation for labelling is demanded; a consensus 
for seed thresholds was not achieved. 
IMPACTS AND FOLLOW UP OF THE DISCOURSE 
All important stakeholders in the field of green biotechnology have participated in 
the discourse. But no changes in the German discussion on gm plants and foods re-
sulted from this exercise – there was no successful mediation across the GM divide. 
The discourse is extensively documented on the “transgen” website 
(www.transgen.de). This official website declares: “In the end the discourse had little 
effect. The various views continue to stand opposed to each other. A number of ques-
tions that were discussed at the time have meanwhile been settled politically, but this 
has hardly calmed down the controversies.” (Transgen 2007) For the in 2002 re-
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elected red-green coalition government, freedom of choice and coexistence remained 
the leading policy goals for the area of biotechnology and food. Following the new 
EU regulation, an amendment of the German regulation on genetic engineering took 
place in 2004 [?]. Pro-GM participants regarded this new regulation as blocking the 
use of gm plants. 
It has been suggested that the discourse had a built-in design to cement rather than to 
mitigate the controversy. A fundamental divide between two sides appeared due to 
the requirement of the pro/contra proportionality in the selection of experts. This 
arrangement offered organisations with more outspoken views greater leverage on 
the kind of expertise that would be presented. Any substantive debate between dif-
ferent experts was frustrated. Experts were used as strategic resources by the partici-
pating organisations. One effect of the discourse was apparently that cooperation and 
coordination within each side of the GM controversy was strengthened (Paula/van 
den Belt 2006, p. 32).  
CHALLENGES IDENTIFIED IN THE DISCOURSE 
In the discourse identified (future) challenges which are still valid (conclusions of the 
reviewer): 
> definition of ecological damage 
> definition and operationalisation of the precautionary principle 
> regulation and impacts of intellectual property rights and patenting 
> consumer benefits from gm foods as improved food products and healthier nutri-
tion 
> feasibility of coexistence, coexistence rules and liability 
> working labelling regime for gm food 
> thresholds for labelling of seeds 
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GENETIC ENGINEERING AND ORGANIC FARMING (2003) 6.4 
BACKGROUND OF THE PROJECT 
In December 2000, the German Federal Environmental Agency (Umweltbundesamt 
– UBA) held a professional conference on the subject of “Green genetic engineering 
and organic farming”. During this conference, possible approaches for protecting 
organic production sites as the use of genetically modified plants increase in conven-
tional agriculture were discussed with persons representing organic farming from the 
research, production and administration sector. 
The experts participating in the conference agreed that the only way to minimise con-
tamination due to introgression from genetically modified plants is to use suitable 
prescribed distances between organic farming areas and fields containing genetically 
modified plants. Additionally, the establishment of zones that are free of GMOs 
should be considered within protected areas. 
At the starting time of the project, there was no basic legal stipulations in Germany 
or in Europe with regard to these calls for minimum prescribed distances and GMO-
free protected areas. 
The objective of the “Green genetic engineering and organic farming” project was 
thus to present different legal scenarios for establishing regulations on minimum pre-
scribed distances between organic farming areas and fields containing genetically 
modified plants within the German und European legal systems. 
BASIC DATA ABOUT THE PROJECT 
The specialist report entitled “Green genetic engineering and organic farming” 
(Barth et al. 2003) was prepared on behalf of the German Federal Environmental 
Agency by the Forschungsinstitut für biologischen Landbau Berlin e.V. and the Öko-
Institut e.V. in the time between June 2001 and August 2002. The report includes the 
results of two workshops held on 29 October 2001 and 16 January 2002 in Berlin 
during which the initial results were discussed with various experts. 
MAJOR OUTCOMES OF THE PROJECT 
There is a world wide consensus among organic farmers not to use genetically engi-
neered organism (GMO). Initially implemented through the guidelines of organic 
farming associations, this rule now gained accession to consumer protection legisla-
tion in the USA, Japan and the European Union. 
EU LAW PERMITS PROTECTIVE MEASURES FOR ORGANIC FARMING 
At the European level neither the EU regulation on organic agriculture nor the seeds 
directives prescribe mandatory measures for the protection of organic crops against 
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pollination by GMO pollen. An evaluation of EU Directive 2001/18/EC on the De-
liberate Release of GMO shows, however, that the permission to market GMO may 
include an order to take measures to avoid property damage through pollination as 
one of the “specific conditions of use and handling” of the GMO. This results from a 
systematic and parallel interpretation of the EU Directive on the release of GMO and 
the EU regulation on organic agriculture. Only inasmuch as the interpretation of the 
Directive on the release of GMO takes into account the legislative targets of the EU 
regulation on organic agriculture will a balance of interests between organic agricul-
ture and the cultivation of GMO be accomplished. 
PROPOSALS FOR ISOLATION DISTANCES 
Currently the most widely discussed option for affording protection against property 
damages is to provide isolation distances between cultures with GMO plants and 
organically managed cultures; another is to demarcate GMO-free regions. 
Isolation distances have for a long time been used in seed production to maintain 
purity of breed. The goal is to keep impurity to a minimum. Statutory minimum iso-
lation distances are based on past experience with seed production and they do not 
completely rule out hybridisation. Nevertheless, the imposition of safety distances 
does offer itself as one possible way of protecting organic agriculture. 
An analysis of empirical data with a view of defining isolation distances revealed 
many gaps and hence an urgent need for further research. Despite this shortcoming, 
and for pragmatic purposes, the present survey was based on what data were avail-
able to derive first recommendations for isolation distances. 
Measures for protection against property damages through GMO pollination in or-
ganic agriculture, such as the declaration of isolation distances on commercial pack-
aging of GMO seeds, could be imposed by way of commercialisation permits. Im-
plemented through commercialisation permits such measures could even today have 
an effect on civil-law relationships between organic farmers and GMO farmers, un-
der certain conditions entitling organic farmers to claims for damages caused by ge-
netic introgression. 
PATHS TOWARD CONCILIATION BETWEEN NEIGHBOURS 
In Germany the private legal rights and spheres of interest of organic farmers and 
users of transgenic varieties are defined and delimited by civil law. The borderline is 
drawn by a system of legal claims governing neighbourly relationships. § 906 of the 
German Civil Code is the central norm of private environmental law. Under this 
paragraph users of transgenic plants can be required to avoid or minimise genetic 
modifications in neighbouring cultures. When an organic farmer suffers market 
losses due to the pollination of organic cultures by GMO pollen, the owner of the 
neighbouring transgenic cultures can be ordered to pay damages. At present it is dif-
ficult to assess the level of enforceable claims. The complex intercalating system of 
claims to desist or to compensate will have an inhibitory impact on the use of trans-
genic seeds, and the economic burden of having to avoid GMO pollination of 
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neighbouring cultures or pay compensation, will not be calculable in advance. How-
ever, organic farmers are so burdened with having to secure cogent proofs of causal-
ity that many will see this as an intolerable manacle. Under these conditions there 
will be little hope of arriving at a state of peaceful coexistence. 
The idea of a self-organised mediation system for temporal and spatial isolation in 
connection with a compensation scheme financed by GMO producers and users is 
introduced. 
PUBLIC REGISTER OF PRODUCTION SITES 
All member states of the European Union are required by the Directive 2001/18/EC 
to establish public registers documenting GMO cultivation sites and the identity of 
cultivated GMO varieties for the purpose of monitoring environmental effects. This 
register could at the same time serve as a production register for GMO. The directive 
leaves it up to the member states to determine the details of register management. 
The directive contains no impediment to requiring farmers to provide precise infor-
mation on the location of their GMO cultures for the register. Information concerning 
the precise design of the GMO and the analytic measures to detect it could be in-
cluded along the lines of the draft of the EU regulation concerning traceability and 
labelling. However, this draft only requires that the codes of GMO sequences be pub-
lished. Since organic farmers must be in a position to reliably detect GMO se-
quences, the cultivation register would need to contain precise information on their 
identity. 
INTRODUCTION OF GOOD PRODUCTION PRACTICE IN GMO CULTIVATION 
Protective measures to avoid GMO pollination could be imposed on users of GMO 
seeds through the introduction of a code of “Good Production Practice in GMO cul-
tivation” (GPP). Such measures could include, for example, defensive cultivation 
planning and the maintenance of specific distances between transgenic and suscepti-
ble organic cultures. For the implementation of the GPP code the administration must 
be empowered to impose specific single protective measures. Non-observance of 
such an order must be penalised as a regulatory offence. GPP could be introduced by 
an amendment to the Gentechnikgesetz (German act on genetic engineering) or the 
Saatgutverkehrsgesetz (German act on the marketing of seed). Alternatively, it could 
be introduced through an amendment to a specific (organic) agriculture statute. 
DAMAGE FUND FOR GMO POLLINATION 
For pollination by GMO from non-determinable sources a system for compensating 
organic farmers for market losses is necessary and indeed feasible. Compensation 
could be provided by a governmental compensation system or a fund model based on 
a statutory regulation or a voluntary self-commitment of producers and users of 
GMO. 
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PROTECTION OF ORGANIC SEED PRODUCTION 
The protection of organic seed production necessitates closed regional production 
areas. This requires the development of an appropriate legal basis. 
IMPACTS AND FOLLOW UP OF THE PROJECT 
Some points are incorporated in the amended German legislation on genetic engi-
neering, but many other points are still discussed controversial. 
CHALLENGES IDENTIFIED IN THE DISCOURSE 
In the project identified (future) challenges which are still valid (conclusions of the 
reviewer): 
> definition of isolation distances and Good Production Practice 
> liability and compensation fund 
> protection of organic seed production 
> coexistence which does justice to consumers’ right to freedom of choice is not 
easily to be arrived 
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GREEN GENETIC ENGINEERING – TRANSGENIC PLANTS 
OF THE SECOND AND THIRD GENERATION (2005) 6.5 
BACKGROUND OF THE PROJECT 
The TAB-project “transgenic plants of the second and third generation” was de-
manded by the Committee for Education, Research and Technology Assessment. The 
term "second generation" was used to describe those genetically modified plants 
(GMP) which are in the pipeline (i.e. in industrial development and shortly before 
licensing), while “third generation” is applied to those in research or a very early 
stage of development. 
The origin of this project can be clearly traced back to the previous TAB project 
"Risk assessment and post-marketing monitoring of transgenic plants", where the 
investigation of this topic was brought up as an important recommendation concern-
ing future TA need (see review 6.2). 
A second motivation was the (as well since a long time especially in the political 
debate repeated) assumption, that a shift in the European consumers' hostile attitude 
towards GMP can't be expected as long as no products from GMP with a convincing 
benefit are on the market. The TAB project to study the potential and risks of future 
transgenic plants was limited to the subset of GMP with modified use properties for 
the consumer (so-called “output traits”). The TA project aimed to answer the follow-
ing questions: 
> how the targeted additional benefits of these GMP are defined, 
> how they are supposed to be achieved, 
> what economic potential can be expected, 
> what new (types of) risks should be assumed, 
> what new questions of safety assessment result from these, 
> whether existing safety measures appear adequate, or whether they need to be 
modified, expanded or supplemented, 
> what regulatory challenges result, and also 
> what effects on consumer acceptance are to be expected. 
BASIC DATA ABOUT THE PROJECT 
The TA-project was executed in 21 months (November 2003 – July 2005), subdi-
vided into two phases. Eight scientific studies (expert opinions) were commissioned 
during the project. In the first phase (until August 2004), based on three of the expert 
opinions, an overview of research and development as well as concerning the eco-
nomic potentials and the international debate on risk evaluation and assessment was 
worked out. The second phase of the project was devoted to an in-depth analysis of 
"molecular farming" which means the use of GMP for the production of industrial 
materials (so-called PMI or plant made industrials) and especially as a source of 
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pharmaceutical substances for human and animal medicine (so-called PMP, or plant 
made pharmaceuticals). The draft final report of TAB was based mainly on the 
commissioned scientific studies and was evaluated by a number of experts from sci-
ence and government. 
The main topics of the final report were: 
> a detailed description of GMP for functional foods, for PMI and PMP12 
> including an in-depth discussion of their economic potentials and 
> their possible ecological and health risks; 
> the possible performance of biological and physical confinement measures; 
> the regulation of molecular farming (in the EU, compared to the U.S. and Can-
ada):  
> areas for action (with regard to the German national and the EU level). 
MAJOR OUTCOMES OF THE PROJECT 
OVERVIEW OF RESEARCH AND DEVELOPMENT – LICENSING AND RELEASE 
GMP with output traits were divided into six groups: 
1. improved contents in plants which are a source of food (functional foods - FF); 
2. improved contents in plants which are a source of animal feed; 
3. optimised or modified plants for production of industrial materials (PMI) or 
4. for production of pharmaceutical substances (PMP); 
5. GMP for phytoremediation (plants for the treatment of contaminated soils); 
6. modified properties of decorative flowers (colour) or plants (e.g. lawn). 
GMP with output traits play no role in global cultivation, which is still completely 
dominated by herbicide and insect resistance. Until 2005 eleven GMP with modified 
output traits have been licensed in various countries (2006: plus one), nine of them 
without relevance for the TAB report (tomatoes with longer shelf life, modified 
decorative flowers, tobacco with reduced nicotine content). The two remaining varie-
ties, a rapeseed with high lauric acid content and a soy bean with increased oleic acid 
content, have been unsuccessful on the US market, and are accordingly not grown to 
any effective extent. In the EU, only the three modified carnations have been li-
censed (since 1997/98). The licensing pipeline contains (since 1997) 21 applications, 
including one PMI GMP, the "famous" potato with modified starch composition. 
Among the releases in the U.S. (1988-2003), GMP with modified output traits ac-
count for c. 20% of the c. 10,000 applications, equivalent to 150-230 a year since 
1994. In the EU, GMP with modified output traits account for c. 15% of all releases 
in 1988-2003 (over 270 of 1,850 applications). In line with the trend for GMP gener-
                                                 
12GMP for animal feedstuff were not dealt with in depth, as their uses are more com-
parable with agronomically modified GMP, and hence do not open up new prospects 
for use in the same way as the other three groups, and because they play only a minor 
role in Europe, quantitatively speaking. 
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ally, there has been a very definite decrease in release applications since 1996/97. A 
breakdown by individual groups shows a much smaller significance of the feedstuff 
sector than in the USA. 
GMP FOR THE PRODUCTION OF FUNCTIONAL FOODS OR THEIR INGREDIENTS 
The range of functional ingredients produced or (to be) modified in plants by genetic 
engineering is still very manageable. The GMP developed so far are predominantly 
prototypes to demonstrate fundamental feasibility, which need further development 
for commercial use and must be tested not only in the field but also on humans in 
nutrition studies.  
For most functional ingredients, the current genetic engineering approaches – over-
expressing or reducing the activity of individual genes directly involved in the rele-
vant metabolic pathways – are not sufficient to achieve commercially attractive con-
tent of the functional ingredients in the GMP. Hopes involve conceptual and meth-
odological further developments in metabolic engineering, which seeks to affect en-
tire metabolic pathways and regulatory networks in a coordinated way. Whether FF 
GMP can be established in the medium term as a source of functional food raw mate-
rials and ingredients depends crucially on whether the assumed cheaper production 
of functional ingredients in GMP can be actually achieved. This is not easy, as there 
are established production platforms already in existence (e.g. chemical synthesis, 
microbial production, isolation from natural sources) for most of the ingredients cur-
rently being researched in GMP, which FF GMP will have to compete with. The re-
source-intensive and comparatively long development period for new GMP varieties 
and the functional foods or ingredients produced from them represent a comparative 
disadvantage, as the regulatory requirements mean tying up resources in the long 
term in a dynamic market which actually requires a rapid and flexible response. In 
addition, GMP approaches generally have to be supplemented by other food technol-
ogy options, as functional GMP for direct consumption can only meet a small seg-
ment of the possible entire supply of and demand for functional foods, for reasons of 
shelf life, seasonal availability, convenience and bioavailability. 
PLANT MADE PHARMACEUTICALS 
GMPs have been discussed for many years as a highly promising new production 
platform for drug production. The hope is particularly for low-cost production in 
large quantities. Products produced using genetic engineering methods account for 
the overwhelming part of pharmaceutically effective proteins and peptides, which are 
also called “biopharmaceuticals”. Significantly less important (and also in very early 
stages of development) are genetic approaches to influencing pharmaceutically effec-
tive so-called secondary metabolites, which were not discussed in the report. 
To date, no PMP GMP has been licensed for placing on the market anywhere in the 
world. There are intensive research and release activities in the USA and Canada, 
while the activities in the EU come predominantly from two French firms (Meristem 
Therapeutics and Biocem). The plant species used are predominantly maize and to-
bacco, followed by rapeseed and soy bean. No PMP has yet been given “real” ap-
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proval as a drug. Several proteins which also have pharmaceutical uses are already 
on the market, although so far they can only be sold as research or diagnostic re-
agents. They come from experimental releases (in the USA). 
Of those PMP in development, so far only two have been recognised as having so-
called orphan drug status (for treating rare diseases). In the EU orphan drug status 
(for use with mucoviscidosis sufferers) was granted in 2003 to a so-called gastric 
lipase (from maize). To date the protein comes from experimental releases in France, 
and could be the first PMP for application for approval as a drug in the EU. In the 
USA a so-called galacosidase was granted orphan drug status in the same year. 15 
PMP were identified in various phases of clinical testing. In addition to gastric lipase, 
an antibody for caries prophylaxis and patient-specific antibodies for treating non-
Hodgkin lymphomas are in an advanced stage of testing. Several PMP are currently 
being developed for veterinary use, with the option of extending these to human in-
dications later if successful. Besides these concrete examples, there is a vast number 
of PMP in preclinical R&D stages. A key area is developing antibodies, presumably 
because possible specific advantages of production in GMP seem most within reach. 
To assess the future potential of PMP GMP, comparison with competing production 
platforms is needed. To date, biopharmaceuticals have almost entirely been produced 
microbially or in animal cell cultures, and transgenic animals are rather more ad-
vanced than PMP approaches (although here again no drug has yet been approved). 
The various production platforms are briefly presented and described in the report. 
Possible specific advantages of PMP GMP were considered in terms of freedom 
from human-pathogenic agents, correct glycosylation and of investment and produc-
tion costs including scalability. These were found to be predominantly dependent on 
the product. For example, it is clear that glycosylation closer to mammalian cells 
(modification of the protein in the cell) from PMP has an advantage over microbial 
systems for many drugs, although this may also prove a pharmacological disadvan-
tage for others. It is fairly certain that general cost advantages cannot be assumed for 
production from PMP – these are only plausible on the unrealistic assumption of only 
slightly regulated open cultivation (plus ideal yields). An in-depth investigation of 
the foreseeable potential of possible oral vaccines showed that oral vaccines do not 
seem very important for vaccine development, and particularly that the idea of inges-
tion in the form of unprocessed fruits (still frequently cited) is entirely unrealistic. 
An overall assessment of the currently foreseeable economic potential  concluded 
that in view of the major and growing importance of biopharmaceuticals generally, 
there is probably also growing potential for production in PMP, without the general 
cost advantages generally assumed. Their competitiveness is decisively determined 
by advances in competing production systems and development of specific regula-
tions for cultivation and corresponding risk management measures. 
PLANT MADE INDUSTRIALS 
Use of PMI GMP seems comparatively further away. This is a little surprising, given 
the intensive work on relevant GMP concepts over many years, and the fact that the 
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first two such GMP were approved and commercialised years ago. The only cur-
rently foreseeable example here in the EU is the starch potato, which has been in the 
approval pipeline for years. 
For all other approaches (whether in “designer oils” or “designer starches”, produc-
tion of industrial enzymes, biopolymers or other special ingredients) it is virtually 
impossible to assess how far the work has come in concrete terms. In some cases, 
this is in-house work, in other cases the development work – e.g. on bioplastics from 
GMP – seems to be taking significantly longer than hoped. The reasons for this dif-
fer, depending on the development goal and plant species, but the examples pre-
sented suggest possible general assessments (which also apply e.g. to development of 
FF GMP). 
> In several cases, expectations particularly of attainable product yields have been 
not been satisfied even after many years of development. In the course of maxi-
mising content, apparently undesired side effects have emerged (are emerging) in 
many cases which then result in lower yields. While this does not make the con-
cept (economically) unusable, it does affect the range of substances which can be 
produced on a commercially competitive basis. 
> In several cases, the transition from the highly promising model plants to specifi-
cally usable ones did not proceed as hoped, as the genes failed to “function” ac-
cordingly. 
> In other products, the alternative production systems (cell-based systems, trans-
genic animals) developed faster or more efficiently. 
An assessment of the prospects for PMI concepts is accordingly (even) more difficult 
than for PMP. Production of bulk products seems unlikely in the foreseeable future, 
the production of renewable raw materials is more likely to be optimised through 
breeding of non-genetically-modified plants. Industry sees realistic prospects for 
high-price special applications, if these can only be produced in GMP and not in 
conventional varieties or the cultured varieties otherwise used. Dual use (e.g. bio-
plastic and feedstuff) depends on relevant approval, which is only conceivable for 
selected approaches. Transgenic trees for plantation farming could become more 
significant worldwide, but cultivation in the EU is unlikely for a long time. 
POSSIBLE ECOLOGICAL AND HEALTH RISKS 
Given the early stage of GMP modified for output traits, no risk discussion has de-
veloped for most sub-aspects, so that no presentation in detail was possible. This 
applied particularly to the possible ecological risks of FF GMP and the possible 
health risks of PMI GMP. The risk discussion for FF GMP is focusing on the basic 
question of safety evaluation of innovative and primarily functional foods, while for 
PMP GMP the emphasis is on possible release into the environment and food and 
preventing this. Therefore the risk debate on molecular farming (of PMP and PMI) 
generally has so far concentrated almost entirely on the question of reliable seques-
tration and containment of GMP. 
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Basically, GMP modified for output traits fundamentally change the situation for risk 
regulation (i.e. risk assessment, risk evaluation and risk management), because at 
least PMP GMP as well as some PMI GMP have an inherent risk because of the 
medical and physiological impact of their ingredients. 
The current goal of risk regulation is to approve only GMP which are risk free as 
compared to "conventionally" bred plants. This concept must be at least modified by 
developing comprehensive and rigorous safety requirements for cultivation and proc-
essing e.g. for PMP GMP with their potential environmental and health risks (as is 
the case in Canada and the USA). It will probably be necessary to impose group-
specific measures which imply moving away from the pure case-by-case principle, or 
at least supplementing it. 
At the same time, the discussion of benefits is taking on new priority compared with 
the 1st generation of GMP, including risk evaluation and regulation. So far, it has 
been possible to ignore doubts about the benefits of the genetically introduced prop-
erties from the regulatory point of view (because no concrete risks to health and the 
environment were established as a prerequisite for approval), and to leave evaluation 
to market forces. In future, the desired benefit (e.g. production of life-saving drugs) 
is likely to play a greater role – at least in some cases – in risk evaluation, including 
in the approval decision. 
BIOLOGICAL AND PHYSICAL CONFINEMENT MEASURES 
In considering possible risk management measures for GMP modified for output 
traits, it is necessary to distinguish between two groups of GMP which pose very 
different requirements for regulation, namely those which can be regarded as just as 
safe as the approved 1st generation GMP, and all others. 
The first group could include several of the conceivable PMI applications, e.g. if 
these involve modified food plants which are currently being used for industrial pur-
poses in their conventional form. At least if the relevant GMP has explicit approval 
for food and feed, large scale cultivation is conceivable subject to the prevailing va-
riety-specific coexistence regulations, and would not differ substantially in quality 
from the food sector. The second group presumably includes most PMP, together 
with a range of conceivable PMI plants for which special containment/confinement 
will be required. In the event of open cultivation, and possibly greenhouse cultiva-
tion, particularly strict biological and physical confinement measures must apply, as 
the current regulations in Canada and the U.S. require. 
The report discusses in detail the question how reliable the various methods in pre-
venting undesired dissemination of GMP are. The overall conclusion was that the 
present state of science and technology is unable to offer any system for confinement 
of transgenic nonfood plants which permits coexistence in open cultivation of GMO 
and non-GMO species completely free of any influence. But it was emphatically 
stressed that the extent to which such influence can be tolerated and under what con-
ditions are matters for society to decide. 
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Only few biological confinement methods have reached a state of development 
where substantial studies on integrity and leak tightness can be carried out. An (al-
most) complete prevention of the escape of a transgene is up to now only possible in 
closed systems. 
REGULATION ISSUES IN MOLECULAR FARMING 
Consideration of the state of regulation of genetic engineering showed that the pre-
sent regulations and procedures for molecular farming are not entirely appropriate or 
adequate. For molecular farming of “high price” products or ingredients on compara-
tively small areas, approval for release under Part B of European Directive 
2001/18/EC is inadequate in many cases (because the relevant products may not be 
placed on the market), although approval for placing on the market under Part C 
would actually not be required, because free trade and unlimited cultivation are not 
goals of GMP development. At least in the medium term, there will accordingly be a 
need for change, particularly in the regulation of genetic engineering. By contrast, 
there is currently hardly any need for change apparent in drug and chemical regula-
tion. 
Activities and discussions in the EU (until summer 2005) showed that very little at-
tention had been paid to the issue of molecular farming so far, particularly in com-
parison with Canada and the U.S. [this has changed a little bit since then, as EFSA 
and IPTS have started several activities, both of them taking notice of the TAB re-
port; see below]. This implies a need at EU and national level for more intensive 
consideration of the opportunities and potential risks of GMP modified for output 
traits. 
AREA FOR ACTION: OPERATIONALISATION OF VISIONS AND SCENARIOS 
Although molecular farming has been described as a future option for many years in 
the debate on genetic engineering, it has mostly been presented in very vague terms, 
either as largely unsupported assumptions about possible benefits (and/or risks) or as 
visions of the future. The relevant documents typically focus on scenarios for the use 
of possible products from GMP modified for output traits, describing scenarios for 
production and cultivation which have little contact with reality, and completely ig-
nore regulatory aspects and realistic coexistence scenarios. Such operationalisation 
accompanied by greater social opening seems very important for the coming debates 
on possible future use of transgenic plants. These tasks should be addressed with a 
view to the coming Framework Programme 7, together with more substantial links to 
the relevant policy areas, strategies and goals (including more extensive use of re-
newable raw materials, development of rural areas, sustainability of agriculture, 
healthier nutrition). 
AREA FOR ACTION: GERMAN RESEARCH POLICY 
Facing the new and complex questions regarding the benefit as well as novel risks 
and their management, for German research policy the development of interminis-
terial promotional R&D measures for research into molecular farming was assessed 
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as being adequate. A viable and societally acceptable approach would require not 
only bringing together the ministries' technical points of view but also including 
various interest groups in developing such promotional programmes and projects. 
No assessment was performed for R&D approaches in detail, e.g. deserving promo-
tion or safety issues requiring particularly urgent investigation. However, a specific 
proposal was made for a “Progress report by the Federal Government on the status of 
publicly funded activities in connection with research, approval, cultivation and mar-
keting of GMP”, which should in detail review the aims and outcomes of the last 10 
to 15 years and draw conclusions for the future promotion and funding of R&D de-
voted to biotechnology and plant sciences (a proposal, which seems to be suited for 
every other country as well as the EU level). Such a report could possibly offer a 
basis or at least a point of reference for more constructive and sustainable further 
development of research policy on green genetic engineering and alternative strate-
gies. 
AREA FOR ACTION: MODIFICATION OF REGULATION AT EU LEVEL 
The need for action concerning modification of regulation was clearly located at EU 
level. The regulation has to come under review if it is suited for the production of 
PMP and PMI (which seems not so; see results above). With regard to national regu-
lations, it was concluded that they have to be revised in a second step according to 
the EU regulation. 
IMPACTS AND FOLLOW UP OF THE PROJECT 
Parliamentary debate and/or decision:  
The proposal of the "Progress Report" was picked up several times in parliamentary 
debates (on GMOs, but not directly connected with the TAB report) and has been 
integrated in the official statement of the (together with the christian democrats gov-
erning) social democrats concerning the current amendment of the gene technology 
law. 
Public perception: 
Compared to other TAB projects, a relatively broad press coverage in print and web-
based media began directly after the acceptance by the Committee for Education, 
Research and Technology Assessment and publication of the report in February 
2006. In June 2006, TAB together with the Committee for Education, Research and 
Technology Assessment organized a public workshop in the German Parliament and 
invited stakeholders from industry, regulatory authorities and academia to answer to 
and to discuss the report's view. The workshop was very well attended, by all kinds 
of stakeholders. The usual heavily polarized debate was astonishingly moderate, in 
our view the outcomes of the report were completely validated, although "the indus-
try" tried to proof a too negative judgement concerning the economic potentials (but 
failed to show any other perspective than was discussed by TAB). 
Scientific recognition: 
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The performance of the report was appreciated a lot (there is up to now no publica-
tion of comparable comprehensiveness in Germany, maybe in Europe?), accompa-
nied by heavy criticism from scientists who refuse to concede that the results of mo-
lecular farming up to now are in many respects of a poor nature (and probably are 
opposing the proposal of the reviewing "Progress Report"). The websites on GMOs 
and biosafety of the German research ministry refer to the report (especially concern-
ing the risk regulation of PMP) and integrated links to TAB. IPTS invited TAB to a 
workshop on molecular farming which was then attended by Armin Spök from IFZ 
(Graz, Austria) who was responsible for two of the expert opinions on risk regula-
tion, and who has published its results recently in TRENDs in Biotechnology. 
CHALLENGES IDENTIFIED IN THE PROJECT 
Due to the up to now very limited presence of the topic "molecular farming" in the 
debate on GMOs (at least in a detailed manner), an overall need at EU and national 
level for more intensive consideration of the opportunities and potential risks of 
GMP modified for output traits is obvious. 
> Technical dimension: The possible performance of future GMP could be assessed 
in a more realistic way (via an in-depth "Progress Report"); with respect to the 
cultivation of PMP and PMI GMP, the development and assessment of biological 
and physical confinement measures are of special and fundamental importance; 
> Social dimension: The possible acceptance of PMI and PMP GMP will (in my 
opinion, A. Sauter) depend on an early and transparent participation already in the 
R&D phase, beyond promotional communication activities like "Plants for the Fu-
ture" (see "operationalisation of visions and scenarios"); 
> Political / regulatory dimension: The whole EU regulation has to be checked for 
appropriateness for molecular farming (EFSA has started a self tasking activity, 
IPTS is also working by order of the Commission). 
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GENTECHNOLOGIEBERICHT 
(GENE TECHNOLOGY REPORT) (2007) 6.6 
BACKGROUND OF THE PROJECT 
The “Gentechnologiebericht” (Gene Technology Report) of the Berlin-Brandenburg 
Academy of Sciences and Humanities is a monitoring project that focuses not only 
on GM plants or GM foods but includes also medical applications. The report as-
sesses the entire field of gene technology, because unlike other technologies this par-
ticular field is affecting the basic principles of life, human existence and that of all 
other living beings.   
The report surveys carefully all present facts and the latest developments in the field 
of gene technology and presents a critical study from an impartial viewpoint. 
BASIC DATA ABOUT THE PROJECT 
The report is edited by an interdisciplinary study group consisting of several mem-
bers of the Berlin-Brandenburg Academy of Sciences and Humanities. The partici-
pating authors are impartial. They are experts on different disciplines of the subject, 
and they observe the subject beyond their own specific discipline as well. Acknowl-
edged external experts are involved additionally for further detailed questions. 
The report was published for the first time in 2005 (Hucho et al.). It consisted of four 
main chapters representing different case studies, which were chosen following pub-
lic controversies at that time. One of these case studies is on gene technology applied 
to plant breeding, farming and foods (green gene technology). A separate supplement 
published in March 2007 updates the data and adds news topics (Müller-Röber et al., 
2007).  
MAJOR OUTCOMES OF THE PROJECT 
The monitoring of the report consists of three parts: The first part is a documentation 
of today's state of technological development including scientific progress and the 
recent range of applications. The second part is a detailed overview of economic, 
ecological, social, political, legal, and ethical aspects. The third part is a system of 
indicators that are suitable to unravel and describe the topics connected with the ap-
plication of gene technology to plant breeding, farming and foods. 
The first part of the monitoring report, the documentation of technological develop-
ments, gives a detailed view on recent research and describes the aims of this re-
search as well as the applied techniques. Cisgenic plants and smart breeding are ex-
amples for two newly invented techniques that were presented in the media as alter-
natives to transgenic plants, which is the “classic” way of modifying plants. The re-
port draws the conclusion that both techniques could be useful extensions of the sci-
entific methods. But they will not be able to replace the methods of genetic engineer-
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ing transferring foreign DNA from other species since the available genes are re-
stricted to closely related species.  
Further topics are the DNA sequencing of plant genome, the use of genetic engineer-
ing in research on biodiversity and ecosystems, enabling technologies in modern 
plant breeding, new methods of selection and both the creation and phenotyping of 
genetic diversity. On top of giving an overview over current scientific progress, the 
monitoring report includes an overview of the input and output traits that are worked 
on in the field of GM plants. Several examples are being examined, including insect 
resistant maize, the cultivation of which has been started in Germany recently, 
“golden rice” that could arouse a great deal of interest especially for poorer people in 
developing countries, and “energy plants” which gain high yield of biomass and are 
being discussed in public as an alternative form of energy production. 
The second part of the monitoring report examines different topics concerning GM 
plants and GM foods, which are debated controversially in the general public. Public 
opinion on GM plants and GM foods is a major factor and has to be taken into ac-
count, not only in Germany but in the whole European Union. The scepticism about 
these particular applications of gene technology is much higher in Europe than in the 
US, Canada or Argentina, where GM plants have been cultivated for almost ten years 
now. The report investigates the background to this poor acceptance. On the one 
hand, GM plants meet with criticism because of possible unforeseen negative eco-
logical side effects, on the other hand GM foods are criticized because of the risk of 
unpredictable health effects. The report examines both argumentations. GM plants 
that are resistant against herbicides or insects are used as two examples to document 
the recent scientific findings on ecological and health effects. Furthermore, the report 
focuses on economic aspects being of particular interest to political debates. An 
overview over several studies on the economic potential of GM plants is being pre-
sented. The topics being discussed are the development of the areas cultivated with 
GM plants, the question who will profit from GM plants, the preconditions for bene-
fiting of today's GM plants, the potential benefits of GM plants for the future, and the 
number of jobs being connected with the use of GM plants in agriculture and food 
production. Furthermore, a portrayal of the current situation of European and Ger-
man laws on GM plants and GM foods is presented, which includes the topics coex-
istence and liability. Despite the fact that ethical questions might be less important 
for the agricultural use of gene technology than for medical use, the report even ex-
amines ethical problems that could be associated with the use of gene technology 
during the process of plant breeding. 
The third part presents indicators that allow to describe the different current devel-
opments in the field of green gene technology clearly and easily to understand. A 
single indicator stands for a “measuring device” which allows to depict complex is-
sues that cannot be measured directly and to assess these issues representatively. An 
indicator reduces complexity through which developments at long and at short inter-
vals are less difficult to spot. A set of indicators makes it possible to back up subjec-
tive perceptions of developments or to falsify them. Proven developments can be 
analysed and interpreted with the help of further data. A misleading concentration on 
certain details frequently produces wrong results or misleading interpretations. The 
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report tries to prevent this serious risk by relating the indicators to one of the specifi-
cally defined problems that are connected strongly or weakly with the subject. All 
these defined problems seen as a whole should describe the issue of green gene tech-
nology entirely. This methodological step prevents observation loopholes if no suit-
able indicator could be found. In detail, the several defined problems take up again 
the different economic, ecological, social, political, legal, and ethical questions and 
also latest scientific research and current applications, which are presented in the 
second part of the report. In addition, connections between these aspects are pointed 
out and even problems connected to GM plants and GM foods less obviously are part 
of the overall picture. The definition of the problems is an important task of its own. 
The definition of what is seen as a problem is based on the public point of view on 
chances and risks, which might be diametrically opposed to an experts viewpoint. 
Nevertheless, this guarantees that the report does not deal with an experts debate 
only.  
The following indicators represent some examples: The number of traits, the number 
of field trials and the number of traits in these field trials are used to examine the 
potential that green gene technology has developed currently. The sales and profits 
being made with genetically modified seeds, the worldwide area under cultivation 
with GM plants and several cultivation data for Germany are some of the indicators 
being used to determine the current economic relevance of GM plants and GM foods. 
The amount of money being spent on research on GM plants and the number of ap-
plied patents are two of the indicators that try to measure the scientific and economic 
importance of green gene technology. Ecological effects are observed for example by 
the number of proven cases, when a GM plant interbreeds with another plant outside 
the field, and the use of pesticides on GM plants compared to the amount used on 
non-GM plants. The dissemination of GM foods can be described for example by the 
number of GM plants being approved for food use in the EU and by the market share 
of these products. The consumers' and the farmers' acceptance of GM plants and GM 
foods are two indicators being used to measure the intensity of conflicts that the in-
troduction of these products might cause. Generally, the indicators are used to de-
scribe the situation in Germany. The data is updated yearly. The report makes use of 
appropriate and valid sources like scientific studies or official databases of the gov-
ernment. The particular scientific work of the monitoring report is the selection of 
the indicators that has to base on intelligible criteria and that should cover all differ-
ent aspects of green gene technology. Single results are linked with each other to 
achieve a more precise assessment and a balanced interpretation. Finally, the report 
publishes recommendations based on this work. 
IMPACTS AND FOLLOW UP OF THE PROJECT 
The monitoring report is not only addressed to the policy makers in parties, govern-
ment, administration, non-profit organisations, scientific societies etc. but also to the 
general public interested in this particular issue. The report would like to make a 
good case for public discussions without taking a position for one side or the other. 
Thus the report wants to achieve a more objective public debate.  
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The next report is going to be published in 2008. Therein the issue of genetically 
modified animals will be dealt with additionally. Further and current information can 
be found at www.gentechnologiebericht.de. 
CHALLENGES IDENTIFIED IN THE PROJECT 
The annual update of the indicators does not only include the presentation and the 
interpretation of the recent data. It includes also a discussion if the indictors them-
selves. The main stress within the complex topics could have changed during the 
time and new additional data could be necessary for a conclusive interpretation. New 
topics have to be recognized as well, for example the debate about the consequences 
of the recent discoveries in the field of epigenomics.  
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NORWAY 7. 
RECONVENING THE LAY PEOPLES PANEL ON 
GM FOOD 4 YEARS AFTER (2000) 7.1 
BACKGROUND OF THE PROJECT 
The lay people’s panel was commissioned in 1996, by the Norwegian Biotechnol-
ogy Advisory Board (NBAB) and The National Committees for Research Ethics 
(NCRE), based on government grants. It consisted of 15 persons randomly chosen 
among 400 applicants. None of these had particular affiliations concerning the ques-
tion of genetically modified food. 
After several meetings to develop internal reflection on the issue of GM-food, the 
panel teamed up with a panel of experts to discuss central challenges regarding GM-
food. After the conference, the lay people’s panel delivered a consensus report with 
advice for action. 
In 2000, the panel reconvened to discuss the issue with a new panel of experts, under 
the auspices of NBAB, NCRE and the Norwegian Board of Technology (NBT). In 
the meanwhile, some members of the panel had continued their involvement in the 
issue, thus establishing themselves as experts on the issue. Again, the lay people’s 
panel delivered a consensus report.  
The conference had the following aims: 
> give a summary of central developments on research and use of GM food since 
the conference in 1996 
> present a consensus report with advice on whether a moratorium on importing and 
marketing GM-food should be imposed and eventually on other relevant topics 
> to strengthen the emphasis on lay people’s insights in technology assessment and 
management 
BASIC DATA ABOUT THE PROJECT 
The project was a consensus conference based on a hearing of experts. The confer-
ence was undertaken on 15th-16th of November 2000. Participants included 15 lay 
people, 18 experts took part in the hearing. In addition there were a number of facili-
tators.  
The hearing focused on the following topics: 
> Status of knowledge about effects on health and environment 
> Status of regulations and control: Are present regulations comprehensive and effi-
cient? 
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> Is a moratorium feasible and legitimate? 
> What are the interests of consumers, retailers, processors and producers? 
MAJOR OUTCOMES OF THE PROJECT 
The panel gave the following conclusions: 
A moratorium should be imposed, prohibiting cultivation of GM food and feed with 
the exception for test purposes. Imports and marketing of GM food and feed should 
also be prohibited. The moratorium should only be lifted when certain criteria are 
met: 
> - Knowledge of the long-range consequences of the technology should be im-
proved 
> - Laws and regulations should be coordinated internationally 
> - Monitoring, control and traceability should be strengthened 
A group representing broad interests should be convened to elaborate these criteria 
and evaluate when these are met. 
Within health, no evidence of harm is given, but this cannot be excluded. Further, the 
technology has not contributed within promising fields of increased nutrition or 
lower allergenic effects.  
There is no evidence that use of pesticides or herbicides have been reduced as a re-
sult of GM-cultivation. On the other hand, GM-agriculture has accentuated the use of 
monocultures and industrial approaches, which is harmful. There are indications that 
GMOs can disturb ecosystems, thus causing irreversible harm. There is an urgent 
need for better knowledge about effects on the environment. 
Although the GM-plants marketed so far are not useful for Norway, they could prove 
advantageous in other regions of the world. However, despite promises that GM 
would especially benefit the poor, such applications have not been delivered. On the 
other hand, the development towards monocultures cannot be seen as serving the 
poor.  
There is a mismatch between regulations on living matter and regulations on food 
and feed. While, according to the Norwegian Gene Technology Act, living matter is 
evaluated on criteria such as societal benefit, ethics and sustainability, these criteria 
are not considered in the Food Act which regulates food. Thus, food imports are not 
evaluated on the same criteria as domestic products. 
The panel expressed disappointment that some members of the expert panel pre-
sented their own judgment of the consensus report, and that they were not able to 
distinguish between normative and factual topics/discussions. 
Insights from experts: 
There is no evidence of adverse health effects of GM food, but knowledge is insuffi-
cient. On environmental effects, knowledge is almost non-existent. Views on the 
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appropriateness of a moratorium vary, the strongest arguments against a moratorium 
is that it would challenge WTO rules. Further, the risk for GM contamination is lim-
ited to imports, and controlling this is dependent on systems for screening and trac-
ing, rather than legal restrictions. 
Acceptance of GMOs can be seen as a combination of risk, benefit and moral accep-
tance. While risk and benefit are quantitative factors, moral acceptance is a qualita-
tive factor, constituting a veto. Opposition to GMOs up to 2000 can be based on per-
ceptions of low benefits, rather than perceptions of high risk. 
The Norwegian agricultural sector, including farmer unions and cooperatives, are 
sceptical towards GMOs, and practice a self-imposed restriction. This is based both 
on internal attitudes, but also on the lack of confidence among consumers. Although 
certain producers may be tempted to consider GM products, experiences with growth 
hormones and foreign cattle breeds indicate that producers are generally sceptical to 
growth-enhancing technologies.  
Norwegians became more sceptical towards bio- and gene technology from 1996 to 
2000, and are relatively more sceptical than the average European. As long as the 
consumers are sceptical, both retailers and food processing businesses try to avoid 
such products – also from imports. Thus, GM production is disadvantageous to Nor-
wegian interests. Regulations that can be trusted by all parties will be advantageous. 
To control products, methodology to reveal GM contamination is necessary. It is also 
necessary to establish a system of traceability to control products based on GM but 
where there are no trace of transgenes in the end-product. However, who shall pay 
for a system of traceability? If the businesses shall cover such expenses, can this be 
something that only the major actors can afford? 
IMPACT AND FOLLOW UP OF THE PROJECT 
The project got overall good coverage by the press and mass media and was looked 
upon as a valuable contribution in the further public debate. The project was de-
scribed in detail in the Norwegian biotechnology journal “Genialt”, published by the 
Norwegian Biotechnology Advisory Board. Furthermore the facilitators were invited 
to present the major conclusions and recommendations from the project in the Nor-
wegian Parliament on January 18th 2001.  
In recent years, several of the challenges identified during the project (see under-
neath) have been met by the Norwegian Government. At present, routines for analys-
ing imported food and feed for GM content are in place and running, legislation for 
traceability and labelling are established and there is a high degree of legislative 
harmonization. 
CHALLENGES IDENTIFIED IN THE PROJECT 
(The panel identified a number of challenges. The reviewer is not in a position to 
judge to what extent these challenges have been met through recent developments.) 
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> Systems for screening GMOs for adverse effects must be developed 
> Systems for controlling GM-contamination must be developed. Existing schemes 
often only indicate GM-contamination, they cannot prove such contamination. 
> Systems for labelling and traceability must be developed.  
> Laws and regulations must be coordinated at the international level. 
While health effects can be expected to be the same across regions, environmental 
effects may vary. Therefore, there is a higher need for independent Norwegian stud-
ies on environmental effects. 
LITERATURE 
Bioteknologinemnda, Forskningsetiske komiteer and Teknologirådet (2000): 
Oppfølgingskonferansen om Genmodifisert mat. Genialt nr. 4/2000. Web: 
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PUBLIC MEETING ON COEXISTENCE (2004) 7.2 
BACKGROUND OF THE PROJECT 
The Norwegian Biotechnology Advisory Board (NBAB) arranges a number of 
meetings and seminars to strengthen public reflection and debate on GMOs and 
to prepare hearings and statements on policies. 
BASIC DATA ABOUT THE PROJECT 
The meeting was held on 29th of April 2004. There were 94 participants, including a 
mixture of stakeholders, government officials and experts, with only a few lay peo-
ple. The project did not intend to build consensus. Thus, outcomes presented under-
neath do not represent common understandings. 
The debate covered the following topics: 
> Case-study on gene flow between GM crops and their relatives – the case of ca-
nola 
> Potential for gene flow in important crops for Norwegian agriculture 
> Possible practical measures to reduce gene flow 
> Possible political measures to minimize gene flow 
> Specific co-existence challenges for organic agriculture 
> Co-existence: strategies in a feed company 
> How to ensure GM-free feed imports 
> How to ensure GM-free seed 
The presentations and key comments are documented in a report based partly on 
documents submitted by participants, and partly on transcripts from recordings. 
MAJOR OUTCOMES OF THE PROJECT 
Closing remarks: 
> New regulatory frameworks for co-existence should not be used as a political in-
strument to introduce GM crops, but also to secure GM-free production. 
> Co-existence is not only about biology, but also a question of commercial inter-
ests and economic compensation. Central stakeholders believe that the “polluter 
pays-principle” should apply and that the burden of proof should be placed on the 
producer.  
Comments from participants (given without consensus): 
> EU-regulation on co-existence is tailored to give consumers a choice. However, 
believing that GM may allow for choice may prove naïve. Separation measures ei-
ther in cultivation or in transport and processing may be prohibitively expensive, 
 95 
thus one type of farming will be harmed if the other is allowed. Which side to 
loose is a political question – and this should be what regulation is all about. 
> Producers, feed industries etc. want to follow a restrictive line, but these sectors 
are dependent on imports of seed and feed. Imports from countries outside EEA 
raises particular challenges: Which can guarantee GM-free products? Can there be 
conflicts b/w objective of avoiding GM and other objectives such as contributing 
to income generation in developing countries? 
> Norwegian producers, including fish farmers, avoid using GM feed because of 
consumer demand. However, this is not displayed on the final products. Wouldn’t 
it be to farmers own interest to establish systems of labelling? 
Perspectives on gene flow 
The challenge of separation is not entirely new as organic products are already han-
dled separately from conventional. However, the challenge of handling gene flow 
between crops/crop rotations is new. 
There are a number of criteria on which the likelihood of gene flow can be evaluated. 
Gene flow through pollen is related to degree of out-crossing. The likelihood of gene 
transfer vary, dependent, inter alia, on the occurrence of related crops nearby. It also 
depends on whether the traits give a fitness advantage (for instance pest tolerance). 
Further, pollen flow is of highest concern when the seeds are the harvest of interest. 
For many vegetables, grasses etc., pollen flow is less relevant. Mitochondrial and 
chloroplastic DNA is not transferred with pollen, so transgenes within will be less 
susceptible to gene flow.  
Particular challenges to particular sectors, some are also particular to Norway:  
> For aquaculture, there is a challenge that soy meal and oils is gaining importance 
but GM-free soy is limited. On the other hand, the combination of fatty acids of 
today’s soy is not entirely suitable for aquaculture – a challenge that could be 
solved by GM. Aquaculture therefore faces particular challenges in relation to 
GM feed, first by securing GM-free soy, and second by being tempted to adopt 
GM feed. 
> In conventional agriculture, the strong position of agricultural cooperatives, 
alongside a high degree of regulation, favour a standard approach shared by 
neighbouring farms. 
> Organic agriculture may have a higher diversity – both intentional and uninten-
tional (weeds). This may allow them to be sinks of GM-volunteers – especially for 
Bt-crops and other GM-crops that may have a fitness advantage. 
IMPACTS AND FOLLOW UP OF THE PROJECT 
Insights from the meeting have been communicated in relation both to the develop-
ment of general regulation, and in relation to specific submissions for deliberate re-
lease. The meeting marked the opening of the debate on co-existence in Norway. 
After the meeting, researchers and experts have been mandated to draft a bill for co-
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existence, addressing crucial issues such as the risk for gene flow in different crop 
species, systems for compensation, and the right to information about GM fields. 
CHALLENGES IDENTIFIED IN THE PROJECT 
(Remaining challenges, based on judgments by the reviewer)  
> What are the defining differences between GMOs and non-GMOs? The tech-
nology that is applied, or the traits that the organisms carry? While it is the 
(potentially harmful) traits that one wants to control, the regulations are de-
fined by the techniques employed. 
> Which properties/practical measures can reduce risk for gene flow? Can for 
instance mitochondrial/chloroplastic transgenes pose lower risk, thus be 
treated differently from regular transgenes? 
> Systems for accountability, liability and compensation. 
> The issue of organic farming becoming a sink of transgenes must be examined, 
including legal and economic aspects. 
> Imports of meat, and of feed from 3rd party countries, increase likelihood of 
meat based on GM feed. This could create an urge for a labeling system for 
such products. However, should this be a mandatory labeling of meat based 
on GM feed, or should it be voluntary labeling of non-GM meat? 
LITERATURE 
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EVALUATING THE CRITERIA OF SUSTAINABILITY AND 
SOCIETAL IMPACTS IN RELATION TO GM FOOD –  
THE WORK OF THE NORWEGIAN BIOTECHNOLOGY 
ADVISORY BOARD 7.3 
BACKGROUND AND BASIC DATA 
GM food on the market today is partly consisting of living entities, for instance intact 
corn grains or entire fruits or vegetables (containing viable seed). In Norway, such 
commodities must be evaluated not only in the food legislation context, but also in 
relation to the act relating to the production and use of genetically modified organ-
isms. This act strongly emphasizes that the deliberate release of genetically modified 
organisms (GMOs) should have no detrimental effects on either health or the envi-
ronment (at the same taking into account that we are not living in a risk-free society). 
This emphasis is fully in line with the legislation of other nations concerning the 
regulation of GMOs. Distinct from the regulations of most other nations, however, 
the Norwegian Gene Technology Act also stresses that the deliberate release of such 
organisms should represent a “benefit to the community” and enable “sustainable 
development”. In general, the GM applications under directive 2001/18/EC or regu-
lation 1829/2003 do not contain information that makes such a comprehensive GMO 
evaluation process possible. 
It is not self-evident how “sustainability” and “benefit to the community” should be 
considered in terms of the practical application of the Act. The Norwegian Biotech-
nology Advisory Board is appointed by the Norwegian government with a mandate 
to give advice on these additional requirements.  
The Norwegian Biotechnology Advisory Board 
The Norwegian Biotechnology Advisory Board (NBAB) is an independent body 
established in 1991. The Board is founded in the Act relating to the application of 
biotechnology in medicine and the Act relating to the production and use of geneti-
cally modified organisms. The Board consists of 21 members, including 13 persons 
mandated by the government, and 8 persons mandated by different organisations. 
Representatives of six ministries have observer status. The Board’s secretariat has 
seven to eight employees. 
The main tasks of the NBAB are to identify and examine the ethical questions raised 
by applications of modern biotechnology on humans, animals, plants and microor-
ganisms and to provide advice that can assist policy-making and stimulate public 
debates on the issues. The Board gives recommendations both concerning the devel-
opment of general regulation, and in relation to specific submissions for deliberate 
release. 
The work of NBAB can be described as a form of technology assessment done by a 
standing expert committee, with a specific emphasis on sustainability and societal 
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impacts. The activities involve meetings, dissemination, statements etc. Statements 
and advice are generally not based on consensus, but on majority votes. 
This document explores how the NBAB interprets and addresses the issues of sus-
tainability and societal impacts. The text is based primarily on conclusions from ac-
tivities that were dedicated to discuss these issues broadly. However, insights from 
statements and advice in specific cases are also included. 
MAJOR OUTCOMES OF THE PROJECT 
The Norwegian Biotechnology Advisory Board finds that it is not clear whether the 
provisions relating to “benefit to the community” and “sustainable development” are 
to be considered as additional requirements or as a softening-up of the requirement 
for non-detrimental effects on either health or the environment. “Sustainable devel-
opment” and “benefit to the community” can be understood as either: 
> additional requirements to the absence of detrimental effects on health and the 
environment; or 
> a softening-up of the requirement of non-detrimental effects; or 
> an additional requirement that alone could be sufficient grounds for refusing ap-
proval or for a softening-up of the requirement of non-detriment. 
According to the first alternative, the requirement would be that, in addition to hav-
ing no detrimental effects on health and the environment, the “deliberate release 
represents a benefit to the community and a contribution to sustainable develop-
ment”. If the deliberate release fails to fulfil this requirement, the recommendation 
would be to reject an application for approval. Under this alternative, any softening-
up of the requirement of non-detriment would be impossible.  
The second alternative does allow for the approval of deliberate releases even when 
the possibility of detrimental effects on health and the environment have been estab-
lished, if it can be demonstrated or argued that the “deliberate release represents a 
benefit to the community and a contribution to sustainable development”. Conse-
quently, the requirements of “sustainable development” and “benefit to the commu-
nity” are being used as an opportunity for softening up or counterbalancing the re-
quirement of non-detriment, but may not be applied as an additional requirement that 
alone could be sufficient grounds for rejecting an application for approval. 
In the third alternative, the requirement of “benefit to the community” and/or “sus-
tainable development” could constitute independent grounds for rejecting an applica-
tion for approval. Furthermore, “sustainable development” and “benefit to the com-
munity” can be used to soften up the requirement of non-detriment. This could be 
considered as a combination of the first two alternatives and is the alternative the 
NBAB judges to be the best interpretation of the Act. 
In the opinion of the NBAB, the Norwegian Gene Technology Act should be inter-
preted to mean that the requirements of “sustainable development”, “benefit to the 
community” and other “ethical and social considerations” represent prerequisites that 
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alone could carry decisive weight against granting an application, but that should 
also be considered in relation to, and weighed against the risk of detrimental effects, 
when such risk is low. 
Hence, an assessment of an individual GM application (also GM food, se above) will 
have the following structure: 
1) Danger of detrimental effects on health and the environment: 
> what are the possible negative consequences? 
> what is the likelihood of such consequences occurring? 
2) The precautionary principle: 
> is the risk assessment associated with justified uncertainty? 
> is there a possibility of substantial or irreversible harm? 
3) Is it: 
> in compliance with the principle of “sustainable development”? 
> of “benefit to the community”? 
> “ethically and socially justifiable”? 
Sustainable development 
“Sustainable development” could be said to build on a series of ideas, including the 
following: 
> the idea of the global effects of human activities; 
> the idea of ecological limits and that these limits have been exceeded in several 
areas; 
> the idea of meeting basic human needs; 
> the idea of just distribution between generations; 
> the idea of just distribution between wealthy and poor nations; 
> the idea of a new form of economic growth. 
This final point indicates that it is not a matter of just any form of economic growth. 
On the contrary, two types of qualification are required. Firstly, it should be eco-
nomic growth involving an absolute – and not only a relative – efficiency improve-
ment in the use of energy and other natural resources. Secondly, this economic 
growth must entail a more balanced distribution between poor and wealthy nations. 
The six points listed above can serve as a structure for assessing whether the deliber-
ate release of a genetically modified organism is in compliance with the requirements 
of “sustainable development”. The same type of checklist questions could be asked 
for each of these points as those considered when assessing health and environmental 
risks and the precautionary principle. The responses to and the discussion of all the 
questions would, in this case, provide an overall picture of the extent to which there 
is compliance or non-compliance with the requirements set. 
Furthermore, a clarification of the relationship between biodiversity (i.e. diversity of 
genes, species and ecosystems) and ecological sustainability is needed. Effects on 
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biodiversity would be assessed in relation to detrimental effects on health and the 
environment and the precautionary principle, thus be included in standard assess-
ments also within the EU. However, relating biodiversity to the question of “sustain-
able development” implies a shift of focus in time and space. Assessments of the 
possible detrimental effects on health and the environment refer primarily to local, 
regional and national contexts. Assessments of the issue of “sustainable develop-
ment” apply globally and also, to a longer time span (generations). When diversity is 
reduced, humankind’s opportunities of promoting “sustainable development” are 
reduced accordingly. Preserving biodiversity represents a form of long-term life in-
surance – for the existence of species, ecosystems and humankind. Another aspect 
worth underlining is the type of ethical assessments associated with the notion of 
intrinsic value. The concept of “sustainable development” encompasses two different 
types of intrinsic value. The first is nature’s own intrinsic value; the second applies to 
certain forms of humankind’s absolute intrinsic value. In the opinion of the NBAB, 
assessments of this kind might be more usefully made in relation to the issue of 
“other ethical and social considerations” and not in relation to the issue of “sustain-
able development”. 
Global effects 
> Is biodiversity affected on a global scale? 
> Is the functional capacity of ecosystems affected? 
> Do these effects differ between production and use? 
Ecological limits 
> Is the efficiency of energy use affected? 
> Is the efficiency of other natural resource use affected? 
> Is the distribution between the use of renewable and non-renewable natural re-
sources affected? 
> Are discharges of pollutants with a global/transboundary range affected? 
> Are emissions of greenhouse gases especially affected? 
> Do these effects differ between production and use? 
Basic human needs 
> Is the fulfilment of basic human needs affected? 
> Do these effects differ between production and use? 
Distribution between generations 
> Is the distribution of benefits between generations affected? 
> Is the distribution of burdens between generations affected? 
> Do these effects differ between production and use? 
Distribution between rich and poor 
> Is the distribution of benefits between rich and poor countries affected? 
> Is the distribution of burdens between rich and poor countries affected? 
> Do these effects differ between production and use? 
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Economic growth 
> Is economic growth’s demands on energy and other natural resources affected? 
> Are economic growth’s global/transboundary environmental impacts affected? 
> Is economic growth’s distribution between rich and poor countries affected? 
> Do these effects differ between production and use? 
Comment 
Compliance with the requirements of “sustainable development” will have to be 
based on an overall assessment and discussion of all these questions. However, not 
all the questions above may be relevant in all cases. 
Benefit to the community 
As mentioned above, the concept of “benefit to the community” appears in the Gene 
Technology Act as one of several criteria for granting an application. It is, in any 
case, a complex concept, for which neither the Act itself nor its legislative history 
provides any clear guidance as to how it should be understood. In the current context, 
the NBAB has opted for a relatively pragmatic approach, and try to ask some “check-
list questions” that may be relevant: 
Product characteristics 
> Is it reasonable to say that there is a need for the product in terms of demand or 
otherwise? 
> Is it reasonable to say that the product will solve or possibly contribute to solving 
a societal problem? 
> Is it reasonable to say that the product is significantly better than equivalent prod-
ucts already on the market? 
> Is it reasonable to say that there are alternatives that are better than the product in 
terms of solving or possibly contributing to solving the societal problem in ques-
tion? 
Production and use of the product 
Among the relevant aspects to be considered are: 
> Does the product contribute to creating new employment opportunities in general 
and in rural areas in particular? 
> Does the product contribute to creating new employment opportunities in other  
> countries? 
> Does the product create problems for existing production whose existence should 
otherwise be preserved? 
> Does the product create problems for existing production in other countries? 
(This list of questions is not meant to be exhaustive, but is meant primarily to serve 
as an indication of the type of questions that should be considered). 
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Comment 
Any assessment of benefit to the community must be based on a discussion of the 
responses as a whole. However, it should be emphasized that every question may not 
be equally relevant in all instances. 
IMPACTS AND FOLLOW UP OF THE PROJECT 
The statements made by the NBAB are generally regarded as high impact contribu-
tions by the competent authorities. Such statements are publicly available and quite 
often they spark a public debate. The statements are communicated to the decision-
makers both through letters and by regular meetings, as the decision-makers have 
status as observers during the relevant NBAB discussions. NBAB is planning a con-
ference on sustainability and GMOs late in 2007.  
CHALLENGES IDENTIFIED IN THE PROJECT 
Operationalizing the criteria of sustainability and societal benefit in relation, for in-
stance, to specific submissions for deliberate release, remains challenging. Even 
more challenging than defining the “checklists”, is to access relevant information 
regarding the products. As Norway appears to be unique in using these criteria, sub-
missions within the EU do not generally include relevant data. And so far, applicants 
do not seem to find it worthwhile to provide such data just for Norway. Without 
relevant documentation, Norway cannot fully undertake the relevant assessments, 
and thus, based on this lack of information, Norwegian authorities may end up not 
authorising a given product. However, the EU might not consider such terms legiti-
mate to reject an authorisation, which could be necessary under Norway’s commit-
ment as member of the EEA. Thus, a number of questions regarding the harmoniza-
tion of regulation within the EU/EEA remain. 
As described above, there also remains a question of whether criteria of sustainability 
and societal impacts should be interpreted as additional requirements to the absence 
of detrimental effects on health and the environment; or as a softening-up of the re-
quirement of non-detrimental effects. 
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assessment of genetically modified organisms. Discussion Paper, The Norwegian 
Biotechnology Advisory Board. ISBN 82-91683-21-2. Web: 
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SWITZERLAND 8. 
PUBLIFORUM »GENETIC TECHNOLOGY AND NUTRITION«  
(1999) 8.1 
BACKGROUND OF THE PROJECT 
The PubliForum on Genetic Technology and Nutrition took place in 1999, under the 
lead of the Swiss Centre for Technology Assessment, referred to below as TA-
SWISS. This centre has been set up in 1992 by the Swiss Parliament and is attached 
to the Swiss Council for Science and Technology. Its mission is to support the politi-
cal decision-making process, firstly by carrying out expert analyses, and secondly by 
canvassing the opinions of the citizens themselves through participatory projects. 
The PubliForum on Genetic Technology and Nutrition was the second participatory 
project ever organised by TA-SWISS13. 
The aim of the PubliForum on Genetic Technology and Nutrition was to set up an 
encounter between the people actively involved in the development of genetic tech-
nology (i.e. scientists, but also industry, public authorities and NGOs) and the public. 
Genetically modified organisms (GMOs) had already been extensively discussed 
about a year before, as Swiss citizens had to vote on an initiative demanding a halt to 
genetic engineering in Switzerland (the “initiative for genetic protection”). During 
the political campaign preceding the vote, all of the interested parties involved de-
bated the issue at great length, but the fact that the rules of the game did not allow for 
a win-win situation (voters had to answer “yes” or “no”) meant that it was difficult to 
get a real dialogue going. For the PubliForum on genetic technology in nutrition, the 
rules of the game were changed, to allow for win-win situations. The inclusion of 
ordinary citizens in the process would then provide greater awareness of their wishes, 
alternative solutions and needs. It would also provide an opportunity to learn about 
their argumentation patterns: how did they perceive and understand the implications 
of genetic technology in nutrition, what were their hopes and fears, and on which 
basic values and standards did they judge the issue?  
Discussing these questions was considered as crucial, as the debate on GMOs was, at 
that time, far from being closed. As a matter of fact, when the Initiative for Genetic 
Protection had been first discussed by Parliament in 1996 and 1997, the Federal As-
sembly charged the government to fill all juridical gaps regarding genetic engineer-
ing in the non-human domain (Motion GENLEX). At the time of the PubliForum, 
government was working on this adaptation of the legislation14. 
                                                 
13 TA-SWISS has been undertaking participatory projects since 1998.  
14 The Swiss government presented its conclusions regarding the GENLEX motion in 
2000, in form of a modification of the Law on environmental protection. This govern-
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BASIC DATA ABOUT THE PROJECT 
The PubliForum on Genetic Technology and Nutrition is a participatory project, us-
ing the “consensus conference” model developed by the Danish Board of Technol-
ogy. This model has been adapted for the multilingual reality of Switzerland: instead 
of 15 citizens being invited to discuss the effects of new technologies, about 30 citi-
zens from all parts of the country were invited to discuss and an interpretation ser-
vice has been offered so that each participant could use their own language. All in 
all, the citizens met three times: 
> In a first preparatory week-end, participants could meet and get to know each 
other, familiarize with the working method and inform themselves about the sub-
ject implications of genetic technology in food and plants. They also selected 
those aspects which they wanted to investigate more closely during the PubliFo-
rum. 
> At the second preparatory weekend, the panel members defined their questions 
more clearly and chose the information persons who were to reply to these ques-
tions during the main PubliForum session. Their questions were related to re-
search, environment, health, ethics and economics.  
> The actual PubliForum lasted three days. During the first two days, which was 
open to the public, the information persons answered the questions of the citizen 
panel. Then the panel went behind closed doors and had 24 hours to draw up a re-
port.  
In order to create an as neutral as possible framework for the PubliForum, an accom-
panying group had been formed consisting of representatives from industry, research, 
administration, media, politics and various non-governmental organisations (NGOs). 
This accompanying group had the task of putting the content of the PubliForum into 
concrete terms and to make sure that the preparation and realisation of the event took 
place in an as balanced as possible way. The accompanying group was also responsi-
ble for the preparation of information sheets meant to help the Citizen Panel familiar-
ise themselves with the subject. Another assignment was that of helping find refer-
ence persons to answer the questions and, finally, influence could be made on the 
composition of the Citizen Panel. 
MAJOR OUTCOMES OF THE PROJECT 
In its report, the Citizens’ Panel acknowledged that today's level of scientific knowl-
edge does not permit the existence of specific risks resulting from genetically modi-
fied organisms to be ruled out. And, as one cannot quantify these risks, the Panel was 
not in a position to make any judgement on their acceptability. Half of the Panel, 
                                                                                                                                          
mental proposal addressed many issues, such as biodiversity preservation, civil responsi-
bility regarding GM crops, authorization procedures and the introduction of a declara-
tion for GM products. But the Parliament, after having examined this proposal, decided 
to write a specific law on genetic engineering. It took more than two years of political 
debate for the Parliament to come to a final text. 
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however, was of the opinion that genetic technology is an encroachment on life-
processes, whereas the other half saw no difference between genetic technology and 
traditional production methods. This gap could be seen in the notion of imposing a 
moratorium on the production and marketing of genetically modified organisms15, 
which was endorsed only by a slender majority of the Panel. Despite these differ-
ences of opinion, the Citizens’ Panel agreed that freedom of choice for consumers 
should be maintained and that GMOs should thus be clearly labelled. It also de-
manded more research on risks and monitoring studies and showed some concern 
about the financial independence of public research. 
IMPACTS AND FOLLOW UP OF THE PROJECT 
The PubliForum on genetic engineering in nutrition caught a great deal of attention 
of the media and political groups, mainly for its proposal of a moratorium made by 
the Citizens’ Panel. TA-SWISS could also present the PubliForum’s results in the 
Parliamentary commission for science, education and culture. Many articles also 
were published in specialized magazines and journals. 
Interestingly, what was a minority position at the time of the publication of the re-
sults of the PubliForum (the idea of a moratorium was in fact only defended by 
ecologists groups) became, with time and the support of farmers’ representatives 
(who became conscious, through the PubliForum and other surveys, that consumers 
didn’t want to consume GMO crops), a potentially majority position. Indeed, during 
the discussions on the new law on genetic engineering by the relevant Parliamentary 
Commission, a slender majority amended the law with a moratorium of 5 years (ex-
cluding field trials for scientific purposes). This proposal was ultimately rejected in 
the final vote in Parliament, where the Commission’s slender majority was unable to 
gain enough support for its proposal. Interestingly, groups in favour of a moratorium 
tried a second time to anchor a 5-year moratorium on GMOs in Swiss legislation. 
This time, they tried to integrate it in the agriculture law, which was revised in 2003. 
And for a second time, they just failed16. Parallel to all these parliamentary debates, 
environmental groups, consumer associations and farmers group have launched an 
Initiative demanding a five-year moratorium on the farming GM crops for use in 
food (the use of GM crops for research purposes would be authorized under strict 
conditions). The group collected over 120’000 signatures in only seven months17. 
This initiative was contested by the government and Parliament (whereas a minority 
of the representatives had been supporting it), as well as by research and industry 
                                                 
15 Clearly defined field trials (specifically by public institutions) should, however, be per-
mitted and supervised in order to obtain extended knowledge on any risks. 
16 The proposal was in fact accepted by the lower chamber of the Parliament (National 
Council), but rejected by the upper chamber (State Council). In an ultimate vote, the 
lower chamber decided to align its position to that of the State Council in order not to 
bring down the whole revision. 
17 To be valid, an initiative must be supported by 100’000 citizens and have to be found in 
a period of 18 monthes. 
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representatives. In November 2005, 55.7% of the Swiss citizens accepted the initia-
tive demanding the five-year moratorium18.  
CHALLENGES IDENTIFIED IN THE PROJECT 
In its report, the Citizen’s Panel gave its opinion on several topics and formulated 
several recommendations. From these, we can consider that the challenges for GM 
plants and food, seen from a citizen perspective, are the following: 
> The freedom of public research must be guaranteed and public funding should 
remain assured. 
> The current supervisory mechanisms are sufficient, but citizens call for an intensi-
fied dialog between the general public and research. 
> GMO-specific risks cannot be ruled out. Therefore, monitoring is absolutely nec-
essary, in order to be able to estimate risk potential in a better way. 
> Switzerland needs to have trained personnel, able to carry out monitoring research 
into GMOs.  
> Backing out of genetic technology in the sense of a unilateral Swiss policy doesn’t 
seem to be an option any more, since this would lead to important economic dis-
advantages, primarily in the Swiss research area and secondarily because of the 
dependence of Switzerland on imported raw materials, which could in the future 
contain GMO-components. Nevertheless, the question on how far a need for the 
use of genetically modified organisms exists in Switzerland must be answered. 
> The existence of traditional, genetic-technology-free agriculture as well as organic 
farming must be guaranteed, in order to provide consumers with a free choice, 
both today and in the future. Moreover, instead of GMO production, organic 
farming could be a chance for Switzerland, as at the moment of the PubliForum 
no contamination is to be feared. 
> The smaller seed producers may disappear in the long term because they will not 
be able to compete with large multi-national industry, which would mean that de-
pendence could develop.  
> The patenting of living organisms is for many of the members of the panel not 
acceptable. On the other hand, patenting creates more transparency, as the appli-
cant has to publish his research results before the patent is granted. It is also un-
derstandable that the high costs of research have to be made to pay for themselves 
somehow. 
> The unequivocal tracing of damage back to a GMO is very difficult. If such evi-
dence exists, it must in all cases be possible to prosecute those responsible (e.g. 
the producer). 
                                                 
18 A survey conducted just after the vote showed that among those who voted against the 
initiative, 13% were actually convinced to vote against gene technology. In other 
words, these persons didn’t correctly understand that the question they had to answer 
(“do you agree or not with the initiative and, eventually, the initiative should have been 
accepted by about 68% of the voters – an extremely high score for a popular initiative 
(Hirter and Linder 2006). 
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RIBIOS FORUM »THE FUTURE OF PLANT 
BIOTECHNOLOGY IN SWITZERLAND« (2003) 8.2 
Excerpts from the report: “The Future of Plant Biotechnology in Switzerland”, Les 
Cahiers du RIBios, No7 
BACKGROUND OF THE PROJECT 
The Forum entitled « The future of plant biotechnology in Switzerland » took place 
at the University of Lausanne on November 3rd, 2003. It was jointly organised by 
the RIBios (Biosafety Interdisciplinary Network, based at the Graduate Institute for 
Development Studies of the University of Geneva) and by the Interface sciences-
société of the University of Lausanne.  
The aim of this Forum was to bring together stakeholders involved in the decisions 
about experimental field releases of transgenic plants in Switzerland.  
BASIC DATA ABOUT THE PROJECT 
The participants of the Forum were representatives of three main groups of stake-
holders: public scientists involved in plant biotechnology research, the governmental 
bodies involved in the decision-making process, and other institutions directly in-
volved in science policy at the national level. All the participants had been invited 
personally, in order to make clear that they should speak in their own name rather 
than in their institution’s name. This sensitive issue was dealt with by agreeing with 
the participants that no material would be published on the content of the debates 
without their prior review of the documents. 
Before the forum, the participants received a position paper written by the organisers. 
This paper was divided into six sections corresponding to important topics that 
would be discussed during the forum. It was aimed at giving some factual informa-
tion, but also some analytical overview to stimulate the debate.  
The forum lasted one day. The debates were organised by topics. In the morning, 
three questions were discussed: «Risk negotiation», «Coordination at the level of 
assessment and decision» and «Coherence between research and environment poli-
cies». In the afternoon the debates focused on «“Socially robust” research policies», 
«Biotechnological research in Switzerland» and «Decision-making under uncer-
tainty: the controversial implementation of precaution». 
The organisers decided to adopt a non-directive strategy for the debate regulation. 
Three persons were assigned to that task. One was in charge of handing over to the 
participants and to keep the schedule. The two other persons acted as facilitators by 
introducing factual or analytical elements pertinent to the debate, and by redirecting 
the discussion when it was clearly out of the topic of this forum. 
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MAJOR OUTCOMES OF THE PROJECT 
Following the forum, a document restituting the main discussed points have been 
published in the “Les Cahiers du Ribios”. The core of the text is made of partici-
pants’ quotations, which are introduced by a short summary. 
CHALLENGES IDENTIFIED IN THE PROJECT 
The richness and diversity of the discussions during the forum show that many open 
questions are remaining with respect to research on GMOs. The lecture of the report 
shows that there is a certain frustration from the side of researchers, or at least a dif-
ficulty to cope with the social and political dimension of the issue. 
CHALLENGES IDENTIFIED WITH RESPECT TO PUBLIC RESEARCH: 
> To regain the public’s confidence, it is necessary to define research priorities that 
correspond to agronomical problems which have been clearly identified and 
which benefit from political support. 
> The distinction between fundamental and applied research must be taken into con-
sideration. There is a sharp difference between commercialisation and experimen-
tal releases. The frontier between these two facets of research is nevertheless dif-
ficult to draw. This distinction is however important as soon as risk assessment is 
concerned. The standards and procedures used in the assessment do indeed de-
pend on the nature of the trials, experimental or commercial.  
> The position of Switzerland on the international scene in terms of knowledge and 
competitiveness in plant biotechnology is an issue to consider. There is a risk to 
see the competitiveness of Switzerland in the field of plant biotechnology de-
crease, as a result of industrial delocalisations and disinterest on behalf of stu-
dents. While Switzerland has still a good knowledge base in the field of plant bio-
technology, research is locked in, in part because of the difficulty to make field 
tests experiments. 
> Research is facing important economical, political or administrative constraints. 
These difficulties have prevented researchers from accumulating the knowledge 
needed to perform an adequate risk assessment of the plants under development. 
> The time lag between the application for an experimental release and the decision 
of the authority may be incompatible with the scientific rationale. 
CHALLENGES IDENTIFIED WITH RESPECT TO RISKS: 
> Rather than talking about the risks of doing research, one should also take into 
account the potential benefits, namely benefits that will derive from this research 
in the future but are still not known. In other words, the risks of doing research 
should be balanced with the risks of not doing it. 
> Risks related to a new technology such as GMOs must not be discussed in isola-
tion but rather in comparison with the risks of the technology it is replacing. 
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CHALLENGES IDENTIFIED WITH RESPECT TO PUBLIC DEBATE: 
> The perception of risk by the public may sometimes be irrational. Risks related to 
GM food are typically over-estimated in comparison to other risks. 
> Some participants pointed out the fact that communication policies have not been 
able until now to reverse this trend, and thus generate a positive picture of plant 
biotechnology in the public. 
> It is more difficult to find support in the public for innovation, than to exploit the 
fears of the public related to these innovations. 
> There is clearly a lack of communication in the field of plant biotechnology. The 
scientific community should do more grassroot work. However, the social accept-
ability of GMOs does not onlydepend on the level of information. In other words, 
more information does not necessarily end up with more people accepting the 
technology: 
> There is a need to find new forms of public debate. Moreover, people and groups 
concerned by new technologies shoudl be included upstream (i.e.when a technol-
ogy is still at the stage of research), so as to make research policies “socially more 
robust”. 
CHALLENGES IDENTIFIED WITH RESPECT TO DECISION-MAKING PROC-
ESSES: 
> There is a risk that scientific arguments are “instrumentalised” by political au-
thorities in the decision-making process. 
> Science should be more able to recognize the limits of its knowledge. This would 
surely be a way to improve society’s confidence in science. 
> Any decision in the field of risk mangement is somehow political, since a zero 
risk level is not achievable. Political decisions consist therefore in determining an 
acceptable level of risk: 
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REPORT ON THE COEXISTENCE OF DIFFERENT GM 
 AND NON-GM AGRICULTURAL CULTIVATION SYSTEMS 
(AGROSCOPE RECKENHOLZ-TÄNIKON RESEARCH 
 STATION ART, 2005) 8.3 
BACKGROUND OF THE PROJECT 
Worldwide GM0 cultivation is increasing year by year. Even though there is little 
likelihood of such cultivation in Switzerland at present, cultivation of GMOs in the 
future cannot be excluded. According to the Gene Technology Law (GTL), when 
GMOs are grown, non-GMO production and consumer’s freedom of choice must be 
safeguarded. So-called “coexistence” must be guaranteed by segregating production 
flows (Warenflussstrennung) during the whole productions chain (from the field to 
shelves of the stores), by regulations and by technical measures. In this respect, legal 
threshold values were defined because it is impossible to rule out mixing completely 
no matter how much care is taken. They specify the percentage of genetically modi-
fied material which can be included in food and animal feeds without having to label 
them as «genetically modified». In line with the EU, a threshold limit of 0.9% is set 
in Switzerland. This limit is for approved GM crops. For non-approved GM crops 
there is, theoretically, a zero-tolerance.  
Agroscope Reckenholz-Tänikon Research Station ART was commissioned by the 
Federal Office for Agriculture (FOAG) to carry out a study on whether GM and non-
GM agricultural systems in Swit-zerland can coexist from a scientific and technical 
point of view within the present legislative framework. Maize, wheat and oilseed 
rape were selected as model crops.  
BASIC DATA ABOUT THE PROJECT 
The aim of the project was to present a concept for a coexistence of GM and non-
GM cropping systems in Switzerland. In a first step mechanisms were analysed 
which can lead to a mixture of agricultural products during cropping. Subsequently, 
technical and organisational measures were listed which can minimize or prevent 
mixing. The study was limited to the agricultural production, i.e. from planting to the 
delivery of the harvest to storing or processing facilities. The cost of segregation of 
different cropping systems varies according to the specific biological characteristics 
of the crops and according to the level of segregation required. Three model crops 
(maize, wheat and oilseed rape) have been chosen as case studies to show what 
specific measures are needed in order to maintain the legally binding GMO threshold 
for food and feed.  
The study was entirely funded from the Agroscope Reckenholz-Tänikon Research 
Station own resources, with no third party funding that could have cast doubts upon 
their independence. The scientists based their statements on objective foundations.  
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MAJOR OUTCOMES OF THE PROJECT 
The investigations on the possibilities and limits of the «coexistence of GM and non-
GM cultivation systems in Switzerland» reached the conclusion that, with the requi-
site crop-specific distances, discussion and agreement between farmers, and careful 
segregation during product handling on the farm, the cultivation of GM maize, GM 
wheat and GM oilseed rape in Switzerland would be technically possible.  
This assessment was based on the threshold limit of 0.9 % GM content and covered 
cultivation up to the delivery of the harvested material at the collection point. Addi-
tional time and costs related to coexistence was not examined. The measures neces-
sary for coexistence are detailed in the “Schriftenreihe der FAL” No 5519. They are 
for example: 
> Usge of certified seed 
> Optimal soil preparation after the harvest and cultivation of non-GM crops before 
subsequent  GM planting. 
> The degree of out-crossing between fields with GM and fields with non-modified 
plants of the same species can be reduced through isolation distances and “buffer 
zones” between GM an non-modified crops.. Moreover, it is possible to avoid that 
cross-pollination happens at the same time. 
> The intermingling of GM and non-modified crops in various machines can be 
avoided by carefully cleaning them after having used them for GM-crop fields. 
> Segragation during harvest, transport, storage and processing of the crops, as well 
as a documentation of these processes is essential to minimize intermingling.  
IMPACT AND FOLLOW UP OF THE PROJECT 
In June 2005, a conference named "Coexistence of GM and non-GM crops - scien-
tific data, practical applications and perspectives for the next decade has been organ-
ised by the authors of the study. About 120 Swiss and international experts discussed 
the issue of coexistence (more info on the conference on: www.coexistence.ethz.ch/). 
The group took part in many other conferences dedicated to the issue of coexistence, 
in Switzerland or at the European level. But, at the time being, it doesn’t carry any 
project on the theme. 
In June 2006, The Federal Office for Agriculture adapted the legislation on coexis-
tence (ordinance on coexistence) and considered some elements analysed in the 
study. There is, however, no evidence on how far the study influenced the legislative 
process. 
                                                 
19 Study summary as pdf (http://www.reckenholz.ch/doc/en/publ/schrift/sr55vz.html): To 
order Study (http://www.reckenholz.ch/cgi-bin/sql/order.pl?ref=4&lang=en&sort=-
feld_0).  
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CHALLENGES IDENTIFIED IN THE PROJECT 
> How to guarantee coexistence? This implies regulatory, technical and organisa-
tional aspects. 
> The probability of intermingling depends on the biological properties of the vari-
ous plants. The necessity for coexistence measures must then be separately as-
sessed, for each cultivated plant. 
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COORDINATION MEETING OF INSTITUTIONS OFFERING 
BIOSAFETY-RELATED TRAINING AND EDUCATION 
PROGRAMS (2004) 8.4 
Excerpts from the “REPORT OF THE COORDINATION MEETING OF INSTI-
TUTIONS OFFERING BIOSAFETYRELATED TRAINING AND EDUCATION 
PROGRAMS”,(http://www.biodiv.org/doc/meetings/bs/bscmet-01/official/bscmet-
01-01-en.pdf) 
BACKGROUND OF THE PROJECT 
The first Coordination Meeting of institutions offering biosafety-related training and 
education programs was held 4-6 October 2004 in Geneva, Switzerland. It was or-
ganized by the Swiss Agency for Environment, Forests and Landscape (SAEFL) in 
collaboration with the CBD Secretariat, the UNEP/GEF Biosafety Unit and the Ge-
neva Environment Network.  
Thirty-seven (37) participants from 28 institutions attended the meeting, including 
representatives from academic and other organizations. The participants came from 
all over the world (Belgium, Namibia, Switzerland, Mexico, New Zealand, USA, 
England, Netherlands, China, Kenya, Norway, Cuba, Thailand, Canada, Austria, 
Chile, Italy, Japan). 
The meeting was a follow-up to the offer made by the Government of Switzerland at 
the first meeting of the Conference of the Parties serving as the meeting of the Parties 
to the Cartagena Protocol on Biosafety (COP MOP). In its decision BS-I/5 on capac-
ity-building, the COP-MOP emphasized the need for a coordinated approach towards 
capacity-building at all levels and accordingly established a Coordination Mecha-
nism to promote partnerships and maximize complementarities and synergies be-
tween various capacity-building initiatives contributing to the effective implementa-
tion of the Protocol. In this regard, the Government of Switzerland offered to sponsor 
a coordination meeting for representatives of academic and research institutions ac-
tively involved in education, training and research programs in biotechnology and 
biosafety in the autumn of 2004. The Swiss Government contracted RIBios – Réseau 
Interdisciplinaire Biosécurité – (Biosafety Interdisciplinary Research Network), 
which is part of Institut Universitaire d’Études du Développement (IUED), to organ-
ize the meeting. 
The primary objective of this meeting was to bring together representatives of insti-
tutions involved in biosafety training and education to share information and com-
pare notes regarding their ongoing programs and to learn more about the about the 
Protocol and the capacity-building needs and priorities for its effective implementa-
tion. The specific objectives of the meeting were: 
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> To review the current status (“state of the art”) regarding training and education 
programs in biosafety, including consideration of the draft compendium of exist-
ing programs; 
> To review the needs and priorities of countries and discuss ways and means for 
enhancing training and education programs to respond to those needs and support 
effective implementation of the Protocol; 
> To identify and discuss key components of biosafety training and education pro-
grams; 
> To explore mechanisms to enhance coordination, networking and collaboration 
among institutions offering biosafety training and education programs. 
BASIC DATA ABOUT THE PROJECT 
The agenda of the meeting consisted of two parts. The first part (day one) included 
presentations on: overview of the Cartagena Protocol and the COP-MOP decisions; 
the capacity building needs of countries and the role of training institutions in ad-
dressing those needs; the experience from the UNEP-GEF projects on capacity-
building in biosafety and overview of the draft compendium. These were followed by 
short presentations by participants on their ongoing and planned programs. 
The second part of the meeting included three plenary session discussions and one 
session of group discussions. The deliberations focused on the compendium; ways 
and means to improve biosafety training and education programs to address the 
needs of different target audiences; possible mechanisms for future networking/ col-
laboration and the next steps. 
MAJOR OUTCOMES OF THE PROJECT 
Overall, the meeting was a big success. It provided the first opportunity for institu-
tions offering training and education in biosafety to meet and interact and laid a good 
foundation for their future collaboration and active involvement in biosafety proc-
esses at international, regional and national levels. 
The meeting represented an important first step in preparing education and training 
institutions to play an effective role in building capacity for effective implementation 
of the Cartagena Protocol on Biosafety and other relevant instruments. It provided 
them with an insight into what the key training need are from the point of view of the 
countries that are now in the process of establishing and implementing their national 
frameworks and an the opportunity to learn more about what other institutions are 
offering and develop ideas for improving their programs. 
The main outcome of the meeting was the development of a common format (ques-
tionnaire) for the compendium of existing biosafety training and education programs. 
The meeting also developed a set of draft recommendations for consideration by 
COP-MOP, governments, education and training institutions and other stakeholders 
in order to enhance biosafety training and education in support of the Protocol im-
plementation.  
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IMPACT AND FOLLOW UP OF THE PROJECT 
No concrete action has been implemented after the coordination meeting. Neverthe-
less, the meeting created a dynamic, in the sense that Malaisia University decided to 
organise a second meeting in April 2007, in Kuala Lumpur. The RIBios network 
(which organised the first meeting) will be participating and hopes that it will be able 
to interact and create synergies with african universities, so as to establish education 
programmes on biosecurity. 
CHALLENGES IDENTIFIED IN THE PROJECT 
While the meeting had resulted in fruitful deliberations, it also raised many new im-
portant questions. For example, questions were raised regarding: 
> how to effectively to involve the newly trained experts in biosafety activities of 
their own countries;  
> how to insure the sustainability of the biosafety training and education programs,  
> how to mobilize adequate funding for biosafety training programs and for scholar-
ships to support students from developing countries;  
> how to insure the availability of technical infrastructure in all countries for the 
effective delivery of biosafety education and training programs and  
> how to fill the gaps in the existing courses. All these questions underline the ardu-
ous challenge ahead. 
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UNITED KINGDOM 9. 
PROJECTS SINCE 2000 
BACKGROUND 
The most important activities concerning GM crops and food carried out in the UK 
since 2000 are 
> the government commissioned dialogue on GM issues (GM dialogue) 
> the Farm-scale evaluations (FSEs) of GM crops 
As the latter study is scientific, this review will focus on the GM dialogue. However 
it should be noted that the FSE’s were one of the pieces of information used by the 
government to inform its policy on GM crops in 2004 – see section on Impact and 
follow-up. POSTnote 211 GM crops in the UK (2004) gives an overview of the GM 
dialogue and the FSEs and discusses the issues raised. It was published prior to the 
Government setting out its policy on GM in March 2004. Other POSTnotes in this 
area published since 2000 are POSTnote 172 Labelling GM foods (2002) and POST-
note 146 GM farm trials (2000). 
GM DIALOGUE 
The GM dialogue ran from May 2002 to January 2004 and consisted of three main 
strands: 
> GM science review –an assessment of the state of current scientific knowledge on 
GM crops and foods; 
> economics review - an evaluation of the potential costs and benefits of GM crops 
in the UK; 
> GM Nation? - a nationwide public debate to find out what people really think 
about GM. 
Information on each strand and its outcome is discussed below. 
GM SCIENCE REVIEW20  
The science review was led by the Government's Chief Scientific Adviser working 
with the Chief Scientific Adviser to the Secretary of State for the Environment, Food 
and Rural Affairs, and with independent advice from the Food Standards Agency. 
The science review was carried out by a 26-member panel comprised of leading sci-
entists from a spectrum of disciplines and perspectives, two lay representatives, a 
social scientist and a leading scientist with cross membership with the Public Debate 
Steering Board. It considered peer-reviewed published scientific literature and was 
                                                 
20 http://www.gmsciencedebate.org.uk/ 
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focused on science-based issues identified by the public and the scientific commu-
nity.  
In July 2003 the panel concluded that for current GM crops and GM food:  
> the risk to human health is very low; 
> these crops are unlikely to invade the countryside and become problematic plants; 
> it is unlikely that these crops, if consumed, would be toxic to wildlife; 
> there is insufficient information to predict the long-term impact of the herbicide 
regimes associated with herbicide-tolerant GM crops on wildlife; 
> the balance of risks and benefits will vary for each GM crop, therefore case-by 
case regulation is appropriate. 
The panel reconvened to consider comments on its July report and the results of the 
FSEs, reporting in January 2004 that:- 
> none of the new research published since the first Report significantly altered the 
earlier conclusions;  
> the FSEs were of high scientific calibre. The panel found that if GM herbicide 
tolerant (GMHT) crops are managed as in the FSEs, a significant reduction would 
be expected in weeds with GMHT beet and spring oilseed rape, whereas the oppo-
site would be found with maize. These effects arise from the herbicides and are 
not a direct consequence of the GM process. The different findings for different 
GM crops reinforced the conclusion of the first Science Review that GM crops 
must be assessed on a case-by-case basis. 
ECONOMICS21 
An evaluation of the costs and benefits of the possible commercial cultivation of GM 
crops in the UK, published in July 2003, was conducted by the Prime Minister’s 
Strategy Unit (SU). The SU performs long term strategic reviews of major areas of 
policy, studies of cross-cutting policy issues, strategic audits and joint work with 
Departments to promote strategic thinking and improve policy-making across White-
hall. It reports directly to the Prime Minister. The study focused on the GM crops 
that were currently available, as well as possible developments in the next 10-15 
years, and developed five scenarios to explore a range of possible futures. The study 
was informed by experts, the public, science and the best available economic data.  
The study concluded that although existing GM crops could offer some advantages 
to UK farmers, at least in the short-term, any economic benefit is likely to be limited 
by negative public attitudes and retailer policies. Over the next 10-15 years, the SU 
considered that there is significant potential for benefits from future developments in 
GM crop technology as well as potential for impacts on wider science and industry. 
The key conclusion of the study was that the future of GM crops will depend on the 
nature of the regulatory system and public attitudes.  
                                                 
21 www.number-10.gov.uk/su/gm/index.htm 
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GM NATION? THE PUBLIC DEBATE22 
A public debate, organised by a steering board independent of government, took 
place in summer 2003. The aim was to promote a programme of debate on GM is-
sues, framed by the public, against the background of the possible cultivation of GM 
crops in the UK.  
> The debate was overseen by a Steering board which comprised of people with 
different perspectives on GM and people with expertise in public engagement. A 
number of external contractors were appointed to manage the debate programme 
and deliver the different strands of the programme. Foundation Discussion work-
shops  -nine workshops of 18-20 participants from different backgrounds/age -
groups held in different regional locations.  
> Public events - a series of public events organized in three ‘tiers’ at na-
tional/regional, county and local levels. These events included different methods - 
round-table discussions, expert speaker Q&A, debating a motion – but were in-
formed by stimulus material approved by the steering  board. Participants were 
self-selecting. 
> Narrow-but-deep element – series of reconvened discussion groups that involved 
a selected cross-section of the wider population, who would be exposed to GM is-
sues over a period of two weeks. 
Over 37,000 people provided feedback from this range of activities which including 
more than 600 meetings and visits to the GM Nation? website. Key messages emerg-
ing from the debate include: 
> people are generally uneasy about GM crops; 
> there is little support for early commercialisation; 
> there is a widespread mistrust of government and multi-national companies; 
> there is a broad desire to know more and for further research to be done; 
> the debate was welcomed and valued. 
IMPACT AND FOLLOW-UP 
The Government considered the reports from all three strands of the GM dialogue 
and published both a detailed response and a Parliamentary statement in March 
200423. In these the Government set out its policy on GM crops and said it would: 
> assess GM crops on a case-by-case basis, taking a precautionary and evidence-
based approach, and making the protection of human health and the environment 
the top priority  
• provide choice for consumers through mandatory labelling of GM food products  
> consult on measures to facilitate the co-existence of GM and non-GM crops, and 
on options to provide compensation to non-GM farmers who suffer a financial 
loss through no fault of their own  
                                                 
22 www.gmnation.org.uk/docs/GMNation_FinalReport.pdf  
23 http://www.defra.gov.uk/corporate/ministers/statements/mb040309.htm 
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There are currently no GM crops being grown in the UK and no commercial cultiva-
tion is expected before 2009 at the earliest. However GM crops have been grown for 
research and development purposes at a number of sites, for example in the FSEs. 
Co-existence 
When GM crops are grown commercially measures will need to be applied to ensure 
that they can coexist with non-GM production. The Department for Environment, 
Food and Rural Affairs (Defra) consulted on proposed coexistence measures for Eng-
land between July and October 2006.  A summary of responses to the consultation 
should be available by the end of this year. Defra expects to have measures in place 
before GM crops are grown commercially. 
CHALLENGES IDENTIFIED IN THE PROJECTS 
> Generally the UK public is uneasy about GM crops. How will consumer attitudes 
develop over the next 5-10 years? This is likely to be key to any future success of 
GM crops. 
> Which future developments in GM technology will offer economic benefits? 
> Assessment and monitoring of the long-term impact of GM crops on the environ-
ment. 
> Co-existence of GM crops with non-GM crop production. Particular problems 
include (1) no legal threshold for the presence of GM crops in organic crops. In 
practice the organic sector works to the limit of detection of the presence of GM. 
(2) EU seed purity levels (less than 0.9%) will challenge the seed industry, who 
work to 1-2% seed purity, while the organic sector would like a level of less than 
0.1%. 
> Liability – who will pay if there is any environmental damage as a result of GM 
crops being grown? 
> WTO – how will the EU respond to the WTO dispute panel’s findings on the im-
plementation of GM crop regulations in Europe. 
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JOINT EPTA PROJECT 
”GENETICALLY MODIFIED PLANTS AND FOODS” 
QUESTIONNAIRE 
– FINAL VERSION – 
 
INTRODUCTION 
Although GM crops and food can be considered an established technology and regula-
tion is in place in many parts of the world, the issue still gives rise to controversy. 
Different countries have taken different approaches to regulating GM crops and foods. 
In the USA, product regulation does not imply any mandatory requirement to tell con-
sumers if a product contains GM material. In contrast, it is a central tenet of the EU ap-
proach that consumers should be made aware that a product contains, or has been pro-
duced using, GM material. This has required the EU to introduce regulations on label-
ling and traceability so that GM and non-GM products can be segregated through the 
entire production and marketing chain.  
The difference in regulatory philosophy across continents has already created some ten-
sion in international trade relations. In 2003 the WTO was asked to rule on the legality 
of the EU’s failure to process marketing applications for new GM agricultural products 
between 1998 and 2001.  
In addition to the possibility of similar challenges in the future, a range of other factors 
might bring pressure to bear on the current EU regulatory approach to GM foods and 
crops. These include inconsistencies among EU Member States on the way that they 
have implemented EU regulations or have dealt with the issue of co-existence.  
So far, the EU regulatory framework has not entailed that all aspects of the regulation of 
GMOs are dealt with uniformly throughout the EU. Member States have been left to 
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devise and implement their own regulations concerning the co-existence of GM and 
non-GM crops and approaches vary considerably across the EU. 
Another key factor may be technological developments particularly if these introduce 
new traits with perceived benefits to consumers or if they render the traditional distinc-
tion between GM and non-GM products less clear-cut. Such factors could influence 
public attitudes towards GM foods and crops within the EU in an unforeseeable way.  
Whatever happens, the future development of the debate on how best to regulate GM 
crops and foods in the EU is undetermined and the current regulatory system may face 
new challenges. 
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I. FACTORS INFLUENCING THE FUTURE OF GM PLANTS IN EUROPE 
I.1 GENERAL ASSESSMENT 
 
Question 1: 
a) Many factors will influence the future of GM plants and food in Europe. Below 
is a list of frequently cited major factors. Please indicate for each factor whether 
you think it will encourage or discourage the demand for GM plants and foods. 
Please feel free to add other important factors not listed.  
major factors Encour-
age  
demand
Discour-
age  
demand
Neither Don’ t 
know 
World food demand     
Attitudes to health      
Attitudes to the environment     
Use of bio-energy and biomass     
Global trade of food products     
Structures and power relations in the food 
chain (for instance increasing retailer power)
    
Differentiation of food products  
(consider developments such as food label-
ling and use of processed foods)  
    
International trade regulation     
Increased use of for pharmaceuticals      
Pest pressure     
Trend towards more efficient agricultural 
production methods 
    
………….     
………….     
b) Overall, would you think that the demand to introduce new GM plants in the 
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European agriculture will increase or decrease?  
(Please select one possibility)  
Increase  
Decrease  
No net effect  
Don’t know  
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Question 2: 
Do you think that the "first generation" of GM plants (as insect resistant (IR), her-
bicide resistant (HR) and virus resistant (VR) plants) will be grown in Europe to a 
noticeable extent (say more than 5 % of the available agricultural crop land) in 
the next 15 years? 
Time scale of introduction in Europe in your country 
Within the next 5 years   
Within 6 – 10 years   
Within 11 - 15 years   
Not within the next 15 years   
Don’t know   
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I.2 NEW GM PLANTS, NEW APPLICATIONS 
Question 3: 
a) Currently there are several classes of new GM plants in development. Please 
check if you believe the following statements are valid for the different classes of 
crops. 
Please feel free to add other classes of new gm plants not listed.  
Statement: "Such crops will become avail-
able within the coming 10 years." 
Valid  Not valid Don’ t 
know 
GM plants with new agricultural input traits 
(e.g. reduced need for fertilizer, water) 
   
GM plants with consumer benefits  
(e.g. improved nutritional value, taste, less allergens) 
   
GM plants for bioenergy 
(e.g. higher biomass yield, new plants) 
   
GM plants for plant made industrials 
(e.g. starch, fibre, plastics) 
   
GM trees designed for industrial/energy purposes    
GM plants for plant made pharmaceuticals 
(e.g. haemo-proteins, vaccines) 
   
GM plants for phytoremediation 
(e.g. plants for extracting toxics from the soil) 
   
New GM flowers etc. 
(e.g. new flower colours, grasses for lawns and golf 
courses) 
   
…………………...    
…………………...    
…………………...    
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Statement: "Such crops will be authorised 
for cultivation in Europe." 
Valid  Not valid Don’ t 
know 
GM plants with new agricultural input traits 
(e.g. reduced need for fertilizer, water) 
   
GM plants with consumer benefits  
(e.g. improved nutritional value, taste, less allergens) 
   
GM plants for bioenergy 
(e.g. higher biomass yield, new plants) 
   
GM plants for plant made industrials 
(e.g. starch, fibre, plastics) 
   
GM trees designed for industrial/energy purposes    
GM plants for plant made pharmaceuticals 
(e.g. haemo-proteins, vaccines) 
   
GM plants for phytoremediation 
(e.g. plants for extracting toxics from the soil) 
   
New GM flowers etc. 
(e.g. new flower colours, grasses for lawns and golf 
courses) 
   
…………………...    
…………………...    
…………………...    
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Statement: "Such crops will find significant 
demand from farmers." 
Valid  Not valid Don’ t 
know 
GM plants with new agricultural input traits 
(e.g. reduced need for fertilizer, water) 
   
GM plants with consumer benefits  
(e.g. improved nutritional value, taste, less allergens) 
   
GM plants for bioenergy 
(e.g. higher biomass yield, new plants) 
   
GM plants for plant made industrials 
(e.g. starch, fibre, plastics) 
   
GM trees designed for industrial/energy purposes    
GM plants for plant made pharmaceuticals 
(e.g. haemo-proteins, vaccines) 
   
GM plants for phytoremediation 
(e.g. plants for extracting toxics from the soil) 
   
New GM flowers etc. 
(e.g. new flower colours, grasses for lawns and golf 
courses) 
   
…………………...    
…………………...    
…………………...    
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Statement: "Products from such crops will 
find acceptance with consumers." 
Valid  Not valid Don’ t 
know 
GM plants with new agricultural input traits 
(e.g. reduced need for fertilizer, water) 
   
GM plants with consumer benefits  
(e.g. improved nutritional value, taste, less allergens) 
   
GM plants for bioenergy 
(e.g. higher biomass yield, new plants) 
   
GM plants for plant made industrials 
(e.g. starch, fibre, plastics) 
   
GM trees designed for industrial/energy purposes    
GM plants for plant made pharmaceuticals 
(e.g. haemo-proteins, vaccines) 
   
GM plants for phytoremediation 
(e.g. plants for extracting toxics from the soil) 
   
New GM flowers etc. 
(e.g. new flower colours, grasses for lawns and golf 
courses) 
   
…………………...    
…………………...    
…………………...    
 
Please feel free to give explanations or comments concerning your answers to these 
questions.  
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
…………………………………………………………………………………………… 
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Question 4: 
a) In future, technical developments such as "cisgenic" GM technology may be-
come more important. While traditional “transgenic” plants result from gene 
transfers which use recombined DNA from other species, "cisgenic" plants result 
from gene transfers which use only recombined DNA from the same species. 
Please indicate if you agree or disagree with the following statements.  
Statement Agree Disagree Don’ t know 
"Cisgenic" GM technology will gain high 
importance in the future. 
   
Such technologies will lead to blurring the 
boundaries between GM and non-GM 
plants in the future. 
   
Products derived from such technologies 
will be regarded as "less hazardous" by the 
public. 
   
"Cisgenic" GM technology will undermine 
the demand for transgenic GM technology. 
   
In the light of these developments, existing 
regulation will have to be adapted. 
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b) “Smart breeding” is another new technical development. "Smart breeding" 
derives from traditional methods of plant breeding but includes tools on the basis 
of modern recombinant DNA technology such as molecular markers. Please indi-
cate if you agree or disagree with the following statements.  
Statement Agree Disagree Don’ t know
“Smart breeding” will gain high importance 
in the future. 
   
"Smart breeding" will have a good public 
image. 
   
"Smart breeding" will overcome the demand 
for currently regulated GM technologies. 
   
"Smart breeding" will overcome the current 
need to regulate GM technologies. 
   
 
Please feel free to give explanations or comments concerning your answer on 
these questions.  
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
…………………………………………………………………………………………… 
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I.3 Public Attitude and Acceptance 
 
Question 5: 
Currently the consumer acceptance of gm plants and food varies across Europe. 
Many factors have been associated with public acceptance. Please rank the fac-
tors in the list below in their importance for consumer acceptance over the next 
10 to 15 years. 
Please feel free to add other factors not listed.  
Factors Not 
impor-
tant  
Little 
impor-
tant  
Important Very 
impor-
tant  
Don’ t 
know 
Risk issues related to environment       
Environmental upsides (e.g. reduced need 
for fertilizer, pesticides or tillage) 
     
Risk issues related to health      
Price benefits for consumers      
Consumer benefits related to food quality 
and health  
     
 functioning risk management       
Perspectives on global food security      
Quality of information to citizens      
Getting accustomed to GM products      
Opportunity for public participation in  
decision making 
     
Efficient and transparent labelling and free 
consumer choice 
     
Global distribution of risks and benefits      
…………..      
…………..      
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…………..      
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Question 6: 
Will public attitudes to GM crops and food change in the next 10 to 15 years? 
 
Issues More nega-
tive 
No change More posi-
tive 
Acceptance of GM technology in general    
Acceptance of new GM food products    
Acceptance of new GM non-food products    
 
Please feel free to give explanations or comments concerning your answer on this 
question.  
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
…………………………………………………………………………………………… 
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II. CHALLENGES FOR EUROPEAN POLICY 
II.1 CHALLENGES LINKED TO FREEDOM OF CHOICE, LABELLING AND CO-
EXISTENCE 
 
Question 7: 
Co-existence measures are a central part of risk management under GM-
cultivation. Co-existence is also a central prerequisite for freedom of choice. Co-
existence may be a challenge, depending on type of crop and location. Do you 
think that co-existence will work for the "first generation" of gm plants (e.g. in-
sect resistant, herbicide resistant  and virus resistant (VR) plants) in the next 15 
years?  
(Please tick one possibility)  
Yes, for the cultivation of GM plants on a large scale 
for almost every crop 
 
Yes, for the cultivation of GM plants on a large scale 
for some specific crops 
 
Yes, but only for the cultivation of GM plants on a 
small scale for almost every crop 
 
Yes, but only for the cultivation of GM plants on a 
small scale for some specific crops 
 
No, not at all  
Don’t know  
 
Please feel free to give explanations or comments concerning your answer on this 
question.  
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
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……………………………………………………………………………………………
…………………………………………………………………………………………… 
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Question 8: 
a) For the cultivation of GM crops some experts have discussed whether there 
could be relevant environmental or economic risks (e.g. to farmers not applying 
gm crops) that would not be contained by current risk assessment and co-
existence schemes. Please tick the statement that comes closest to your opinion. 
 
Relevant risks do not exist at all  
Relevant risks exist for a few particular GM crops  
Relevant risks exist for all GM crops  
Don’t know  
 
 
If you think that relevant risks do not exist at all, or if you don’t know, proceed to Ques-
tion 9. 
 
b) If you think that relevant risks might exist, please tick those statements that 
come closest to your opinion (multiple answers possible). 
In general, risks are negligible  
Environmental risks are balanced by benefits to society and accept-
able 
 
Economic risks to other farmers can be negotiated between parties 
involved 
 
Such risks are unacceptable and need regulatory intervention   
Don’t know  
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c) Do you think that current regulatory provisions are sufficient to deal with such 
risks, today or for the foreseeable future?  
Yes, in the current situation and in the foreseeable future  
Yes in the current situation, but not in the foreseeable future  
No, not at all  
Don’t know  
 
 
d) If you ticked “No, not at all” or “not in the foreseeable future”, how do you 
think these risks should be addressed? Please indicate the measure you consider 
most appropriate to address such risks (multiple answers possible).  
New criteria for risk assessment  
More stringent litigation schemes  
Stronger liability of gm producer and user  
New regulation  
………..  
………..  
Don’t know  
 
 
19 
 
Question 9: 
Co-existence and labelling of GM food are closely connected. There are different 
opinions over how well the current EU regulations would cope with the extended 
use and growing of gm plants in Europe. Please indicate which scenario in your 
opinion is most likely.  
(Please tick one scenario)  
Scenario  
Successful coexistence:  
The labelling of GM food is generally correct 
(including occasional mishap), non GM food is 
also available. 
 
Misapplication of labelling:  
All food is labelled as “may contain GM”, also 
non GM food. 
 
Failure of labelling regime:  
GM food is on the market, but not labelled cor-
rectly. 
 
Failure of coexistence:  
More or less all food is GM or contains GM com-
ponents, and is labelled as GM food. 
 
Blockade of GM food: 
Very little GM food on the market so that label-
ling is of little relevance. 
 
Don’t know  
 
Please feel free to give explanations or comments concerning your answer on this 
question.  
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
…………………………………………………………………………………………… 
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II.2 CHALLENGES LINKED TO NEW GENERATION GM CROPS 
 
Question 10: 
a) Newly developed GM plants for the non-food sector (e.g. gm plants for plant 
made pharmaceuticals, for industrial raw materials, and for bio-energy) are 
sometimes said to have new properties compared to gm plants for food and 
therefore pose new regulatory challenges. Do you or don’ t you agree with the 
following statement? 
 Yes No Don’ t know 
New GM plants for the 
non-food sector will 
pose new regulatory 
challenges 
   
 
 
If you ticked "No" or "Don’t know", proceed to question 11. 
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b) If you ticked "Yes", please assess which regulatory challenges non-food GM 
plants will raise in the next 10-15 years, and whether this will be very likely, 
likely, unlikely or highly unlikely.  
 
Please feel free to add other regulatory challenges not listed.  
Type of regulatory  
challenge 
Very likely Likely Unlikely Highly 
unlikely 
Don’t know
New parameters for risk  
assessment and manage-
ment 
     
Confinement / containment 
measures 
     
Regulation of coexistence      
Labelling      
Liability      
……….       
……….      
……….      
 
 
Please feel free to give explanations or comments concerning your answer on this 
question.  
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
…………………………………………………………………………………………… 
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Question 11: 
So far, the assessment procedures for GM plants and food only takes into account 
potential risks. Some actors have advocated that also potential benefits should 
be taken into consideration as applied in areas such as pharmaceuticals.  
Below is a list of potential benefits that could be included in such considerations. 
Please assess how likely it is that in future different benefits will be considered 
for GM approvals. 
Please feel free to add other groups not listed.  
Aspect Very likely Likely Unlikely Highly 
unlikely  
Don’ t 
know 
Environmental benefit      
Economic return      
Food safety       
Food quality      
Nutritional benefit      
…………….      
…………….      
…………….      
 
Please feel free to give explanations or comments concerning your answer on this 
question.  
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
…………………………………………………………………………………………… 
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Question 12: 
In order to assess risks and benefits of GM cultivation, it must be compared to 
established practices in agriculture. In Europe, these practices vary according to 
climate or soil, but also to the tasks assigned to agriculture. For example, and 
apart from efficiently producing crops or providing jobs, agriculture should also 
protect the traditional landscape and the natural environment, among others.  
Thus, agriculture must pursue different aims, against which the performance of 
GM cultivation will be measured. Please rank the aims in the list below in their 
importance over the next 10 to 15 years. 
 
Aims in agriculture Not im-
portant 
Little 
impor-
tant 
Impor-
tant 
Very 
impor-
tant 
Don’ t 
know 
Achieving high yields in crop 
production 
     
Reducing inputs in crop pro-
duction 
     
Efficient crop production under 
difficult agricultural conditions 
(erosion, pest pressure etc.) 
     
Staying competitive in times of 
market liberalisation and re-
duced subsidies 
     
Crop production with least 
possible environmental impact 
     
Producing high quality food in 
great variety 
     
Providing jobs for the rural 
population 
     
Protecting the traditional cul-
tivated landscape 
     
Promoting organic farming      
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II.3 GLOBAL ASPECTS OF GM REGULATION 
 
Question 13: 
a) It is probable that more types of GM crops will be released both in export coun-
tries and in Europe. The current EU regulation, based on the precautionary princi-
ple and case-by-case risk assessment and authorisation, might be challenged by 
the US and other countries also in the future. Please give your judgement on how 
robust the EU regulatory system will turn out to be to challenges for example at 
the WTO in the next 10 to 15 years. 
(Please tick one possibility)  
Robustness of the  
current EU regulatory system 
 
The general principles and approaches of the EU regulation and 
the varying implementation of the EU Member States can with-
stand challenges through the WTO. 
 
The general principles and approaches of the EU regulation can 
be maintained. However, the most restrictive practices of indi-
vidual EU Member States will have to be changed. 
 
The general principles and approaches of the EU regulation can 
be maintained, but a more substantial harmonisation among 
the EU Member States will be necessary. 
 
The EU regulatory system can not be maintained due to chal-
lenges through the WTO. 
 
Don’t know  
 
b) The EU legalisation has been a model for regulations in some other countries. 
Will the EU regulation continue to be influential in the future? 
(Please tick one possibility)  
Yes  
No  
Don’t know  
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Please feel free to give explanations or comments concerning your answer on this 
question.  
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
…………………………………………………………………………………………… 
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III. CHALLENGES FOR RESEARCH POLICY 
 
Question 14: 
In view of new developments in the research on GM plants, what will be the ob-
jectives of publicly-funded research in your country in the coming years? 
Please feel free to add other objectives not listed.  
 
Objectives of R&D Very li-
kely  
Likely Unlikely Highly 
unlikely 
Don’ t 
know 
Risk assessment and management 
 
     
Development of products/solutions 
responding to agronomic problems not 
covered by private research 
     
Development of innovative products 
with the intent to improve economic 
competitiveness 
     
……………      
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IV. AREAS OF ACTION 
 
Question 15: 
In order to meet challenges that have been explored in this questionnaire, it 
could be necessary for government institutions to take further action. Please pri-
oritise the areas below in which you consider action needs to be taken. 
Please feel free to add areas of action not listed. 
Area of action Very low 
priority 
Low prio-
rity 
High prio-
rity 
Very high 
priority 
Don’ t 
know 
Research funding      
Better implementation of exist-
ing regulation 
     
Amendment of existing regula-
tion  
     
Adaptation to international 
ruling (e.g. WTO) 
     
Reform of competent  
authorities/institutions 
     
Subsidiarity / change in the 
level of decision making 
     
Expert involvement in decision 
making 
     
Stakeholder involvement in 
decision making 
     
Public involvement in decision 
making 
     
None, let the system work as it 
is  
     
…………………………………      
…………………………………      
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…………………………………      
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Question 16: 
In order to further explore new challenges, within which areas do you consider 
further investigations (for example technology assessment projects) to be most 
relevant. 
(Please give key words)  
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
……………………………………………………………………………………………
…………………………………………………………………………………………… 
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ANNEX 5: TABLES OF RESULTS 
FIGURE 1: INFLUENCING FACTORS FOR THE FUTURE OF  
 GM PLANTS AND FOOD IN EUROPE (Question 1A; n = 71) 
Question: Many factors will influence the future of GM plants and food in Europe. Be-
low is a list of frequently cited major factors. Please indicate for each factor 
whether you think it will encourage or discourage the demand for GM 
plants and foods. Please feel free to add other important factors not listed. 
 
Nei ther Don’t know Total
% % % % % n
World food demand 50.7% 8.5% 33.8% 7.0% 100.0% 71
Attitudes to health 31.0% 43.7% 15.5% 9.9% 100.0% 71
Attitudes to the environment 28.2% 54.9% 12.7% 4.2% 100.0% 71
Use of bio-energy and biomass 74.6% 1.4% 19.7% 4.2% 100.0% 71
Global trade of food products 50.7% 8.5% 29.6% 11.3% 100.0% 71
9.9% 49.3% 23.9% 16.9% 100.0% 71
22.5% 33.8% 31.0% 12.7% 100.0% 71
International trade regulation 52.1% 8.5% 25.4% 14.1% 100.0% 71
Increased use of for pharmaceuticals 52.1% 5.6% 31.0% 11.3% 100.0% 71
Pest pressure 53.5% 11.3% 28.2% 7.0% 100.0% 71
66.2% 8.5% 19.7% 5.6% 100.0% 71
Encourage 
demand
Discourage 
demand
Structures and power relations in the 
food chain (for instance increasing 
retailer power)
Differentiation of food products 
(consider developments such as food 
labelling and use of processed foods)
Trend towards more efficient 
agricultural production methods  
FIGURE 2: FUTURE DEMAND FOR NEW GM PLANTS IN EUROPEAN  
 AGRICULTURE (Question 1B; n = 71) 
Question: Overall, would you think that the demand to introduce new GM plants in 
the European agriculture will increase or decrease? 
ABB. 2  
 Column % Count
Increase 62.0% 44
Decrease 14.1% 10
No net effect 18.3% 13
Don’t know 5.6% 4
Total 100.0% 71
g
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FIGURE 3: FUTURE CULTIVATION OF FIRST GENERATION GM PLANTS IN EUROPE  
 (Question 2; n = 71) 
Question: Do you think that the "first generation" of GM plants (as insect resistant (IR), 
herbicide resistant (HR) and virus resistant (VR) plants) will be grown in 
Europe to a noticeable extent (say more than 5 % of the available agricul-
tural crop land) in the next 15 years)? 
 
Don't know Tot al
% % % % % % n
in Europe 21.1% 35.2% 15.5% 19.7% 8.5% 100.0% 71
in your country 1.4% 23.9% 21.1% 40.8% 12.7% 100.0% 71
Within the next 
5 years
Within 6 – 10 
years
Within 11 -  15 
years
Not within the 
next 15 years
 
FIGURE 4: AVAILABILITY OF NOVEL GM PLANTS  
 (Question 3A; n = 71) 
Question: Currently there are several classes of new GM plants in development. Please 
check if you believe the statement: “Such crops will become available within 
the coming 10 years.” 
Valid Not valid 
Don’t 
know Total 
 % % % % n 
GM plants with new agricultural 
input traits (e.g. reduced need for 
fertiliser, water) 
54,9% 22,5% 22,5% 100,0% 71 
GM plants with consumer benefits 
(e.g. improved nutritional value, 
taste, less allergens) 
50,7% 32,4% 16,9% 100,0% 71 
GM plants for bioenergy (e.g. 
higher biomass yield, new plants) 
60,6% 15,5% 23,9% 100,0% 71 
GM plants for plant made industri-
als (e.g. starch, fibre, plastics) 
78,9% 4,2% 16,9% 100,0% 71 
GM trees designed for indus-
trial/energy purposes 
25,4% 46,5% 28,2% 100,0% 71 
GM plants for plant made pharma-
ceuticals (e.g. haemo-proteins, 
vaccines) 
64,8% 14,1% 21,1% 100,0% 71 
GM plants for phytoremediation 
(e.g. plants for extracting toxins 
from the soil) 
23,9% 39,4% 36,6% 100,0% 71 
New GM flowers etc. (e.g. new 
flower colours, grasses for lawns 
and golf courses) 
60,6% 14,1% 25,4% 100,0% 71 
3 
 
FIGURE 5: AUTHORISATION OF NOVEL GM PLANTS (Question 3B; n = 71) 
Question: Currently there are several classes of new GM plants in development. Please 
check if you believe the statement: “Such crops will be authorised for culti-
vation in Europe.” 
Valid Not valid Don’t 
know 
Total  
% % % % n 
GM plants with new agricultural input 
traits (e.g. reduced need for fertiliser, 
water) 
57,7% 22,5% 19,7% 100,0% 71 
GM plants with consumer benefits (e.g. 
improved nutritional value, taste, less 
allergens) 
53,5% 26,8% 19,7% 100,0% 71 
GM plants for bioenergy (e.g. higher 
biomass yield, new plants) 
62,0% 18,3% 19,7% 100,0% 71 
GM plants for plant made industrials 
(e.g. starch, fibre, plastics) 
70,4% 14,1% 15,5% 100,0% 71 
GM trees designed for industrial/energy 
purposes 
32,4% 38,0% 29,6% 100,0% 71 
GM plants for plant made pharmaceuti-
cals (e.g. haemo-proteins, vaccines) 
43,7% 29,6% 26,8% 100,0% 71 
GM plants for phytoremediation (e.g. 
plants for extracting toxins from the 
soil) 
32,4% 31,0% 36,6% 100,0% 71 
New GM flowers etc. (e.g. new flower 
colours, grasses for lawns and golf 
courses) 
50,7% 16,9% 32,4% 100,0% 71 
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FIGURE 6: DEMAND FROM FARMERS FOR NOVEL GM PLANTS (Question 3C; n = 71) 
Question: Currently there are several classes of new GM plants in development. Please 
check if you believe the statement: “Such crops will find significant demand 
from farmers.” 
Valid Not valid Don’t 
know 
Total  
% % % % n 
GM plants with new agricultural input 
traits (e.g. reduced need for fertiliser, 
water) 
66,2% 19,7% 14,1% 100,0% 71 
GM plants with consumer benefits (e.g. 
improved nutritional value, taste, less 
allergens) 
39,4% 36,6% 23,9% 100,0% 71 
GM plants for bioenergy (e.g. higher 
biomass yield, new plants) 
64,8% 16,9% 18,3% 100,0% 71 
GM plants for plant made industrials 
(e.g. starch, fibre, plastics) 
57,7% 23,9% 18,3% 100,0% 71 
GM trees designed for industrial/energy 
purposes 
26,8% 43,7% 29,6% 100,0% 71 
GM plants for plant made pharmaceuti-
cals (e.g. haemo-proteins, vaccines) 
22,5% 45,1% 32,4% 100,0% 71 
GM plants for phytoremediation (e.g. 
plants for extracting toxins from the soil) 
16,9% 53,5% 29,6% 100,0% 71 
New GM flowers etc. (e.g. new flower 
colours, grasses for lawns and golf 
courses) 
32,4% 38,0% 29,6% 100,0% 71 
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FIGURE 7: ACCEPTANCE WITH CONSUMERS OF NOVEL GM PLANTS (Question 3D; n = 71) 
Question: Currently there are several classes of new GM plants in development. Please 
check if you believe the statement: “Products from such crops will find ac-
ceptance with consumers.” 
Valid Not 
valid 
Don’t 
know 
Total  
% % % % n 
GM plants with new agricultural input traits 
(e.g. reduced need for fertiliser, water) 
31,0% 43,7% 25,4% 100,0% 71 
GM plants with consumer benefits (e.g. im-
proved nutritional value, taste, less allergens) 
56,3% 29,6% 14,1% 100,0% 71 
GM plants for bioenergy (e.g. higher biomass 
yield, new plants) 
50,7% 29,6% 19,7% 100,0% 71 
GM plants for plant made industrials (e.g. 
starch, fibre, plastics) 
50,7% 26,8% 22,5% 100,0% 71 
GM trees designed for industrial/energy pur-
poses 
35,2% 38,0% 26,8% 100,0% 71 
GM plants for plant made pharmaceuticals 
(e.g. haemo-proteins, vaccines) 
47,9% 26,8% 25,4% 100,0% 71 
GM plants for phytoremediation (e.g. plants 
for extracting toxins from the soil) 
47,9% 25,4% 26,8% 100,0% 71 
New GM flowers etc. (e.g. new flower colours, 
grasses for lawns and golf courses) 
39,4% 28,2% 32,4% 100,0% 71 
 
6 
FIGURE 8: FUTURE IMPORTANCE OF “CISGENIC” GM TECHNOLOGY (Question 4A; n = 71) 
Question: In the future, technical developments such as “cisgenic” GM technology 
may become more important. While traditional “transgenic” plants result 
from gene transfers which use recombined DNA from other species, “cis-
genic” plants result from gene transfers which use only recombined DNA 
from the same species. Please indicate if you agree or disagree with the fol-
lowing statements. 
Agree Disagree Don’t know Total  
% % % % n 
“Cisgenic” GM technology will gain high 
importance in the future. 
33,8% 14,1% 52,1% 100,0% 71 
Such technologies will lead to blurring the 
boundaries between GM and non-GM 
plants in the future. 
50,7% 31,0% 18,3% 100,0% 71 
Products derived from such technologies 
will be regarded as “less hazardous” by 
the public. 
35,2% 39,4% 25,4% 100,0% 71 
“Cisgenic” GM technology will undermine 
the demand for transgenic GM technol-
ogy. 
16,9% 50,7% 32,4% 100,0% 71 
In the light of these developments, exist-
ing regulation will have to be adapted. 
57,7% 22,5% 19,7% 100,0% 71 
 
FIGURE 9: FUTURE IMPORTANCE OF “SMART BREEDING” (Question 4B; n = 71) 
Question: “Smart breeding” is another new technical development. "Smart breeding" 
derives from traditional methods of plant breeding but includes tools on the 
basis of modern recombinant DNA technology such as molecular markers. 
Please indicate if you agree or disagree with the following statements. 
Agree Disagree Don’t know Total  
% % % % n 
“Smart breeding” will gain high impor-
tance in the future. 
69,0% 7,0% 23,9% 100,0% 71 
“Smart breeding” will have a good 
public image. 
56,3% 14,1% 29,6% 100,0% 71 
“Smart breeding” will overcome the 
demand for currently regulated GM 
technologies. 
15,5% 54,9% 29,6% 100,0% 71 
“Smart breeding” will overcome the 
current need to regulate GM technolo-
9,9% 74,6% 15,5% 100,0% 71 
7 
gies. 
 
FIGURE 10: NEW REGULATORY CHALLENGES CAUSED BY NOVEL GM PLANTS? 
 (Question 10A; n = 71) 
Question: Newly developed GM plants for the non-food sector (e.g. gm plants for 
plant made pharmaceuticals, for industrial raw materials, and for bio-
energy) are sometimes said to have new properties compared to gm plants 
for food and therefore pose new regulatory challenges. Do you or don’t you 
agree with the following statement? 
 Column % Count 
Yes 62,0% 44 
No 35,2% 25 
Don’t know 2,8% 2 
New GM plants for the non-food sector 
will pose new regulatory challenges  
Total 100,0% 71 
 
FIGURE 11: AREAS OF NEW REGULATORY CHALLENGES OF NOVEL GM PLANTS  
 (Question 10B; n = 44) 
Question: If you ticked "Yes" [in question 10B], please assess which regulatory chal-
lenges non-food GM plants will raise in the next 10-15 years, and whether 
this will be very likely, likely, unlikely or highly unlikely. Please feel free to 
add other regulatory challenges not listed. 
Very 
likely 
Likely Unlikely Highly 
unlikely 
Don’t 
know 
Total Type of regulatory chal-
lenge 
% % % % % % n 
New parameters for risk 
assessment and man-
agement 
45,5% 45,5% 6,8% 0,0% 2,3% 100,0% 44 
Confinement/contain-
ment measures 
52,3% 36,4% 6,8% 0,0% 4,6% 100,0% 44 
Regulation of coexistence 56,8% 36,4% 4,5% 0,0% 2,3% 100,0% 44 
Labelling 25,0% 43,2% 29,5% 0,0% 2,3% 100,0% 44 
Liability 34,1% 54,5% 2,3% 0,0% 9,1% 100,0% 44 
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FIGURE 12: PUBLIC ATTITUDES (Question 6; n = 71) 
Question: Will public attitudes to GM crops and food change in the next 10 to 15 
years? 
 More 
negative 
No change More 
positive 
Total 
 % % % % n 
Acceptance of GM technology in general 5,6% 36,6% 57,7% 100,0% 71 
Acceptance of new GM food products 9,9% 52,1% 38,0% 100,0% 71 
Acceptance of new GM non-food products 2,8% 22,5% 74,6% 100,0% 71 
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FIGURE 13: FACTORS INFLUENCING PUBLIC ATTITUDES (Question 5; n = 71) 
Question: Currently the consumer acceptance of gm plants and food varies across Eu-
rope. Many factors have been associated with public acceptance. Please 
rank the factors in the list below in their importance for consumer accep-
tance over the next 10 to 15 years. Please feel free to add other factors not 
listed. 
Factors 
Not im-
portant 
Little 
impor-
tant 
Impor-
tant 
Very 
impor-
tant 
Don’t 
know 
Total   
% % % % % % n 
Risk issues related to environ-
ment 
4,2% 12,7% 45,1% 35,2% 2,8% 100,0% 71
Environmental upsides (e.g. 
reduced need for fertiliser, 
pesticides or tillage) 
4,2% 47,9% 28,2% 16,9% 2,8% 100,0% 71
Risk issues related to health 1,4% 5,6% 35,2% 54,9% 2,8% 100,0% 71
Price benefits for consumers 8,5% 23,9% 31,0% 35,2% 1,4% 100,0% 71
Consumer benefits related to 
food quality and health 
2,8% 12,7% 33,8% 49,3% 1,4% 100,0% 71
Performance of risk manage-
ment systems 
2,8% 23,9% 43,7% 25,4% 4,2% 100,0% 71
Perspectives on global food 
security 
16,9% 38,0% 25,4% 15,5% 4,2% 100,0% 71
Quality of information to citi-
zens 
2,8% 18,3% 42,3% 35,2% 1,4% 100,0% 71
Getting accustomed to GM 
products 
8,5% 15,5% 42,3% 29,6% 4,2% 100,0% 71
Opportunity for public partici-
pation in decision making 
8,5% 40,8% 36,6% 11,3% 2,8% 100,0% 71
Efficient and transparent label-
ling and free consumer choice 
2,8% 9,9% 43,7% 42,3% 1,4% 100,0% 71
Global distribution of risks and 
benefits 
8,5% 45,1% 32,4% 8,5% 5,6% 100,0% 71
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FIGURE 14: WILL COEXISTENCE WORK FOR FIRST GENERATION GM PLANTS?  
 (Question 7; n = 71) 
Question: Co-existence measures are a central part of risk management under GM-
cultivation. Co-existence is also a central prerequisite for freedom of choice. 
Co-existence may be a challenge, depending on type of crop and location. 
Do you think that co-existence will work for the "first generation" of gm 
plants (e.g. insect resistant, herbicide resistant and virus resistant (VR) 
plants) in the next 15 years? (Please tick one possibility). 
   Percentage Count
Yes, for the cultivation of GM plants on a large scale for almost every
crop 
15,5% 11 
Yes, for the cultivation of GM plants on a large scale for some spe-
cific crops 
31,0% 22 
Yes, but only for the cultivation of GM plants on a small scale for 
almost every crop 
5,6% 4 
Yes, but only for the cultivation of GM plants on a small scale for 
some specific crops 
25,4% 18 
No, not at all 15,5% 11 
Don’t know 7,0% 5 
Total 100,0% 71 
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FIGURE 15: CAN CONSUMERS’  CHOICE BE MAINTAINED? (Question 9; n = 71) 
Question: Co-existence and labelling of GM food are closely connected. There are dif-
ferent opinions over how well the current EU regulations would cope with 
the extended use and growing of gm plants in Europe. Please indicate 
which scenario in your opinion is most likely. (Please tick one scenario) 
   Percentage Count
Successful coexistence: The labelling of GM food is generally correct 
(including occasional mishap), non GM food is also available. 
52,1% 37 
Misapplication of labelling: All food is labelled as “may contain GM”, 
also non GM food. 
5,6% 4 
Failure of labelling regime: GM food is on the market, but not labelled 
correctly. 
14,1% 10 
Failure of coexistence: More or less all food is GM or contains GM com-
ponents, and must be labelled as GM food. 
7,0% 5 
Blockade of GM food: Very little GM food on the market so that label-
ling is of little relevance. 
16,9% 12 
Don’t know 4,2% 3 
Total 100,0% 71 
 
FIGURE 16: DO COEXISTENCE SCHEMES ADDRESS RISKS? (Question 8A; n = 71) 
Question: For the cultivation of GM crops some experts have discussed whether there 
could be relevant environmental or economic risks (e.g. to farmers not ap-
plying gm crops) that would not be contained by current risk assessment 
and co-existence schemes. Please tick the statement that comes closest to 
your opinion. 
 Percentage Count 
Relevant risks do not exist at all 15,5% 11 
Relevant risks exist for a few particular GM crops 29,6% 21 
Relevant risks exist for all GM crops 49,3% 35 
Don’t know 5,6% 4 
Total 100,0% 71 
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FIGURE 17: HOW TO MEET RISKS? (Question 8B; n = 56) 
Question: If you think that relevant risks might exist [in question 8A], please tick those 
statements that come closest to your opinion (multiple answers possible). 
 Respondents Responses Percentage (n=71)
In general, risks are negligible 9 13 % 
Environmental risks are balanced by bene-
fits to society and acceptable 
17 24 % 
Economic risks to other farmers can be 
negotiated between parties involved 
23 32 % 
Such risks are unacceptable and need 
regulatory intervention 
26 37 % 
Don’t know 2 3 % 
Total 56 78 
 
FIGURE 18: ARE REGULATORY PROVISIONS SUFFICIENT? (Question 8C; n = 56) 
Question: Do you think that current regulatory provisions are sufficient to deal with 
such risks [see question 8B], today or for the foreseeable future? 
 Count Percentage 
Yes, in the current situation and in the foreseeable future 19 27 % 
Yes in the current situation, but not in the foreseeable future 16 23 % 
No, not at all 20 28 % 
Don’t know 1 1 % 
Total 56  
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FIGURE 19: BENEFIT ASSESSMENT (Question 11; n = 71) 
Question: So far, the assessment procedures for GM plants and food only takes into 
account potential risks. Some actors have advocated that also potential 
benefits should be taken into consideration as applied in areas such as 
pharmaceuticals.  
Below is a list of potential benefits that could be included in such considera-
tions. Please assess how likely it is that in future different benefits will be 
considered for GM approvals. Please feel free to add other groups not listed. 
Highly 
unlikely 
Unlikely Likely Very 
likely 
Don’t 
know 
Total  
% % % % % % n 
Environmental benefit 15,5% 25,4% 38,0% 16,9% 4,2% 100,0% 71 
Economic return 29,6% 28,2% 23,9% 12,7% 5,6% 100,0% 71 
Food safety 16,9% 25,4% 33,8% 18,3% 5,6% 100,0% 71 
Food quality 16,9% 31,0% 31,0% 15,5% 5,6% 100,0% 71 
Nutritional benefit 15,5% 31,0% 35,2% 12,7% 5,6% 100,0% 71 
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FIGURE 20: AIMS IN AGRICULTURE (Question 12; n = 71) 
Question: In order to assess risks and benefits of GM cultivation, it must be compared 
to established practices in agriculture. In Europe, these practices vary ac-
cording to climate or soil, but also to the tasks assigned to agriculture. For 
example, and apart from efficiently producing crops or providing jobs, agri-
culture should also protect the traditional landscape and the natural envi-
ronment, among others. Thus, agriculture must pursue different aims, 
against which the performance of GM cultivation will be measured. Please 
rank the aims in the list below in their importance over the next 10 to 15 
years. 
Not 
impor
tant 
Little 
impor-
tant 
Impor-
tant 
Very 
impor-
tant 
Don’t 
know 
Total  
% % % % % % n 
Achieving high yields in crop 
production 
5,6% 19,7% 36,6% 31,0% 7,0% 100,0% 71 
Reducing inputs in crop produc-
tion 
2,8% 5,6% 46,5% 36,6% 8,5% 100,0% 71 
Efficient crop production under 
difficult agricultural conditions 
(erosion, pest pressure etc.) 
2,8% 14,1% 42,3% 33,8% 7,0% 100,0% 71 
Staying competitive in times of 
market liberalisation and re-
duced subsidies 
1,4% 15,5% 39,4% 33,8% 9,9% 100,0% 71 
Crop production with least pos-
sible environmental impact 
0,0% 4,2% 39,4% 52,1% 4,2% 100,0% 71 
Producing high quality food in 
great variety 
1,4% 7,0% 35,2% 50,7% 5,6% 100,0% 71 
Providing jobs for the rural 
population 
7,0% 21,1% 45,1% 19,7% 7,0% 100,0% 71 
Protecting the traditional culti-
vated landscape 
7,0% 12,7% 40,8% 33,8% 5,6% 100,0% 71 
Promoting organic farming 8,5% 32,4% 23,9% 26,8% 8,5% 100,0% 71 
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FIGURE 21: ROBUSTNESS OF THE EU REGULATORY SYSTEM (Question 13A; n = 71) 
Question: It is probable that more types of GM crops will be released both in export 
countries and in Europe. The current EU regulation, based on the precau-
tionary principle and case-by-case risk assessment and authorisation, might 
be challenged by the US and other countries also in the future. Please give 
your judgement on how robust the EU regulatory system will turn out to be 
to challenges for example at the WTO in the next 10 to 15 years. (Please tick 
one possibility) 
Answers % of answers Number of answers 
The general principles and approaches of the EU 
regulation and the varying implementation of 
the EU Member States can withstand challenges 
through the WTO. 
22,5 16 
The general principles and approaches of the EU 
regulation can be maintained. However, the 
most restrictive practices of individual EU Mem-
ber States will have to be changed. 
32,4 23 
The general principles and approaches of the EU 
regulation can be maintained, but a more sub-
stantial harmonisation among the EU Member 
States will be necessary. 
23,9 17 
The EU regulatory system can not be maintained
due to challenges through the WTO. 
14,1 10 
Don’t know 7,0 5 
Total 100,0 71 
 
FIGURE 22: THE FUTURE ROLE OF THE EU LEGISLATION (Question 13B; n = 71) 
Question: The EU legalisation has been a model for regulations in some other coun-
tries. Will the EU regulation continue to be influential in the future? (Please 
tick one possibility) 
Answers % of answers Number of answers 
Yes 69,0 49 
No 12,7 9 
Don’t know 18,3 13 
Total 100,0 71 
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FIGURE 23: PRIORITISATION OF POLICY FIELDS (Question 15; n = 71) 
Question: In order to meet challenges that have been explored in this questionnaire, it 
could be necessary for government institutions to take further action. 
Please prioritise the areas below in which you consider action needs to be 
taken. Please feel free to add areas of action not listed 
Very 
low 
priority 
Low 
priority 
High 
priority 
Very 
high 
priority 
Don’t 
know 
Total  
% % % % % % n 
Research funding 0,0% 9,9% 46,5% 38,0% 5,6% 100,0% 71 
Better implementation of 
existing regulation 
5,6% 29,6% 39,4% 16,9% 8,5% 100,0% 71 
Amendment of existing 
regulation 
2,8% 33,8% 32,4% 21,1% 9,9% 100,0% 71 
Adaptation to international 
ruling (e.g. WTO) 
9,9% 33,8% 28,2% 16,9% 11,3% 100,0% 71 
Reform of competent au-
thorities/institutions 
12,7% 25,4% 33,8% 21,1% 7,0% 100,0% 71 
Subsidiarity/change in the 
level of decision making 
4,2% 39,4% 35,2% 7,0% 14,1% 100,0% 71 
Expert involvement in 
decision making 
2,8% 19,7% 36,6% 35,2% 5,6% 100,0% 71 
Stakeholder involvement 
in decision making 
8,5% 26,8% 42,3% 16,9% 5,6% 100,0% 71 
Public involvement in deci-
sion making 
11,3% 31,0% 33,8% 19,7% 4,2% 100,0% 71 
None, let the system work 
as it is 
56,3% 15,5% 5,6% 1,4% 21,1% 100,0% 71 
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FIGURE 24: OBJECTIVES OF PUBLICLY FUNDED RESEARCH (Question 14; n = 71) 
Question: In view of new developments in the research on GM plants, what will be the 
objectives of publicly-funded research in your country in the coming years? 
Please feel free to add other objectives not listed. 
Highly 
unlikely 
Unlikely Likely Very 
likely 
Don’t 
know 
Total  
% % % % % % n 
Risk assessment and man-
agement 
2,8% 23,9% 35,2% 31,0% 7,0% 100,0% 71 
Development of prod-
ucts/solutions responding to 
agronomic problems not 
covered by private research 
5,6% 28,2% 39,4% 16,9% 9,9% 100,0% 71 
Development of innovative 
products with the intent to 
improve economic competi-
tiveness 
7,0% 31,0% 32,4% 18,3% 11,3% 100,0% 71 
 
 
